100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
LOVENOX NNP I-NP B-m
( ( O I-m
ENOXAPARIN NNP B-NP I-m
) ) O I-m
120 CD O B-do
MG NNP B-NP I-do
SC NNP I-NP B-mo
BEDTIME NNP I-NP B-f
TARCEVA NNP I-NP B-m
( ( O I-m
ERLOTINIB NNP B-NP I-m
) ) O I-m
100 CD O B-do
mg JJ B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
( ( O O
HT: NNP B-NP O
61.0in CD O O
154.9cm CD O O
WT: NNP B-NP O
129.5kg CD O O
BSA: NNP B-NP O
2.20 CD O O
) ) O O
Primary NNP B-NP O
DX: NNP I-NP O
chest JJS B-NP O
pain NN I-NP O
Day NNP I-NP O
1: CD O O
0/11/06 CD O O
Previous- JJ B-NP O
Weight:136kg NNP I-NP O
BSA:2.24 NNP I-NP O
Admit- NNP I-NP O
Weight:129.5kg NNP I-NP O
BSA:2.20 NNP I-NP O
FOLIC NNP I-NP B-m
ACID NNP I-NP I-m
1 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
FUROSEMIDE NNP I-NP B-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Starting NNP I-NP O
IN NNP I-NP O
AM NNP I-NP O
( ( O O
4/9 CD O O
) ) O O
DILAUDID NNP B-NP B-m
( ( O I-m
HYDROMORPHONE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
0.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q4H NNP I-NP B-f
PRN NNP I-NP I-f
Pain NNP I-NP B-r
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
9/11/06 CD O O
by IN B-VP O
BORSH NNP B-NP O
, , O O
WADE NNP B-NP O
M NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
DILAUDID NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
925975305 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
PROBABLE NNP I-NP O
allergy NN I-NP O
to TO O O
PERCOCET; NNP B-NP O
reaction NN I-NP O
is VBZ O O
Unknown JJ B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
Previous NNP I-NP O
Alert NNP I-NP O
overridden NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
9/11/06 CD O O
by IN B-VP O
WILBANKS NNP B-NP O
, , O O
JASPER NNP B-NP O
C NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
TRAMADOL NNP I-NP B-m
HCL NNP I-NP I-m
&amp; NNP I-NP O
HYDROMORPHONE NNP I-NP B-m
HCL NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
LIDODERM NNP I-NP B-m
5% CD O I-m
PATCH NNP B-NP I-m
( ( O I-m
LIDOCAINE NNP B-NP I-m
5% CD O I-m
PATCH NNP B-NP I-m
) ) O I-m
1 CD O B-do
EA NNP B-NP I-do
TP NNP I-NP B-mo
DAILY NNP I-NP B-f
Instructions: NNP I-NP O
12h CD O O
on/12h VBD B-VP O
off RB O O
, , O O
apply VB O O
to TO O O
L NNP B-NP O
breast NN I-NP O
PRAVACHOL NNP I-NP B-m
( ( O I-m
PRAVASTATIN NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BEDTIME NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
VITAMIN NNP B-NP B-m
B6 NNP I-NP I-m
( ( O I-m
PYRIDOXINE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
ULTRAM NNP I-NP B-m
( ( O I-m
TRAMADOL NNP B-NP I-m
) ) O I-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP I-f
Pain NNP I-NP B-r
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
9/11/06 CD O O
by IN B-VP O
INTERIANO NNP B-NP O
, , O O
FLOYD NNP B-NP O
E NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
DILAUDID NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
925975305 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
TRAMADOL NNP I-NP B-m
HCL NNP I-NP I-m
&amp; NNP I-NP O
HYDROMORPHONE NNP I-NP B-m
HCL NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
Previous NNP I-NP O
override NN I-NP O
information: NN I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
2/29/06 CD O O
by IN B-VP O
NOGALES NNP B-NP O
, , O O
ARNOLD NNP B-NP O
C NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
ULTRAM NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
417339527 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
PROBABLE NNP I-NP O
allergy NN I-NP O
to TO O O
PERCOCET; NNP B-NP O
reaction NN I-NP O
is VBZ O O
Unknown JJ B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
MD NNP I-NP O
aware JJ B-NP O
Previous NNP I-NP O
Alert NNP I-NP O
overridden NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
2/29/06 CD O O
by IN B-VP O
BECKLIN NNP B-NP O
, , O O
JOAN NNP B-NP O
N NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
MORPHINE NNP I-NP B-m
&amp; NNP I-NP O
TRAMADOL NNP I-NP B-m
HCL NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
dc VB O O
morphine JJ B-NP B-m
Number NNP I-NP B-du
Number NNP I-NP B-du
of IN B-VP I-du
of IN B-VP I-du
Doses NNP B-NP I-du
Doses NNP I-NP I-du
Required NNP I-NP I-du
Required NNP I-NP I-du
( ( O I-du
( ( O I-du
approximate VB O I-du
approximate NN B-NP I-du
): NNP I-NP I-du
): VBD B-VP I-du
15 CD O I-du
15 CD O I-du
DIET: NNP B-NP O
Patient NNP I-NP O
should MD O O
measure VB O O
weight JJ B-NP O
daily JJ I-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
2 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Lagnese NNP I-NP O
, , O O
call NN B-NP O
to TO O O
schedule NN B-NP O
, , O O
Dr NNP B-NP O
Olufson NNP I-NP O
call NN I-NP O
to TO O O
schedule VB O O
246-729-9224 JJ O O
, , O O
Dr NNP B-NP O
Izzard NNP I-NP O
cardiology NN I-NP O
1/19/07 CD O O
11:30 CD O O
scheduled VBN O O
, , O O
ALLERGY: NNP B-NP O
PERCOCET NNP I-NP O
, , O O
DICLOXACILLIN NNP B-NP O
, , O O
LISINOPRIL NNP B-NP O
, , O O
WARFARIN NNP B-NP O
SODIUM NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
Chest NNP I-NP O
pain NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Non NNP B-NP O
cardiac JJ B-NP O
chest NN I-NP O
pain NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
s/p JJ B-NP O
MVA NNP I-NP O
10/3 CD O O
s/p NN B-NP O
B NNP I-NP O
TKA NNP I-NP O
htn NN I-NP O
( ( O O
hypertension NN B-NP O
) ) O O
svt NN B-NP O
( ( O O
supraventricular JJ B-NP O
tachycardia NN I-NP O
) ) O O
thrombophlebitis NN B-NP O
( ( O O
superficial JJ B-NP O
thrombophlebitis NN I-NP O
) ) O O
recurrent NN B-NP O
bilat JJ B-NP O
LE NNP I-NP O
cellulitis NN I-NP O
( ( O O
cellulitis NN B-NP O
) ) O O
pernicious JJ B-NP O
anemia NN I-NP O
( ( O O
pernicious JJ B-NP O
anemia NN I-NP O
) ) O O
afib NN B-NP O
( ( O O
atrial JJ B-NP O
fibrillation NN I-NP O
) ) O O
dvt NN B-NP O
( ( O O
deep JJ B-NP O
venous JJ I-NP O
thrombosis NN I-NP O
) ) O O
multiple NN B-NP O
episodes NNS I-NP O
of IN B-VP O
cellulitis NN B-NP O
( ( O O
cellulitis NN B-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
None NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
None NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC: NNP I-NP O
chest JJS B-NP O
pain NN I-NP O
***** NN I-NP O
81 CD O O
year NN B-NP O
old JJ B-NP O
woman NN I-NP O
with IN B-VP O
Afib NNP B-NP B-r
( ( O O
on IN B-VP O
fondaparinux NN B-NP B-m
no DT B-NP O
coumadin NN I-NP O
secondary JJ O O
to TO O O
prior VB O O
epistaxis NN B-NP O
) ) O O
, , O O
NSC NNP B-NP O
lung NN I-NP O
ca MD O O
, , O O
presents NNS B-NP O
with IN B-VP O
3 CD O O
days NNS B-NP O
of IN B-VP O
constant JJ B-NP O
chest NN I-NP O
pain NN I-NP O
pleuritic JJ O O
, , O O
not RB O O
exertional JJ O O
, , O O
related VBN O O
mostly RB O O
to TO O O
arm VB O O
movement NN B-NP O
Concern NNP I-NP O
for IN B-VP O
bone NN B-NP O
met VBD B-VP O
vs.subsegmental JJ B-NP O
PE NNP I-NP O
on IN B-VP O
admission NN B-NP O
She PRP O O
had VBD B-VP O
been VBN O O
on IN B-VP O
fondapurinox NN B-NP B-m
as IN B-VP O
oupt NN B-NP O
( ( O O
hx NN B-NP O
of IN B-VP O
lung NN B-NP O
ca MD O O
and CC O O
afib VB O O
with IN B-VP O
intolerance NN B-NP O
of IN B-VP O
coumadin NN B-NP O
) ) O O
Continued VBD B-VP O
work NN B-NP O
up RB O O
with IN B-VP O
question NN B-NP O
of IN B-VP O
breast NN B-NP O
nodule NN I-NP O
, , O O
pt NN B-NP O
identifies NNS I-NP O
one CD O O
particular JJ B-NP O
area NN I-NP O
which WDT O O
she PRP O O
feels VBZ O O
is VBZ O O
the DT B-NP O
primary JJ I-NP O
site NN I-NP O
of IN B-VP O
her PRP$ O O
pain NN B-NP O
***** NN I-NP O
In IN B-VP O
ED: NNP B-NP O
PE NNP I-NP O
CT NNP I-NP O
neg VBZ O O
No DT B-NP O
ekg NN I-NP O
changes VBZ O O
ASA NNP B-NP B-m
and CC O O
no DT B-NP O
change NN I-NP O
with IN B-VP O
NGL NNP B-NP B-m
***** NNP I-NP O
Patient NNP I-NP O
status: NN I-NP O
AF NNP I-NP O
, , O O
BP NNP B-NP O
125/51 CD O O
P60 NNP B-NP O
O2 NNP I-NP O
98% CD O O
RA NNP B-NP O
RR18 NNP I-NP O
AAO NNP I-NP O
x NNP I-NP O
3 CD O O
, , O O
obese JJ O O
, , O O
resting VBG O O
and CC O O
breathing VBG O O
comfortably RB O O
irr JJ B-NP O
irr JJ I-NP O
1-2/6 JJ I-NP O
SEM NNP I-NP O
crackles NNS I-NP O
at IN B-VP O
left JJ B-NP O
base NN I-NP O
+palpable JJ B-NP O
L NNP I-NP O
breast NN I-NP O
mass NN I-NP O
at IN B-VP O
approx $ O O
12 CD O O
oclock NN B-NP O
a DT B-NP O
few JJ I-NP O
inches NNS I-NP O
above IN B-VP O
nipple NN B-NP O
, , O O
diffusely RB O O
nodular JJ B-NP O
breasts NNS I-NP O
abd VBP O O
soft JJ B-NP O
nt NNS I-NP O
Ext NNP I-NP O
1+ CD O O
edema NN B-NP O
, , O O
no DT B-NP O
calf NN I-NP O
tenderness NN I-NP O
***** NNP I-NP O
Significant NNP I-NP O
studies: VBD B-VP O
CT-PE: NNP B-NP O
IMPRESSION: NNP I-NP O
1 CD O O
No NNP B-NP O
evidence NN I-NP O
of IN B-VP O
pulmonary JJ B-NP O
embolism NN I-NP O
or CC O O
deep JJ B-NP O
venous JJ I-NP O
thrombosis NN I-NP O
2 CD O O
Post NNP B-NP O
right NN I-NP O
lower RBR O O
lobe NN B-NP O
resection NN I-NP O
changes NNS I-NP O
3 CD O O
Interval NNP B-NP O
resolution NN I-NP O
of IN B-VP O
the DT B-NP O
left JJ I-NP O
upper JJ I-NP O
lobe NN I-NP O
nodule NN I-NP O
without IN B-VP O
new JJ B-NP O
nodules NNS I-NP O
per IN B-VP O
discussion NN B-NP O
with IN B-VP O
radiology NN B-NP O
possible JJ B-NP O
chronic JJ I-NP O
subsegmental JJ I-NP O
PE NNP I-NP O
CXR-no NNP I-NP O
acute NN I-NP O
process NN I-NP O
+lupus NNP I-NP O
anticoag NN I-NP O
***** NN I-NP O
Problem NNP I-NP O
List/Hospital NNP I-NP O
Course: NNP I-NP O
* NNP I-NP O
Chest NNP I-NP O
pain-No NN I-NP O
met VBD B-VP O
seen VBN O O
on IN B-VP O
CXR NNP B-NP O
or CC O O
CT NNP B-NP O
No NNP I-NP O
large JJ B-NP O
PE NNP I-NP O
, , O O
but CC O O
evidence NN B-NP O
for IN B-VP O
pulm NN B-NP O
HTN NNP I-NP O
Given NNP I-NP O
question NN I-NP O
of IN B-VP O
chronic JJ B-NP O
PE NNP I-NP O
and CC O O
outpt JJ B-NP O
treatment NN I-NP O
with IN B-VP O
fondapurinox NN B-NP B-m
will MD O O
transition VB O O
to TO O O
lovenox VB O B-m
while IN B-VP O
inpatient NN B-NP O
for IN B-VP O
maintenance NN B-NP O
( ( O O
intolerance NN B-NP O
of IN B-VP O
coumadin NN B-NP O
with IN B-VP O
epistaxis NN B-NP O
) ) O O
No DT B-NP O
evidence NN I-NP O
of IN B-VP O
cardiac JJ B-NP O
process NN I-NP O
on IN B-VP O
this DT B-NP O
admission NN I-NP O
no DT B-NP O
hypoxia NN I-NP O
, , O O
unclear JJ B-NP O
etiology NN I-NP O
of IN B-VP O
chest JJS B-NP O
pain NN I-NP O
may MD O O
be VB O O
related VBN O O
to TO O O
painful JJ B-NP O
breast NN I-NP O
lump NN I-NP O
, , O O
pt NN B-NP O
will MD O O
have VB O O
mammogram VBN O O
next JJ B-NP O
week NN I-NP O
for IN B-VP O
evaluation NN B-NP O
, , O O
continue VBP O O
pain VB O B-r
control NN B-NP I-r
with IN B-VP O
Lidoderm NNP B-NP B-m
patch NN I-NP B-mo
, , O O
ultram JJ O B-m
and CC O O
low JJ B-NP B-do
dose NN I-NP I-do
dilaudid NN I-NP B-m
as IN B-VP B-f
needed VBN O I-f
for IN B-VP O
severe JJ B-NP B-r
pain NN I-NP I-r
* JJ B-NP O
Lung NNP I-NP O
CA- NNP I-NP O
Continuing NNP I-NP O
tarceva NN I-NP B-m
as IN B-VP O
per IN B-VP O
outpatient NN B-NP O
oncologist NN I-NP O
Dr NNP I-NP O
Goetzke NNP I-NP O
, , O O
no DT B-NP O
new JJ I-NP O
findings NNS I-NP O
on IN B-VP O
imaging NN B-NP O
but CC O O
would MD O O
consider VB O O
bone JJ B-NP O
scan NN I-NP O
as IN B-VP O
an DT B-NP O
oupatient NN I-NP O
if IN B-VP O
continues VBZ O O
to TO O O
have VB O O
severe JJ B-NP O
pain NN I-NP O
* VBD B-VP O
A DT B-NP O
fib- JJ I-NP O
Lowered NNP I-NP O
acebutolol NN I-NP B-m
acebutolol NN I-NP B-m
dose NN I-NP O
from IN B-VP O
400mg CD O B-do
BID NNP B-NP B-f
to TO O O
400mg CD O B-do
daily RB O B-f
due JJ O O
to TO O O
intermittent JJ B-NP O
bradycardia NN I-NP O
( ( O O
asymptomatic JJ O O
) ) O O
Pt NNP B-NP O
to TO O O
d/c VB O O
fondaparinux NN B-NP B-m
and CC O O
continue VB O O
on IN B-VP O
lovenox NN B-NP B-m
as IN B-VP O
outpt JJ O O
* IN B-VP O
CHF-gently NNP B-NP O
diuresing NN I-NP O
, , O O
restarting VBG O O
home NN B-NP O
dose NN I-NP O
of IN B-VP O
lasix NN B-NP B-m
on IN B-VP O
4/8 CD O O
at IN B-VP O
40 CD O B-do
mg NNS B-NP I-do
daily RB O B-f
with IN B-VP O
improvement NN B-NP O
in IN B-VP O
crackles NNS B-NP O
at IN B-VP O
left JJ B-NP O
base NN I-NP O
Will NNP I-NP O
need VBP O O
to TO O O
follow VB O O
daily JJ B-NP O
weights NNS I-NP O
and CC O O
titrate VB O B-do
lasix NN B-NP B-m
as IN B-VP B-f
needed VBN O I-f
* NN B-NP O
ID NNP I-NP O
- : O O
Klebsiella NNP B-NP B-r
UTI NNP I-NP I-r
, , O O
treating VBG O O
with IN B-VP O
Cipro NNP B-NP B-m
starting VBG O O
4/8 CD O O
with IN B-VP O
250mg CD O B-do
BID NNP B-NP B-f
* NNP I-NP O
Pain NNP I-NP B-r
- : O O
tx NN B-NP O
with IN B-VP O
lidoderm JJ B-NP B-m
patch NN I-NP B-mo
, , O O
ultram JJ O B-m
on IN B-VP O
day NN B-NP O
of IN B-VP O
discharge NN B-NP O
adding VBG O O
low JJ B-NP B-do
dose NN I-NP O
dilaudid NN I-NP B-m
for IN B-VP O
treatment NN B-NP O
of IN B-VP O
breakthrough NN B-NP B-r
pain NN I-NP I-r
* NNP I-NP O
Dispo NNP I-NP O
to TO O O
rehabilitation NN B-NP O
for IN B-VP O
continued JJ B-NP O
reconditioning NN I-NP O
and CC O O
improvement NN B-NP O
in IN B-VP O
functional JJ B-NP O
status NN I-NP O
* NN I-NP O
CODE: NNP I-NP O
FULL NNP I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Ms NNP I-NP O
Cheramie NNP I-NP O
, , O O
it PRP O O
was VBD B-VP O
a DT B-NP O
pleasure NN I-NP O
to TO O O
be VB O O
involved VBN O O
in IN B-VP O
your PRP$ O O
care NN B-NP O
Please NNP I-NP O
follow VB O O
up RP O O
with IN B-VP O
your PRP$ O O
regular JJ B-NP O
primary JJ I-NP O
care NN I-NP O
provider NN I-NP O
, , O O
Dr NNP B-NP O
Sauro NNP I-NP O
and CC O O
with IN B-VP O
your PRP$ O O
oncologist NN B-NP O
Dr NNP I-NP O
Willard NNP I-NP O
Camps NNP I-NP O
Please NNP I-NP O
also RB O O
keep VB O O
your PRP$ O O
appointment NN B-NP O
to TO O O
have VB O O
mammogram VBN O O
as IN B-VP O
scheduled VBN O O
on IN B-VP O
November NNP B-NP O
at IN B-VP O
PNH NNP B-NP O
You PRP O O
should MD O O
also RB O O
follow VB O O
up RP O O
with IN B-VP O
yoru NNS B-NP O
cardiologist VBP O O
Dr NNP B-NP O
Bennie NNP I-NP O
Tomaselli NNP I-NP O
for IN B-VP O
continued JJ B-NP O
management NN I-NP O
of IN B-VP O
your PRP$ O O
heart NN B-NP O
conditions NNS I-NP O
Please NNP I-NP O
continue VBP O O
to TO O O
work VB O O
with IN B-VP O
the DT B-NP O
rehabilitation NN I-NP O
specialists NNS I-NP O
to TO O O
try VB O O
to TO O O
regain VB O O
strength NN B-NP O
and CC O O
function NN B-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
1 CD O O
Check NNP B-NP O
Factor NNP I-NP O
Xa NNP I-NP O
level NN I-NP O
to TO O O
insure VB O O
Lovenox NNP B-NP B-m
dosing NN I-NP O
is VBZ O O
therapeutic JJ O O
2 CD O O
Follow NNP B-NP O
up RB O O
on IN B-VP O
mammogram NNS B-NP O
scheduled VBN O O
for IN B-VP O
November NNP B-NP O
3 CD O O
Continue NNP B-NP O
to TO O O
monitor VB O O
heart NN B-NP O
rate NN I-NP O
intermittently RB O O
to TO O O
insure VB O O
adequate JJ B-NP B-r
rate NN I-NP O
control NN I-NP O
with IN B-VP O
decreased JJ B-NP B-do
dose NN I-NP I-do
of IN B-VP O
Acebutolol NNP B-NP B-m
4 CD O O
Continue NNP B-NP O
Lasix NNP I-NP B-m
Lasix NNP I-NP B-m
Lasix NNP I-NP B-m
at IN B-VP O
40mg CD O B-do
40mg CD O B-do
daily JJ O B-f
( ( O O
admit NN B-NP O
dose NN I-NP O
had VBD B-VP O
been VBN O O
40mg CD O B-do
alternating VBG O O
with IN B-VP O
60mg CD O O
) ) O O
and CC O O
monitor JJ B-NP O
daily JJ I-NP O
weights NNS I-NP O
5 CD O O
Complete NNP B-NP O
course NN I-NP O
of IN B-VP O
Cipro NNP B-NP B-m
250mg CD O B-do
BID NNP B-NP B-f
x VBD B-VP B-du
3 CD O I-du
days NNS B-NP I-du
( ( O O
4 CD O O
doses NNS B-NP O
to TO O O
complete VB O O
on IN B-VP O
discharge NN B-NP O
) ) O O
for IN B-VP O
Klebsiella NNP B-NP B-r
UTI NNP I-NP I-r
6 CD O O
Follow NNP B-NP O
up RB O O
with IN B-VP O
oncologist NN B-NP O
, , O O
PCP NNP B-NP O
and CC O O
with IN B-VP O
cardiologist NN B-NP O
as IN B-VP O
above IN B-VP O
No NNP B-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
WALLINGER NNP I-NP O
, , O O
COLIN NNP B-NP O
D NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
( ( O O
NG11 NNP B-NP O
) ) O O
9/11/06 CD O O
@ $ O O
04:29 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#941312 VBZ O O
955804700 CD O O
KPMMCO NNP B-NP O
96181967 CD O O
1176706 CD O O
5/8/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
CHF NNP I-NP O
, , O O
pneumonia NN B-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
0/28/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
10/15/2005 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
SAMU NNP I-NP O
, , O O
CURTIS NNP B-NP O
759-74-53-9 CD O O
Beth NNP B-NP O
Ba NNP I-NP O
Ri NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
1/29/05 CD O O
AT NNP B-NP O
04:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Attending NNP I-NP O
evaluation NN I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
TIMBERLAKE NNP I-NP O
, , O O
MEL NNP B-NP O
WYATT NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Assisted NNP I-NP O
Living NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/17/05 CD O O
by IN B-VP O
THEUNISSEN NNP B-NP O
, , O O
LYNWOOD NNP B-NP O
D NNP I-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
29937145 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
Previous NNP I-NP O
override NN I-NP O
information: NN I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
8/0/05 CD O O
by IN B-VP O
BOURNS NNP B-NP O
, , O O
WALTON NNP B-NP O
JERALD NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
50397676 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
DIGOXIN NNP I-NP B-m
0.125 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
8/0/05 CD O O
by IN B-VP O
CHRISTOFFERSE NNP B-NP O
, , O O
KRIS NNP B-NP O
MARCELLUS NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
LEVOTHYROXINE NNP B-NP B-m
SODIUM NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
13700176 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
DIGOXIN NNP I-NP B-m
&amp; NNP I-NP O
LEVOTHYROXINE NNP I-NP B-m
SODIUM NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
COLACE NNP I-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
FERROUS NNP I-NP B-m
SULFATE NNP I-NP I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
milk NN I-NP O
and CC O O
antacid JJ B-NP O
MOTRIN NNP I-NP B-m
( ( O I-m
IBUPROFEN NNP B-NP I-m
) ) O I-m
600 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q8H NNP I-NP O
Starting VBG O O
Today NNP B-NP O
( ( O O
10/7 CD O O
) ) O O
PRN NNP B-NP O
Pain NNP I-NP B-r
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
with IN B-VP O
food NN B-NP O
LEVOTHYROXINE NNP I-NP B-m
SODIUM NNP I-NP I-m
75 CD O B-do
MCG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/17/05 CD O O
by IN B-VP O
CONNELLY NNP B-NP O
, , O O
ELIAS NNP B-NP O
E NNP I-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
29937145 CD O O
) ) O O
SERIOUS NNP B-NP O
INTERACTION: NNP I-NP O
LEVOTHYROXINE NNP I-NP B-m
SODIUM NNP I-NP I-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
Previous NNP I-NP O
override NN I-NP O
information: NN I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
8/0/05 CD O O
by IN B-VP O
ORMONDE NNP B-NP O
, , O O
GUY NNP B-NP O
NICHOLAS NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
DIGOXIN NNP I-NP B-m
&amp; NNP I-NP O
LEVOTHYROXINE NNP I-NP B-m
SODIUM NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
LEVOTHYROXINE NNP I-NP B-m
SODIUM NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
REGLAN NNP I-NP B-m
( ( O I-m
METOCLOPRAMIDE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
AC NNP I-NP B-f
SIMETHICONE NNP I-NP B-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QID NNP I-NP B-f
VITAMIN NNP I-NP B-m
B1 NNP I-NP I-m
( ( O I-m
THIAMINE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
TRAZODONE NNP I-NP B-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
HS NNP I-NP B-f
COUMADIN NNP I-NP B-m
( ( O I-m
WARFARIN NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QPM NNP I-NP B-f
Starting NNP I-NP O
ROUTINE NNP I-NP O
, , O O
20:00 CD O O
( ( O O
Standard NNP B-NP O
Admin NNP I-NP O
Time NNP I-NP O
) ) O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
No NNP I-NP O
high JJ B-NP O
Vitamin-K NNP I-NP O
containing VBG O O
foods NNS B-NP O
Alert NNP I-NP O
overridden: VBD B-VP O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
6/17/05 CD O O
by IN B-VP O
MORKVE NNP B-NP O
, , O O
OLLIE NNP B-NP O
J NNP I-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LEVOTHYROXINE NNP I-NP B-m
SODIUM NNP I-NP I-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LEVOFLOXACIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LEVOFLOXACIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
MVI NNP I-NP B-m
THERAPEUTIC NNP I-NP I-m
( ( O I-m
THERAPEUTIC NNP B-NP I-m
MULTIVITAMINS NNP I-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
8/0/05 CD O O
by IN B-VP O
MUNGO NNP B-NP O
, , O O
KOREY NNP B-NP O
DEON NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
TOPROL NNP I-NP B-m
XL NNP I-NP I-m
( ( O I-m
METOPROLOL NNP B-NP I-m
SUCCINATE NNP I-NP I-m
EXTENDED NNP I-NP I-m
RELEASE NNP I-NP I-m
) ) O I-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
10 CD O I-du
GABAPENTIN NNP B-NP B-m
200 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
TORSEMIDE NNP I-NP B-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
COZAAR NNP I-NP B-m
( ( O I-m
LOSARTAN NNP B-NP I-m
) ) O I-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
10 CD O I-du
LEVOCARNITINE NNP B-NP B-m
1 CD O B-do
GM NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
8/21 CD O O
) ) O O
Instructions: NNP B-NP O
on IN B-VP O
15 CD O O
ml NN B-NP O
at IN B-VP O
home NN B-NP O
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
10 CD O I-du
CITALOPRAM NNP B-NP B-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ADVAIR NNP I-NP B-m
DISKUS NNP I-NP I-m
250/50 CD O I-m
( ( O I-m
FLUTICASONE NNP B-NP I-m
PROPIONATE/ NNP I-NP I-m
) ) O I-m
1 CD O B-do
PUFF NNP B-NP I-do
INH NNP I-NP B-mo
BID NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
8/0/05 CD O O
by IN B-VP O
WHITESELL NNP B-NP O
, , O O
OTIS NNP B-NP O
DARRICK NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
LEVOFLOXACIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
24 CD O O
of IN B-VP O
June NNP B-NP O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SALMETEROL NNP I-NP B-m
XINAFOATE NNP I-NP I-m
&amp; NNP I-NP O
LEVOFLOXACIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
NEXIUM NNP I-NP B-m
( ( O I-m
ESOMEPRAZOLE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
LANTUS NNP I-NP B-m
( ( O I-m
INSULIN NNP B-NP I-m
GLARGINE NNP I-NP I-m
) ) O I-m
60 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
QHS NNP I-NP B-f
NOVOLOG NNP I-NP B-m
NOVOLOG NNP I-NP B-m
NOVOLOG NNP I-NP B-m
NOVOLOG NNP I-NP B-m
NOVOLOG NNP I-NP B-m
NOVOLOG NNP I-NP B-m
NOVOLOG NNP I-NP B-m
NOVOLOG NNP I-NP B-m
( ( O I-m
( ( O I-m
( ( O I-m
( ( O I-m
( ( O I-m
( ( O I-m
( ( O I-m
( ( O I-m
INSULIN NNP B-NP I-m
INSULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
) ) O I-m
) ) O I-m
) ) O I-m
) ) O I-m
) ) O I-m
) ) O I-m
) ) O I-m
) ) O I-m
Sliding VBG O B-do
Scale NNP B-NP I-do
( ( O B-mo
subcutaneously RB O I-mo
) ) O I-mo
SC NNP B-NP I-mo
AC NNP I-NP B-f
If IN B-VP O
BS NNP B-NP O
is VBZ O O
less JJR O O
than IN B-VP O
125 CD O O
, , O O
then RB O O
give VB O O
0 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
125-150 JJ O O
, , O O
then RB O O
give VB O O
2 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
151-200 CD O O
, , O O
then RB O O
give VB O O
3 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
201-250 JJ O O
, , O O
then RB O O
give VB O O
4 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
251-300 JJ O O
, , O O
then RB O O
give VB O O
6 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
301-350 JJ O O
, , O O
then RB O O
give VB O O
8 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
351-400 CD O O
, , O O
then RB O O
give VB O O
10 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
and CC O O
call VB O O
HO NNP B-NP O
Call NNP I-NP O
HO NNP I-NP O
if IN B-VP O
BS NNP B-NP O
is VBZ O O
greater JJR O O
than IN B-VP O
400 CD O O
LIPITOR NNP B-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QPM NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/17/05 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
&amp; NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP I-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
COMBIVENT NNP I-NP B-m
( ( O I-m
IPRATROPIUM NNP B-NP I-m
AND NNP I-NP I-m
ALBUTEROL NNP I-NP I-m
SULFATE NNP I-NP I-m
) ) O I-m
2 CD O B-do
PUFF NNP B-NP I-do
INH NNP I-NP B-mo
QID NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
1800 CD O O
cals/dy NN B-NP O
DIET: NNP I-NP O
2 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Follow NNP I-NP O
up RP O O
with IN B-VP O
you PRP O O
Primary NNP B-NP O
Care NNP I-NP O
Provider NNP I-NP O
within IN B-VP O
the DT O O
next JJ O O
two CD O O
weeks NNS B-NP O
, , O O
Arrange NNP B-NP O
INR NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
on IN B-VP O
8/17/05 CD O O
with IN B-VP O
f/u JJ B-NP O
INR's NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
every DT O O
2 CD O O
days NNS B-NP O
INR's NNP I-NP O
will MD O O
be VB O O
followed VBN O O
by IN B-VP O
Dr NNP B-NP O
Hechinger NNP I-NP O
AH NNP I-NP O
ALLERGY: NNP I-NP O
SHRIMP NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
CHF NNP I-NP O
, , O O
pneumonia NN B-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
CHF NNP B-NP O
, , O O
pneumonia VBZ O O
OTHER NNP B-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
Adriamycin NNP I-NP B-m
induced VBD B-VP O
CMP NNP B-NP O
HTN NNP I-NP O
IDDM NNP I-NP O
Sarcoid NNP I-NP O
Left NNP I-NP O
Breast NNP I-NP O
CA- NNP I-NP O
s/p NN I-NP O
lumpect NN I-NP O
and CC O O
XRT/Adria-'84 JJ B-NP O
hypercholesterolemia NN I-NP O
? . B-VP O
GI NNP B-NP O
origin NN I-NP O
of IN B-VP O
epigastric JJ B-NP O
pain NN I-NP O
dvt NN I-NP O
( ( O O
deep JJ B-NP O
venous JJ I-NP O
thrombosis NN I-NP O
) ) O O
osteoarthritis NN B-NP O
( ( O O
unspecified JJ O O
or CC O O
generalized JJ B-NP O
OA NNP I-NP O
) ) O O
hypothyroid NN B-NP O
( ( O O
hypothyroidism NN B-NP O
) ) O O
cad NN B-NP O
( ( O O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
none NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
Midline NNP B-NP O
placed VBN O O
on IN B-VP O
8/10 CD O O
for IN B-VP O
blood NN B-NP O
draws NNS I-NP O
but CC O O
did VBD B-VP O
not RB O O
work VB O O
Midline NNP B-NP O
taken VBN O O
out RP O O
before IN B-VP O
discharge NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC: NNP I-NP O
SOB NNP I-NP O
HPI: NNP I-NP O
61 CD O O
yo NN B-NP O
F NNP I-NP O
with IN B-VP O
multiple JJ B-NP O
medical JJ I-NP O
problems NNS I-NP O
, , O O
including VBG O O
dilated VBN O O
CMP NNP B-NP O
, , O O
s/p NN B-NP O
chemo NN I-NP O
and CC O O
XRT NN B-NP O
for IN B-VP O
Breast NNP B-NP O
CA NNP I-NP O
, , O O
CAD NNP B-NP O
, , O O
s/p NN B-NP O
MI NNP I-NP O
, , O O
COPD NNP B-NP O
, , O O
on IN B-VP O
occasional JJ B-NP O
O2 NNP I-NP O
, , O O
presents VBZ O O
with IN B-VP O
dry JJ B-NP O
cough NN I-NP O
associated VBN O O
with IN B-VP O
some DT B-NP O
SOB NNP I-NP O
x VBD B-VP O
2 CD O O
days NNS B-NP O
and CC O O
increased JJ B-NP O
DOE NNP I-NP O
as RB O O
well RB O O
At IN B-VP O
baseline NN B-NP O
pt NN I-NP O
is VBZ O O
able JJ O O
to TO O O
walk VB O O
1 CD O O
block NN B-NP O
( ( O O
with IN B-VP O
walker NN B-NP O
) ) O O
before IN B-VP O
DOE NNP B-NP O
, , O O
now RB O O
DOE NNP B-NP O
after IN B-VP O
1/2 CD O O
block NN B-NP O
Pt NNP I-NP O
denies VBZ O O
CP NNP B-NP O
Pt NNP I-NP O
reports NNS I-NP O
orthopnea NN I-NP O
and CC O O
PND NNP B-NP O
Pt NNP I-NP O
has VBZ O O
chronic VBN O O
abd RB O O
pain NN B-NP O
at IN B-VP O
baseline NN B-NP O
that WDT O O
has VBZ O O
been VBN O O
evaluated VBN O O
in IN B-VP O
the DT O O
past JJ O O
with IN B-VP O
Abd NNP B-NP O
CT NNP I-NP O
, , O O
U/S NNP B-NP O
showing VBG O O
sludge NN B-NP O
Pt NNP I-NP O
has VBZ O O
a DT B-NP O
Hx NNP I-NP O
of IN B-VP O
increased VBN O O
Alk NNP B-NP O
Phos NNP I-NP O
She PRP O O
reports VBZ O O
no DT B-NP O
change NN I-NP O
in IN B-VP O
abd NN B-NP O
pain NN I-NP O
at IN B-VP O
this DT B-NP O
time NN I-NP O
, , O O
except IN B-VP O
increased VBN O O
bloating NN B-NP O
No DT O O
increased VBN O O
leg NN B-NP O
edema NN I-NP O
, , O O
but CC O O
reports NNS B-NP O
increased VBD B-VP O
in IN B-VP O
size NN B-NP O
of IN B-VP O
L NNP B-NP O
arm NN I-NP O
Pt NNP I-NP O
also RB O O
reports VBZ O O
wheezing VBG O O
without IN B-VP O
increased VBN O O
O2 NNP B-NP O
need NN I-NP O
at IN B-VP O
night NN B-NP O
No NNP I-NP O
sick NN I-NP O
contacts NNS I-NP O
, , O O
no DT B-NP O
diarrhea NN I-NP O
, , O O
no DT B-NP O
constipation NN I-NP O
**** VBZ O O
PE NNP B-NP O
on IN B-VP O
admission: NN B-NP O
VS: NNP I-NP O
T97.8 NNP I-NP O
HR73 NNP I-NP O
BP113/71 NNP I-NP O
RR18 NNP I-NP O
O2Sat NNP I-NP O
92% CD O O
Gen: NNP B-NP O
NAD NNP I-NP O
HEENT: NNP I-NP O
oropharynx MD O O
clear VB O O
, , O O
no DT B-NP O
JVD NNP I-NP O
CV: NNP I-NP O
distant JJ B-NP O
heart NN I-NP O
sounds VBZ O O
, , O O
1/6 CD O O
SEM NNP B-NP O
Pulm:ant NNP I-NP O
endexp NN I-NP O
wheezes NNS I-NP O
, , O O
no DT B-NP O
crackles NNS I-NP O
Abd: NNP I-NP O
mild NN I-NP O
tenderness NN I-NP O
in IN B-VP O
epigastrium NN B-NP O
, , O O
RUQ NNP B-NP O
, , O O
distended VBD B-VP O
Ext:Venous JJ B-NP O
stasis NN I-NP O
, , O O
1+ CD O O
edema NN B-NP O
, , O O
L NNP B-NP O
arm NN I-NP O
larger JJR O O
than IN B-VP O
R NNP B-NP O
arm NN I-NP O
***** NN I-NP O
Tests: NNP I-NP O
ALK NNP I-NP O
Phos: NNP I-NP O
627 CD O O
ALT: NNP B-NP O
71 CD O O
AST: NNP B-NP O
65 CD O O
Card NNP B-NP O
Enzymes: NNP I-NP O
neg VBD B-VP O
WBC: NNP B-NP O
6.4 CD O O
UA: NNP B-NP O
1.011 CD O O
, , O O
1+prot CD O O
, , O O
5-10WBC JJ O O
, , O O
2+bact CD O O
CXR: NNP B-NP O
LLL NNP I-NP O
opacity NN I-NP O
, , O O
seen VBN O O
best JJS O O
on IN B-VP O
lateral JJ B-NP O
view NN I-NP O
EKG: NNP I-NP O
prolonged VBD B-VP O
PR NNP B-NP O
, , O O
q NN B-NP O
in IN B-VP O
AVL NNP B-NP O
, , O O
flat JJ B-NP O
Ts NNP I-NP O
laterally RB O O
, , O O
unchanged JJ O O
from IN B-VP O
9/5 CD O O
RUQ NNP B-NP O
US: NNP I-NP O
sludge NN I-NP O
, , O O
gall NN B-NP O
bladder NN I-NP O
wall NN I-NP O
thickened VBD B-VP O
8mm CD O O
, , O O
neg JJ B-NP O
sonographic JJ I-NP O
Murphy's NNP I-NP O
sign NN I-NP O
, , O O
B/L NNP B-NP O
small JJ B-NP O
pleural JJ I-NP O
effusions NNS I-NP O
2/4 CD O O
Echo: NNP B-NP O
EF NNP I-NP O
25% CD O O
, , O O
LV NNP B-NP O
mild NN I-NP O
to TO O O
mod VB O O
dilated VBN O O
at IN B-VP O
4.2cm CD O O
, , O O
some DT B-NP O
RWMA NNP I-NP O
, , O O
mod-severe JJ B-NP O
MR NNP I-NP O
6/7 CD O O
Abd NNP B-NP O
U/S: NNP I-NP O
sludge NN I-NP O
in IN B-VP O
gallbladder NN B-NP O
2/4 CD O O
Abd NNP B-NP O
CT: NNP I-NP O
Ascites VBZ O O
2/4 CD O O
PE NNP B-NP O
protocol NN I-NP O
CT: NNP I-NP O
mild NN I-NP O
edema NN I-NP O
, , O O
bilat JJ B-NP O
effusions NNS I-NP O
, , O O
anasarca VBP O O
********************************************************************** JJ B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
61F CD O O
with IN B-VP O
LLL NNP B-NP O
PNA NNP I-NP O
and CC O O
CHF NNP B-NP O
1 CD O O
) ) O O
ID: NNP B-NP O
Pt NNP I-NP O
placed VBD B-VP O
on IN B-VP O
po NN B-NP B-mo
levofloxacin NN I-NP B-m
for IN B-VP O
LLL NNP B-NP B-r
pneumonia NN I-NP I-r
She PRP O O
received VBD B-VP O
a DT O O
7 CD O B-du
days NNS B-NP O
course NN I-NP O
and CC O O
symptoms NNS B-NP O
resolved VBD B-VP O
Stable JJ B-NP O
vitals NNS I-NP O
and CC O O
O2 NNP B-NP O
sats VBZ O O
2 CD O O
) ) O O
Pulm: NNP B-NP O
HX NNP I-NP O
of IN B-VP O
CHF NNP B-NP O
Pt's NNP I-NP O
weight VBD B-VP O
227lbs CD O O
7/6/05 CD O O
( ( O O
dry JJ B-NP O
weight NN I-NP O
~ NNP I-NP O
200 CD O O
) ) O O
Pt NN B-NP O
on IN B-VP O
torsemide JJ O B-m
100mg CD O B-do
bid NN B-NP B-f
at IN B-VP O
baseline NN B-NP O
Pt NNP I-NP O
given VBN O O
po VBP O B-mo
lasix JJ B-NP B-m
lasix NN I-NP B-m
( ( O O
in IN B-VP O
place NN B-NP O
of IN B-VP O
torsemide NN B-NP B-m
on IN B-VP O
admit NN B-NP O
) ) O O
and CC O O
was VBD B-VP O
increased VBN O O
to TO O O
200bid CD O B-do
x NNS B-NP B-du
2 CD O I-du
doses NNS B-NP I-du
Then RB O O
, , O O
pt NN B-NP O
placed VBD B-VP O
back RB O O
on IN B-VP O
torsemide NN B-NP B-m
and CC O O
zaroxyln $ O B-m
5mg CD O B-do
po NN B-NP B-mo
BID NNP I-NP B-f
x VBZ O B-du
6 CD O I-du
doses NNS B-NP I-du
was VBD B-VP O
added VBN O O
Lytes NNP B-NP O
closely RB O O
monitored VBD B-VP O
, , O O
however RB O O
, , O O
pt NN B-NP O
was VBD B-VP O
difficult JJ O O
to TO O O
draw VB O O
blood NN B-NP O
from IN B-VP O
secondary JJ O O
to TO O O
poor JJ B-NP O
access NN I-NP O
Followed VBD B-VP O
daily JJ B-NP O
weights NNS I-NP O
On IN B-VP O
D/C NNP B-NP O
, , O O
pt's NN B-NP O
breathing NN I-NP O
was VBD B-VP O
improved VBN O O
and CC O O
she PRP O O
was VBD B-VP O
ambulating VBG O O
with IN B-VP O
walker NN B-NP O
@ NNP I-NP O
her PRP$ O O
baseline NN B-NP O
Lungs NNPS I-NP O
were VBD B-VP O
clear JJ O O
and CC O O
pt NN B-NP O
still RB O O
had VBD B-VP O
BLE NNP B-NP O
edema NN I-NP O
on IN B-VP O
d/c NN B-NP O
3 CD O O
) ) O O
GI: NNP B-NP O
Hx NNP I-NP O
of IN B-VP O
gallbladder NN B-NP O
sludge NN I-NP O
, , O O
with IN B-VP O
chronic JJ B-NP O
RUQ NNP I-NP O
pain NN I-NP O
, , O O
w/u NN B-NP O
with IN B-VP O
CT NNP B-NP O
and CC O O
US NNP B-NP O
in IN B-VP O
the DT O O
past JJ O O
, , O O
but CC O O
pt VBZ O O
not RB O O
surgical JJ B-NP O
candidate NN I-NP O
RUQ NNP I-NP O
US NNP I-NP O
showed VBD B-VP O
just RB O O
sludge NN B-NP O
, , O O
gallbladder NN B-NP O
wall NN I-NP O
thickened VBD B-VP O
8mm CD O O
, , O O
neg JJ B-NP O
sonographic JJ I-NP O
murphy's NN I-NP O
sign NN I-NP O
4 CD O O
) ) O O
Rheum- JJ O O
6/26 CD O O
pt NN B-NP O
c/o NN I-NP O
right JJ B-NP O
thumb NN I-NP O
pain- JJ B-NP O
thumb NN I-NP O
was VBD B-VP O
red JJ O O
, , O O
warm JJ O O
, , O O
and CC O O
painful JJ O O
to TO O O
touch VB O O
at IN B-VP O
joint JJ B-NP O
Pt NNP I-NP O
has VBZ O O
h/o VBN O O
gout- NN B-NP B-r
was VBD B-VP O
started VBN O O
on IN B-VP O
motrin NN B-NP B-m
TID NNP I-NP B-f
6 CD O O
) ) O O
Endo- NN B-NP O
BS NNP I-NP B-r
were VBD B-VP O
high JJ O O
during IN B-VP B-du
hospitalization NN B-NP I-du
and CC O O
insulin NN B-NP B-m
was VBD B-VP O
adjusted VBN O O
appropriately RB O O
Lantus NNP B-NP B-m
Lantus NNP I-NP B-m
increased VBD B-VP O
to TO O O
60mg CD O B-do
QHS NNP B-NP B-f
and CC O O
novolog RB O B-m
novolog RB O B-m
8u CD O B-do
QAC NNP B-NP B-f
QAC NNP I-NP B-f
and CC O O
sliding VBG O B-do
scale JJ B-NP I-do
Pt NNP I-NP O
will MD O O
be VB O O
d/c'd JJ B-NP O
home NN I-NP O
on IN B-VP O
lantus NN B-NP B-m
60u CD O B-do
QHS NNP B-NP B-f
with IN B-VP O
novolog JJ O B-m
sliding VBG O B-do
scale JJ O I-do
7 CD O O
) ) O O
Heme- NNP B-NP O
Pt NNP I-NP O
was VBD B-VP O
restarted VBN O O
on IN B-VP O
coumadin NN B-NP B-m
5mg CD O B-do
po NN B-NP B-mo
QD NNP I-NP B-f
for IN B-VP O
DVT NNP B-NP B-r
on IN B-VP O
5/16 CD O O
Follow NNP B-NP O
up RB O O
INR NNP B-NP O
to TO O O
be VB O O
drawn VBN O O
on IN B-VP O
11/2 CD O O
INR NNP B-NP O
on IN B-VP O
6/26 CD O O
was VBD B-VP O
1.2 CD O O
FULL NNP B-NP O
CODE NNP I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
1 CD O O
) ) O O
Primary NNP B-NP O
care NN I-NP O
follow VB O O
up RB O O
to TO O O
check VB O O
lytes NNS B-NP O
on IN B-VP O
torsemide IN B-VP B-m
2 CD O O
) ) O O
INR NN B-NP O
checks NNS I-NP O
to TO O O
be VB O O
arranged VBN O O
by IN B-VP O
RMC NNP B-NP O
and CC O O
coumadin VB O B-m
dosing NN B-NP O
to TO O O
be VB O O
called VBN O O
into IN B-VP O
Ak NNP B-NP O
Heim NNP I-NP O
pharmacy NN I-NP O
3 CD O O
) ) O O
Monitor NNP B-NP O
weight VBD B-VP O
2x/week CD O O
4 CD O O
) ) O O
VNA NNP B-NP O
arranged VBD B-VP O
DISCHARGE NNP B-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
1 CD O O
INR NNP B-NP O
to TO O O
be VB O O
checked VBN O O
on IN B-VP O
0/29 CD O O
( ( O O
goal NN B-NP O
2-3 CD O O
) ) O O
Pt NNP B-NP O
sent VBD B-VP O
home NN B-NP O
on IN B-VP O
coumadin NN B-NP B-m
5mg CD O B-do
po NN B-NP B-mo
QHS NNP I-NP B-f
INR NNP I-NP O
results NNS I-NP O
interepreted VBN O O
by IN B-VP O
NH NNP B-NP O
and CC O O
coumadin NNS B-NP B-m
dose VB O O
should MD O O
be VB O O
calle VBN O O
into IN B-VP O
A NNP B-NP O
Larepitbrown NNP I-NP O
Lyoco NNP I-NP O
pharmacy NN I-NP O
862-435-6102 JJ O O
2 CD O O
Continue NNP B-NP O
diuresis NN I-NP B-r
with IN B-VP O
torsemide JJ O B-m
100mg CD O B-do
twice RB O B-f
a DT B-NP I-f
day NN I-NP I-f
and CC O O
monitor NN B-NP O
weights NNS I-NP O
2x/week CD O O
Keep NNP B-NP O
legs NNS I-NP O
elevated VBD B-VP O
while IN B-VP O
in IN B-VP O
bed NN B-NP O
to TO O O
help VB O O
reduce VB O O
swelling VBG O O
3 CD O O
Please NNP B-NP O
make VB O O
follow VB O O
up RP O O
appointment NN B-NP O
with IN B-VP O
Dr NNP B-NP O
Danahy NNP I-NP O
within IN B-VP O
the DT O O
next JJ O O
two CD O O
weeks NNS B-NP O
You PRP O O
will MD O O
need VB O O
follow VB O O
up RP O O
blood NN B-NP O
work NN I-NP O
4 CD O O
Take NNP B-NP O
motrin NN I-NP B-m
600mg CD O B-do
as IN B-VP B-f
needed VBN O I-f
for IN B-VP O
your PRP$ O B-r
thumb NN B-NP I-r
pain NN I-NP I-r
Once RB O O
pain JJ B-NP O
resolves NNS I-NP O
, , O O
resume VB O O
taking VBG O O
your PRP$ O O
allopurinol NN B-NP B-m
100mg CD O B-do
daily NN B-NP B-f
for IN B-VP O
gout NN B-NP B-r
prophylaxis NN I-NP I-r
5 CD O O
Your PRP$ O O
lantus NN B-NP B-m
insulin NN I-NP I-m
dose NN I-NP O
was VBD B-VP O
increased VBN O O
to TO O O
60units CD O B-do
at IN B-VP B-f
night NN B-NP I-f
Please NNP I-NP O
continue VB O O
your PRP$ O O
sliding VBG O O
scale NN B-NP O
as IN B-VP O
usual JJ O O
6 CD O O
You PRP O O
no RB O O
longer RBR O O
need VB O O
procrit RB O O
, , O O
as IN B-VP O
your PRP$ O O
blood NN B-NP O
levels NNS I-NP O
were VBD B-VP O
within IN B-VP O
normal JJ B-NP O
range NN I-NP O
Follow NNP I-NP O
up RP O O
with IN B-VP O
your PRP$ O O
PCP NNP B-NP O
for IN B-VP O
bloodwork NN B-NP O
monitoring NN I-NP O
7 CD O O
Contact NNP B-NP O
your PRP$ O O
primary JJ B-NP O
care NN I-NP O
provider NN I-NP O
or CC O O
come VBN O O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
if IN B-VP O
you PRP O O
experience VBP O O
difficulty NN B-NP O
breathing NN I-NP O
, , O O
chest NN B-NP O
pain NN I-NP O
, , O O
or CC O O
fever RB O O
No RB O O
dictated JJ B-NP O
summary NN I-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
FLY NNP I-NP O
, , O O
RENATO NNP B-NP O
T NNP I-NP O
( ( O O
GN51 NNP B-NP O
) ) O O
1/29/05 CD O O
@ $ O O
01:29 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#941507 VBZ O O
333596015 CD O O
NAFCH NNP B-NP O
64068685 CD O O
8123326 CD O O
1/21/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
chronic JJ B-NP O
cough NN I-NP O
, , O O
LBBB NNP B-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
7/24/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
0/25/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
SARP NNP I-NP O
, , O O
TYRONE NNP B-NP O
L NNP I-NP O
306-51-94-4 JJ B-NP O
Pla NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
8/2/06 CD O O
AT NNP B-NP O
12:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
ESCOBEDO NNP I-NP O
, , O O
FRANK NNP B-NP O
JULIUS NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
LIPITOR NNP I-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
8/2/06 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
AZITHROMYCIN NNP I-NP B-m
&amp; NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
be VB O O
monitored VBN O O
by IN B-VP O
PCP NNP B-NP O
AZITHROMYCIN NNP I-NP B-m
250 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
X NNP I-NP B-du
3 CD O I-du
doses NNS B-NP I-du
Starting VBG O O
IN NNP B-NP O
AM NNP I-NP O
( ( O O
7/9 CD O O
) ) O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
antacids NNS I-NP O
Take VBP O O
with IN B-VP O
food NN B-NP O
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
8/15/06 CD O O
by IN B-VP O
DZIUBAN NNP B-NP O
, , O O
GERMAN NNP B-NP O
W NNP I-NP O
, , O O
M.D NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
AZITHROMYCIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
AZITHROMYCIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
monitor VB O O
ECASA NNP B-NP B-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
FLONASE NNP I-NP B-m
NASAL NNP I-NP I-m
SPRAY NNP I-NP I-m
( ( O I-m
FLUTICASONE NNP B-NP I-m
NASAL NNP I-NP I-m
SPRAY NNP I-NP I-m
) ) O I-m
2 CD O B-do
SPRAY NNP B-NP I-do
NA NNP I-NP B-mo
DAILY NNP I-NP B-f
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
6 CD O I-du
LANTUS NNP B-NP B-m
( ( O I-m
INSULIN NNP B-NP I-m
GLARGINE NNP I-NP I-m
) ) O I-m
100 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
DAILY NNP I-NP B-f
HUMALOG NNP I-NP B-m
INSULIN NNP I-NP I-m
( ( O I-m
INSULIN NNP B-NP I-m
LISPRO NNP I-NP I-m
) ) O I-m
12 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
AC NNP I-NP B-f
COMBIVENT NNP I-NP B-m
( ( O I-m
IPRATROPIUM NNP B-NP I-m
AND NNP I-NP I-m
ALBUTEROL NNP I-NP I-m
SULFATE NNP I-NP I-m
) ) O I-m
2 CD O B-do
PUFF NNP B-NP I-do
INH NNP I-NP B-mo
QID NNP I-NP O
Starting VBG O O
Today NNP B-NP O
( ( O O
5/25 CD O O
) ) O O
PRN NNP B-NP O
Wheezing NNP I-NP B-r
Instructions: NNP I-NP O
use NN I-NP O
with IN B-VP O
a DT B-NP O
spacer NN I-NP O
LORATADINE NNP I-NP B-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
5/25 CD O O
) ) O O
Instructions: IN B-VP O
you PRP O O
can MD O O
buy VB O O
the DT O O
over IN B-VP O
the DT B-NP O
counter JJ I-NP O
version NN I-NP O
of IN B-VP O
this DT B-NP B-m
medication NN I-NP I-m
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
Give VBP O O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
METFORMIN NNP B-NP B-m
1 CD O B-do
, , O I-do
000 CD O I-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
PRILOSEC NNP I-NP B-m
( ( O I-m
OMEPRAZOLE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
5/25 CD O O
) ) O O
Instructions: IN B-VP O
You PRP O O
can MD O O
by IN B-VP O
the DT O O
over IN B-VP O
the DT B-NP O
counter JJ I-NP O
version NN I-NP O
of IN B-VP O
prilosec NN B-NP B-m
DIOVAN NNP I-NP B-m
( ( O I-m
VALSARTAN NNP B-NP I-m
) ) O I-m
160 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
8/15/06 CD O O
by IN B-VP O
NAUMANN NNP B-NP O
, , O O
CLAIR NNP B-NP O
L NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
POTASSIUM NNP B-NP B-m
CHLORIDE NNP I-NP I-m
IMMED NNP I-NP I-m
REL NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
845941861 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
VALSARTAN NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
monitor VB O O
Number NNP B-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ B-NP O
): NN I-NP O
6 CD O O
DIET: NNP B-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
2100 CD O O
cals/dy NN B-NP O
DIET: NNP I-NP O
2 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Teskey NNP I-NP O
063-074-7637 JJ B-NP O
call NN I-NP O
to TO O O
make VB O O
appt NN B-NP O
at IN B-VP O
your PRP$ O O
convenience NN B-NP O
1-2 JJ B-NP O
weeks NNS I-NP O
, , O O
ALLERGY: NNP B-NP O
NKA NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
chronic JJ B-NP O
cough NN I-NP O
, , O O
atypical JJ B-NP O
chest NN I-NP O
pain NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
chronic JJ B-NP O
cough NN I-NP O
, , O O
LBBB NNP B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
htn NN I-NP O
iddm NN I-NP O
CRI NNP I-NP O
Colon NNP I-NP O
CA NNP I-NP O
Prostate NNP I-NP O
CA NNP I-NP O
hyperchol NN I-NP O
otitis NN I-NP O
externa VBP O O
bullous JJ B-NP O
myringitis NN I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
none NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC: NNP I-NP O
upper JJ B-NP O
respiratory NN I-NP O
sx NN I-NP O
************************** NNP I-NP O
HPI: NNP I-NP O
63 CD O O
yo NN B-NP O
M NNP I-NP O
w/hx NN I-NP O
of IN B-VP O
IDDM NNP B-NP O
, , O O
HTN NNP B-NP O
, , O O
hyperchol NN B-NP O
, , O O
obesity NN B-NP O
p/w NN I-NP O
URI NNP I-NP O
sx VBD B-VP O
4 CD O O
wks NN B-NP O
chronic JJ B-NP O
productive JJ I-NP O
cough NN I-NP O
, , O O
rhinorrhea NN B-NP O
, , O O
sensation NN B-NP O
of IN B-VP O
nasal NN B-NP O
discharge VBP O O
down RP O O
back RB O O
of IN B-VP O
throat NN B-NP O
Also RB O O
w/assoc JJ B-NP O
episode NN I-NP O
of IN B-VP O
mild JJ B-NP O
CP NNP I-NP O
2 CD O O
days NNS B-NP O
2 CD O O
episodes NNS B-NP O
of IN B-VP O
CP NNP B-NP O
assoc NN I-NP O
w/cough NN I-NP O
, , O O
lasting VBG O O
min NN B-NP O
, , O O
did VBD B-VP O
not RB O O
occur JJ B-NP O
w/exertion NN I-NP O
, , O O
no DT B-NP O
SOB NNP I-NP O
, , O O
no DT B-NP O
N/V/diaphoresis NNP I-NP O
, , O O
resolved VBD B-VP O
spontaneously RB O O
Presented VBN O O
to TO O O
ED NNP B-NP O
2/2 CD O O
cough NN B-NP O
which WDT O O
was VBD B-VP O
keeping VBG O O
him PRP O O
up RP O O
at IN B-VP O
night NN B-NP O
No NNP I-NP O
F/C/SOB/DOE/PND/orthopnea NNP I-NP O
No NNP I-NP O
LE NNP I-NP O
edema VBZ O O
Able JJ O O
to TO O O
walk VB O O
3-4 JJ B-NP O
miles NNS I-NP O
2-3 JJ B-NP O
times NNS I-NP O
per IN B-VP O
wk NN B-NP O
w/ VBP O O
exertional JJ B-NP O
symptoms NNS I-NP O
Noted VBD B-VP O
to TO O O
have VB O O
LBBB NNP B-NP O
that WDT O O
was VBD B-VP O
new JJ O O
from IN B-VP O
last JJ B-NP O
ekg NN I-NP O
done VBN O O
12 CD O O
yrs NN B-NP O
ago RB O O
, , O O
admitted VBD B-VP O
for IN B-VP O
ROMI NNP B-NP O
*************************** NNP I-NP O
PMH: NNP I-NP O
as IN B-VP O
above IN B-VP O
, , O O
colon NN B-NP O
CA NNP I-NP O
s/p VBZ O O
partial JJ B-NP O
colectomy NN I-NP O
1992 CD O O
, , O O
prostate NN B-NP O
CA NNP I-NP O
s/p NN I-NP O
XRT NNP I-NP O
( ( O O
dx JJ O O
6 CD O O
yrs NN B-NP O
ago RB O O
) ) O O
, , O O
CRI NNP B-NP O
( ( O O
Cr NNP B-NP O
1.0-1.9 CD O O
) ) O O
2/2 CD O O
htn NN B-NP O
, , O O
dm; NN B-NP O
LBP NNP I-NP O
*************************** NNP I-NP O
MEDS: NNP I-NP O
diovan NN I-NP B-m
, , O O
asa NN B-NP B-m
, , O O
lisinopril NN B-NP B-m
, , O O
lipitor NN B-NP B-m
, , O O
metformin NN B-NP B-m
, , O O
lantus NN B-NP B-m
, , O O
humalog NN B-NP B-m
*************************** NNP I-NP O
STUDIES: NNP I-NP O
LABS: NNP I-NP O
nl MD O O
chem7 VB O O
, , O O
nl FW O O
CBC NNP B-NP O
, , O O
neg JJ B-NP O
cardiac JJ I-NP O
enzymes NNS I-NP O
x3 VBP O O
CXR: NNP B-NP O
no DT B-NP O
acute JJ I-NP O
process NN I-NP O
**************************** NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
63M CD O O
w/ NN B-NP O
hx NN I-NP O
of IN B-VP O
DM NNP B-NP O
, , O O
HTN NNP B-NP O
, , O O
obesity NN B-NP O
, , O O
hyperlipidemia NN B-NP O
a/w NN I-NP O
chest NN I-NP O
pain NN I-NP O
2 CD O O
d NN B-NP O
ago RB O O
atypical JJ O O
of IN B-VP O
cardiac JJ B-NP O
etiology NN I-NP O
with IN B-VP O
LBBB NNP B-NP O
from IN B-VP O
last JJ B-NP O
ekg NN I-NP O
in IN B-VP O
1994 CD O O
C/V: NNP B-NP O
I: NNP I-NP O
hx VBD B-VP O
very RB O O
atypical JJ O O
of IN B-VP O
cardiac JJ B-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
more RBR O O
likely JJ O O
related VBN O O
to TO O O
cough VB O O
Given NNP B-NP O
LBBB NNP I-NP O
, , O O
cardiac JJ B-NP O
enzymes NNS I-NP O
were VBD B-VP O
checked VBN O O
and CC O O
were VBD B-VP O
negative JJ O O
x JJ O O
3 CD O O
( ( O O
would MD O O
have VB O O
expected VBN O O
+ JJ B-NP O
enzymes NNS I-NP O
on IN B-VP O
initial JJ B-NP O
set NN I-NP O
if IN B-VP O
ischemia NN B-NP O
was VBD B-VP O
present JJ O O
given VBN O O
pain NN B-NP O
was VBD B-VP O
&gt;24 JJ B-NP O
hrs NN I-NP O
prior RB O O
to TO O O
presentation NN B-NP O
) ) O O
Lipid NNP B-NP O
panel NN I-NP O
shows VBZ O O
LDL NNP B-NP O
at IN B-VP O
goal NN B-NP O
for IN B-VP O
diabetic; NN B-NP O
HDL NNP I-NP O
slightly RB O O
low JJ O O
but CC O O
can MD O O
be VB O O
followed VBN O O
up RP O O
by IN B-VP O
PCP NNP B-NP O
Cont NNP I-NP O
ASA NNP I-NP B-m
and CC O O
statin JJ B-NP B-m
Consider NNP I-NP O
outpt MD O O
ETT-mibi NNP B-NP O
( ( O O
LBBB NNP B-NP O
precludes VBZ O O
simple JJ B-NP O
ETT NNP I-NP O
) ) O O
, , O O
but CC O O
will MD O O
defer VB O O
to TO O O
PCP VB O O
at IN B-VP O
this DT B-NP O
point NN I-NP O
P: NNP I-NP O
Cont NNP I-NP O
home NN I-NP O
anti-htnsive JJ B-NP B-m
regimen NNS I-NP I-m
No DT B-NP O
sx NN I-NP O
of IN B-VP O
CHF NNP B-NP O
to TO O O
warrant VB O O
echo NN B-NP O
at IN B-VP O
this DT B-NP O
time NN I-NP O
R: NNP I-NP O
new JJ B-NP O
LBBB NNP I-NP O
since IN B-VP O
last JJ O O
ekg JJ O O
12 CD O O
yrs NN B-NP O
ago RB O O
, , O O
no DT B-NP O
events NNS I-NP O
on IN B-VP O
tele NN B-NP O
Pulm/Chronic NNP I-NP O
Cough: NNP I-NP O
Most NNP I-NP O
likely JJ B-NP O
gerd NN I-NP O
v NN I-NP O
PND NNP I-NP O
v NN I-NP O
bronchitis NN I-NP O
Given NNP I-NP O
sx VBD B-VP O
worse JJR O O
at IN B-VP O
night NN B-NP O
, , O O
may MD O O
have VB O O
GERD NNP B-NP B-r
component NN I-NP O
given VBN O O
body NN B-NP O
habitus- JJ B-NP O
trial NN I-NP O
of IN B-VP O
PPI NNP B-NP B-m
Given NNP I-NP O
sx VBD B-VP O
for IN B-VP O
1 CD O O
mo NN B-NP O
, , O O
started VBD B-VP O
on IN B-VP O
z-pak NN B-NP B-m
Added NNP I-NP O
flonase NN I-NP B-m
and CC O O
loratidine NN B-NP B-m
for IN B-VP O
PND NNP B-NP B-r
PND NNP I-NP B-r
Inhalers NNP I-NP B-m
for IN B-VP O
wheezing VBG O B-r
prn NN B-NP B-f
( ( O O
improved VBN O O
prior RB O O
to TO O O
d/c VB O O
) ) O O
ENDO: NNP B-NP O
cont NN I-NP O
home NN I-NP O
regimen NNS I-NP O
ONC: NNP I-NP O
no DT B-NP O
active JJ I-NP O
inpatient NN I-NP O
issues NNS I-NP O
RENAL: NNP I-NP O
at IN B-VP O
baseline JJ B-NP O
creatinine NN I-NP O
FEN: NNP I-NP O
cardiac NN I-NP O
, , O O
diabetic JJ O O
, , O O
diet JJ B-NP O
PROPHY: NNP I-NP O
lovenox NN I-NP B-m
, , O O
nexium JJ B-NP B-m
nexium NN I-NP B-m
CODE: NNP I-NP O
full JJ B-NP O
DISPO: NNP I-NP O
f/u NN I-NP O
w/ NN I-NP O
PCP NNP I-NP O
for IN B-VP O
poss NN B-NP O
outpt NN I-NP O
stress NN I-NP O
imaging VBG O O
ADDITIONAL NNP B-NP O
COMMENTS: NNP I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
1 CD O O
) ) O O
Follow NNP B-NP O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Kreager NNP I-NP O
he PRP O O
can MD O O
decide VB O O
to TO O O
have VB O O
you PRP O O
undergo VBP O O
a DT B-NP O
stress JJ I-NP O
test NN I-NP O
as IN B-VP O
an DT O O
outpatient JJ O O
2 CD O O
) ) O O
Take VB O O
your PRP$ O B-m
medications NNS B-NP I-m
as IN B-VP O
directed JJ B-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
PIH NNP I-NP O
, , O O
DEANDRE NNP B-NP O
B NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
CS01 NNP B-NP O
) ) O O
8/2/06 CD O O
@ $ O O
11 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#942556 VBZ O O
152184884 CD O O
ESHMC NNP B-NP O
03895233 CD O O
3083193 CD O O
8/2/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
Coronary NNP I-NP O
artery NN I-NP O
disease NN I-NP O
414.01 CD O O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
9/29/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
4/25/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
MCLYMAN NNP I-NP O
, , O O
ANDREAS NNP B-NP O
764-41-05-5 CD O O
Pervgle NNP B-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
7/24/06 CD O O
AT NNP B-NP O
02:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Attending NNP I-NP O
evaluation NN I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
FERGE NNP I-NP O
, , O O
WALLY NNP B-NP O
E NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ENTERIC NNP I-NP B-m
COATED NNP I-NP I-m
ASA NNP I-NP I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
TESSALON NNP I-NP B-m
PERLES NNP I-NP I-m
( ( O I-m
BENZONATATE NNP B-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
PRN NNP I-NP O
Shortness NNP I-NP B-r
of IN B-VP I-r
Breath NNP B-NP I-r
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
6 CD O I-du
PLAVIX NNP B-NP B-m
( ( O I-m
CLOPIDOGREL NNP B-NP I-m
) ) O I-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Starting NNP I-NP O
IN NNP I-NP O
AM NNP I-NP O
( ( O O
6/9 CD O O
) ) O O
CODEINE NNP B-NP B-m
PHOSPHATE NNP I-NP I-m
15 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q3H NNP I-NP B-f
PRN NNP I-NP I-f
Pain NNP I-NP B-r
HOLD NNP I-NP O
IF: NNP I-NP O
sedated VBD B-VP O
, , O O
rr&lt;12 VB O O
DEXTROMETHORPHAN NNP B-NP B-m
HBR NNP I-NP I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP I-f
Other:cough NNP I-NP B-r
HOLD NNP I-NP O
IF: NNP I-NP O
sedated VBD B-VP O
, , O O
rr&lt;12 JJ B-NP O
Number NNP I-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ B-NP O
): NN I-NP O
6 CD O O
ZETIA NNP B-NP B-m
( ( O I-m
EZETIMIBE NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
LANTUS NNP I-NP B-m
( ( O I-m
INSULIN NNP B-NP I-m
GLARGINE NNP I-NP I-m
) ) O I-m
20 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
BEDTIME NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
call VB O O
HO NNP B-NP O
if IN B-VP O
BG NNP B-NP O
&lt;90 NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
IMMED NNP I-NP I-m
REL NNP I-NP I-m
( ( O I-m
KCL NNP B-NP I-m
IMMEDIATE NNP I-NP I-m
) ) O I-m
*** VBD B-VP O
LOW NNP B-NP O
KCL NNP I-NP O
REPLACEMENT NNP I-NP O
SCALE NNP I-NP O
ORAL NNP I-NP O
PO NNP I-NP O
Scale NNP I-NP O
Frequency NNP I-NP O
1.Only CD O O
KCL NNP B-NP B-m
Immediate NNP I-NP I-m
Release NNP I-NP I-m
products NNS I-NP O
may MD O O
be VB O O
used VBN O O
for IN B-VP O
KCL NNP B-NP B-m
scales NNS I-NP O
2.Do CD O O
not RB O O
use VB O O
sustained-release JJ B-NP O
potassium NN I-NP O
for IN B-VP O
KCL NNP B-NP O
scale NN I-NP O
doses VBZ O O
3.Replace CD O O
KCL NNP B-NP O
based VBN O O
on IN B-VP O
lab NN B-NP O
values NNS I-NP O
4.As CD O O
per IN B-VP O
SMH NNP B-NP O
Potassium NNP I-NP B-m
Chloride NNP I-NP I-m
Policy: NNP I-NP O
each DT O O
20 CD O B-do
mEq NN B-NP I-do
dose NN I-NP O
is VBZ O O
to TO O O
be VB O O
given VBN O O
with IN B-VP O
4oz CD O O
of IN B-VP O
fluid NN B-NP O
5.A CD O O
serum NN B-NP O
creatinine NN I-NP O
must MD O O
be VB O O
ordered VBN O O
and CC O O
checked VBN O O
daily RB O O
while IN B-VP O
patient NN B-NP O
is VBZ O O
ordered VBN O O
for IN B-VP O
a DT B-NP O
K-scale JJ I-NP O
6.K-scale JJ I-NP O
cannot NN I-NP O
be VB O O
used VBN O O
on IN B-VP O
patients NNS B-NP O
with: JJ O O
* VBP O O
A DT B-NP O
serum NN I-NP O
creatinine NN I-NP O
greater JJR O O
than IN B-VP O
or CC O O
equal JJ O O
to TO O O
2.0 CD O O
mg/dl; NN B-NP O
or CC O O
* VB O O
A DT B-NP O
serum NN I-NP O
creatinine JJ B-NP O
increase NN I-NP O
of IN B-VP O
0.5 CD O O
mg/dl NNS B-NP O
within IN B-VP O
24 CD O O
hours NNS B-NP O
* VBP O O
Hold NNP B-NP O
scale NN I-NP O
and CC O O
contact NN B-NP O
MD NNP I-NP O
if IN B-VP O
SCr NNP B-NP O
is VBZ O O
greater JJR O O
than IN B-VP O
2.0 CD O O
----------------------------------------------------------- JJ B-NP O
----------- NN I-NP O
If IN B-VP O
K+ NNP B-NP O
Level NNP I-NP O
is VBZ O O
less JJR O O
than IN B-VP O
3.1 CD O O
then RB O O
call VB O O
H.O NNP B-NP O
If IN B-VP O
K+ NNP B-NP O
Level NNP I-NP O
is VBZ O O
3.1-3.3 JJ O O
, , O O
then RB O O
administer RB O O
KCL NNP B-NP B-m
KCL NNP I-NP B-m
40 CD O B-do
meq NN B-NP I-do
orally RB O B-mo
followed VBN O O
by IN B-VP O
20 CD O B-do
meq NNS B-NP O
orally RB O B-mo
2 CD O O
hours NNS B-NP O
later RB O O
Recheck NNP B-NP O
K+ NNP I-NP O
Level NNP I-NP O
2 CD O O
hours NNS B-NP O
after IN B-VP O
dose NN B-NP O
was VBD B-VP O
given VBN O O
If IN B-VP O
K+ NNP B-NP O
Level NNP I-NP O
is VBZ O O
3.4-3.6 JJ O O
, , O O
then RB O O
administer RB O O
KCL NNP B-NP B-m
40 CD O B-do
meq NN B-NP I-do
orally RB O B-mo
Recheck NNP B-NP O
K+ NNP I-NP O
Level NNP I-NP O
2 CD O O
hours NNS B-NP O
after IN B-VP O
dose NN B-NP O
was VBD B-VP O
given VBN O O
If IN B-VP O
K+ NNP B-NP O
Level NNP I-NP O
is VBZ O O
3.7-4.0 JJ O O
, , O O
then RB O O
administer RB O O
KCL NNP B-NP B-m
20 CD O B-do
meq NN B-NP I-do
orally RB O B-mo
Recheck NNP B-NP O
K+ NNP I-NP O
Level NNP I-NP O
2 CD O O
hours NNS B-NP O
after IN B-VP O
dose NN B-NP O
was VBD B-VP O
given VBN O O
If IN B-VP O
K+ NNP B-NP O
Level NNP I-NP O
is VBZ O O
4.1-5.0 JJ O O
, , O O
then RB O O
DO NNP B-NP O
NOT NNP I-NP O
administer VB O O
KCL NNP B-NP B-m
Recheck NNP I-NP O
K+ NNP I-NP O
Level NNP I-NP O
in IN B-VP O
QAM NNP B-NP O
If IN B-VP O
K+ NNP B-NP O
Level NNP I-NP O
is VBZ O O
greater JJR O O
than IN B-VP O
5.0 CD O O
then RB O O
call VB O O
H.O NNP B-NP O
----------------------------------------------------------- NNP I-NP O
----------- NNP I-NP O
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
7/24/06 CD O O
by IN B-VP O
MERLING NN B-NP O
, , O O
SHIRLEY NNP B-NP O
M NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
DIOVAN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
032637277 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
VALSARTAN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
MAALOX-TABLETS NNP I-NP B-m
QUICK NNP I-NP I-m
DISSOLVE/CHEWABLE NNP I-NP I-m
1-2 JJ B-NP B-do
TAB NNP I-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP O
Upset NNP I-NP B-r
Stomach NNP I-NP I-r
MAGNESIUM NNP I-NP B-m
GLUCONATE NNP I-NP I-m
Sliding NNP I-NP B-do
Scale NNP I-NP I-do
PO NNP I-NP B-mo
( ( O I-mo
orally RB O I-mo
) ) O I-mo
DAILY NNP B-NP B-f
-&gt; NNP I-NP O
Mg-scales NNP I-NP O
cannot NN I-NP O
be VB O O
used VBN O O
and CC O O
magnesium JJ B-NP B-m
doses NNS I-NP O
must MD O O
be VB O O
individualized VBN O O
for IN B-VP O
patients NNS B-NP O
who WP O O
have: VBP O O
- : O O
a DT B-NP O
serum JJ I-NP O
creatinine NN I-NP O
greater JJR O O
than IN B-VP O
or CC O O
equal JJ O O
to TO O O
2.0 CD O O
mg/dL; NN B-NP O
or CC O O
- : O O
a DT B-NP O
serum JJ I-NP O
creatinine NN I-NP O
greater JJR O O
than IN B-VP O
or CC O O
equal JJ O O
to TO O O
1.5 CD O O
mg/dL NN B-NP O
and CC O O
an DT B-NP O
increase NN I-NP O
of IN B-VP O
0.5mg/dL CD O O
within IN B-VP O
24 CD O O
hours NNS B-NP O
Call NNP I-NP O
HO NNP I-NP O
if IN B-VP O
Mg NNP B-NP O
level NN I-NP O
is VBZ O O
less JJR O O
than IN B-VP O
0.8 CD O O
If IN B-VP O
Mg NNP B-NP O
level NN I-NP O
is VBZ O O
less JJR O O
than IN B-VP O
1 CD O O
, , O O
then RB O O
give VB O O
3 CD O B-do
gm NN B-NP I-do
Mg NNP I-NP B-m
Gluconate NNP I-NP I-m
orally RB O B-mo
and CC O O
call VB O O
HO NNP B-NP O
If IN B-VP O
Mg NNP B-NP O
level NN I-NP O
is VBZ O O
1.0-1.5 JJ O O
, , O O
then RB O O
give VB O O
2 CD O B-do
gm NN B-NP I-do
Mg NNP I-NP B-m
Gluconate NNP I-NP I-m
orally RB O B-mo
If IN B-VP O
Mg NNP B-NP O
level NN I-NP O
is VBZ O O
1.6-1.9 JJ O O
, , O O
then RB O O
give VB O O
1 CD O B-do
gm NN B-NP I-do
Mg NNP I-NP B-m
Gluconate NNP I-NP I-m
orally RB O B-mo
If IN B-VP O
Mg NNP B-NP O
level NN I-NP O
is VBZ O O
2.0-2.5 JJ O O
, , O O
then RB O O
Do NNP B-NP O
Not RB O O
administer VB O O
Mg NNP B-NP O
Gluconate NNP I-NP O
Call NNP I-NP O
HO NNP I-NP O
if IN B-VP O
Mg NNP B-NP O
level NN I-NP O
is VBZ O O
greater JJR O O
than IN B-VP O
2.5 CD O O
NITROGLYCERIN JJ O B-m
1/150 CD O I-m
( ( O I-m
0.4 CD O I-m
MG NNP B-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
SL NNP I-NP B-mo
q5min VBD B-VP B-f
x $ O B-du
3 CD O I-du
PRN NNP B-NP O
chest NN I-NP B-r
pain NN I-NP I-r
HOLD NNP I-NP O
IF: NNP I-NP O
SBP NNP I-NP O
&lt; VBD B-VP O
100 CD O O
OXYCODONE NNP B-NP B-m
5-10 JJ B-NP B-do
MG NNP I-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP I-f
Pain NNP I-NP B-r
PINDOLOL NNP I-NP B-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp&lt;90 NN I-NP O
, , O O
HR&lt;50 NNP B-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
ZOCOR NNP I-NP B-m
( ( O I-m
SIMVASTATIN NNP B-NP I-m
) ) O I-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BEDTIME NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
DIOVAN NNP B-NP B-m
( ( O I-m
VALSARTAN NNP B-NP I-m
) ) O I-m
160 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Starting NNP I-NP O
IN NNP I-NP O
AM NNP I-NP O
( ( O O
11/12 CD O O
) ) O O
Alert NNP B-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
7/24/06 CD O O
by IN B-VP O
MCCALEBB NNP B-NP O
, , O O
TYRONE NNP B-NP O
A NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
VALSARTAN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
Number NNP I-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ B-NP O
): NN I-NP O
5 CD O O
DIET: NNP B-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
2100 CD O O
cals/dy NN B-NP O
DIET: NNP I-NP O
2 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated JJ B-NP O
Lift NNP I-NP O
restrictions: NN I-NP O
Do NNP I-NP O
not RB O O
lift VB O O
greater JJR O O
then RB O O
15 CD O O
pounds NNS B-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Muehl NNP I-NP O
He PRP O O
will MD O O
arrange VB O O
, , O O
ALLERGY: NNP B-NP O
NKA NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
Elective NNP I-NP O
cardiac JJ B-NP O
catheterization NN I-NP O
with IN B-VP O
PCI NNP B-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Coronary NNP B-NP O
artery NN I-NP O
disease NN I-NP O
414.01 CD O O
OTHER NNP B-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
CAD NNP I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
Cardiac NNP I-NP O
catheterization NN I-NP O
with IN B-VP O
stent NN B-NP O
to TO O O
old JJ B-NP O
CABG NNP I-NP O
vessel NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
CXR NNP B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC: NNP I-NP O
Elective NNP I-NP O
Cardiac NNP I-NP O
Cath NNP I-NP O
HPI: NNP I-NP O
58 CD O O
yo NNP B-NP O
female JJ B-NP O
smoker NN I-NP O
with IN B-VP O
hx NN B-NP O
of IN B-VP O
CAD NNP B-NP O
, , O O
s/p NN B-NP O
CABG NNP I-NP O
x3 NNP I-NP O
, , O O
DM NNP B-NP O
II NNP I-NP O
, , O O
HTN NNP B-NP O
, , O O
and CC O O
hyperlipidemia RB O O
admitted VBN O O
to TO O O
the DT B-NP O
CCU NNP I-NP O
after IN B-VP O
elective JJ B-NP O
cardiac JJ I-NP O
cath NN I-NP O
s/p NN I-NP O
abnormal JJ B-NP O
stress NN I-NP O
test NN I-NP O
Cath NN I-NP O
showed VBD B-VP O
impaired JJ B-NP O
flow NN I-NP O
in IN B-VP O
the DT O O
inferior JJ O O
and CC O O
posterolateral JJ B-NP O
zones NNS I-NP O
due JJ O O
to TO O O
obstructive JJ B-NP O
degenerative JJ I-NP O
disease NN I-NP O
in IN B-VP O
the DT B-NP O
SVGs NNP I-NP O
to TO O O
the DT B-NP O
RCA NNP I-NP O
and CC O O
LCF-OM NNP B-NP O
Stent NNP I-NP O
placed VBD B-VP O
in IN B-VP O
the DT B-NP O
RCA NNP I-NP O
graft NN I-NP O
though IN B-VP O
there EX O O
was VBD B-VP O
extensive JJ B-NP O
calcification NN I-NP O
and CC O O
difficulty NN B-NP O
obtaining VBG O O
full JJ B-NP O
stent NN I-NP O
expansion NN I-NP O
, , O O
and CC O O
following VBG O O
the DT B-NP O
stent JJ I-NP O
deployment NN I-NP O
there EX O O
was VBD B-VP O
poor JJ O O
reflow JJ O O
accompanied VBN O O
by IN B-VP O
mild JJ B-NP O
chest NN I-NP O
pain NN I-NP O
and CC O O
EKG NNP B-NP O
changes NNS I-NP O
, , O O
without IN B-VP O
hemodynamic JJ B-NP O
embarrassment NN I-NP O
Pt NNP I-NP O
was VBD B-VP O
transferred VBN O O
back RB O O
to TO O O
the DT B-NP O
CCU NNP I-NP O
stable JJ O O
and CC O O
without IN B-VP O
pain NN B-NP O
Pt NNP I-NP O
was VBD B-VP O
scheduled VBN O O
for IN B-VP O
call NN B-NP O
out IN B-VP O
to TO O O
floor NN B-NP O
, , O O
but CC O O
had VBD B-VP O
an DT B-NP O
episode NN I-NP O
of IN B-VP O
jaw NN B-NP O
sensation NN I-NP O
, , O O
different JJ O O
from IN B-VP O
previous JJ B-NP O
angina NNS I-NP O
Pt NNP I-NP O
was VBD B-VP O
upset VBN O O
by IN B-VP O
turn NN B-NP O
of IN B-VP O
events NNS B-NP O
, , O O
but CC O O
was VBD B-VP O
calmed VBN O O
by IN B-VP O
staff NN B-NP O
Was NNP I-NP O
then RB O O
evaluated VBD B-VP O
by IN B-VP O
Dr NNP B-NP O
Demora NNP I-NP O
and CC O O
came VBD B-VP O
out RB O O
to TO O O
the DT B-NP O
floor NN I-NP O
Seygo NNP I-NP O
No NNP I-NP O
Wood NNP I-NP O
night NN I-NP O
PMH NNP I-NP O
DMII NNP I-NP O
, , O O
HTN NNP B-NP O
, , O O
Hyperlipidemia NNP B-NP O
, , O O
Cirrhosis NNP B-NP O
s/p VBD B-VP O
CABG NNP B-NP O
x NNP I-NP O
3 CD O O
1997 CD O O
s/p NN B-NP O
AAA NNP I-NP O
repair NN I-NP O
1996 CD O O
s/p NN B-NP O
aorto-fem JJ B-NP O
bypass NN I-NP O
1996 CD O O
s/p NN B-NP O
TAHBSO NNP I-NP O
Meds NNP I-NP O
Lantus NNP I-NP B-m
40u CD O B-do
qd NN B-NP B-f
Estradiol NNP I-NP B-m
0.05 CD O I-m
Diltiazem NNP B-NP B-m
180 CD O B-do
mg NN B-NP I-do
qd NN I-NP B-f
HCTZ NNP I-NP B-m
25 CD O B-do
mg NN B-NP I-do
qd NN I-NP B-f
Zetia NNP I-NP B-m
10mg CD O B-do
qd NN B-NP B-f
Diovan NNP I-NP B-m
160 CD O B-do
mg NN B-NP I-do
qd NN I-NP B-f
Plavix NNP I-NP B-m
75 CD O B-do
mg NN B-NP I-do
qd NN I-NP B-f
Zocor NNP I-NP B-m
80 CD O B-do
mg NN B-NP I-do
qd NN I-NP B-f
ASA NNP I-NP B-m
325 CD O B-do
mg NN B-NP I-do
qd NN I-NP B-f
MV NNP I-NP O
Meds NNP I-NP O
in IN B-VP O
CCU NNP B-NP O
ASA NNP I-NP B-m
325 CD O B-do
mg NN B-NP I-do
qd NN I-NP B-f
Lantus NNP I-NP B-m
20u CD O B-do
qd NN B-NP B-f
Plavix NNP I-NP B-m
75 CD O B-do
mg NN B-NP I-do
qd NN I-NP B-f
Zetia NNP I-NP B-m
10mg CD O B-do
qd NN B-NP B-f
Famotidine NNP I-NP B-m
20 CD O B-do
mg NN B-NP I-do
BID NNP I-NP B-f
Pindolol NNP I-NP B-m
5 CD O B-do
mg NN B-NP I-do
BID NNP I-NP B-f
Lovenox NNP I-NP B-m
40 CD O B-do
sc NN B-NP B-mo
qd NN I-NP B-f
nicotine JJ B-NP B-m
patch NN I-NP O
MgSO4 NNP I-NP B-m
SS NNP I-NP B-do
KCL NNP I-NP B-m
SS NNP I-NP O
Novolog NNP I-NP B-m
SS NNP I-NP O
Pt NNP I-NP O
Status NNP I-NP O
Vitals NNP I-NP O
Gen NNP I-NP O
- : O O
Awake NNP B-NP O
, , O O
Alert NNP B-NP O
, , O O
NAD NNP B-NP O
HEENT NNP I-NP O
- : O O
JVP NNP B-NP O
6 CD O O
cm NN B-NP O
, , O O
No NNP B-NP O
bruits VBZ O O
Chest NNP B-NP O
- : O O
CTAB NN B-NP O
with IN B-VP O
mild JJ B-NP O
rhonchi/wheezes NNS I-NP O
R&gt;L NNP I-NP O
CV NNP I-NP O
- : O O
RRR NNP B-NP O
, , O O
Nml NNP B-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
, , O O
II/VI NNP B-NP O
SEM NNP I-NP O
at IN B-VP O
LLSB NNP B-NP O
Abd NNP I-NP O
- : O O
Soft JJ O O
, , O O
NT NNP B-NP O
, , O O
ND NNP B-NP O
, , O O
No NNP B-NP O
organomegaly NN I-NP O
Extr NNP I-NP O
- : O O
L NNP B-NP O
femoral JJ B-NP O
bruit NN I-NP O
, , O O
R NNP B-NP O
cath NN I-NP O
site NN I-NP O
, , O O
oozing VBG O O
, , O O
no DT B-NP O
edema NN I-NP O
, , O O
hematoma NN B-NP O
, , O O
ecchymosis NN B-NP O
present JJ B-NP O
Studies NNPS I-NP O
CAth NNP I-NP O
- : O O
Right JJ B-NP O
Dominant NNP I-NP O
Circulation NNP I-NP O
Left NNP I-NP O
Main NNP I-NP O
Coronary NNP I-NP O
Artery NNP I-NP O
No NNP I-NP O
significant JJ B-NP O
LM NNP I-NP O
lesions NNS I-NP O
identified VBD B-VP O
Left NNP B-NP O
Anterior NNP I-NP O
Descending NNP I-NP O
Artery NNP I-NP O
LAD NNP I-NP O
( ( O O
Proximal NNP B-NP O
) ) O O
, , O O
Discrete NNP B-NP O
90% CD O O
lesion NN B-NP O
LAD NNP I-NP O
( ( O O
Ostial NNP B-NP O
) ) O O
, , O O
Discrete NNP B-NP O
90% CD O O
lesion NN B-NP O
Left NNP I-NP O
Circumflex NNP I-NP O
Artery NNP I-NP O
CX NNP I-NP O
( ( O O
Proximal NNP B-NP O
) ) O O
, , O O
Discrete NNP B-NP O
90% CD O O
lesion NN B-NP O
Right NNP I-NP O
Coronary NNP I-NP O
Artery NNP I-NP O
RCA NNP I-NP O
( ( O O
Proximal NNP B-NP O
) ) O O
, , O O
Discrete NNP B-NP O
100% CD O O
lesion NN B-NP O
RT NNP I-NP O
PDA NNP I-NP O
( ( O O
Mid NNP B-NP O
) ) O O
, , O O
Discrete NNP B-NP O
100% CD O O
lesion NN B-NP O
Coronary NNP I-NP O
Artery NNP I-NP O
Bypass NNP I-NP O
Grafts: NNP I-NP O
SVG NNP I-NP O
Graft NNP I-NP O
to TO O O
RT NNP B-NP O
PDA NNP I-NP O
( ( O O
Mid NNP B-NP O
) ) O O
, , O O
Discrete NNP B-NP O
90% CD O O
lesion NN B-NP O
STENT NNP I-NP O
to TO O O
20% CD O O
LIMA NNP B-NP O
Graft NNP I-NP O
to TO O O
LAD NNP B-NP O
SVG NNP I-NP O
Graft NNP I-NP O
to TO O O
MARG1 NNP B-NP O
( ( O O
Ostial NNP B-NP O
) ) O O
, , O O
Discrete NNP B-NP O
90% CD O O
lesion NN B-NP O
SVG NNP I-NP O
Graft NNP I-NP O
to TO O O
MARG1 NNP B-NP O
( ( O O
Proximal NNP B-NP O
) ) O O
, , O O
Discrete NNP B-NP O
90% CD O O
lesion NN B-NP O
Collateral NNP I-NP O
flow NN I-NP O
from IN B-VP O
LAD NNP B-NP O
to TO O O
RT NNP B-NP O
PDA NNP I-NP O
A/P NNP I-NP O
1 CD O O
Cardiac NNP B-NP O
Ischemia- NNP I-NP O
Pt NNP I-NP O
had VBD B-VP O
elective JJ B-NP O
PCI NNP I-NP O
on IN B-VP O
10/28/06 CD O O
with IN B-VP O
results NNS B-NP O
as IN B-VP O
mentioned JJ O O
previously RB O O
She PRP O O
did VBD B-VP O
experience VB O O
jaw NN B-NP O
sensations NNS I-NP O
and CC O O
chest JJS B-NP O
pain NN I-NP O
post NN I-NP O
procedure NN I-NP O
that IN B-VP O
she PRP O O
describes VBZ O O
as IN B-VP O
different JJ O O
from IN B-VP O
periprocedure NN B-NP O
pain NN I-NP O
, , O O
and CC O O
previous JJ B-NP O
episodes NNS I-NP O
of IN B-VP O
angina NN B-NP O
After IN B-VP O
release NN B-NP O
from IN B-VP O
CCU NNP B-NP O
, , O O
had VBD B-VP O
no DT B-NP O
further JJ I-NP O
events NNS I-NP O
No DT B-NP O
current JJ I-NP O
chest NN I-NP O
or CC O O
jaw NN B-NP O
pain NN I-NP O
Continuing NNP I-NP O
plavix NN I-NP B-m
, , O O
zocor NN B-NP B-m
, , O O
zetia NN B-NP B-m
as IN B-VP O
outpt NN B-NP O
and CC O O
heparin NN B-NP B-m
and CC O O
Integrelin NNP B-NP O
have VBP O O
been VBN O O
discontinued VBN O O
Pump- NNP B-NP O
PT NNP I-NP O
has VBZ O O
preserved VBN O O
fxn NNS B-NP O
, , O O
BP NNP B-NP O
low JJ O O
normal JJ O O
, , O O
pt JJ B-NP O
euvolemic JJ I-NP O
Rhythm NNP I-NP O
- : O O
NSR NN B-NP O
on IN B-VP O
telemetry NN B-NP O
will MD O O
d/c VB O O
on IN B-VP O
Betablocker NNP B-NP O
2 CD O O
Pulm NNP B-NP O
- : O O
Pt NN B-NP O
has VBZ O O
chronic JJ B-NP O
cough NN I-NP O
due JJ O O
to TO O O
Post NNP B-NP O
nasal NN I-NP O
drip NN I-NP O
Taken NNP I-NP O
off NN I-NP O
of IN B-VP O
her PRP$ O O
antihistamine NN B-NP O
on IN B-VP O
admission NN B-NP O
It PRP O O
is VBZ O O
USOH NNP B-NP O
per IN B-VP O
pt NN B-NP O
DID NNP I-NP O
NOT NNP I-NP O
GIVE NNP I-NP O
ANTIHISTAMINES NNP I-NP O
in IN B-VP O
this DT B-NP O
hospital NN I-NP O
course NN I-NP O
CXR NNP I-NP O
was VBD B-VP O
normal JJ O O
with IN B-VP O
no DT B-NP O
acute NN I-NP O
changes NNS I-NP O
on IN B-VP O
admission NN B-NP O
3 CD O O
Renal NNP B-NP O
- : O O
NO DT B-NP O
hx NN I-NP O
of IN B-VP O
renal JJ B-NP O
dz NN I-NP O
, , O O
No NNP B-NP O
renal JJ B-NP O
issues NNS I-NP O
during IN B-VP O
hospital JJ B-NP O
course NN I-NP O
4 CD O O
Endo NNP B-NP O
- : O O
DMII NN B-NP O
on IN B-VP O
Lantus NNP B-NP B-m
, , O O
Novolog NNP B-NP B-m
SS NNP I-NP O
, , O O
while IN B-VP O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
FS NNP I-NP O
Glu NNP I-NP O
monitored VBD B-VP O
No DT B-NP O
adjustment NN I-NP O
needed VBN O O
Will NNP B-NP O
send VB O O
out RP O O
on IN B-VP O
home NN B-NP B-do
doses NNS I-NP I-do
o VBP O O
insulin NN B-NP B-m
5 CD O O
Heme NNP B-NP O
- : O O
Pt NN B-NP O
had VBD B-VP O
cath NN B-NP O
and CC O O
subsequent JJ B-NP O
oozing NN I-NP O
from IN B-VP O
site NN B-NP O
in IN B-VP O
groin JJ B-NP O
Hct NNP I-NP O
was VBD B-VP O
stable JJ B-NP O
post NN I-NP O
cath NN I-NP O
, , O O
Anticoagulation NNP B-NP B-m
stopped VBD B-VP O
Pt NNP B-NP O
to TO O O
be VB O O
discharged VBN O O
on IN B-VP O
home NN B-NP O
meds NNS I-NP O
including VBG O O
plavix NN B-NP B-m
and CC O O
ASA NNP B-NP B-m
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Please NNP I-NP O
return VB O O
if IN B-VP O
you PRP O O
have VBP O O
any DT B-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
jaw NN B-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
groin NN B-NP O
pain NN I-NP O
, , O O
groin NN B-NP O
swelling NN I-NP O
, , O O
dizziness NN B-NP O
, , O O
or CC O O
fever NN B-NP O
and CC O O
chills VBZ O O
Please NNP B-NP O
take VB O O
medicines NNS B-NP O
as IN B-VP O
previously RB O O
prescribed VBN O O
Please NNP B-NP O
limit NN I-NP O
activity NN I-NP O
for IN B-VP O
the DT B-NP O
next JJ I-NP O
few JJ I-NP O
day NN I-NP O
to TO O O
non-strenuous JJ B-NP O
work NN I-NP O
Please NNP I-NP O
make VB O O
follow VB O O
up RP O O
appts NNS B-NP O
with IN B-VP O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
and CC O O
cardiologist NN B-NP O
within IN B-VP O
the DT O O
next JJ O O
2 CD O O
weeks NNS B-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
Please NNP I-NP O
follow VB O O
up RP O O
on IN B-VP O
groin NNS B-NP O
site NN I-NP O
and CC O O
evaluate NN B-NP O
for IN B-VP O
bruits NNS B-NP O
or CC O O
hematoma NN B-NP O
Please NNP I-NP O
follow VB O O
Hct NNP B-NP O
to TO O O
ensure VB O O
no DT B-NP O
acute JJ I-NP O
blood NN I-NP O
loss NN I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
TRANER NNP I-NP O
, , O O
BLAINE NNP B-NP O
D NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
RR0 NNP B-NP O
) ) O O
7/24/06 CD O O
@ $ O O
05:01 CD O O
PM NNP B-NP O
REVIEWED NNP I-NP O
BY: NNP I-NP O
ELLERBECK NNP I-NP O
, , O O
JAIME NNP B-NP O
R NNP I-NP O
, , O O
M.D NNP B-NP O
****** NNP I-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#943779 VBZ O O
867779708 CD O O
RH NNP B-NP O
47134929 CD O O
0640935 CD O O
6/12/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
pyelonephritis NN I-NP O
, , O O
urosepsis JJ B-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
6/12/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
11/12/2005 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
WOODBURY NNP I-NP O
, , O O
CHRISTOPHER NNP B-NP O
C NNP I-NP O
020-11-72-4 JJ B-NP O
Own NNP I-NP O
Si NNP I-NP O
A NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
9/24/05 CD O O
AT NNP B-NP O
01:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
TRUSSELL NNP I-NP O
, , O O
JERE NNP B-NP O
SCOT NNP I-NP O
, , O O
M.D NNP B-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
LISINOPRIL NNP I-NP B-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
6/25 CD O O
) ) O O
HOLD NNP B-NP O
IF: NNP I-NP O
sbp&lt;95 VBD B-VP O
Override NNP B-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
11/4/05 CD O O
by IN B-VP O
PRAWL NNP B-NP O
, , O O
LUCIO NNP B-NP O
A NNP I-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
SLOW NNP I-NP I-m
RELEASE NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
761602437 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP O
&amp; NNP I-NP O
POTASSIUM NNP I-NP O
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
Previous NNP I-NP O
override NN I-NP O
information: NN I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
11/4/05 CD O O
by IN B-VP O
MILTZ NNP B-NP O
, , O O
DOMINIC NNP B-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
LISINOPRIL NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
362261331 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
PROBABLE NNP I-NP O
allergy NN I-NP O
to TO O O
ENALAPRIL NNP B-NP O
MALEATE; NNP I-NP O
reactions NNS I-NP O
are VBP O O
HOT NNP B-NP O
FLASHES NNP I-NP O
, , O O
FACIAL NNP B-NP O
FLUSHING NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
pt NN I-NP O
has VBZ O O
tolerated VBN O O
TOPROL NNP B-NP B-m
XL NNP I-NP I-m
( ( O I-m
METOPROLOL NNP B-NP I-m
SUCCINATE NNP I-NP I-m
EXTENDED NNP I-NP I-m
RELEASE NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
hr&lt;55 NN I-NP O
, , O O
sbp&lt;95 JJ B-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
11/4/05 CD O O
by IN B-VP O
APODACA NNP B-NP O
, , O O
RORY NNP B-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
DILTIAZEM NNP I-NP O
HCL NNP I-NP O
&amp; NNP I-NP O
METOPROLOL NNP I-NP O
TARTRATE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
Number NNP I-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ B-NP O
): NN I-NP O
6 CD O O
LANTUS NNP B-NP B-m
LANTUS NNP I-NP B-m
( ( O I-m
( ( O I-m
INSULIN NNP B-NP I-m
INSULIN NNP I-NP I-m
GLARGINE NNP I-NP I-m
GLARGINE NNP I-NP I-m
) ) O I-m
) ) O I-m
19 CD O B-do
19 CD O B-do
UNITS NNP B-NP I-do
UNITS NNP I-NP I-do
QAM NNP I-NP B-f
QAM NNP I-NP B-f
SC NNP I-NP B-mo
SC NNP I-NP B-mo
QAM NNP I-NP O
19 CD O O
UNITS NNP B-NP O
QAM NNP I-NP O
Starting VBG O O
Today NNP B-NP O
( ( O O
6/17 CD O O
) ) O O
Instructions: NNP B-NP O
1/2 CD O O
dose NN B-NP O
if IN B-VP O
pt JJ B-NP O
npo NN I-NP O
or CC O O
decreased VBN O O
po's JJ B-NP O
WARFARIN NNP I-NP B-m
SODIUM NNP I-NP I-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QPM NNP I-NP O
Starting NNP I-NP O
ROUTINE NNP I-NP O
, , O O
20:00 CD O O
( ( O O
Standard NNP B-NP O
Admin NNP I-NP O
Time NNP I-NP O
) ) O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
No NNP I-NP O
high JJ B-NP O
Vitamin-K NNP I-NP O
containing VBG O O
foods NNS B-NP O
Alert NNP I-NP O
overridden: VBD B-VP O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
11/4/05 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP O
&amp; NNP I-NP O
WARFARIN NNP I-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ATORVASTATIN NNP I-NP O
CALCIUM NNP I-NP O
&amp; NNP I-NP O
WARFARIN NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
ROSIGLITAZONE NNP I-NP B-m
2 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
FUROSEMIDE NNP I-NP B-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP O
Starting VBG O O
Today NNP B-NP O
( ( O O
6/25 CD O O
) ) O O
PRN NNP B-NP O
Other:LE NNP I-NP O
edema NN I-NP B-r
Instructions: NNP I-NP O
Do NNP I-NP O
not RB O O
use VB O O
more JJR O O
than IN B-VP O
1-2 JJ B-NP O
days NNS I-NP O
per IN B-VP O
week NN B-NP O
for IN B-VP O
potential JJ B-NP O
toxicity NN I-NP O
with IN B-VP O
digoxin NN B-NP O
SIMVASTATIN NNP I-NP B-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
Alert NNP B-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
11/4/05 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP O
&amp; NNP I-NP O
SIMVASTATIN NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
already RB O O
tolerated VBN O O
, , O O
home NN B-NP B-m
medication NN I-NP I-m
, , O O
aware JJ B-NP O
CEFPODOXIME NNP I-NP B-m
PROXETIL NNP I-NP I-m
200 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP O
X NNP I-NP B-du
16 CD O I-du
doses NNS B-NP I-du
Starting VBG O O
Today NNP B-NP O
( ( O O
6/25 CD O O
) ) O O
HOLD NNP B-NP O
IF: NNP I-NP O
rash VBP O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
with IN B-VP O
meals NNS B-NP O
Alert NNP I-NP O
overridden: VBD B-VP O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
11/4/05 CD O O
by IN B-VP O
: : O O
on IN B-VP O
order NN B-NP O
for IN B-VP O
CEFPODOXIME NNP B-NP B-m
PROXETIL NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
703442345 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
POSSIBLE NNP I-NP O
allergy NN I-NP O
to TO O O
Penicillins; NNP B-NP O
reaction NN I-NP O
is VBZ O O
RASH NNP B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
cannot NN I-NP O
tolerate NN I-NP O
floroquinolones NNS I-NP O
and CC O O
needs VBZ O O
gram JJ B-NP O
neg NN I-NP O
coverage NN I-NP O
has VBZ O O
tolerated VBN O O
cefalosporins NNS B-NP B-m
well RB O O
in IN B-VP O
the DT B-NP O
past JJ I-NP O
DIGOXIN NNP I-NP B-m
0.125 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QOD NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
NAS NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
2000 CD O O
cals/day NN B-NP O
/ NNP I-NP O
Low NNP I-NP O
saturated VBD B-VP O
fat JJ B-NP O
low JJ I-NP O
cholesterol NN I-NP O
/ NNP I-NP O
low JJ B-NP O
vit NN I-NP O
k NN I-NP O
foods NNS I-NP O
(FDI) VBP O O
ACTIVITY: NNP B-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Maobi NNP I-NP O
within IN B-VP O
1wk CD O O
, , O O
ALLERGY: NNP B-NP O
Penicillins NNP I-NP O
, , O O
ENALAPRIL NNP B-NP O
MALEATE NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
pyelonephritis NN I-NP O
, , O O
urosepsis NN B-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
pyelonephritis NN B-NP O
, , O O
urosepsis NN B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
AFIB NNP I-NP O
( ( O O
atrial JJ B-NP O
fibrillation NN I-NP O
) ) O O
PYELONEPHRITIS NNP B-NP O
( ( O O
pyelonephritis NN B-NP O
) ) O O
DM NNP B-NP O
( ( O O
diabetes VBZ O O
mellitus VBP O O
type JJ O O
2 CD O O
) ) O O
HTN NNP B-NP O
( ( O O
hypertension NN B-NP O
) ) O O
HYPERLIPID NNP B-NP O
( ( O O
hyperlipidemia NN B-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
none NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
TTE NNP B-NP O
, , O O
Adenosine-MIBI NNP B-NP B-m
, , O O
PE NNP B-NP O
protocol NN I-NP O
CT NNP I-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
77 CD O O
year NN B-NP O
old JJ B-NP O
woman NN I-NP O
admitted VBN O O
with IN B-VP O
complaint NN B-NP O
of IN B-VP O
urinary JJ B-NP O
frequency NN I-NP O
and CC O O
AMS NNP B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
positive JJ B-NP O
blood NN I-NP O
and CC O O
urine JJ B-NP O
cultures NNS I-NP O
for IN B-VP O
Klebsiella NNP B-NP O
and CC O O
her PRP$ O O
AFIB NNP B-NP O
became VBD B-VP O
tachy JJ O O
to TO O O
140's CD O O
She PRP O O
was VBD B-VP O
also RB O O
noted VBN O O
to TO O O
have VB O O
an DT O O
elevated VBN O O
troponin NN B-NP O
to TO O O
1.69 CD O O
which WDT O O
rose VBD B-VP O
to TO O O
a DT B-NP O
max NN I-NP O
of IN B-VP O
2.41 CD O O
with IN B-VP O
no DT B-NP O
ekg NN I-NP O
changes VBZ O O
She PRP O O
was VBD B-VP O
rate NN B-NP O
controlled VBN O O
and CC O O
started VBN O O
on IN B-VP O
Levofloxacin NNP B-NP B-m
Her NNP I-NP O
mental NN I-NP O
status NN I-NP O
improved VBN O O
and CC O O
fever RB O O
resolved VBD B-VP O
She PRP O O
remained VBD B-VP O
tachycardic JJ O O
and CC O O
nodal JJ B-NP O
block NN I-NP O
was VBD B-VP O
supressing VBG O O
blood NN B-NP O
pressure NN I-NP O
She PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
digoxin NN B-NP B-m
with IN B-VP O
excellent JJ B-NP O
response NN I-NP O
HR NNP I-NP O
stayed VBD B-VP O
in IN B-VP O
70-80's CD O O
and CC O O
up RB O O
to TO O O
100's CD O O
with IN B-VP O
exersion NN B-NP O
Her NNP I-NP O
cardiac NN I-NP O
workup NN I-NP O
included VBD B-VP O
an DT B-NP O
echocardiogram NN I-NP O
with IN B-VP O
RV NNP B-NP O
dialation NN I-NP O
and CC O O
wall NN B-NP O
akinesis NN I-NP O
with IN B-VP O
apical JJ B-NP O
sparing NN I-NP O
, , O O
a DT B-NP O
new JJ I-NP O
finding NN I-NP O
since IN B-VP O
last JJ B-NP O
echo NN I-NP O
in IN B-VP O
'03 NNP B-NP O
Right NNP I-NP O
sided VBD B-VP O
EKG NNP B-NP O
neg IN B-VP O
A NNP B-NP O
PE NNP I-NP O
was VBD B-VP O
then RB O O
ruled VBN O O
out RP O O
with IN B-VP O
PE NNP B-NP O
protocol NN I-NP O
CT NNP I-NP O
The DT B-NP O
following JJ I-NP O
day NN I-NP O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
adenosine JJ I-NP B-m
MIBI NNP I-NP O
that WDT O O
showed VBD B-VP O
no DT B-NP O
perfusion NN I-NP O
defects VBZ O O
Her PRP$ O O
INR NNP B-NP O
was VBD B-VP O
increasing VBG O O
due JJ O O
to TO O O
the DT B-NP O
levofloxacin JJ I-NP B-m
effect NN I-NP O
and CC O O
was VBD B-VP O
switched VBN O O
to TO O O
ceftriaxone VB O B-m
consistant NN B-NP O
with IN B-VP O
blood NN B-NP O
culture NN I-NP O
succeptabilities NNS I-NP O
Follow VBP O O
up RP O O
blood NN B-NP O
cultures NNS I-NP O
on IN B-VP O
0/27 CD O O
then RB O O
demostrated VBD B-VP O
gram JJ B-NP O
positive JJ I-NP O
cocci NN I-NP O
in IN B-VP O
clusters NNS B-NP O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
given VBN O O
2 CD O B-du
doses NNS B-NP I-du
of IN B-VP O
vancomycin NN B-NP B-m
to TO O O
cover VB O O
potential JJ B-NP B-r
staph JJ I-NP O
infection NN I-NP O
Cultures NNS I-NP O
were VBD B-VP O
found VBN O O
to TO O O
be VB O O
skin JJ B-NP O
flora NNS I-NP O
and CC O O
patient JJ O O
asymptomatic JJ O O
and CC O O
antibiotics NNS B-NP B-m
d/c'd VBP O O
Repeat NNP B-NP O
cultures NNS I-NP O
were VBD B-VP O
negative JJ B-NP O
Patient NNP I-NP O
was VBD B-VP O
discharged VBN O O
in IN B-VP O
good JJ B-NP O
condition NN I-NP O
and CC O O
will MD O O
return VB O O
to TO O O
PCP NNP B-NP O
for IN B-VP O
close RB O O
follow VBP O O
up RP O O
ADDITIONAL NNP B-NP O
COMMENTS: NNP I-NP O
Call NNP I-NP O
PCP NNP I-NP O
with IN B-VP O
any DT B-NP O
changes NNS I-NP O
in IN B-VP O
urinary JJ B-NP O
symptoms NNS I-NP O
, , O O
or CC O O
fever RB O O
&gt;101.0 JJ B-NP O
Return NNP I-NP O
to TO O O
ER VB O O
if IN B-VP O
any DT B-NP O
changes NNS I-NP O
in IN B-VP O
mental JJ B-NP O
status NN I-NP O
, , O O
chest NN B-NP O
pain NN I-NP O
, , O O
SOB NNP B-NP O
, , O O
or CC O O
syncope VB O O
Complete JJ O O
the DT B-NP O
full JJ I-NP O
course NN I-NP O
of IN B-VP O
antibiotics NNS B-NP B-m
which WDT O O
cover VBP O O
the DT O O
next JJ O O
8days CD O B-du
F/U NNP B-NP O
with IN B-VP O
PCP NNP B-NP O
within IN B-VP O
the DT B-NP O
next JJ I-NP O
week NN I-NP O
with IN B-VP O
INR NNP B-NP O
and CC O O
digoxin NN B-NP B-m
levels NNS I-NP O
Do VBP O O
not RB O O
use VB O O
lasix JJ O B-m
unless IN B-VP O
necessary JJ O O
and CC O O
contact JJ B-NP O
PCP NNP I-NP O
if IN B-VP O
using VBG O O
more JJR O O
than IN B-VP O
1-2 JJ B-NP O
times NNS I-NP O
per IN B-VP O
week NN B-NP O
due JJ O O
to TO O O
possible JJ B-NP O
toxicity NN I-NP O
with IN B-VP O
digoxin NN B-NP O
use NN I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
VNA NNP I-NP O
instructions: NN I-NP O
Please NNP I-NP O
do VBP O O
vital JJ B-NP O
signs NNS I-NP O
checks NNS I-NP O
Patient NNP I-NP O
needs VBZ O O
a DT B-NP O
digoxin NN I-NP O
level NN I-NP O
and CC O O
INR NNP B-NP O
checked VBD B-VP O
weekly JJ O O
, , O O
and CC O O
the DT B-NP O
first JJ I-NP O
set NN I-NP O
of IN B-VP O
labs NN B-NP O
should MD O O
be VB O O
drawn VBN O O
1-2 JJ B-NP O
days NNS I-NP O
after IN B-VP O
discharge NN B-NP O
PCP NNP I-NP O
will MD O O
follow-up VB O O
labs JJ B-NP O
Guiac NNP I-NP O
+ NNP I-NP O
x VBD B-VP O
1 CD O O
needs NNS B-NP O
f/u NN I-NP O
TO VBP O O
THE NNP B-NP O
PATIENT: NNP I-NP O
We PRP O O
have VBP O O
altered VBN O O
cardiac JJ B-NP B-m
medications NNS I-NP I-m
for IN B-VP O
better JJR B-NP B-r
rate NN I-NP O
control NN I-NP O
We PRP O O
have VBP O O
cancelled VBN O O
the DT B-NP O
coreg( NN I-NP B-m
carvedelol NN I-NP I-m
) ) O I-m
and CC O O
Norvasc( NNP B-NP B-m
amilodipine NN I-NP I-m
) ) O I-m
and CC O O
replaced VBD B-VP O
them PRP O O
with IN B-VP O
a DT B-NP O
blood NN I-NP O
pressure NN I-NP O
medication NN I-NP O
, , O O
Toprol NNP B-NP B-m
XL( NNP I-NP I-m
Metoprolol NNP I-NP I-m
XL NNP I-NP I-m
) ) O I-m
to TO O O
better RBR O O
control VB O O
the DT B-NP O
rate NN I-NP O
of IN B-VP O
your PRP$ O O
atrial JJ B-NP B-r
fibrillation NN I-NP O
The DT B-NP O
digoxin NN I-NP B-m
was VBD B-VP O
also RB O O
added VBN O O
for IN B-VP O
heart NN B-NP B-r
rate NN I-NP I-r
control NN I-NP I-r
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
FASSNACHT NNP I-NP O
, , O O
LUCAS NNP B-NP O
, , O O
M.D NNP B-NP O
( ( O O
HD39 NNP B-NP O
) ) O O
9/24/05 CD O O
@ $ O O
01 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#944118 VBZ O O
908771041 CD O O
GSRH NNP B-NP O
57601693 CD O O
6324061 CD O O
7/10/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
2 CD O O
episodes NNS B-NP O
lethargy JJ O O
, , O O
unsteady JJ B-NP O
gait NN I-NP O
of IN B-VP O
unclear JJ B-NP O
etiology NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
8/14/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
9/24/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
MYREN NNP I-NP O
, , O O
JAYSON NNP B-NP O
E NNP I-NP O
502-87-60-2 JJ B-NP O
E NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
10/5/06 CD O O
AT NNP B-NP O
01:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
QUESNELL NNP I-NP O
, , O O
ABRAHAM NNP B-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
10/27 CD O O
) ) O O
LIPITOR NNP B-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
GLYBURIDE NNP I-NP B-m
2.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
X NNP I-NP B-du
60 CD O I-du
doses NNS B-NP I-du
METFORMIN NNP I-NP B-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
RETURN NNP I-NP O
TO NNP I-NP O
WORK: NNP I-NP O
Immediately RB O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Rigoberto NNP I-NP O
Lannom NNP I-NP O
Monday NNP I-NP O
February NNP I-NP O
scheduled VBD B-VP O
, , O O
ALLERGY: NNP B-NP O
NKA NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
2 CD O O
episodes NNS B-NP O
lethargy JJ O O
, , O O
unsteady JJ B-NP O
gait NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
2 CD O O
episodes NNS B-NP O
lethargy JJ O O
, , O O
unsteady JJ B-NP O
gait NN I-NP O
of IN B-VP O
unclear JJ B-NP O
etiology NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
newly-diagnosed JJ B-NP O
DM NNP I-NP O
h/o NN I-NP O
EtOH NNP I-NP O
abuse NN I-NP O
( ( O O
7 CD O O
) ) O O
hyperlipidemia NN B-NP O
glaucoma NN I-NP O
L NNP I-NP O
eye NN I-NP O
( ( O O
3 CD O O
) ) O O
erectile NN B-NP O
dysfunction NN I-NP O
dysfunction NN I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
none NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC: NNP I-NP O
lethargy NN I-NP O
, , O O
unsteady JJ B-NP O
gait NN I-NP O
-- : O O
readmission NN B-NP O
after IN B-VP O
similar JJ B-NP O
symptoms NNS I-NP O
Wed NNP I-NP O
HPI:60M NNP I-NP O
w/ VBD B-VP O
newly-diagnosed JJ B-NP O
DM NNP I-NP O
, , O O
hyperlipidemia NN B-NP O
, , O O
glaucoma NN B-NP O
, , O O
h/o NN B-NP O
EtOH NNP I-NP O
abuse NN I-NP O
, , O O
and CC O O
erectile JJ B-NP O
dysfunction NN I-NP O
presents NNS I-NP O
to TO O O
ED NNP B-NP O
for IN B-VP O
2nd CD O O
time NN B-NP O
in IN B-VP O
3 CD O O
days NNS B-NP O
w/ JJ O O
unsteadiness JJ O O
and CC O O
sleepiness NN B-NP O
He PRP O O
was VBD B-VP O
admitted VBN O O
8/4/06 CD O O
with IN B-VP O
similar JJ B-NP O
sleepiness NN I-NP O
and CC O O
poor JJ B-NP O
hand NN I-NP O
coordination NN I-NP O
and CC O O
trouble NN B-NP O
driving NN I-NP O
, , O O
was VBD B-VP O
brought VBN O O
to TO O O
ED NNP B-NP O
somnolent NN I-NP O
and CC O O
found VBN O O
to TO O O
have VB O O
BS NNP B-NP O
200-300 JJ B-NP O
Workup NNP I-NP O
including VBG O O
head NN B-NP O
CTA NNP I-NP O
, , O O
MR NNP B-NP O
were VBD B-VP O
negative JJ O O
and CC O O
patient JJ B-NP O
d/c'ed NN I-NP O
Thursday NNP I-NP O
night NN I-NP O
w/ NN I-NP O
metformin NN I-NP B-m
and CC O O
plans NNS B-NP O
for IN B-VP O
Holter NNP B-NP O
and CC O O
TTE NNP B-NP O
on IN B-VP O
Monday NNP B-NP O
Patient NNP I-NP O
felt VBD B-VP O
great JJ O O
until IN B-VP O
Friday NNP B-NP O
morning NN I-NP O
when WRB O O
noted VBN O O
to TO O O
have VB O O
unsteadiness JJ O O
and CC O O
sleepiness NN B-NP O
, , O O
similar JJ O O
but CC O O
less RBR O O
severe JJ O O
than IN B-VP O
Wed NNP B-NP O
Returned VBD B-VP O
to TO O O
ED NNP B-NP O
with IN B-VP O
BS NNP B-NP O
277 CD O O
No NNP B-NP O
fevers NNS I-NP O
, , O O
headaches NNS B-NP O
, , O O
focal JJ B-NP O
neuro NN I-NP O
findings NNS I-NP O
, , O O
vertigo NN B-NP O
, , O O
visual JJ B-NP O
changes NNS I-NP O
, , O O
CP NNP B-NP O
, , O O
SOB NNP B-NP O
, , O O
n/v RB O O
, , O O
abd JJ B-NP O
pain NN I-NP O
, , O O
dysuria NN B-NP O
, , O O
joint JJ B-NP O
pain NN I-NP O
Reported VBD B-VP O
small JJ B-NP B-r
rash NN I-NP I-r
on IN B-VP I-r
penis NN B-NP I-r
for IN B-VP I-r
which WDT O I-r
was VBD B-VP I-r
taking VBG O I-r
acyclovir NN B-NP B-m
this DT B-NP B-du
week NN I-NP I-du
but CC O O
stopped VBD B-VP O
Wed NNP B-NP O
for IN B-VP O
possible JJ B-NP O
neuro JJ I-NP O
side NN I-NP O
effects NNS I-NP O
Admit NNP I-NP O
labs VBD B-VP O
significant JJ O O
for IN B-VP O
glucose JJ O O
314 CD O O
, , O O
elevated VBN O O
lipids NNS B-NP O
( ( O O
Chol NNP B-NP O
302 CD O O
, , O O
Trig NNP B-NP O
323 CD O O
, , O O
LDL NNP B-NP O
189 CD O O
) ) O O
, , O O
otherwise RB O O
normal JJ O O
, , O O
negative JJ B-NP O
cardiac NN I-NP O
enzymes NNS I-NP O
Urine NNP I-NP O
toxin NN I-NP O
screen NN I-NP O
was VBD B-VP O
negative JJ B-NP O
CBC NNP I-NP O
normal JJ O O
except IN B-VP O
for IN B-VP O
MCV NNP B-NP O
78 CD O O
with IN B-VP O
normal JJ B-NP O
iron NN I-NP O
studies NNS I-NP O
and CC O O
normal JJ B-NP O
RBC NNP I-NP O
mass NN I-NP O
HbA1c NNP I-NP O
was VBD B-VP O
11.1% CD O O
EKG NNP B-NP O
had VBD B-VP O
old JJ B-NP O
j-point JJ I-NP O
elevation NN I-NP O
laterally RB O O
, , O O
otherwise RB O O
NSR NNP B-NP O
without IN B-VP O
LVH NNP B-NP O
or CC O O
LAE NNP B-NP O
Physical NNP I-NP O
and CC O O
neuro JJ B-NP O
exam NN I-NP O
normal JJ B-NP O
MRI/MRA NNP I-NP O
and CC O O
CTA NNP B-NP O
were VBD B-VP O
unremarkable JJ O O
in IN B-VP O
1st CD O O
admission NN B-NP O
2 CD O O
days NNS B-NP O
prior RB O O
and CC O O
so RB O O
were VBD B-VP O
not RB O O
repeated VBN O O
Patient NNP B-NP O
was VBD B-VP O
stable JJ O O
overnight JJ O O
and CC O O
felt VBD B-VP O
great JJ O O
on IN B-VP O
Saturday NNP B-NP O
0/11/06 CD O O
morning NN B-NP O
No NNP I-NP O
abnormal JJ B-NP O
events NNS I-NP O
were VBD B-VP O
recorded VBN O O
on IN B-VP O
telemetry NN B-NP O
overnight NN I-NP O
and CC O O
after IN B-VP O
patient NN B-NP O
was VBD B-VP O
walked VBN O O
around IN B-VP O
the DT B-NP O
floor NN I-NP O
Patient NNP I-NP O
sugars NNS I-NP O
were VBD B-VP O
managed VBN O O
o/n NN B-NP O
with IN B-VP O
sliding VBG O B-do
scale JJ B-NP I-do
insulin NN I-NP B-m
and CC O O
diabetic JJ B-NP O
low-fat JJ I-NP O
house NN I-NP O
diet NN I-NP O
, , O O
and CC O O
blood NN B-NP B-r
sugar NN I-NP I-r
in IN B-VP O
morning NN B-NP O
responded VBD B-VP O
down RB O O
to TO O O
185 CD O O
Explanations NNS B-NP O
for IN B-VP O
episodes NNS B-NP O
considered VBN O O
were VBD B-VP O
TIA NNP B-NP O
of IN B-VP O
posterior JJ B-NP O
circulation NN I-NP O
vs NN I-NP O
seizure NN I-NP O
, , O O
less RBR O O
likely JJ B-NP O
atypical JJ I-NP O
migraine NN I-NP O
or CC O O
sleep JJ B-NP O
disorder NN I-NP O
-- : O O
see VB O O
admit JJ B-NP O
notes NNS I-NP O
for IN B-VP O
discussion NN B-NP O
At IN B-VP O
time NN B-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
patient NN B-NP O
was VBD B-VP O
stable JJ O O
and CC O O
feeling JJ O O
very RB O O
good JJ O O
, , O O
eager JJ O O
to TO O O
leave VB O O
for IN B-VP O
an DT B-NP O
afternoon NN I-NP O
function NN I-NP O
and CC O O
preferred VBD B-VP O
not RB O O
to TO O O
stay VB O O
for IN B-VP O
further JJ B-NP O
workup NN I-NP O
He PRP O O
will MD O O
followup VB O O
with IN B-VP O
Dr NNP B-NP O
Clesen NNP I-NP O
on IN B-VP O
Monday NNP B-NP O
He PRP O O
will MD O O
be VB O O
evaluated VBN O O
this DT B-NP O
week NN I-NP O
with IN B-VP O
TTE NNP B-NP O
with IN B-VP O
bubble-study NN B-NP O
to TO O O
r/o VB O O
intracardiac JJ B-NP O
source NN I-NP O
or CC O O
PFO NNP B-NP O
Would NNP I-NP O
also RB O O
consider VBP O O
EEG NNP B-NP O
if IN B-VP O
Neurology NNP B-NP O
deems VBZ O O
possibility NN B-NP O
of IN B-VP O
seizure NN B-NP O
In IN B-VP O
the DT B-NP O
meantime NN I-NP O
, , O O
added VBD B-VP O
low-dose JJ B-NP B-do
glyburide NN I-NP B-m
to TO O O
metformin VB O B-m
to TO O O
manage VB O O
hyperglycemia NN B-NP B-r
at IN B-VP O
home NN B-NP O
, , O O
with IN B-VP O
more RBR O O
strips NNS B-NP O
to TO O O
monitor VB O O
blood NN B-NP O
sugars NNS I-NP O
3-4x JJ B-NP O
/ NNP I-NP O
day NN I-NP O
Have NNP I-NP O
also RB O O
increased VBD B-VP O
aspirin JJ B-NP B-m
aspirin NN I-NP B-m
dose NN I-NP O
from IN B-VP O
81 CD O B-do
mg NNS B-NP I-do
to TO O O
325 CD O B-do
mg NNS B-NP I-do
qd JJ B-NP B-f
qd JJ I-NP B-f
Patient NNP I-NP O
was VBD B-VP O
also RB O O
given VBN O O
prescription NN B-NP O
for IN B-VP O
automatic JJ B-NP O
BP NNP I-NP O
cuff NN I-NP O
for IN B-VP O
monitoring NN B-NP O
at IN B-VP O
home NN B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
To TO O O
better RBR O O
manage VB O O
your PRP$ O O
blood NN B-NP B-r
sugars NNS I-NP I-r
, , O O
added VBD B-VP O
glyburide NN B-NP B-m
which WDT O O
you PRP O O
should MD O O
take VB O O
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
in IN B-VP O
addition NN B-NP O
to TO O O
metformin VB O B-m
twice RB O B-f
a DT B-NP I-f
day NN I-NP I-f
Continue NNP I-NP O
to TO O O
check VB O O
your PRP$ O O
blood NN B-NP O
sugars NNS I-NP O
3-4 JJ B-NP O
times NNS I-NP O
per IN B-VP O
day NN B-NP O
You PRP O O
can MD O O
also RB O O
obtain VB O O
an DT B-NP O
automatic JJ I-NP O
BP NNP I-NP O
cuff NN I-NP O
for IN B-VP O
monitoring NN B-NP O
at IN B-VP O
home NN B-NP O
If IN B-VP O
episode JJ B-NP O
recurs NNS I-NP O
, , O O
do VBP O O
not RB O O
drive VB O O
, , O O
check VB O O
sugars NNS B-NP O
and CC O O
BP NNP B-NP O
, , O O
drink NN B-NP O
fluids NNS I-NP O
, , O O
contact NN B-NP O
MD NNP I-NP O
or CC O O
return VB O O
to TO O O
ED NNP B-NP O
as RB O O
soon RB O O
as IN B-VP O
possible JJ B-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
f/u NN I-NP O
with IN B-VP O
Dr NNP B-NP O
Wantuck NNP I-NP O
on IN B-VP O
February NNP B-NP O
, , O O
that IN B-VP O
week NN B-NP O
should MD O O
have VB O O
TTE NNP B-NP O
with IN B-VP O
bubble JJ B-NP O
study NN I-NP O
to TO O O
evaluate VB O O
heart NN B-NP O
, , O O
EEG NNP B-NP O
to TO O O
r/o VB O O
seizure NN B-NP O
, , O O
titer NN B-NP O
hyperglycemia NN I-NP O
meds VBZ O O
No NNP B-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
RIEGLE NNP I-NP O
, , O O
TRISTAN NNP B-NP O
F NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
SN83 NNP B-NP O
) ) O O
10/5/06 CD O O
@ $ O O
01:46 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#945230 VBZ O O
955804700 CD O O
OH NNP B-NP O
96181967 CD O O
3755263 CD O O
5/19/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
Congestive NNP I-NP O
Heart NNP I-NP O
Failure NNP I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
9/6/2004 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
5/22/2004 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
TURTURO NNP I-NP O
, , O O
RAYFORD NNP B-NP O
759-74-53-9 CD O O
Reve NNP B-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
4/12/04 CD O O
AT NNP B-NP O
04:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
CORKERN NNP I-NP O
, , O O
ROBERTO NNP B-NP O
R NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
1/16/04 CD O O
by IN B-VP O
JAHNS NNP B-NP O
, , O O
WINFRED NNP B-NP O
M NNP I-NP O
W NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.P.H NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
WARFARIN NNP B-NP B-m
SODIUM NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
94959833 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
pt NN I-NP O
on IN B-VP O
as IN B-VP O
outpt JJ B-NP O
ALLOPURINOL NNP I-NP B-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
1/16/04 CD O O
by IN B-VP O
ZORRILLA NNP B-NP O
, , O O
OMAR NNP B-NP O
C NNP I-NP O
E NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.P.H NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
ALLOPURINOL NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
monitor VB O O
DIGOXIN NNP B-NP B-m
0.125 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
1/16/04 CD O O
by IN B-VP O
BEGUN NNP B-NP O
, , O O
LANNY NNP B-NP O
E NNP I-NP O
F NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.P.H NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
LEVOXYL NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
70031810 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
DIGOXIN NNP I-NP B-m
&amp; NNP I-NP O
LEVOTHYROXINE NNP I-NP B-m
SODIUM NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
pt NN I-NP O
has VBZ O O
been VBN O O
on IN B-VP O
this DT O O
as IN B-VP O
an DT B-NP O
outpt NN I-NP O
LEVOXYL NNP I-NP B-m
( ( O I-m
LEVOTHYROXINE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
75 CD O B-do
MCG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
1/16/04 CD O O
by IN B-VP O
CUZCO NNP B-NP O
, , O O
JAMISON NNP B-NP O
D NNP I-NP O
V NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.P.H NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
WARFARIN NNP B-NP B-m
SODIUM NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
94959833 CD O O
) ) O O
SERIOUS NNP B-NP O
INTERACTION: NNP I-NP O
LEVOTHYROXINE NNP I-NP B-m
SODIUM NNP I-NP I-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
pt NN I-NP O
on IN B-VP O
as IN B-VP O
outpt JJ B-NP O
Previous NNP I-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
1/16/04 CD O O
by IN B-VP O
BRIDGETTE NNP B-NP O
, , O O
OSWALDO NNP B-NP O
T NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.P.H NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
DIGOXIN NNP I-NP B-m
&amp; NNP I-NP O
LEVOTHYROXINE NNP I-NP B-m
SODIUM NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
pt NN I-NP O
has VBZ O O
been VBN O O
on IN B-VP O
this DT O O
as IN B-VP O
an DT B-NP O
outpt NN I-NP O
TOPROL NNP I-NP B-m
XL NNP I-NP I-m
( ( O I-m
METOPROLOL NNP B-NP I-m
( ( O I-m
SUST NNP B-NP I-m
REL NNP I-NP I-m
) ) O I-m
) ) O I-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
8 CD O I-du
NEURONTIN NNP B-NP B-m
( ( O I-m
GABAPENTIN NNP B-NP I-m
) ) O I-m
200 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
COZAAR NNP I-NP B-m
( ( O I-m
LOSARTAN NNP B-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp&lt;100 VBD B-VP O
Number NNP B-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
9 CD O I-du
CELEXA NNP B-NP B-m
( ( O I-m
CITALOPRAM NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
LANTUS NNP I-NP B-m
( ( O I-m
INSULIN NNP B-NP I-m
GLARGINE NNP I-NP I-m
) ) O I-m
50 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
QHS NNP I-NP B-f
WARFARIN NNP I-NP B-m
SODIUM NNP I-NP I-m
3 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QPM NNP I-NP B-f
Starting NNP I-NP O
ROUTINE NNP I-NP O
, , O O
20:00 CD O O
( ( O O
7/5 CD O O
) ) O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
No NNP I-NP O
high JJ B-NP O
Vitamin-K NNP I-NP O
containing VBG O O
foods NNS B-NP O
Alert NNP I-NP O
overridden: VBD B-VP O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
5/18/04 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LEVOTHYROXINE NNP I-NP B-m
SODIUM NNP I-NP I-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ALLOPURINOL NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LEVOFLOXACIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LEVOFLOXACIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
pt NN I-NP O
on IN B-VP O
as IN B-VP O
outpt NN B-NP O
will MD O O
monitor VB O O
LIPITOR NNP B-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
PRILOSEC NNP I-NP B-m
( ( O I-m
OMEPRAZOLE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
TORSEMIDE NNP I-NP B-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QAM NNP I-NP B-f
TORSEMIDE NNP I-NP B-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QPM NNP I-NP B-f
DIET: NNP I-NP O
Patient NNP I-NP O
should MD O O
measure VB O O
weight JJ B-NP O
daily JJ I-NP O
DIET: NNP I-NP O
Fluid NNP I-NP O
restriction: VBD B-VP O
2 CD O O
liters NNS B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
1800 CD O O
cals/dy NN B-NP O
DIET: NNP I-NP O
2 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Wilfinger NNP I-NP O
, , O O
PCP NNP B-NP O
2 CD O O
weeks NNS B-NP O
, , O O
Corey NNP B-NP O
Ortmeyer NNP I-NP O
, , O O
CHF NNP B-NP O
clinic NN I-NP O
, , O O
Laxo NNP B-NP O
Hospital NNP I-NP O
, , O O
10:30am CD O O
11/28/04 CD O O
scheduled VBN O O
, , O O
Salvatore NNP B-NP O
Angeli NNP I-NP O
, , O O
pacer/icd NN B-NP O
clinic JJ O O
9:30am CD O O
( ( O O
463 CD O O
) ) O O
281 CD O O
7305 CD O O
7/1/04 CD O O
scheduled VBN O O
, , O O
INR NNP B-NP O
check NN I-NP O
at IN B-VP O
regular JJ B-NP O
location NN I-NP O
11/28/04 CD O O
, , O O
ALLERGY: NNP B-NP O
SHRIMP NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
Congestive NNP I-NP O
Heart NNP I-NP O
Failure NNP I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Congestive NNP B-NP O
Heart NNP I-NP O
Failure NNP I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
Adriamycin NNP I-NP B-m
induced VBD B-VP O
CMP NNP B-NP O
, , O O
HTN NNP B-NP O
, , O O
IDDM NNP B-NP O
, , O O
Sarcoid NNP B-NP O
, , O O
Left NNP B-NP O
Breast NNP I-NP O
CA- NNP I-NP O
s/p NN I-NP O
lumpect NN I-NP O
and CC O O
XRT/Adria-'84 NN B-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
? . B-VP O
GI NNP B-NP O
origin NN I-NP O
of IN B-VP O
epigastric JJ B-NP O
pain NN I-NP O
, , O O
dvt NN B-NP O
( ( O O
deep JJ B-NP O
venous JJ I-NP O
thrombosis NN I-NP O
) ) O O
, , O O
osteoarthritis FW O O
( ( O O
unspecified JJ O O
or CC O O
generalized JJ B-NP O
OA NNP I-NP O
) ) O O
, , O O
hypothyroid JJ O O
( ( O O
hypothyroidism NN B-NP O
) ) O O
cad NN B-NP O
( ( O O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
VVI/R NNP I-NP O
ICD NNP I-NP O
placement NN I-NP O
11/16/4 CD O O
by IN B-VP O
Dr NNP B-NP O
Chan NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
This DT O O
is VBZ O O
a DT O O
60 CD O O
year NN B-NP O
old JJ B-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
breast NN B-NP O
cancer NN I-NP O
and CC O O
chemotherapy NN B-NP O
induced VBD B-VP O
CMP( NNP B-NP O
EF NNP I-NP O
20% CD O O
, , O O
followed VBN O O
by IN B-VP O
CMP NNP B-NP O
clinic; NN I-NP O
on IN B-VP O
2 CD O O
L NNP B-NP O
O2 NNP I-NP O
at IN B-VP O
night NN B-NP O
) ) O O
, , O O
COPD NNP B-NP O
, , O O
s/p JJ B-NP O
DVT NNP I-NP O
now RB O O
anticoagulated VBD B-VP O
, , O O
HTN NNP B-NP O
, , O O
afib NN B-NP O
, , O O
DM NNP B-NP O
, , O O
admitted VBD B-VP O
with IN B-VP O
presumed JJ B-NP O
CHF NNP I-NP O
flare NN I-NP O
Ms NNP I-NP O
Guerena NNP I-NP O
was VBD B-VP O
recently RB O O
admitted VBN O O
for IN B-VP O
CHF NNP B-NP O
flare NN I-NP O
and CC O O
received VBD B-VP O
intravenous JJ B-NP O
diuresis NN I-NP O
She PRP O O
reponded VBD B-VP O
well RB O O
and CC O O
was VBD B-VP O
discharged VBN O O
at IN B-VP O
a DT B-NP O
dry JJ I-NP O
weight NN I-NP O
of IN B-VP O
approximately RB O O
185 CD O O
pounds NNS B-NP O
Ms NNP I-NP O
Kimmell NNP I-NP O
presented VBD B-VP O
on IN B-VP O
this DT B-NP O
admission NN I-NP O
with IN B-VP O
2 CD O O
days NNS B-NP O
of IN B-VP O
increasing VBG O O
SOB NNP B-NP O
, , O O
abdominal JJ B-NP O
discomfort NN I-NP O
, , O O
nausea NN B-NP O
and CC O O
vomitting VBG O O
She PRP O O
denied VBD B-VP O
increasing VBG O O
edema NN B-NP O
, , O O
change NN B-NP O
in IN B-VP O
number NN B-NP O
of IN B-VP O
pillows NNS B-NP O
She PRP O O
did VBD B-VP O
endorse VB O O
PND NNP B-NP O
present JJ O O
but CC O O
states VBZ O O
that IN B-VP O
it PRP O O
is VBZ O O
unchanged JJ O O
In IN B-VP O
ED NNP B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
afebile RB O O
, , O O
inital JJ B-NP O
ly NN I-NP O
with IN B-VP O
oxygen NN B-NP O
saturation NN I-NP O
in IN B-VP O
the DT O O
high JJ O O
90's CD O O
on IN B-VP O
2 CD O O
L NNP B-NP O
BP NNP I-NP O
154/84 CD O O
BNP NNP B-NP O
was VBD B-VP O
greater JJR O O
than IN B-VP O
3000 CD O O
CXR NNP B-NP O
showed VBD B-VP O
pulmonary JJ B-NP O
edema JJ I-NP O
Abdominal NNP I-NP O
CT NNP I-NP O
was VBD B-VP O
obtained VBN O O
due JJ O O
to TO O O
concern NN B-NP O
for IN B-VP O
the DT B-NP O
patients NNS I-NP O
abdominal JJ B-NP O
pain NN I-NP O
and CC O O
showed VBD B-VP O
an DT O O
engorged VBN O O
, , O O
fatty JJ B-NP O
liver NN I-NP O
, , O O
ascites NNS B-NP O
, , O O
pleural JJ B-NP O
effusions NNS I-NP O
( ( O O
not RB O O
seen VBN O O
on IN B-VP O
CXR NNP B-NP O
) ) O O
A NNP B-NP O
surgical JJ B-NP O
consult NN I-NP O
was VBD B-VP O
obtained VBN O O
and CC O O
the DT B-NP O
surgeons NNS I-NP O
felt VBD B-VP O
the DT B-NP O
patients NNS I-NP O
abdominal JJ B-NP O
pain NN I-NP O
was VBD B-VP O
not RB O O
surgical JJ O O
in IN B-VP O
nature NN B-NP O
but CC O O
rather RB O O
secondary JJ O O
to TO O O
CHF NNP B-NP O
Hospital NNP I-NP O
Course: NNP I-NP O
1 CD O O
) ) O O
Cardiovascular: NNP B-NP O
a DT O O
) ) O O
Pump- NNP B-NP O
CHF NNP I-NP O
exacerbation NN I-NP O
We PRP O O
diuresed VBD B-VP O
the DT B-NP O
patient NN I-NP O
initially RB O O
with IN B-VP O
intravenous JJ B-NP B-mo
lasix NN I-NP B-m
until IN B-VP B-du
her PRP$ O O
respiratory NN B-NP O
status NN I-NP O
imroved VBN O O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
able JJ O O
to TO O O
maintain VB O O
good JJ B-NP O
oxygen NN I-NP O
saturation NN I-NP O
on IN B-VP O
room NN B-NP O
air NN I-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
her PRP$ O O
oxygen NN B-NP O
saturation NN I-NP O
on IN B-VP O
room NN B-NP O
air NN I-NP O
was VBD B-VP O
in IN B-VP O
the DT O O
high JJ O O
90's CD O O
and CC O O
was VBD B-VP O
between IN B-VP O
94-96 CD O O
% NN B-NP O
with IN B-VP O
ambulation NN B-NP O
We PRP O O
continued VBD B-VP O
the DT B-NP O
patient's NN I-NP O
home NN I-NP B-do
doses NNS I-NP I-do
of IN B-VP O
beta NN B-NP B-m
blocker NN I-NP I-m
, , O O
angiotension NN B-NP B-m
receptor NN I-NP O
blocker NN I-NP O
and CC O O
statin VB O B-m
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
again RB O O
encouraged VBN O O
to TO O O
adhere VB O O
to TO O O
a DT B-NP O
low-salt JJ I-NP O
diet NN I-NP O
and CC O O
weight VBD B-VP O
herself PRP O O
daily RB O O
The DT B-NP O
patient NN I-NP O
will MD O O
be VB O O
discharged VBN O O
on IN B-VP O
Torsemide NNP B-NP B-m
Torsemide NNP I-NP B-m
100 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
q NN I-NP B-f
am VBP O I-f
and CC O O
50 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
q NN I-NP B-f
pm NN I-NP I-f
, , O O
a DT B-NP O
regimine NN I-NP O
t NN I-NP O
has VBZ O O
worked VBN O O
will MD O O
for IN B-VP O
the DT B-NP O
patient NN I-NP O
in IN B-VP O
the DT O O
past JJ O O
She PRP O O
will MD O O
f/uw VB O O
iht VB O O
the DT B-NP O
Naiimo NNP I-NP O
Hospital NNP I-NP O
CHF NNP I-NP O
Clinic NNP I-NP O
( ( O O
Harold NNP B-NP O
Gohring NNP I-NP O
) ) O O
on IN B-VP O
5/10 CD O O
at IN B-VP O
10:30 CD O O
am VBP O O
The DT B-NP O
patient NN I-NP O
will MD O O
be VB O O
followed VBN O O
by IN B-VP O
Rangespo NNP B-NP O
Chica NNP I-NP O
Li NNP I-NP O
VNA NNP I-NP O
who WP O O
will MD O O
assist VB O O
in IN B-VP O
her PRP$ O O
CHF NNP B-NP O
monitoring NN I-NP O
and CC O O
assess VB O O
her PRP$ O O
for IN B-VP O
home NN B-NP O
PT NNP I-NP O
b NN I-NP O
) ) O O
Rhythm- NNP B-NP O
The DT B-NP O
pa NN I-NP O
tient NN I-NP O
is VBZ O O
know VBN O O
to TO O O
have VB O O
frequent JJ B-NP O
PVCs NNP I-NP O
and CC O O
non-sustained JJ B-NP O
ventricular NN I-NP O
tachycardia NN I-NP O
which WDT O O
was VBD B-VP O
agian JJ O O
noted VBN O O
on IN B-VP O
this DT B-NP O
admission NN I-NP O
on IN B-VP O
telemetry NN B-NP O
She PRP O O
was VBD B-VP O
asymptomatic JJ O O
with IN B-VP O
the DT B-NP O
NSVT NNP I-NP O
and CC O O
remains VBZ O O
hemodynamically RB O O
stable JJ O O
We PRP O O
obtained VBD B-VP O
an DT B-NP O
electrophysiology NN I-NP O
consult NN I-NP O
to TO O O
evaluate VB O O
the DT B-NP O
need NN I-NP O
for IN B-VP O
an DT B-NP O
AICD NNP I-NP O
or CC O O
biventricular JJ O O
pacing VBG O O
The DT B-NP O
patietns NN I-NP O
electrolytes NNS I-NP O
and CC O O
magnesium NN B-NP O
were VBD B-VP O
monitored VBN O O
and CC O O
rempleted VBN O O
and CC O O
she PRP O O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
a DT B-NP O
beta NN I-NP B-m
blocker NN I-NP I-m
On IN B-VP O
10/7 CD O O
the DT B-NP O
EP NNP I-NP O
service NN I-NP O
placed VBD B-VP O
a DT B-NP O
VVI/R NNP I-NP O
ICD NNP I-NP O
device NN I-NP O
without IN B-VP O
complications NNS B-NP O
It PRP O O
was VBD B-VP O
interogated VBN O O
ont IN B-VP O
he PRP O O
day NN B-NP O
of IN B-VP O
d/c NN B-NP O
and CC O O
the DT B-NP O
patietn NN I-NP O
was VBD B-VP O
provided VBN O O
with IN B-VP O
written VBN O O
instructions NNS B-NP O
from IN B-VP O
the DT B-NP O
EP NNP I-NP O
service NN I-NP O
for IN B-VP O
d/c NN B-NP O
She PRP O O
will MD O O
follow-up VB O O
with IN B-VP O
the DT B-NP O
Dr NNP I-NP O
Cradduck NNP I-NP O
on IN B-VP O
6/22 CD O O
as IN B-VP O
described VBN O O
c NN B-NP O
) ) O O
Ischemia: NNP B-NP O
Patient NNP I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
CAD NNP B-NP O
ED NNP I-NP O
initially RB O O
concerned VBD B-VP O
for IN B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
She PRP O O
was VBD B-VP O
ruled VBN O O
o RP O O
ut JJ O O
for IN B-VP O
an DT B-NP O
MI NNP I-NP O
with IN B-VP O
negative JJ B-NP O
cardiac JJ I-NP O
enzymes NNS I-NP O
x VBP O O
3 CD O O
Serial JJ B-NP O
EKG's NNP I-NP O
were VBD B-VP O
unchanged JJ O O
We PRP O O
continued VBD B-VP O
the DT B-NP O
patient NN I-NP O
on IN B-VP O
ASA NNP B-NP B-m
, , O O
beta NN B-NP B-m
blocker NN I-NP I-m
, , O O
s JJ B-NP O
tatin NN I-NP O
and CC O O
ARB NNP B-NP B-m
2 CD O O
)Heme: NNP B-NP O
Ms NNP I-NP O
Egerton NNP I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
DVT NNP B-NP B-r
, , O O
therapeutic JJ O O
on IN B-VP O
coumadin NN B-NP B-m
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
We PRP O O
did VBD B-VP O
decreased VBD B-VP O
her PRP$ O O
dose NN B-NP O
while IN B-VP O
being VBG O O
treated VBN O O
with IN B-VP O
levofloxacin NN B-NP B-m
In IN B-VP O
addition NN B-NP O
her PRP$ O O
coumadin NN B-NP B-m
was VBD B-VP O
held VBN O O
for IN B-VP O
her PRP$ O B-r
EP JJ B-NP I-r
procedure NN I-NP I-r
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
d/c NN B-NP O
she PRP O O
will MD O O
be VB O O
resuming VBG O O
her PRP$ O O
regular JJ B-NP B-do
dose NN I-NP I-do
of IN B-VP O
coumadin NN B-NP B-m
and CC O O
should MD O O
follow-up VB O O
at IN B-VP O
her PRP$ O O
usualy JJ B-NP O
JMC NNP I-NP O
lab NN I-NP O
to TO O O
have VB O O
her PRP$ O O
INR NNP B-NP O
checked NN I-NP O
on IN B-VP O
Thursday NNP B-NP O
5/10 CD O O
3 CD O O
)ID: JJ B-NP O
+UA NN I-NP O
on IN B-VP O
admission NN B-NP O
treated VBN O O
for IN B-VP B-du
three CD O I-du
days NNS B-NP I-du
with IN B-VP O
levofloxacin NN B-NP B-m
( ( O O
Last JJ B-NP O
day NN I-NP O
was VBD B-VP O
1/16/4 CD O O
) ) O O
Her PRP$ O O
cx NN B-NP O
grew VBD B-VP O
citrobacter NN B-NP O
which WDT O O
was VBD B-VP O
sensitive JJ O O
to TO O O
levo VB O B-m
Repeat NNP B-NP O
UA NNP I-NP O
was VBD B-VP O
negative JJ O O
4 CD O O
) ) O O
GI: NNP B-NP O
Abdominal NNP I-NP O
discomfort NN I-NP O
presumably RB O O
due JJ O O
to TO O O
hepatic JJ B-NP O
congestion NN I-NP O
Abdominal NNP I-NP O
CT NNP I-NP O
showed VBD B-VP O
no DT B-NP O
acute JJ I-NP O
surgical JJ I-NP O
process NN I-NP O
Abdominal NNP I-NP O
pain NN I-NP O
was VBD B-VP O
resolved VBN O O
with IN B-VP O
diuresis NN B-NP O
She PRP O O
does VBZ O O
have VB O O
a DT B-NP O
chronic JJ I-NP O
elevated JJ I-NP O
alk NN I-NP O
phos NN I-NP O
which WDT O O
may MD O O
be VB O O
related VBN O O
to TO O O
her PRP$ O O
sarcoid JJ O O
6 CD O O
)Endocrine: JJ B-NP O
Continued NNP I-NP O
levoxyl NN I-NP B-m
for IN B-VP O
the DT B-NP B-r
patient's NN I-NP I-r
hypothyroid NN I-NP I-r
Pt NNP I-NP O
with IN B-VP O
IDDM NNP B-NP O
We PRP O O
decreased VBD B-VP O
her PRP O O
lantus NN B-NP B-m
lantus NN I-NP B-m
dose NN I-NP O
from IN B-VP O
50 CD O B-do
u JJ B-NP I-do
sc NN I-NP B-mo
to TO O O
30 CD O B-do
u JJ B-NP I-do
sc NN I-NP B-mo
on IN B-VP O
admission NN B-NP O
as IN B-VP O
po JJ B-NP O
intake NN I-NP O
was VBD B-VP O
initially RB O O
low JJ B-NP O
Pt NNP I-NP O
can MD O O
resume VB O O
regular JJ B-NP B-m
insulin NN I-NP O
dose NN I-NP O
after IN B-VP O
discharge NN B-NP O
when WRB O O
she PRP O O
resumes VBZ O O
her PRP$ O O
outpatient JJ B-NP O
eating JJ I-NP O
habits NNS I-NP O
7 CD O O
) ) O O
General: NNP B-NP O
PT NNP I-NP O
consulted VBD B-VP O
to TO O O
assist VB O O
in IN B-VP O
prevention NN B-NP O
deconditioning VBG O O
while IN B-VP O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
VNA NNP I-NP O
will MD O O
evaluate VB O O
need NN B-NP O
for IN B-VP O
home NN B-NP O
PT NNP I-NP O
services NNS I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
1 CD O O
Weight NNP B-NP O
yourself PRP O O
daily RB O O
, , O O
call VB O O
your PRP$ O O
doctor NN B-NP O
when WRB O O
your PRP$ O O
weight NN B-NP O
increases VBZ O O
2 CD O O
Follow-up JJ O O
with IN B-VP O
your PRP$ O O
Primary NNP B-NP O
Care NNP I-NP O
Physician NNP I-NP O
in IN B-VP O
2 CD O O
weeks NNS B-NP O
3 CD O O
Follow-up NN B-NP O
at IN B-VP O
the DT B-NP O
CHF NNP I-NP O
clinic NN I-NP O
on IN B-VP O
Thursday NNP B-NP O
5/10 CD O O
with IN B-VP O
Jeffry NNP B-NP O
Vaudrain NNP I-NP O
at IN B-VP O
10:30am CD O O
4.New CD O O
Medication: NNP B-NP O
( ( O O
Replaces NNP B-NP O
lasix RB O B-m
) ) O O
Torsemide NNP B-NP B-m
Torsemide NNP I-NP B-m
100 CD O B-do
mg NN B-NP I-do
every DT B-NP B-f
morning NN I-NP I-f
and CC O O
100 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
everynight VBD B-VP B-f
5 CD O O
Follow-up JJ O O
with IN B-VP O
Dr NNP B-NP O
Newsome NNP I-NP O
( ( O O
377 CD O O
)062-0660 JJ O O
0/27 CD O O
at IN B-VP O
9:30 CD O O
am VBP O O
for IN B-VP O
your PRP$ O O
ICD NNP B-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
1 CD O O
Keep NNP B-NP O
appointments NNS I-NP O
as IN B-VP O
outlined VBN O O
above IN B-VP O
2 CD O O
Have VBP O O
your PRP$ O O
INR NNP B-NP O
checked VBD B-VP O
on IN B-VP O
Friday NNP B-NP O
5/10 CD O O
3 CD O O
Weight NNP B-NP O
yourself PRP O O
daily RB O O
Call VB O O
your PRP$ O O
PCP NNP B-NP O
if IN B-VP O
your PRP$ O O
weight NN B-NP O
increases VBZ O O
4 CD O O
Follow NNP B-NP O
written VBN O O
EP NNP B-NP O
discharge NN I-NP O
instructions NNS I-NP O
5 CD O O
Fort NNP B-NP O
VNA NNP I-NP O
will MD O O
resume VB O O
services NNS B-NP O
adn RB O O
follow VBP O O
pt NN B-NP O
for IN B-VP O
CHF NNP B-NP O
as RB O O
well RB O O
as IN B-VP O
assess NN B-NP O
need NN I-NP O
for IN B-VP O
home NN B-NP O
PT NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
HAMON NNP I-NP O
, , O O
DANIAL NNP B-NP O
A NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.P.H NNP B-NP O
( ( O O
YM190 NNP B-NP O
) ) O O
4/12/04 CD O O
@ $ O O
04:06 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#948640 VBZ O O
459567785 CD O O
C NNP B-NP O
08087955 CD O O
1334797 CD O O
0/10/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
Dehydration NNP I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
0/23/2004 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
3/17/2004 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
KIMME NNP I-NP O
, , O O
ODELL NNP B-NP O
037-96-25-8 NNP I-NP O
Saso NNP I-NP O
Downallge NNP I-NP O
As IN B-VP O
Service: NNP B-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
2/21/04 CD O O
AT NNP B-NP O
04:30 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
HO NNP I-NP O
evaluation NN I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
PESTRONK NNP I-NP O
, , O O
VERN NNP B-NP O
N NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
No NNP I-NP O
CPR NNP I-NP O
/ VBZ O O
No DT B-NP O
defib NN I-NP O
/ VBZ O O
No DT B-NP O
intubation NN I-NP O
/ VBZ O O
DISPOSITION: NNP B-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ECASA NNP I-NP B-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/24/04 CD O O
by IN B-VP O
BLAIN NNP B-NP O
, , O O
GUILLERMO NNP B-NP O
P NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
11219725 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
monitor VB O O
FOLATE NNP B-NP B-m
( ( O I-m
FOLIC NNP B-NP I-m
ACID NNP I-NP I-m
) ) O I-m
1 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
9/24 CD O O
) ) O O
LISINOPRIL FW O B-m
30 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/24/04 CD O O
by IN B-VP O
HIND NNP B-NP O
, , O O
JORGE NNP B-NP O
M NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
POTASSIUM NNP B-NP B-m
CHLORIDE NNP I-NP I-m
IMMED NNP I-NP I-m
REL NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
22545591 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
monitor VB O O
THIAMINE NNP B-NP B-m
HCL NNP I-NP I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
MVI NNP I-NP B-m
THERAPEUTIC NNP I-NP I-m
( ( O I-m
THERAPEUTIC NNP B-NP I-m
MULTIVITAMINS NNP I-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/24/04 CD O O
by IN B-VP O
DEGRANGE NNP B-NP O
, , O O
DIEGO NNP B-NP O
A NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
SIMVASTATIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
59315078 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
&amp; NNP I-NP O
SIMVASTATIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
monitor VB O O
CREON NNP B-NP B-m
20 CD O I-m
( ( O I-m
PANCRELIPASE NNP B-NP I-m
20000U CD O I-m
) ) O I-m
4 CD O B-do
CAPSULE NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
Instructions: NNP I-NP O
with IN B-VP O
meals NNS B-NP O
LEVOFLOXACIN NNP I-NP B-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
9/24 CD O O
) ) O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Administer NNP I-NP O
iron NN I-NP B-m
products NNS I-NP I-m
a DT B-NP O
minimum NN I-NP O
of IN B-VP O
2 CD O O
hours NNS B-NP O
before IN B-VP O
or CC O O
after IN B-VP O
a DT B-NP O
levofloxacin NN I-NP B-m
or CC O O
ciprofloxacin NN B-NP B-m
dose VBP O O
dose JJ O O
If IN B-VP O
on IN B-VP O
tube NN B-NP O
feeds NNS I-NP O
, , O O
please VB O O
cycle NN B-NP O
( ( O O
hold VB O O
1 CD O O
hr NN B-NP O
before IN B-VP O
to TO O O
2 CD O O
hr NNS B-NP O
after IN B-VP O
) ) O O
Take VBP O O
2 CD O O
hours NNS B-NP O
before IN B-VP O
or CC O O
2 CD O O
hours NNS B-NP O
after IN B-VP O
dairy NN B-NP O
products NNS I-NP O
Alert NNP I-NP O
overridden: MD O O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
11/16/04 CD O O
by IN B-VP O
NORSETH NNP B-NP O
, , O O
ARMANDO NNP B-NP O
T NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
LEVOFLOXACIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitoring NN I-NP O
LANTUS NNP I-NP B-m
( ( O I-m
INSULIN NNP B-NP I-m
GLARGINE NNP I-NP I-m
) ) O I-m
20 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
QD NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
9/24 CD O O
) ) O O
LASIX NNP B-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
LIPITOR NNP I-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
2/21/04 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
&amp; NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
not RB O O
prescribe VB O O
niacin JJ B-NP O
COUMADIN NNP I-NP B-m
( ( O I-m
WARFARIN NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QPM NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
No NNP I-NP O
high JJ B-NP O
Vitamin-K NNP I-NP O
containing VBG O O
foods NNS B-NP O
Alert NNP I-NP O
overridden: VBD B-VP O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
2/21/04 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LEVOFLOXACIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LEVOFLOXACIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
follow VB O O
closely RB O O
DIET: NNP B-NP O
Patient NNP I-NP O
should MD O O
measure VB O O
weight JJ B-NP O
daily JJ I-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
2100 CD O O
cals/dy NN B-NP O
DIET: NNP I-NP O
2 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Clemente NNP I-NP O
Bollozos NNP I-NP O
- : O O
You PRP O O
will MD O O
be VB O O
contacted VBN O O
with IN B-VP O
an DT B-NP O
appointment NN I-NP O
for IN B-VP O
this DT B-NP O
week NN I-NP O
, , O O
Arrange NNP B-NP O
INR NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
on IN B-VP O
8/26/04 CD O O
with IN B-VP O
f/u JJ B-NP O
INR's NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
every DT O O
3 CD O O
days NNS B-NP O
INR's NNP I-NP O
will MD O O
be VB O O
followed VBN O O
by IN B-VP O
Dr NNP B-NP O
Tedeschi NNP I-NP O
No NNP I-NP O
Known NNP I-NP O
Allergies NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
Hyperglycemia NNP I-NP O
, , O O
dehydration NN B-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Dehydration NNP B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
CAD NNP I-NP O
, , O O
complete JJ B-NP O
heart NN I-NP O
block NN I-NP O
ETOH NNP I-NP O
, , O O
HTN NNP B-NP O
, , O O
substance NN B-NP O
abuse NN I-NP O
S/P NNP I-NP O
PACER NNP I-NP O
PLCT NNP I-NP O
1980 CD O O
H/O NNP B-NP O
SILENT NNP I-NP O
IMI NNP I-NP O
s/p VBD B-VP O
l JJ B-NP O
nephrectomy JJ I-NP O
s/p NN I-NP O
appy JJ B-NP O
h/o NN I-NP O
spinal JJ B-NP O
stenosis NN I-NP O
DM NNP I-NP O
2/2 CD O O
pancreatitis NN B-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
None NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
ECHOCARDIOGRAM NNP B-NP O
6/12/04 CD O O
- : O O
EF NN B-NP O
20-25% JJ O O
, , O O
moderate JJ O O
to TO O O
severe VB O O
global JJ B-NP O
hypokinesis NN I-NP O
, , O O
trace NN B-NP O
AI NNP I-NP O
, , O O
mild JJ B-NP O
MR NNP I-NP O
, , O O
TV NN B-NP O
pacer NN I-NP O
wire NN I-NP O
still RB O O
has VBZ O O
clot/veg VBN O O
OFFICIAL NNP B-NP O
READ NNP I-NP O
STILL NNP I-NP O
PENDING NNP I-NP O
AT NNP I-NP O
TIME NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ABDMONINAL NNP I-NP O
CT NNP I-NP O
7/20/04 CD O O
- : O O
No DT B-NP O
acute JJ I-NP O
disease NN I-NP O
, , O O
gall JJ B-NP O
stones NNS I-NP O
, , O O
RLL NNP B-NP O
inflammation NN I-NP O
? . B-VP O
PNA NNP B-NP O
, , O O
ectatic JJ B-NP O
aorta NN I-NP O
, , O O
non-obstructing JJ B-NP O
ventral JJ I-NP O
hernia NN I-NP O
V/Q NNP I-NP O
SCAN NNP I-NP O
7/20/04 CD O O
- : O O
Low JJ B-NP O
probability NN I-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
66 CD O O
YO NNP B-NP O
male NN I-NP O
with IN B-VP O
complicated JJ B-NP O
PMH NNP I-NP O
including VBG O O
CHF NNP B-NP O
w/ NN I-NP O
EF NNP I-NP O
25% CD O O
, , O O
COPD NNP B-NP O
, , O O
PVD NNP B-NP O
, , O O
DM2 NNP B-NP O
, , O O
CHB NNP B-NP O
with IN B-VP O
pacer NN B-NP O
and CC O O
evidence NN B-NP O
of IN B-VP O
clot NN B-NP O
on IN B-VP O
pacer NN B-NP O
wire NN I-NP O
, , O O
non-compliant JJ O O
with IN B-VP O
medications NNS B-NP O
and CC O O
diet JJ O O
and CC O O
who WP O O
developed VBD B-VP O
sx NN B-NP O
of IN B-VP O
abd NN B-NP O
pain NN I-NP O
and CC O O
SOB NNP B-NP O
with IN B-VP O
FS NNP B-NP O
of IN B-VP O
500-600 JJ B-NP O
PCP NNP I-NP O
asked VBD B-VP O
patient NN B-NP O
to TO O O
come VB O O
to TO O O
ED NNP B-NP O
where WRB O O
he PRP O O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
FS NNP B-NP O
of IN B-VP O
700 CD O O
with IN B-VP O
hypotension NN B-NP O
70s-80s CD O O
SBP NNP B-NP O
but CC O O
mentating VBG O O
No NNP B-NP O
gap NN I-NP O
and CC O O
no DT B-NP O
ketones NNS I-NP O
No DT B-NP O
signs NNS I-NP O
or CC O O
sx NN B-NP O
of IN B-VP O
infection NN B-NP O
with IN B-VP O
admission NN B-NP O
for IN B-VP O
medical JJ B-NP O
management NN I-NP O
VS: NNP I-NP O
99.5 CD O O
101/62 CD O O
70s CD O O
SaO2 NNP B-NP O
96% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
EXAM: NNP I-NP O
GEN: NNP I-NP O
elderly JJ B-NP O
ill NN I-NP O
appearing VBG O O
male NN B-NP O
in IN B-VP O
NAD NNP B-NP O
HEENT: NNP I-NP O
Anicteric NNP I-NP O
sclera NN I-NP O
, , O O
PERRL NNP B-NP O
, , O O
dry JJ B-NP O
mucous JJ I-NP O
membranes NNS I-NP O
, , O O
poor JJ B-NP O
dentition NN I-NP O
NECK: NNP I-NP O
Supple NNP I-NP O
, , O O
no DT B-NP O
adenopathy NN I-NP O
, , O O
JVP NNP B-NP O
flat JJ B-NP O
CHEST: NNP I-NP O
CTA NNP I-NP O
bilaterally RB O O
CV: NNP B-NP O
RRR NNP I-NP O
with IN B-VP O
diffuse NN B-NP O
PMI NNP I-NP O
, , O O
Nl NNP B-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
S3 NNP I-NP O
present JJ B-NP O
ABD: NNP I-NP O
Reducible NNP I-NP O
ventral JJ B-NP O
hernia NN I-NP O
, , O O
NT NNP B-NP O
, , O O
ND NNP B-NP O
, , O O
bowel NN B-NP O
sounds NNS I-NP O
present JJ B-NP O
EXT: NNP I-NP O
No NNP I-NP O
edema NN I-NP O
or CC O O
wounds NNS B-NP O
SKIN: NNP I-NP O
No NNP I-NP O
rashes VBZ O O
EKG: NNP B-NP O
paced VBD B-VP O
CXR: NNP B-NP O
clear JJ O O
with IN B-VP O
NAD NNP B-NP O
ABD NNP I-NP O
CT: NNP I-NP O
small JJ B-NP O
ventral JJ I-NP O
hernia NN I-NP O
, , O O
gallstones NNS B-NP O
, , O O
ectasia NN B-NP O
of IN B-VP O
the DT B-NP O
infrarenal JJ I-NP O
aorta NN I-NP O
, , O O
RLL NNP B-NP O
inflammatory NN I-NP O
changes NNS I-NP O
suggestive VBP O O
of IN B-VP O
PNA NNP B-NP O
VQ: NNP I-NP O
Low NNP I-NP O
probability NN I-NP O
LABS: NNP I-NP O
Creatinine NNP I-NP O
of IN B-VP O
2.2 CD O O
that WDT O O
dropped VBD B-VP O
to TO O O
1.5 CD O O
with IN B-VP O
hydration NN B-NP O
( ( O O
BL NNP B-NP O
1.2-1.3 CD O O
) ) O O
HCT $ O O
41.6 CD O O
with IN B-VP O
drop NN B-NP O
after IN B-VP O
aggresive JJ B-NP O
hydration NN I-NP O
Lipase NNP I-NP O
of IN B-VP O
132 CD O O
but CC O O
has VBZ O O
chronic JJ B-NP O
pancreatitis NN I-NP O
and CC O O
is VBZ O O
now RB O O
normalizing VBG O O
UA NNP B-NP O
and CC O O
ACE NNP B-NP O
negative JJ B-NP O
ASSESSMENT NNP I-NP O
&amp; NNP I-NP O
PLAN: NNP I-NP O
66 CD O O
YO NNP B-NP O
male NN I-NP O
with IN B-VP O
complicated VBN O O
PMH NNP B-NP O
admitted VBN O O
with IN B-VP O
hyperglycemia NN B-NP O
likely RB O O
due JJ O O
to TO O O
non-compliance JJ O O
and CC O O
hypotension NN B-NP O
likely RB O O
due JJ O O
to TO O O
hypovolemia VB O B-r
In IN B-VP O
ED NNP B-NP O
the DT B-NP O
patient NN I-NP O
received VBD B-VP O
5 CD O B-do
liters NNS B-NP I-do
of IN B-VP O
IVF NNP B-NP B-m
and CC O O
36U CD O B-do
of IN B-VP O
insulin NN B-NP B-m
His PRP$ O O
blood NN B-NP O
pressure NN I-NP O
stabilized VBN O O
with IN B-VP O
volume NN B-NP O
and CC O O
he PRP O O
was VBD B-VP O
transfered VBN O O
to TO O O
the DT B-NP O
medical JJ I-NP O
floor NN I-NP O
ENDOCRINE NNP I-NP O
- : O O
DMII NN B-NP B-r
but CC O O
with IN B-VP O
history NN B-NP O
of IN B-VP O
pancreatitis NN B-NP O
so RB O O
behaves VBZ O O
more RBR O O
like IN B-VP O
type NN B-NP O
1 CD O O
- : O O
needs NNS B-NP O
insulin VBP O B-m
all PDT O O
the DT B-NP O
time NN I-NP O
Per NNP I-NP O
patient NN I-NP O
he PRP O O
had VBD B-VP O
been VBN O O
taking VBG O O
20 CD O B-do
units NNS B-NP O
of IN B-VP O
Lantus NNP B-NP B-m
QAM NNP I-NP B-f
QAM NNP I-NP B-f
but CC O O
patient JJ O O
admitted VBN O O
to TO O O
poor JJ B-NP O
compliance NN I-NP O
with IN B-VP O
both DT O O
diet JJ O O
and CC O O
insulin VB O B-m
His PRP$ O O
A1C NNP B-NP O
was VBD B-VP O
checked VBN O O
and CC O O
returned VBN O O
at IN B-VP O
19 CD O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
Lantus NNP B-NP B-m
and CC O O
Lispro NNP B-NP B-m
and CC O O
maintained VBN O O
on IN B-VP O
an DT B-NP O
ADA NNP I-NP O
diet NN I-NP O
He PRP O O
was VBD B-VP O
titrated VBN O B-do
to TO O I-do
20 CD O I-do
units NNS B-NP I-do
of IN B-VP O
Lantus NNP B-NP B-m
QHS NNP I-NP B-f
and CC O O
was VBD B-VP O
requring VBG O O
Lispro NNP B-NP B-m
for IN B-VP O
FS NNP B-NP B-r
ranging VBG O O
from IN B-VP O
120-600 JJ O O
By IN B-VP O
10/21 CD O O
his PRP$ O B-r
FS NN B-NP I-r
remained VBD B-VP O
better RBR O O
controlled VBN O O
but CC O O
were VBD B-VP O
still RB O O
high JJ O O
ranging VBG O O
from IN B-VP O
200 CD O O
to TO O O
400 CD O O
on IN B-VP O
Lantus NNP B-NP B-m
16 CD O B-do
On IN B-VP O
3/23 CD O O
the DT B-NP O
patient NN I-NP O
expressed VBD B-VP O
that IN B-VP O
he PRP O O
would MD O O
like VB O O
to TO O O
leave VB O O
He PRP O O
is VBZ O O
discharged VBN O O
o JJ B-NP O
n JJ I-NP O
Lantus NNP I-NP B-m
20 CD O B-do
and CC O O
Lispro NNP B-NP B-m
SS NNP I-NP B-do
with IN B-VP O
VNA NNP B-NP O
to TO O O
follow VB O O
finger NN B-NP O
sticks NNS I-NP O
He PRP O O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
an DT B-NP O
ADA NNP I-NP O
diet NN I-NP O
, , O O
however RB O O
, , O O
there EX O O
was VBD B-VP O
some DT B-NP O
concern NN I-NP O
he PRP O O
may MD O O
have VB O O
been VBN O O
eating VBG O O
sweets NNS B-NP O
on IN B-VP O
his PRP$ O O
own JJ B-NP O
Nutrition NNP I-NP O
was VBD B-VP O
consulted VBN O O
and CC O O
provided VBN O O
teaching VBG O O
regaring VBG O O
diet JJ O O
and CC O O
diabetes VBZ O O
The DT B-NP O
patient NN I-NP O
is VBZ O O
discharged VBN O O
to TO O O
home NN B-NP O
on IN B-VP O
Lantus NNP B-NP B-m
and CC O O
lispro JJ O B-m
with IN B-VP O
VNA NNP B-NP O
following VBG O O
HEME NNP B-NP O
- : O O
on IN B-VP O
coumadin NN B-NP B-m
for IN B-VP O
hx NN B-NP O
of IN B-VP O
pacer NN B-NP B-r
clot NN I-NP I-r
Echo NNP I-NP O
shows VBZ O O
pacer NN B-NP O
clot NN I-NP B-r
but CC O O
not RB O O
clear JJ O O
whether IN B-VP O
patient NN B-NP O
will MD O O
be VB O O
compliant JJ O O
enough JJ O O
to TO O O
go VB O O
home NN B-NP O
on IN B-VP O
coumadin NN B-NP B-m
as IN B-VP O
he PRP O O
has VBZ O O
not RB O O
been VBN O O
in IN B-VP O
the DT O O
past JJ O O
After IN B-VP O
discussion NN B-NP O
with IN B-VP O
patient JJ B-NP O
agreement NN I-NP O
is VBZ O O
that IN B-VP O
we PRP O O
will MD O O
d/c VB O O
on IN B-VP O
coumadin NN B-NP B-m
5 CD O B-do
QD NNP B-NP B-f
( ( O O
INR NNP B-NP O
on IN B-VP O
day NN B-NP O
of IN B-VP O
d/c $ O O
1.2 CD O O
) ) O O
with IN B-VP O
enough JJ B-NP O
supply NN I-NP O
for IN B-VP B-du
one CD O I-du
week NN B-NP I-du
He PRP O O
will MD O O
have VB O O
blood VBN O O
drawn VBN O O
by IN B-VP O
VNA NNP B-NP O
with IN B-VP O
results NNS B-NP O
sent VBD B-VP O
to TO O O
Dr NNP B-NP O
Zarkin NNP I-NP O
If IN B-VP O
he PRP O O
his PRP$ O O
not RB O O
compliant VB O O
with IN B-VP O
his PRP$ O O
lab NN B-NP O
work NN I-NP O
the DT B-NP O
coumadin NN I-NP B-m
will MD O O
be VB O O
stopped VBN O O
CV NNP B-NP O
- : O O
ISCHEMIA: NNP B-NP O
Nonobstuctive NNP I-NP O
CAD NNP I-NP O
on IN B-VP O
cath NN B-NP O
in IN B-VP O
July NNP B-NP O
with IN B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
acute JJ B-NP O
episode NN I-NP O
Maintained VBD B-VP O
on IN B-VP O
ASA NNP B-NP B-m
, , O O
ACEi NNP B-NP B-m
, , O O
and CC O O
Statin NNP B-NP B-m
No NNP I-NP O
BB NNP I-NP O
as IN B-VP O
current JJ B-NP O
cocaine NN I-NP O
user NN I-NP O
and CC O O
considered VBN O O
to TO O O
dangerous JJ B-NP O
PUMP: NNP I-NP O
EF: NNP I-NP O
20-25% JJ B-NP O
Hypovolemic NNP I-NP O
at IN B-VP O
admission NN B-NP O
with IN B-VP O
good JJ B-NP O
response NN I-NP O
to TO O O
hydration NN B-NP O
No NNP I-NP O
episodes NNS I-NP O
of IN B-VP O
volume NN B-NP O
overload NN I-NP O
On IN B-VP O
ACEi NNP B-NP O
for IN B-VP O
AL NNP B-NP O
reduction NN I-NP O
RHYTHM: NNP I-NP O
CHB NNP I-NP O
with IN B-VP O
PPM NNP B-NP O
in IN B-VP O
place NN B-NP O
GI: NNP I-NP O
elevated VBD B-VP O
lipase NN B-NP O
with IN B-VP O
chronic JJ B-NP O
pancreatitis NN I-NP O
with IN B-VP O
no DT B-NP O
symptoms NNS I-NP O
and CC O O
resolution NN B-NP O
after IN B-VP O
hydration NN B-NP O
DISPO: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
discharged VBN O O
to TO O O
home NN B-NP O
in IN B-VP O
fair JJ B-NP O
condition NN I-NP O
He PRP O O
has VBZ O O
been VBN O O
given VBN O O
teaching VBG O O
regarding VBG O O
nutrition NN B-NP O
, , O O
diabetes VBZ O O
, , O O
and CC O O
coumadin VB O B-m
His PRP$ O O
medications NNS B-NP O
has VBZ O O
been VBN O O
discussed VBN O O
with IN B-VP O
him PRP O O
He PRP O O
agrees VBZ O O
to TO O O
be VB O O
compliant JJ O O
with IN B-VP O
all DT B-NP O
medications NNS I-NP O
, , O O
to TO O O
work VB O O
with IN B-VP O
VNA NNP B-NP O
, , O O
and CC O O
to TO O O
attend VB O O
all DT O O
of IN B-VP O
his PRP$ O O
appointments NNS B-NP O
and CC O O
blood NN B-NP O
draws NN I-NP O
He PRP O O
is VBZ O O
discharged VBN O O
home NN B-NP O
on IN B-VP O
coumadin NN B-NP B-m
and CC O O
Lantus NNP B-NP B-m
to TO O O
be VB O O
followed VBN O O
by IN B-VP O
VNA NNP B-NP O
He PRP O O
is VBZ O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Harnage NNP I-NP O
within IN B-VP O
the DT B-NP O
next JJ I-NP O
week NN I-NP O
and CC O O
will MD O O
be VB O O
contacted VBN O O
with IN B-VP O
an DT B-NP O
appointment NN I-NP O
CODE: NNP I-NP O
DNR/DNI NNP I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
1 CD O O
) ) O O
Please NNP B-NP O
take VB O O
your PRP$ O O
insulin NN B-NP B-m
shot NN I-NP O
( ( O O
20 CD O B-do
units NNS B-NP I-do
of IN B-VP O
Lantus NNP B-NP B-m
) ) O O
every DT B-NP B-f
night NN I-NP O
at IN B-VP O
10 CD O O
PM NNP B-NP O
You PRP O O
will MD O O
get VB O O
your PRP$ O O
dose NN B-NP O
for IN B-VP O
Sunday NNP B-NP O
3/23 CD O O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
You PRP O O
first RB O O
dose VB O O
at IN B-VP O
home NN B-NP O
will MD O O
be VB O O
Monday NNP B-NP O
7/28 CD O O
at IN B-VP O
10 CD O O
PM NNP B-NP O
2 CD O O
) ) O O
Visiting VBG O O
nursing NN B-NP O
will MD O O
come VB O O
to TO O O
your PRP$ O O
home NN B-NP O
tomorrow NN I-NP O
to TO O O
help VB O O
you PRP O O
with IN B-VP O
your PRP$ O B-m
medications NNS B-NP I-m
3 CD O O
) ) O O
Please NNP B-NP O
take VB O O
all DT O O
your PRP$ O O
medications NNS B-NP O
as IN B-VP O
directed VBN O O
It PRP O O
is VBZ O O
very RB O O
important JJ O O
to TO O O
have VB O O
your PRP$ O O
blood NN B-NP O
checked VBD B-VP O
regularly RB O O
to TO O O
make VB O O
sure JJ O O
your PRP$ O O
medications NNS B-NP O
are VBP O O
at IN B-VP O
the DT B-NP O
right JJ I-NP O
level NN I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Fair NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
1 CD O O
) ) O O
Take VB O O
your PRP$ O O
Lantus NNP B-NP B-m
every DT B-NP B-f
night NN I-NP I-f
at IN B-VP I-f
10 CD O I-f
PM NNP B-NP I-f
starting VBG O O
on IN B-VP O
Monday NNP B-NP O
7/7/04 CD O O
Take NNP B-NP O
a DT B-NP O
shot NN I-NP B-mo
with IN B-VP O
20 CD O B-do
units NNS B-NP I-do
of IN B-VP O
insulin NN B-NP B-m
in IN B-VP O
it PRP O O
2 CD O O
) ) O O
Check VB O O
your PRP$ O O
fingersticks NNS B-NP O
daily RB O O
and CC O O
record VB O O
the DT B-NP O
level NN I-NP O
Please NNP I-NP O
call VB O O
Dr NNP B-NP O
Mattias NNP I-NP O
if IN B-VP O
your PRP$ O O
blood NN B-NP O
sugar NN I-NP O
is VBZ O O
higher JJR O O
then RB O O
350 CD O O
or CC O O
lower JJR O O
then RB O O
50 CD O O
3 CD O O
) ) O O
Take VB O O
all DT O O
you PRP O O
other JJ B-NP B-m
medications NNS I-NP I-m
as IN B-VP O
directed VBN O O
Do NNP B-NP O
not RB O O
take VB O O
any DT B-NP O
medications NNS I-NP O
that WDT O O
are VBP O O
not RB O O
on IN B-VP O
this DT B-NP O
list NN I-NP O
4 CD O O
) ) O O
Please NNP B-NP O
attend VBP O O
all DT O O
of IN B-VP O
your PRP$ O O
appointments NNS B-NP O
and CC O O
blood NN B-NP O
draws NN I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
MARCUSSEN NNP I-NP O
, , O O
WILL NNP B-NP O
JAE NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
AV507 NNP B-NP O
) ) O O
2/21/04 CD O O
@ $ O O
04 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#948961 VBZ O O
288978562 CD O O
THO NNP B-NP O
40164507 CD O O
6818698 CD O O
5/8/2007 CD O O
12:00:00 CD O O
AM NNP B-NP O
bilateral JJ B-NP O
breast NN I-NP O
reduction NN I-NP O
, , O O
panniculectomy NN B-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
11/28/2007 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
10/20/2007 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
HUNTZINGER NNP I-NP O
, , O O
HOWARD NNP B-NP O
940-78-98-8 CD O O
U NNP B-NP O
Sa NNP I-NP O
Fre NNP I-NP O
Service: NNP I-NP O
PLA NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
11/24/07 CD O O
AT NNP B-NP O
09:00 CD O O
AM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
SNF/rehab NNP I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
MEDE NNP I-NP O
, , O O
HOBERT NNP B-NP O
JODY NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Skilled VBD B-VP O
Nursing NNP B-NP O
Facility NNP I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
1 CD O O
ACETAMINOPHEN NNP B-NP B-m
1000 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
2 CD O O
LEVOTHYROXINE NNP B-NP B-m
SODIUM NNP I-NP I-m
75 CD O B-do
MCG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
3 CD O O
QUINAPRIL NNP B-NP B-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QAM NNP I-NP B-f
4 CD O O
RANITIDINE NNP B-NP B-m
HCL NNP I-NP I-m
150 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
5 CD O O
MULTIVITAMINS NNP B-NP B-m
1 CD O B-do
CAPSULE NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
MEDICATIONS NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
TYLENOL NNP I-NP B-m
( ( O I-m
ACETAMINOPHEN NNP B-NP I-m
) ) O I-m
650 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q4H NNP I-NP B-f
PRN NNP I-NP I-f
Headache NNP I-NP B-r
VITAMIN NNP I-NP B-m
C NNP I-NP I-m
( ( O I-m
ASCORBIC NNP B-NP I-m
ACID NNP I-NP I-m
) ) O I-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
DULCOLAX NNP I-NP B-m
( ( O I-m
BISACODYL NNP B-NP I-m
) ) O I-m
5-10 JJ B-NP B-do
MG NNP I-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
PRN NNP I-NP I-f
Constipation NNP I-NP B-r
KEFLEX NNP I-NP B-m
( ( O I-m
CEPHALEXIN NNP B-NP I-m
) ) O I-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QID NNP I-NP B-f
COLACE NNP I-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
PEPCID NNP I-NP B-m
( ( O I-m
FAMOTIDINE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
DILAUDID NNP I-NP B-m
( ( O I-m
HYDROMORPHONE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
2-4 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q3H NNP I-NP B-f
PRN NNP I-NP I-f
Pain NNP I-NP B-r
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
5/8/07 CD O O
by IN B-VP O
: : O O
on IN B-VP O
order NN B-NP O
for IN B-VP O
DILAUDID NNP B-NP B-m
PO NNP I-NP B-mo
2-4 JJ B-NP B-do
MG NNP I-NP I-do
Q3H NNP I-NP B-f
( ( O O
ref JJ O O
# # O O
901341233 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
PROBABLE NNP I-NP O
allergy NN I-NP O
to TO O O
Morphine; NNP B-NP O
reaction NN I-NP O
is VBZ O O
GI NNP B-NP O
Intolerance NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
fine VBP O O
Previous NNP B-NP O
Alert NNP I-NP O
overridden NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
5/8/07 CD O O
by IN B-VP O
SIENKIEWICZ NNP B-NP O
, , O O
BRODERICK NNP B-NP O
GINO NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
DILAUDID NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
797774923 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
PROBABLE NNP I-NP O
allergy NN I-NP O
to TO O O
Morphine; NNP B-NP O
reaction NN I-NP O
is VBZ O O
GI NNP B-NP O
Intolerance NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
INSULIN NNP I-NP B-m
REGULAR NNP I-NP I-m
HUMAN NNP I-NP I-m
Sliding NNP I-NP B-do
Scale NNP I-NP I-do
( ( O B-mo
subcutaneously RB O I-mo
) ) O I-mo
SC NNP B-NP I-mo
AC+HS NNP I-NP B-f
Medium NNP I-NP O
Scale NNP I-NP O
Call NNP I-NP O
HO NNP I-NP O
if IN B-VP O
BS NNP B-NP O
less JJR O O
than IN B-VP O
60 CD O O
If IN B-VP O
BS NNP B-NP O
is VBZ O O
less JJR O O
than IN B-VP O
125 CD O O
, , O O
then RB O O
DO NNP B-NP O
NOT NNP I-NP O
Administer NNP I-NP O
supplemental NN I-NP O
( ( O O
sliding VBG O O
scale NN B-NP O
) ) O O
insulin NN B-NP B-m
insulin NN I-NP B-m
insulin NN I-NP B-m
insulin NN I-NP B-m
insulin NN I-NP B-m
insulin NN I-NP B-m
If IN B-VP O
BS NNP B-NP O
is VBZ O O
125-150 JJ O O
, , O O
then RB O O
give VB O O
0 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
151-200 CD O O
, , O O
then RB O O
give VB O O
1 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
201-250 JJ O O
, , O O
then RB O O
give VB O O
3 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
251-300 JJ O O
, , O O
then RB O O
give VB O O
5 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
301-350 JJ O O
, , O O
then RB O O
give VB O O
7 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
351-400 CD O O
, , O O
then RB O O
give VB O O
8 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
Call NNP B-NP O
HO NNP I-NP O
if IN B-VP O
BS NNP B-NP O
is VBZ O O
greater JJR O O
than IN B-VP O
350 CD O O
If IN B-VP O
receiving VBG O O
standing VBG O O
regular JJ B-NP B-m
insulin NN I-NP I-m
, , O O
please VB O O
give VB O O
at IN B-VP O
same JJ B-NP O
time NN I-NP O
and CC O O
in IN B-VP O
addition NN B-NP O
to TO O O
standing VBG O O
regular JJ B-NP B-m
insulin NN I-NP I-m
SYNTHROID NNP I-NP B-m
( ( O I-m
LEVOTHYROXINE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
75 CD O B-do
MCG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
MAALOX-TABLETS NNP I-NP B-m
QUICK NNP I-NP I-m
DISSOLVE/CHEWABLE NNP I-NP I-m
1-2 JJ B-NP B-do
TAB NNP I-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP O
Upset NNP I-NP B-r
Stomach NNP I-NP I-r
MILK NNP I-NP B-m
OF NNP I-NP I-m
MAGNESIA NNP I-NP I-m
( ( O I-m
MAGNESIUM NNP B-NP I-m
HYDROXIDE NNP I-NP I-m
) ) O I-m
30 CD O B-do
MILLILITERS NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
PRN NNP I-NP I-f
Constipation NNP I-NP B-r
REGLAN NNP I-NP B-m
( ( O I-m
METOCLOPRAMIDE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
IV NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP I-f
Nausea NNP I-NP B-r
ZOFRAN NNP I-NP B-m
( ( O I-m
POST-OP NNP B-NP I-m
N/V NNP I-NP I-m
) ) O I-m
( ( O I-m
ONDANSETRON NNP B-NP I-m
HCL NNP I-NP I-m
( ( O I-m
POST- NNP B-NP I-m
) ) O I-m
1 CD O B-do
MG NNP B-NP I-do
IV NNP I-NP B-mo
Q6H NNP I-NP O
X NNP I-NP B-du
2 CD O I-du
doses NNS B-NP I-du
PRN NNP I-NP O
Nausea NNP I-NP B-r
QUINAPRIL NNP I-NP B-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
5/8/07 CD O O
by IN B-VP O
REBURN NNP B-NP O
, , O O
CHARLEY NNP B-NP O
M NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
IV NNP I-NP I-m
( ( O O
ref JJ O O
# # O O
964491549 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
QUINAPRIL NNP I-NP B-m
HCL NNP I-NP I-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
QUINAPRIL NNP I-NP B-m
HCL NNP I-NP I-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
needs NNS I-NP O
Number NNP I-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ B-NP O
): NN I-NP O
2 CD O O
SIMETHICONE NNP B-NP B-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QID NNP I-NP B-f
PRN NNP I-NP I-f
Upset NNP I-NP B-r
Stomach NNP I-NP I-r
MULTIVITAMIN NNP I-NP B-m
THERAPEUTIC NNP I-NP I-m
( ( O I-m
THERAPEUTIC NNP B-NP I-m
MULTIVI NNP I-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
TIGAN NNP I-NP B-m
( ( O I-m
TRIMETHOBENZAMIDE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
200 CD O B-do
MG NNP B-NP I-do
PR NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP I-f
Nausea NNP I-NP B-r
TIGAN NNP I-NP B-m
( ( O I-m
TRIMETHOBENZAMIDE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
300 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP I-f
Nausea NNP I-NP B-r
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
10 CD O I-du
DIET: NNP B-NP O
No NNP I-NP O
Restrictions NNP I-NP O
ACTIVITY: NNP I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated JJ B-NP O
Lift NNP I-NP O
restrictions: NN I-NP O
Do NNP I-NP O
not RB O O
lift VB O O
greater JJR O O
then RB O O
10 CD O O
pounds NNS B-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
dr NN I-NP O
w NN I-NP O
, , O O
- : O O
please NN B-NP O
call VB O O
810 CD O O
676-4625 JJ O O
to TO O O
schedule VB O O
7 CD O O
days NNS B-NP O
, , O O
ALLERGY: NNP B-NP O
Morphine NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
macromastia NN I-NP O
, , O O
panniculectomy NN B-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
bilateral VBD B-VP O
breast NN B-NP O
reduction NN I-NP O
, , O O
panniculectomy NN B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
s/p RB O O
massive JJ B-NP O
weight NN I-NP O
loss NN I-NP O
2/2 CD O O
gastric JJ B-NP O
bypass NN I-NP O
, , O O
breast NN B-NP O
reduction NN I-NP O
, , O O
panniculectomy JJ B-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
5/8/07 CD O O
CHALET NNP B-NP O
, , O O
ODIS NNP B-NP O
RONALD NNP I-NP O
, , O O
M.D NNP B-NP O
BILATERAL NNP I-NP O
REDUCTION NNP I-NP O
MAMMOPLASTY NNP I-NP O
, , O O
EXCISION NNP B-NP O
PUBIC NNP I-NP O
PANNICUECTOMY NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
57 CD O O
y.o NNS B-NP O
female JJ O O
with IN B-VP O
macromastia NN B-NP O
and CC O O
abdominal JJ B-NP O
skin NN I-NP O
laxity NN I-NP O
s/p VBP O O
massive JJ B-NP O
weight NN I-NP O
loss NN I-NP O
2/2 CD O O
gastric JJ B-NP O
bypass NN I-NP O
, , O O
admitted VBN O O
to TO O O
plastic VB O O
surgery NN B-NP O
on IN B-VP O
5/8/07 CD O O
for IN B-VP O
bilateral JJ B-NP O
breast NN I-NP O
reduction NN I-NP O
and CC O O
panniculectomy NN B-NP O
pt NN I-NP O
tolerated VBD B-VP O
all DT B-NP O
procedures NNS I-NP O
without IN B-VP O
difficulty NN B-NP O
post-op JJ B-NP O
period NN I-NP O
has VBZ O O
been VBN O O
uneventful JJ O O
at IN B-VP O
discharge NN B-NP O
pt NN I-NP O
is VBZ O O
afebrile JJ O O
with IN B-VP O
stable JJ B-NP O
vitals NNS I-NP O
, , O O
taking VBG O O
po's/voiding VBG O O
q JJ B-NP O
shift NN I-NP O
, , O O
ambulating VBG O O
independently RB O O
and CC O O
pain NN B-NP O
has VBZ O O
been VBN O O
well RB O O
managed VBN O O
Incisions NNS B-NP O
are VBP O O
clean JJ O O
, , O O
dry JJ O O
and CC O O
intact JJ B-NP O
Jp's NNP I-NP O
with IN B-VP O
moderate JJ B-NP O
serosanguinous JJ I-NP O
output NN I-NP O
remain VBP O O
in IN B-VP O
place NN B-NP O
Pt NNP I-NP O
is VBZ O O
discharged VBN O O
to TO O O
home VB O O
rehab NN B-NP O
stable JJ B-NP O
condition NN I-NP O
instructions NNS I-NP O
given VBN O O
ADDITIONAL NNP B-NP O
COMMENTS: NNP I-NP O
1 CD O O
Medications: NNP B-NP O
resume NN I-NP O
previously RB O O
prescribed VBN O O
medications NNS B-NP O
Do VBP O O
not RB O O
take VB O O
medications NNS B-NP O
that WDT O O
cause VBP O O
bleeding VBG O O
- : O O
no DT B-NP O
aspirin NN I-NP O
, , O O
motrin NN B-NP O
, , O O
aleve VBP O O
, , O O
advil VBP O O
or CC O O
ibuprfen VBP O O
Do NNP B-NP O
not RB O O
drink/drive/operate VB O O
machinery NN B-NP O
with IN B-VP O
pain NN B-NP B-m
medications NNS I-NP I-m
Take VBP O O
a DT B-NP O
stool NN I-NP B-m
softener NN I-NP I-m
to TO O O
prevent VB O O
constipation NN B-NP B-r
2 CD O O
Monitor/return NNP B-NP O
for IN B-VP O
increased VBN O O
pain NN B-NP O
, , O O
swelling VBG O O
, , O O
redness NN B-NP O
, , O O
fever NN B-NP O
or CC O O
other JJ B-NP O
concerns NNS I-NP O
Call NNP I-NP O
dr NN I-NP O
xx NN I-NP O
, , O O
or CC O O
Garret NNP B-NP O
Murak NNP I-NP O
NP NNP I-NP O
for IN B-VP O
questions NNS B-NP O
525 CD O O
503-3214 JJ B-NP O
pager NN I-NP O
85184 CD O O
3 CD O O
Activity NNP B-NP O
- : O O
sponge NN B-NP O
baths NNS I-NP O
only RB O O
while IN B-VP O
drains NNS B-NP O
are VBP O O
in IN B-VP O
place NN B-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
No NNP B-NP O
lifting VBG O O
more JJR O O
than IN B-VP O
10 CD O O
pounds NNS B-NP O
No DT B-NP O
jogging NN I-NP O
, , O O
swimming NN B-NP O
, , O O
or CC O O
aerobics NNS B-NP O
x JJ B-NP O
4-6 JJ I-NP O
weeks NNS I-NP O
4 CD O O
Continue NNP B-NP O
your PRP$ O O
antibiotics NNS B-NP B-m
as RB O B-du
long RB O I-du
as IN B-VP I-du
you PRP O I-du
have VBP O I-du
a DT B-NP I-du
drain NN I-NP I-du
in IN B-VP I-du
place NN B-NP I-du
Drain NNP I-NP O
care NN I-NP O
- : O O
monitor/record NN B-NP O
drain NN I-NP O
output NN I-NP O
, , O O
when WRB O O
less JJR O O
than IN B-VP O
30 CD O O
cc NN B-NP O
in IN B-VP O
24 CD O O
hours NNS B-NP O
, , O O
call NN B-NP O
for IN B-VP O
appointment NN B-NP O
for IN B-VP O
removal JJ B-NP O
change NN I-NP O
drain NN I-NP O
sponges NNS I-NP O
daily RB O O
strip VBP O O
drains NNS B-NP O
twice RB O O
daily RB O O
5 CD O O
daily JJ B-NP O
wound NN I-NP O
check NN I-NP O
, , O O
dsd NN B-NP O
as IN B-VP O
needed VBN O O
DISCHARGE NNP B-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
wound NN I-NP O
check NN I-NP O
, , O O
drain NN B-NP O
care NN I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
GLANCY NNP I-NP O
, , O O
CURTIS NNP B-NP O
T NNP I-NP O
, , O O
NP NNP B-NP O
( ( O O
) ) O O
11/24/07 CD O O
@ $ O O
09:51 CD O O
AM NNP B-NP O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#952189 VBZ O O
663835632 CD O O
B NNP B-NP O
02570459 CD O O
3290042 CD O O
7/3/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
right JJ B-NP O
leg NN I-NP O
pain NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
4/9/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
8/17/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
MALATESTA NNP I-NP O
, , O O
TRISTAN NNP B-NP O
606-71-69-4 CD O O
Re NNP B-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
1/12/06 CD O O
AT NNP B-NP O
04:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
SANLUIS NNP I-NP O
, , O O
EDUARDO NNP B-NP O
MALCOLM NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
TYLENOL NNP I-NP B-m
( ( O I-m
ACETAMINOPHEN NNP B-NP I-m
) ) O I-m
650 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
CALCIUM NNP I-NP B-m
CARBONATE NNP I-NP I-m
( ( O I-m
500 CD O I-m
MG NNP B-NP I-m
ELEMENTAL NNP I-NP I-m
CA++ NNP I-NP I-m
) ) O I-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
HYDROCHLOROTHIAZIDE NNP I-NP B-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
2/4 CD O O
) ) O O
LISINOPRIL FW O B-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
MULTIVITAMIN NNP I-NP B-m
THERAPEUTIC NNP I-NP I-m
( ( O I-m
THERAPEUTIC NNP B-NP I-m
MULTIVI NNP I-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
LIPITOR NNP I-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
1/12/06 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
&amp; NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
ACTIVITY: NNP I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Please NNP I-NP O
call VB O O
Sol NNP B-NP O
Newville NNP I-NP O
NP NNP I-NP O
at IN B-VP O
Westhey NNP B-NP O
Hospital NNP I-NP O
center NN I-NP O
for IN B-VP O
appointment NN B-NP O
within IN B-VP O
2 CD O O
weeks NNS B-NP O
- : O O
291-543-8499 JJ O O
, , O O
ALLERGY: NNP B-NP O
NKA NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
right JJ B-NP O
leg NN I-NP O
pain NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
right VBD B-VP O
leg NN B-NP O
pain NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
HTN NNP I-NP O
( ( O O
hypertension NN B-NP O
) ) O O
dyslipidemia NN B-NP O
( ( O O
dyslipidemia NN B-NP O
) ) O O
s/p NN B-NP O
CCK NNP I-NP O
s/p NN I-NP O
hysterectomy NN I-NP O
( ( O O
S/P NNP B-NP O
hysterectomy NN I-NP O
) ) O O
arthritis NN B-NP O
( ( O O
arthritis NN B-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
none NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
tylenol NN B-NP B-m
, , O O
ibuprofen JJ B-NP B-m
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
cc: VBZ O O
admit NN B-NP O
for IN B-VP O
right JJ B-NP O
leg NN I-NP O
pain NN I-NP O
, , O O
poor JJ B-NP O
ambulation NN I-NP O
hpi: NN I-NP O
80F CD O O
, , O O
h/o NN B-NP O
OA NNP I-NP O
, , O O
poor JJ B-NP O
baseline NN I-NP O
ambulation NN I-NP O
, , O O
has VBZ O O
had VBN O O
chronic VBN O O
right RB O O
sided VBN O O
hip/knee NN B-NP O
pain NN I-NP O
w/ambulation NN I-NP O
p/w IN B-VP O
acute JJ B-NP O
worsening NN I-NP O
of IN B-VP O
R NNP B-NP O
leg NN I-NP O
pain NN I-NP O
Localizes NNP I-NP O
another DT B-NP O
pain NN I-NP O
x3days VBZ O O
to TO O O
right VB O O
medial JJ B-NP O
supramalleolar JJ I-NP O
area NN I-NP O
, , O O
no DT B-NP O
trauma NN I-NP O
, , O O
f/c/ns NN B-NP O
, , O O
redness NN B-NP O
, , O O
swelling VBG O O
+pn JJ B-NP O
w/ambulation NN I-NP O
to TO O O
right JJ B-NP O
leg NN I-NP O
, , O O
hip NN B-NP O
, , O O
achy IN B-VP O
not RB O O
sharp JJ B-NP O
Denies NNPS I-NP O
bowl/bladder NN I-NP O
changes NNS I-NP O
In IN B-VP O
ED NNP B-NP O
got VBD B-VP O
ASA NNP B-NP B-m
PMH: NNP I-NP O
see VBP O O
problems NNS B-NP O
SH: NNP I-NP O
lives VBZ O O
with IN B-VP O
older JJR B-NP O
son NN I-NP O
, , O O
seen VBN O O
with IN B-VP O
other JJ B-NP O
son NN I-NP O
, , O O
doesn't VB O O
do VB O O
much JJ B-NP O
activity NN I-NP O
without IN B-VP O
assistance NN B-NP O
STATUS: NNP I-NP O
VS NNP I-NP O
97.8 CD O O
, , O O
80 CD O O
, , O O
179/83 CD O O
, , O O
16 CD O O
, , O O
96%RA CD O O
, , O O
exam FW O O
wnl NN B-NP O
except IN B-VP O
4x6cm CD O O
area NN B-NP O
of IN B-VP O
dark JJ B-NP O
induration NN I-NP O
on IN B-VP O
medial JJ B-NP O
area NN I-NP O
above IN B-VP O
ankle NN B-NP O
, , O O
ttp NN B-NP O
, , O O
no DT O O
red JJ O O
, , O O
slight JJ B-NP O
warm NN I-NP O
no DT B-NP O
edema NN I-NP O
2+b/l CD O O
ext JJ B-NP O
pulses NNS I-NP O
Str NNP I-NP O
5/5 CD O O
all DT B-NP O
ext JJ I-NP O
Stands NNP I-NP O
and CC O O
walks NNS B-NP O
w/o VBP O O
intalgia JJ B-NP O
neuro JJ I-NP O
sensory JJ I-NP O
intact NN I-NP O
to TO O O
LT NNP B-NP O
bil NN I-NP O
MEDS: NNP I-NP O
lisinopril VBZ O B-m
20 CD O B-do
, , O O
hctz NN B-NP B-m
25 CD O B-do
, , O O
lipitor NN B-NP B-m
10 CD O B-do
, , O O
mvi NN B-NP B-m
, , O O
fosomax JJ B-NP B-m
NKDA NNP I-NP O
LABS: NNP I-NP O
WNL NNP I-NP O
, , O O
ddimer NN B-NP O
&lt;500 NNP I-NP O
STUDIES: NNP I-NP O
ECG NNP I-NP O
- : O O
NSR NN B-NP O
, , O O
??old JJ B-NP O
septal JJ I-NP O
infract NN I-NP O
with IN B-VP O
q's NN B-NP O
in IN B-VP O
v1 NN B-NP O
, , O O
v2 FW O O
infarct NN B-NP O
CXR NNP I-NP O
- : O O
no DT B-NP O
effusion NN I-NP O
, , O O
infiltrate NN B-NP O
, , O O
or CC O O
acute JJ B-NP O
abnl NN I-NP O
RIGHT NNP I-NP O
HIP NNP I-NP O
, , O O
KNEE NNP B-NP O
, , O O
ANKLE NNP B-NP O
, , O O
LEG NNP B-NP O
Xrays NNP I-NP O
- : O O
no DT B-NP O
joint JJ I-NP O
space NN I-NP O
disease NN I-NP O
or CC O O
fractures VBZ O O
****HOSPITAL JJ B-NP O
COURSE**** NNP I-NP O
Patient NNP I-NP O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
difficulty NN B-NP O
for IN B-VP O
ambulation NN B-NP O
and CC O O
work NN B-NP O
up RB O O
of IN B-VP O
her PRP$ O O
leg NN B-NP O
pains VBZ O O
She PRP O O
had VBD B-VP O
two CD O O
pain NN B-NP O
syndromes NNS I-NP O
( ( O O
1 CD O O
) ) O O
focal JJ B-NP O
area NN I-NP O
of IN B-VP O
induration NN B-NP O
2cm CD O O
above IN B-VP O
right JJ B-NP O
medial JJ I-NP O
malleolus NN I-NP O
with IN B-VP O
slight JJ B-NP O
warmth NNS I-NP O
but CC O O
not RB O O
true JJ B-NP O
redness NN I-NP O
or CC O O
swelling VBG O O
Likely JJ B-NP O
chronic JJ I-NP O
venous JJ I-NP O
stasis NN I-NP O
vs NN I-NP O
superficial JJ B-NP O
thrombophlebitis NN I-NP O
DDimer NNP I-NP O
was VBD B-VP O
&lt;500 JJ O O
and CC O O
negative JJ O O
This DT O O
improved VBN O O
with IN B-VP O
tylenol NN B-NP B-m
and CC O O
though IN B-VP O
cellulitis NN B-NP O
was VBD B-VP O
considered VBN O O
she PRP O O
was VBD B-VP O
afebrile RB O O
, , O O
nl JJ B-NP O
WBC NNP I-NP O
count NN I-NP O
, , O O
and CC O O
it PRP O O
did VBD B-VP O
not RB O O
have VB O O
the DT B-NP O
clinical JJ I-NP O
signs NNS I-NP O
consistent JJ O O
with IN B-VP O
cellulitis NN B-NP O
Regardless NNP I-NP O
it PRP O O
should MD O O
be VB O O
followed VBN O O
for IN B-VP O
progression NN B-NP O
Also RB O O
considered VBD B-VP O
atypical JJ B-NP O
gout NN I-NP O
and CC O O
this DT O O
should MD O O
be VB O O
considered VBN O O
in IN B-VP O
the DT B-NP O
future NN I-NP O
if IN B-VP O
it PRP O O
persists VBZ O O
( ( O O
2 CD O O
) ) O O
Pt NNP B-NP O
complained VBD B-VP O
of IN B-VP O
right NN B-NP O
sided VBD B-VP O
aching VBG O O
lower JJR B-NP O
extremity NN I-NP O
pain NN I-NP O
that WDT O O
was VBD B-VP O
present JJ O O
with IN B-VP O
ambulation NN B-NP O
Xrays NNS I-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
lower JJR I-NP O
extremity NN I-NP O
joints NNS I-NP O
including VBG O O
hip NN B-NP O
, , O O
knee NN B-NP O
, , O O
ankle NN B-NP O
, , O O
and CC O O
LE NNP B-NP O
bones NNS I-NP O
showed VBD B-VP O
no DT B-NP O
abnormality NN I-NP O
She PRP O O
was VBD B-VP O
evaluated VBN O O
by IN B-VP O
physical JJ B-NP O
therapy NN I-NP O
which WDT O O
recommended VBD B-VP O
use NN B-NP O
of IN B-VP O
her PRP$ O O
cane NN B-NP O
and CC O O
that IN B-VP O
she PRP O O
did VBD B-VP O
not RB O O
have VB O O
acute JJ B-NP O
PT NNP I-NP O
needs NNS I-NP O
Cleared NNP I-NP O
to TO O O
go VB O O
home NN B-NP O
Her NNP I-NP B-r
Her NNP I-NP B-r
pains NN I-NP I-r
pains NNS I-NP I-r
were VBD B-VP O
treated VBN O O
with IN B-VP O
tylenol JJ O B-m
650mg CD O B-do
po NN B-NP B-mo
q6hr NN I-NP B-f
ATC NNP I-NP O
and CC O O
PRN NNP B-NP B-f
ibuprofen VBP O B-m
The DT B-NP O
day NN I-NP O
after IN B-VP O
admission NN B-NP O
her PRP$ O O
pain NN B-NP O
had VBD B-VP O
improved VBN O O
and CC O O
she PRP O O
was VBD B-VP O
ambulating VBG O O
at IN B-VP O
baseline NN B-NP O
with IN B-VP O
decreased JJ B-NP O
discomfort NN I-NP O
She PRP O O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
her PRP$ O O
outpatient JJ B-NP O
cardiovascular JJ I-NP B-m
medications NNS I-NP I-m
Notably RB O O
she PRP O O
was VBD B-VP O
hypertensive JJ O O
but CC O O
her PRP$ O O
medications NNS B-NP O
were VBD B-VP O
not RB O O
altered VBN O O
Her NNP B-NP O
BP NNP I-NP O
should MD O O
be VB O O
followed VBN O O
up RP O O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
and CC O O
he PRP O O
BP NNP B-NP B-m
meds RB O I-m
titrated VBD B-VP B-do
as IN B-VP B-f
needed VBN O I-f
She PRP O O
was VBD B-VP O
discharged VBN O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
to TO O O
her PRP$ O O
son NN B-NP O
Her PRP$ O O
NP NNP B-NP O
Ezekiel NNP I-NP O
Boyton NNP I-NP O
was VBD B-VP O
contacted VBN O O
to TO O O
continue VB O O
follow VB O O
up RP O O
care NN B-NP O
( ( O O
291-543-8499 JJ O O
) ) O O
ADDITIONAL NNP B-NP O
COMMENTS: NNP I-NP O
Please NNP I-NP O
take VB O O
tylenol NN B-NP B-m
at IN B-VP B-f
least JJS O I-f
twice JJ O I-f
daily RB O I-f
to TO O O
help VB O O
improve VB O O
you PRP O O
leg VBP O B-r
pain VB O I-r
Seek NNP B-NP O
medical JJ B-NP O
attention NN I-NP O
if IN B-VP O
your PRP$ O O
leg NN B-NP O
becomes VBZ O O
more RBR O O
red JJ O O
, , O O
swollen JJ O O
, , O O
or CC O O
tender NN B-NP O
, , O O
or CC O O
if IN B-VP O
you PRP O O
have VBP O O
any DT B-NP O
fevers NNS I-NP O
, , O O
or CC O O
if IN B-VP O
you PRP O O
have VBP O O
any DT B-NP O
new JJ I-NP O
problems NNS I-NP O
with IN B-VP O
your PRP$ O O
leg NN B-NP O
Please NNP I-NP O
try NN I-NP O
to TO O O
use VB O O
you PRP O O
cane VBP O O
to TO O O
assist VB O O
with IN B-VP O
your PRP$ O O
walking VBG O O
Please NNP B-NP O
call VB O O
your PRP$ O O
nurse NN B-NP O
practioner NN I-NP O
within IN B-VP O
2 CD O O
weeks NNS B-NP O
for IN B-VP O
an DT B-NP O
appointment NN I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
1 CD O O
tylenol NN B-NP B-m
for IN B-VP O
pain NN B-NP B-r
2 CD O O
ibuprofen NN B-NP B-m
as IN B-VP B-f
needed JJ O I-f
3 CD O O
follow VBP O O
up RP O O
with IN B-VP O
lenard JJ B-NP O
dimmitt NN I-NP O
for IN B-VP O
blood NN B-NP O
pressure NN I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
BUCKEY NNP I-NP O
, , O O
REED NNP B-NP O
S NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
LQ21 NNP B-NP O
) ) O O
1/12/06 CD O O
@ $ O O
01:40 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#957953 VBZ O O
895562413 CD O O
REH NNP B-NP O
55829947 CD O O
817500 CD O O
11/16/1990 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
2/2/1990 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Unsigned NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
8/0/1990 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT O O
39 CD O O
year NN B-NP O
old JJ B-NP O
Wark NNP I-NP O
Na NNP I-NP O
Bo NNP I-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
discoid JJ B-NP O
lupus NN I-NP O
and CC O O
pericarditis NN B-NP O
, , O O
who WP O O
presents VBZ O O
with IN B-VP O
severe JJ B-NP O
substernal JJ I-NP O
chest NN I-NP O
pain NN I-NP O
after IN B-VP O
having VBG O O
prednisone NN B-NP B-m
and CC O O
Plaquenil NNP B-NP B-m
discontinued VBD B-VP O
She PRP O O
first RB O O
developed VBD B-VP O
discoid JJ B-NP O
lupus NN I-NP O
in IN B-VP O
1983 CD O O
She PRP O O
subsequently RB O O
over IN B-VP O
the DT B-NP O
years NNS I-NP O
developed VBD B-VP O
arthralgias JJ B-NP B-r
arthralgias NNS I-NP B-r
of IN B-VP O
various JJ B-NP O
joints NNS I-NP O
, , O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
aspirin NN B-NP B-m
, , O O
Motrin NNP B-NP O
and CC O O
steroids NNS B-NP B-m
In IN B-VP O
1985 CD O O
, , O O
she PRP O O
developed VBD B-VP O
pleuritic JJ B-NP O
substernal JJ I-NP O
chest NN I-NP O
pain NN I-NP O
She PRP O O
was VBD B-VP O
diagnosed VBN O O
at IN B-VP O
Westten NNP B-NP O
Hospital NNP I-NP O
with IN B-VP O
pericarditis NN B-NP O
and CC O O
underwent JJ B-NP O
pericardiocentesis NN I-NP O
In IN B-VP O
1988 CD O O
, , O O
she PRP O O
was VBD B-VP O
seen VBN O O
at IN B-VP O
the DT B-NP O
Arthritis NNP I-NP O
Clinic NNP I-NP O
by IN B-VP O
Dr NNP B-NP O
Goerlitz NNP I-NP O
, , O O
who WP O O
noted VBD B-VP O
a DT B-NP O
discoid JJ I-NP O
lupus NN I-NP O
on IN B-VP O
examination NN B-NP O
, , O O
a DT B-NP O
mild JJ I-NP O
anemia NN I-NP O
, , O O
sedimentation NN B-NP O
rate NN I-NP O
85 CD O O
, , O O
CH-50 NNP B-NP O
178 CD O O
, , O O
VNA NNP B-NP O
positive JJ O O
at IN B-VP O
1:160 CD O O
, , O O
positive JJ B-NP O
anti-double-stranded JJ I-NP O
DNA NN I-NP O
and CC O O
3+ CD O O
positive JJ B-NP O
Smith/anti-Smith NNP I-NP O
antibody NN I-NP O
She PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
Plaquenil NNP B-NP B-m
200 CD O B-do
bid NN B-NP B-f
, , O O
plus CC O O
aspirin NN B-NP B-m
and CC O O
Naprosyn NNP B-NP B-m
In IN B-VP O
22 CD O O
of IN B-VP O
May NNP B-NP O
, , O O
she PRP O O
was VBD B-VP O
diagnosed VBN O O
with IN B-VP O
a DT B-NP B-r
lupus NN I-NP I-r
flare NN I-NP I-r
and CC O O
was VBD B-VP O
put VBN O O
on IN B-VP O
prednisone NN B-NP B-m
30 CD O B-do
q NN B-NP B-f
am VBP O I-f
She PRP O O
did VBD B-VP O
well RB O O
and CC O O
in IN B-VP O
23 CD O O
of IN B-VP O
March NNP B-NP O
the DT B-NP O
steroids NNS I-NP B-m
were VBD B-VP O
tapered VBN O O
off RB O O
and CC O O
discontinued VBN O O
However RB O O
, , O O
she PRP O O
presented VBD B-VP O
with IN B-VP O
substernal JJ B-NP B-r
chest NN I-NP I-r
pain NN I-NP I-r
at IN B-VP O
that DT B-NP O
time NN I-NP O
and CC O O
had VBD B-VP O
her PRP$ O O
prednisone NN B-NP B-m
restarted VBD B-VP O
She PRP O O
was VBD B-VP O
put VBN O O
on IN B-VP O
another DT B-NP O
prednisone NN I-NP B-m
taper NN I-NP O
In IN B-VP O
26 CD O O
of IN B-VP O
May NNP B-NP O
, , O O
she PRP O O
had VBD B-VP O
a DT B-NP O
negative JJ I-NP O
brain NN I-NP O
magnetic JJ B-NP O
resonance NN I-NP O
imaging NN I-NP O
In IN B-VP O
1 CD O O
of IN B-VP O
October NNP B-NP O
, , O O
she PRP O O
had VBD B-VP O
an DT B-NP O
echocardiogram NN I-NP O
which WDT O O
showed VBD B-VP O
pericardial JJ B-NP O
thickening NN I-NP O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
constriction NN B-NP O
consistent NN I-NP O
with IN B-VP O
prior JJ B-NP O
pericarditis NN I-NP O
Over IN B-VP O
the DT B-NP O
following JJ I-NP O
several JJ I-NP O
months NNS I-NP O
, , O O
she PRP O O
had VBD B-VP O
occasional JJ B-NP O
flares NNS I-NP O
because IN B-VP O
of IN B-VP O
medical JJ B-NP O
noncompliance NN I-NP O
She PRP O O
was VBD B-VP O
put VBN O O
on IN B-VP O
Plaquenil NNP B-NP B-m
Plaquenil NNP I-NP B-m
200 CD O B-do
200 CD O B-do
bid NN B-NP B-f
, , O O
which WDT O O
was VBD B-VP O
increased VBN O O
to TO O O
tid VB O B-f
, , O O
and CC O O
Motrin NNP B-NP B-m
800 CD O B-do
bid NN B-NP B-f
In IN B-VP O
15 CD O O
of IN B-VP O
January NNP B-NP O
, , O O
she PRP O O
again RB O O
came VBD B-VP O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
with IN B-VP O
substernal JJ B-NP O
chest NN I-NP O
pain NN I-NP O
and CC O O
a DT B-NP O
mild JJ I-NP O
pulsus NN I-NP O
paradoxus NN I-NP O
, , O O
no DT B-NP O
jugular JJ I-NP O
venous JJ I-NP O
distention NN I-NP O
An DT B-NP O
electrocardiogram NN I-NP O
was VBD B-VP O
without IN B-VP O
change NN B-NP O
Chest NNP I-NP O
x-ray NN I-NP O
showed VBD B-VP O
slight JJ B-NP O
increase NN I-NP O
in IN B-VP O
the DT B-NP O
heart NN I-NP O
size NN I-NP O
She PRP O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
prednisone NN B-NP B-m
30 CD O B-do
q JJ B-NP B-f
day NN I-NP I-f
, , O O
Tylenol NNP B-NP B-m
with IN B-VP I-m
codeine NN B-NP I-m
and CC O O
did VBD B-VP O
well RB O O
On IN B-VP O
21 CD O O
of IN B-VP O
January NNP B-NP O
, , O O
she PRP O O
was VBD B-VP O
seen VBN O O
in IN B-VP O
the DT B-NP O
clinic NN I-NP O
and CC O O
had VBD B-VP O
substernal JJ B-NP O
chest NN I-NP O
pain NN I-NP O
consistent JJ O O
with IN B-VP O
pericardial JJ B-NP O
pain NN I-NP O
, , O O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
, , O O
increased VBD B-VP O
arthralgias RB O B-r
secondary JJ O I-r
to TO O O
discontinuing VBG O O
her PRP$ O O
steroids NNS B-NP B-m
At IN B-VP O
that DT B-NP O
time NN I-NP O
, , O O
she PRP O O
had VBD B-VP O
her PRP O O
Plaquenil NNP B-NP B-m
and CC O O
prednisone NN B-NP B-m
restarted VBN O O
Over IN B-VP O
the DT O O
last JJ O O
3 CD O O
weeks NNS B-NP O
prior RB O O
to TO O O
admission VB O O
she PRP O O
noticed VBD B-VP O
that IN B-VP O
the DT B-NP O
prednisone NN I-NP B-m
and CC O O
Plaquenil NNP B-NP B-m
increased VBD B-VP O
stomachaches NNS B-NP O
and CC O O
she PRP O O
stopped VBD B-VP O
the DT B-NP O
medication NN I-NP O
Over IN B-VP O
the DT O O
last JJ O O
7 CD O O
days NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
she PRP O O
has VBZ O O
had VBD B-VP O
increasing VBG O O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
and CC O O
substernal JJ B-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
which WDT O O
is VBZ O O
sharp JJ O O
, , O O
increases NNS B-NP O
with IN B-VP O
cough NN B-NP O
or CC O O
deep JJ B-NP O
breaths NNS I-NP O
She PRP O O
denied VBD B-VP O
any DT B-NP O
orthopnea NN I-NP O
or CC O O
paroxysmal JJ B-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
, , O O
palpitations NNS B-NP O
or CC O O
syncope NN B-NP O
She PRP O O
has VBZ O O
no DT B-NP O
nausea NN I-NP O
, , O O
vomiting VBG O O
, , O O
fevers NNS B-NP O
, , O O
chills NNS B-NP O
or CC O O
melena VB O O
She PRP O O
does VBZ O O
have VB O O
increasing VBG O O
joint JJ B-NP O
pain NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
revealed VBD B-VP O
seizure NN B-NP B-r
disorder NN I-NP O
with IN B-VP O
Dilantin NNP B-NP B-m
, , O O
hypothyroidism NN B-NP B-r
treated VBN O O
with IN B-VP O
L-thyroxine NNP B-NP B-m
, , O O
iron NN B-NP O
deficiency NN I-NP O
anemia NN I-NP O
without IN B-VP O
prior JJ B-NP O
work-up NN I-NP O
, , O O
thoracic JJ B-NP O
spine NN I-NP O
compression NN I-NP O
fractures NNS I-NP O
, , O O
gastritis NN B-NP O
questionably RB O O
secondary JJ O O
to TO O O
Naprosyn NNP B-NP B-m
She PRP O O
has VBZ O O
no DT O O
known VBN O O
ALLERGIES NNP B-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
were VBD B-VP O
Plaquenil NNP B-NP B-m
200 CD O B-do
bid NN B-NP B-f
, , O O
Motrin NNP B-NP B-m
80 CD O B-do
tid NN B-NP B-f
, , O O
prednisone NN B-NP B-m
10 CD O B-do
q NN B-NP B-f
am VBP O I-f
, , O O
Dilantin NNP B-NP B-m
Dilantin NNP I-NP B-m
400 CD O B-do
400 CD O B-do
q NN B-NP B-f
am VBP O I-f
, , O O
L-thyroxine JJ O B-m
0.2 CD O B-do
q JJ B-NP B-f
q JJ I-NP B-f
day NN I-NP I-f
day NN I-NP I-f
, , O O
folate VBP O B-m
1 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
, , O O
iron NN B-NP B-m
sulfate NN I-NP I-m
225 CD O B-do
tid NN B-NP B-f
, , O O
Diprosone NNP B-NP B-m
Ointment NNP I-NP I-m
bid NN I-NP B-f
She PRP O O
does VBZ O O
not RB O O
smoke VB O O
or CC O O
drink VB O O
FAMILY NNP B-NP O
HISTORY NNP I-NP O
is VBZ O O
negative JJ O O
for IN B-VP O
collagen NN B-NP O
vascular NN I-NP O
diseases NNS I-NP O
She PRP O O
is VBZ O O
the DT B-NP O
mother NN I-NP O
of IN B-VP O
5 CD O O
children NNS B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
She PRP O O
was VBD B-VP O
an DT B-NP O
obese JJ I-NP O
Hispanic JJ I-NP O
female NN I-NP O
in IN B-VP O
mild JJ B-NP O
distress JJ I-NP O
Temperature NN I-NP O
was VBD B-VP O
99 CD O O
, , O O
pulse RB O O
60 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
130/70 CD O O
, , O O
respirations NNS B-NP O
18 CD O O
, , O O
pulsus NN B-NP O
paradoxus NN I-NP O
of IN B-VP O
10 CD O O
Skin NNP B-NP O
showed VBD B-VP O
numerous JJ B-NP O
discoid JJ I-NP O
lesions NNS I-NP O
of IN B-VP O
the DT B-NP O
scalp NN I-NP O
, , O O
face NN B-NP O
and CC O O
right JJ B-NP O
forearm NN I-NP O
and CC O O
lower JJR B-NP O
extremities NNS I-NP O
with IN B-VP O
patchy JJ B-NP O
alopecia JJ I-NP O
Head NNP I-NP O
, , O O
eyes NNS B-NP O
, , O O
ears NNS B-NP O
, , O O
nose RB O O
and CC O O
throat VB O O
examination NN B-NP O
was VBD B-VP O
unremarkable JJ B-NP O
Neck NNP I-NP O
was VBD B-VP O
supple JJ O O
, , O O
no DT B-NP O
adenopathy NN I-NP O
noted VBD B-VP O
Chest NNP B-NP O
was VBD B-VP O
clear JJ B-NP O
Cardiac NNP I-NP O
examination NN I-NP O
showed VBD B-VP O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
normal JJ B-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
, , O O
with IN B-VP O
a DT B-NP O
I/VI NNP I-NP O
systolic JJ B-NP O
ejection NN I-NP O
murmur NN I-NP O
at IN B-VP O
the DT B-NP O
left NN I-NP O
lower RBR O O
sternal JJ B-NP O
border NN I-NP O
, , O O
otherwise RB O O
no DT B-NP O
rubs NN I-NP O
or CC O O
gallops NNS B-NP O
Back RP O O
showed VBD B-VP O
no DT B-NP O
costovertebral JJ I-NP O
angle NN I-NP O
or CC O O
spinal JJ B-NP O
tenderness JJ I-NP O
Abdominal NNP I-NP O
examination NN I-NP O
was VBD B-VP O
benign JJ O O
, , O O
liver EX O O
is VBZ O O
10 CD O O
cm NN B-NP O
, , O O
and CC O O
the DT B-NP O
spleen JJ I-NP O
tip NN I-NP O
is VBZ O O
not RB O O
palpable JJ B-NP O
Rectal JJ I-NP O
examination NN I-NP O
was VBD B-VP O
guaiac JJ O O
negative JJ O O
, , O O
soft JJ B-NP O
brown NN I-NP O
stools NNS I-NP O
She PRP O O
does VBZ O O
have VB O O
external JJ B-NP O
hemorrhoids NNS I-NP O
Extremities NNS I-NP O
were VBD B-VP O
negative JJ O O
without IN B-VP O
cords NNS B-NP O
or CC O O
Homan's NNP B-NP O
sign NN I-NP O
Neurologic NNP I-NP O
examination NN I-NP O
was VBD B-VP O
grossly RB O O
intact JJ O O
, , O O
with IN B-VP O
normal JJ B-NP O
cranial JJ I-NP O
nerve NN I-NP O
function NN I-NP O
, , O O
motor NN B-NP O
, , O O
sensory NN B-NP O
, , O O
coordination NN B-NP O
and CC O O
deep JJ B-NP O
tendon NN I-NP O
reflexes NNS I-NP O
, , O O
except IN B-VP O
for IN B-VP O
question NN B-NP O
of IN B-VP O
slight JJ B-NP O
slowing NN I-NP O
of IN B-VP O
the DT B-NP O
relaxation NN I-NP O
phase NN I-NP O
of IN B-VP O
the DT B-NP O
reflexes NNS I-NP O
in IN B-VP O
the DT O O
upper JJ O O
and CC O O
lower JJR B-NP O
extremities NNS I-NP O
Musculoskeletal NNP I-NP O
examination NN I-NP O
showed VBD B-VP O
diffuse IN B-VP O
bilateral JJ O O
asymmetric JJ O O
synovial JJ O O
thickening VBG O O
with IN B-VP O
slightly RB O O
decreased VBN O O
range NN B-NP O
of IN B-VP O
motion NN B-NP O
most RBS O O
notably RB O O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
elbow NN I-NP O
, , O O
right JJ B-NP O
metacarpophalangeal NN I-NP O
joint NN I-NP O
, , O O
left VBD B-VP O
carpal JJ O O
, , O O
bilateral JJ B-NP O
knees NNS I-NP O
and CC O O
ankles NNS B-NP O
LABORATORY NNP I-NP O
EXAMINATION: NNP I-NP O
Electrolytes NNP I-NP O
were VBD B-VP O
all DT O O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
Her PRP$ O O
CK NNP B-NP O
was VBD B-VP O
76 CD O O
Dilantin NNP B-NP O
level NN I-NP O
5.6 CD O O
White NNP B-NP O
count NN I-NP O
was VBD B-VP O
4.7 CD O O
, , O O
hematocrit NN B-NP O
30 CD O O
, , O O
platelets NNS B-NP O
352 CD O O
, , O O
000 CD O O
, , O O
mean JJ B-NP O
corpuscular JJ I-NP O
volume NN I-NP O
83 CD O O
, , O O
ESR NNP B-NP O
88 CD O O
, , O O
oxygen NN B-NP O
saturation NN I-NP O
99% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
Urinalysis NNP I-NP O
showed VBD B-VP O
specific JJ B-NP O
gravity NN I-NP O
1.026 CD O O
, , O O
2+ CD O O
protein NN B-NP O
, , O O
10 CD O O
to TO O O
15 CD O O
white JJ B-NP O
cells NNS I-NP O
, , O O
8 CD O O
to TO O O
10 CD O O
red JJ B-NP O
blood NN I-NP O
cells NNS I-NP O
and CC O O
a DT B-NP O
few JJ I-NP O
granular JJ I-NP O
casts NNS I-NP O
Chest NNP I-NP O
x-ray NN I-NP O
showed VBD B-VP O
increased JJ B-NP O
heart NN I-NP O
size NN I-NP O
, , O O
otherwise RB O O
negative JJ O O
, , O O
no DT B-NP O
change NN I-NP O
from IN B-VP O
15 CD O O
of IN B-VP O
January NNP B-NP O
She PRP O O
does VBZ O O
have VB O O
multiple JJ B-NP O
thoracic JJ I-NP O
compression NN I-NP O
fractures NNS I-NP O
and CC O O
osteopenia VB O O
The DT B-NP O
electrocardiogram NN I-NP O
showed VBD B-VP O
sinus JJ B-NP O
rhythm NN I-NP O
with IN B-VP O
frequent JJ B-NP O
premature NN I-NP O
ventricular JJ B-NP O
contractions NNS I-NP O
at IN B-VP O
a DT B-NP O
rate NN I-NP O
of IN B-VP O
approximately RB O O
70 CD O O
, , O O
positive JJ O O
45 CD O O
degree JJ B-NP O
axis NN I-NP O
, , O O
normal JJ B-NP O
intervals NNS I-NP O
, , O O
T-wave NNP B-NP O
inversion NN I-NP O
in IN B-VP O
III NNP B-NP O
and CC O O
V2 NNP B-NP O
through IN B-VP O
V3 NNP B-NP O
without IN B-VP O
changes NNS B-NP O
in IN B-VP O
the DT B-NP O
PR NNP I-NP O
or CC O O
ST NNP B-NP O
segments NNS I-NP O
compared VBN O O
with IN B-VP O
15 CD O O
of IN B-VP O
January NNP B-NP O
, , O O
and CC O O
no DT B-NP O
decrease NN I-NP O
in IN B-VP O
the DT B-NP O
voltages NNS I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
Problem NNP I-NP O
#1 NNP I-NP O
was VBD B-VP O
substernal JJ B-NP O
chest NN I-NP O
pain NN I-NP O
This DT O O
seemed VBD B-VP O
to TO O O
be VB O O
a DT B-NP O
pericardial JJ I-NP O
pain NN I-NP O
secondary JJ O O
to TO O O
discontinuation NN B-NP O
of IN B-VP O
her PRP$ O O
prednisone NN B-NP B-m
and CC O O
Plaquenil NNP B-NP B-m
as IN B-VP O
it PRP O O
happened VBD B-VP O
numerous JJ B-NP O
times NNS I-NP O
in IN B-VP O
the DT O O
past JJ O O
She PRP O O
was VBD B-VP O
ruled VBN O O
out RP O O
for IN B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
She PRP O O
had VBD B-VP O
an DT B-NP O
echocardiogram NN I-NP O
which WDT O O
showed VBD B-VP O
a DT B-NP O
small JJ I-NP O
amount NN I-NP O
of IN B-VP O
pericardial JJ B-NP O
fluid NN I-NP O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
right JJ B-NP O
ventricular JJ I-NP O
indentation NN I-NP O
or CC O O
compromise NN B-NP O
She PRP O O
was VBD B-VP O
placed VBN O O
back RB O O
on IN B-VP O
her PRP$ O O
Plaquenil NNP B-NP B-m
200 CD O B-do
bid NN B-NP B-f
, , O O
and CC O O
prednisone RB O B-m
30 CD O B-do
q JJ B-NP B-f
day NN I-NP I-f
and CC O O
did VBD B-VP O
well RB O O
in IN B-VP O
that DT B-NP O
regard NN I-NP O
Problem NNP I-NP O
#2 NNP I-NP O
was VBD B-VP O
decreased VBN O O
hematocrit NN B-NP O
This DT O O
was VBD B-VP O
felt VBN O O
to TO O O
be VB O O
probably RB O O
secondary JJ O O
to TO O O
hydration NN B-NP O
as IN B-VP O
the DT B-NP O
hematocrit NN I-NP O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
#2 VB O O
went VBD B-VP O
from IN B-VP O
31 CD O O
to TO O O
27 CD O O
with IN B-VP O
several JJ B-NP O
liters NNS I-NP O
of IN B-VP O
intravenous JJ B-NP O
fluid JJ I-NP O
Stool NNP I-NP O
guaiacs NN I-NP O
were VBD B-VP O
negative JJ O O
throughout IN B-VP O
the DT B-NP O
hospitalization NN I-NP O
The DT B-NP O
hematocrit NN I-NP O
remained VBD B-VP O
stable JJ O O
between IN B-VP O
27 CD O O
and CC O O
30 CD O O
without IN B-VP O
transfusions NNS B-NP O
or CC O O
further JJ B-NP O
intervention NN I-NP O
She PRP O O
did VBD B-VP O
have VB O O
a DT B-NP O
Coombs NNP I-NP O
test NN I-NP O
sent VBD B-VP O
which WDT O O
was VBD B-VP O
mildly RB O O
positive JJ O O
, , O O
although IN B-VP O
her PRP$ O O
hematocrit NN B-NP O
was VBD B-VP O
stable JJ O O
She PRP O O
was VBD B-VP O
discharged VBN O O
on IN B-VP O
folate NN B-NP B-m
and CC O O
iron NN B-NP O
Problem NNP I-NP O
#3 NNP I-NP O
is VBZ O O
hematuria JJ O O
and CC O O
pyuria NN B-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
Urine NNP I-NP O
culture NN I-NP O
and CC O O
urine JJ B-NP O
gram NN I-NP O
stain NN I-NP O
were VBD B-VP O
both DT O O
negative JJ O O
for IN B-VP O
infection NN B-NP O
and CC O O
this DT O O
was VBD B-VP O
followed VBN O O
up RP O O
with IN B-VP O
a DT B-NP O
24-hour JJ I-NP O
urine JJ I-NP O
collection NN I-NP O
for IN B-VP O
protein NN B-NP O
to TO O O
assess VB O O
for IN B-VP O
potential JJ B-NP O
lupus JJ I-NP O
involvement NN I-NP O
of IN B-VP O
the DT B-NP O
kidney NN I-NP O
, , O O
and CC O O
this DT O O
will MD O O
need VB O O
to TO O O
be VB O O
followed VBN O O
up RP O O
on IN B-VP O
DISPOSITION: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
for IN B-VP O
FOLLOW-UP NNP B-NP O
in IN B-VP O
Rheumatology NNP B-NP O
Clinic NNP I-NP O
with IN B-VP O
Dr NNP B-NP O
Grondin NNP I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
included VBD B-VP O
Plaquenil NNP B-NP B-m
200 CD O B-do
bid NN B-NP B-f
, , O O
prednisone NN B-NP B-m
20 CD O B-do
q JJ B-NP B-f
day NN I-NP I-f
, , O O
Dilantin NNP B-NP B-m
400 CD O B-do
q NN B-NP B-f
day NN I-NP I-f
, , O O
L-thyroxine JJ O B-m
0.2 CD O B-do
q NN B-NP B-f
am VBP O I-f
, , O O
Motrin NNP B-NP B-m
800 CD O B-do
tid NN B-NP B-f
, , O O
Carafate NNP B-NP B-m
, , O O
iron NN B-NP O
and CC O O
folate VB O B-m
________________________________ NNP B-NP O
PC935/9478 NNP I-NP O
DARRELL NNP I-NP O
PITCAVAGE NNP I-NP O
, , O O
M.D NNP B-NP O
NJ8 NNP I-NP O
D: NNP I-NP O
9/23/90 CD O O
Batch: NNP B-NP O
5309 CD O O
Report: NNP B-NP O
Q6251C81 NNP I-NP O
T: NNP I-NP O
10/14/90 CD O O
Dictated NNP B-NP O
By: NNP I-NP O
JOESPH NNP I-NP O
ZUEHL NNP I-NP O
, , O O
M.D NNP B-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#961115 VBZ O O
895226877 CD O O
YMC NNP B-NP O
33406917 CD O O
2170940 CD O O
9/12/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
Upper NNP I-NP O
Respiratory NNP I-NP O
Infection NNP I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
6/27/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
1/26/2005 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
GREGSTON NNP I-NP O
, , O O
DARREL NNP B-NP O
163-08-42-8 CD O O
MT NNP B-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
3/26/05 CD O O
AT NNP B-NP O
02:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
HO NNP I-NP O
evaluation NN I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
OELTJEN NNP I-NP O
, , O O
DONN NNP B-NP O
EARLE NNP I-NP O
, , O O
M.D NNP B-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
IBUPROFEN NNP I-NP B-m
600-800 JJ B-NP B-do
MG NNP I-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
PRN NNP I-NP I-f
Pain NNP I-NP B-r
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
with IN B-VP O
food NN B-NP O
DIET: NNP I-NP O
No NNP I-NP O
Restrictions NNP I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
primary JJ B-NP O
care NN I-NP O
doctor NN I-NP O
25 CD O O
of IN B-VP O
October NNP B-NP O
, , O O
ALLERGY: NNP B-NP O
NKA NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
Shortness NNP I-NP O
of IN B-VP O
breath NN B-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Upper NNP B-NP O
Respiratory NNP I-NP O
Infection NNP I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
hypertension NN I-NP O
( ( O O
hypertension NN B-NP O
) ) O O
appendectomy NN B-NP O
( ( O O
appendectomy NN B-NP O
) ) O O
obesity NN B-NP O
( ( O O
obesity NN B-NP O
) ) O O
sleep NN B-NP O
apnea NN I-NP O
( ( O O
sleep JJ B-NP O
apnea NN I-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
none NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
Lower NNP B-NP O
extremity NN I-NP O
ultrasound NN I-NP O
of IN B-VP O
the DT B-NP O
Right NNP I-NP O
leg NN I-NP O
Negative NNP I-NP O
for IN B-VP O
deep RB O O
venous JJ B-NP O
thrombus NN I-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
26 CD O O
M NNP B-NP O
PMHx NNP I-NP O
of IN B-VP O
HTN NNP B-NP O
, , O O
obesity NN B-NP O
, , O O
sleep JJ B-NP O
apnea NN I-NP O
who WP O O
was VBD B-VP O
in IN B-VP O
NH NNP B-NP O
until IN B-VP O
2 CD O O
days NNS B-NP O
prior RB O O
to TO O O
admit VB O O
when WRB O O
developed JJ B-NP O
SOB NNP I-NP O
Pt NNP I-NP O
was VBD B-VP O
otherwise RB O O
well RB O O
until IN B-VP O
this DT B-NP O
AM NNP I-NP O
when WRB O O
he PRP O O
reports VBZ O O
palpitations NNS B-NP O
, , O O
cough NN B-NP O
with IN B-VP O
sputum NN B-NP O
, , O O
SOB NNP B-NP O
Feeling NNP I-NP O
warm NN I-NP O
but CC O O
no DT B-NP O
cp NN I-NP O
, , O O
vomiting VBG O O
, , O O
hemoptysis NN B-NP O
, , O O
BRBPR NNP B-NP O
, , O O
abdominal JJ B-NP O
pain NN I-NP O
, , O O
diarrhea VBZ O O
No NNP B-NP O
sick JJ B-NP O
contacts NNS I-NP O
Also RB O O
reports VBP O O
R NNP B-NP O
leg NN I-NP O
pain NN I-NP O
which WDT O O
he PRP O O
has VBZ O O
gotten VBN O O
in IN B-VP O
past NN B-NP O
in IN B-VP O
setting NN B-NP O
of IN B-VP O
pna NN B-NP O
VS NNP I-NP O
T NNP I-NP O
101.2 CD O O
P NNP B-NP O
110 CD O O
BP NNP B-NP O
128/72 CD O O
O2 NNP B-NP O
SAT NNP I-NP O
95% CD O O
RA NNP B-NP O
, , O O
98% CD O O
while IN B-VP O
ambulating VBG O O
Exam: NNP B-NP O
Gen: NNP I-NP O
NAD NNP I-NP O
HEENT: NNP I-NP O
Dry NNP I-NP O
mm NN I-NP O
Chest: NNP I-NP O
Dec NNP I-NP O
BS NNP I-NP O
R NNP I-NP O
lower JJR B-NP O
base NN I-NP O
no DT O O
wheezing VBG O O
CV: NNP B-NP O
Tachy NNP I-NP O
regular JJ B-NP O
rhythm NN I-NP O
ABD: NNP I-NP O
+BS NNP I-NP O
non JJ B-NP O
tender NN I-NP O
Ext: NNP I-NP O
no DT B-NP O
edema NN I-NP O
TTP NNP I-NP O
R NNP I-NP O
calf NN I-NP O
All: NNP I-NP O
Nkda NNP I-NP O
denies VBZ O O
smoking VBG O O
LABS: NNP B-NP O
WBC NNP I-NP O
14 CD O O
MCV NNP B-NP O
70 CD O O
HCT NNP B-NP O
47 CD O O
Nl NNP B-NP O
chem NN I-NP O
7 CD O O
BNP NNP B-NP O
2 CD O O
D-dimer NNP B-NP O
226 CD O O
Cardiac NNP B-NP O
enzymes NNS I-NP O
Neg NNP I-NP O
EKG: NNP I-NP O
sinus VBD B-VP O
tachy JJ B-NP O
T NNP I-NP O
wave NN I-NP O
inv NN I-NP O
III NNP I-NP O
unchanged JJ O O
from IN B-VP O
prior JJ B-NP O
CXR: NNP I-NP O
NL NNP I-NP O
a/p: VBD B-VP O
26 CD O O
obese JJ O O
, , O O
HTN NNP B-NP O
, , O O
male NN B-NP O
with IN B-VP O
SOB NNP B-NP O
1 CD O O
URI: NNP B-NP O
likely JJ B-NP O
viral NN I-NP O
in IN B-VP O
nature NN B-NP O
Nl NNP I-NP O
CXR NNP I-NP O
, , O O
nl JJ B-NP O
SATs NNP I-NP O
, , O O
albuterol NN B-NP B-m
prn NN I-NP B-f
wheezing VBG O B-r
while IN B-VP B-du
in IN B-VP I-du
hospital NN B-NP I-du
but CC O O
did VBD B-VP O
not RB O O
affect VB O O
patient's NN B-NP O
sob JJ B-NP O
Neg NNP I-NP O
D-dimer NNP I-NP O
but CC O O
due JJ O O
to TO O O
acute VB O O
onset JJ B-NP O
SOB NNP I-NP O
and CC O O
concominant VB O O
Right NNP B-NP O
lower JJR B-NP O
extremity NN I-NP O
pain NN I-NP O
, , O O
LENI's NNP B-NP O
done VBN O O
which WDT O O
were VBD B-VP O
negative JJ O O
for IN B-VP O
DVT NNP B-NP O
Patient NNP I-NP O
felt VBD B-VP O
better RBR O O
with IN B-VP O
IVF NNP B-NP B-m
given VBN O O
in IN B-VP O
ER NNP B-NP O
and CC O O
did VBD B-VP O
not RB O O
take VB O O
any DT B-NP O
nebulizers NNS I-NP O
while IN B-VP O
on IN B-VP O
the DT B-NP O
floor NN I-NP O
2.HTN: CD O O
BP NNP B-NP O
well RB O O
controlled VBD B-VP O
, , O O
pt NN B-NP O
has VBZ O O
never RB O O
taken VBN O O
HCTZ NNP B-NP O
or CC O O
any DT B-NP O
other JJ I-NP O
Rx NNP I-NP O
HTN NNP I-NP O
medications NNS I-NP O
will MD O O
go VB O O
home NN B-NP O
on IN B-VP O
no DT B-NP O
medications NNS I-NP O
3.Palpitations: CD O O
resolved VBD B-VP O
, , O O
no DT B-NP O
cp NN I-NP O
, , O O
no DT B-NP O
changes NNS I-NP O
in IN B-VP O
EKG NNP B-NP O
, , O O
neg JJ O O
enzymes RB O O
4.proph: CD O O
Lovenox NNP B-NP B-m
5.Right CD O B-r
leg NN B-NP I-r
pain: NN I-NP I-r
likely JJ B-NP O
musculoskeletal NN I-NP O
in IN B-VP O
nature NN B-NP O
No NNP I-NP O
DVT NNP I-NP O
found VBD B-VP O
on IN B-VP O
LENI NNP B-NP O
treat NN I-NP O
with IN B-VP O
elevation NN B-NP O
and CC O O
Ibuprofen NNP B-NP B-m
prn NN I-NP B-f
follow VB O O
up RP O O
with IN B-VP O
primary JJ B-NP O
care NN I-NP O
doctor NN I-NP O
if IN B-VP O
right JJ B-NP O
lower JJR I-NP O
extremity NN I-NP O
pain NN I-NP O
persists VBZ O O
6 CD O O
Low JJ B-NP O
MCV: NNP I-NP O
Consider NNP I-NP O
outpt MD O O
workup VB O O
for IN B-VP O
thalasemia JJ B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
follow VB O O
up RP O O
with IN B-VP O
your PRP$ O O
primary JJ B-NP O
care NN I-NP O
doctor NN I-NP O
for IN B-VP O
further JJ B-NP O
evaluation NN I-NP O
of IN B-VP O
your PRP$ O O
leg NN B-NP O
pain NN I-NP O
You PRP O O
can MD O O
elevate VB O O
your PRP$ O O
leg NN B-NP O
and CC O O
use NN B-NP O
Ibuprofen NNP I-NP B-m
as IN B-VP B-f
needed VBN O I-f
for IN B-VP O
pain NN B-NP B-r
control NN I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
as IN B-VP O
above IN B-VP O
No NNP B-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
MOLLENHAUER NNP I-NP O
, , O O
REGINALD NNP B-NP O
P NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
WK163 NNP B-NP O
) ) O O
3/26/05 CD O O
@ $ O O
01:44 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#966404 VBZ O O
267363543 CD O O
VUMC NNP B-NP O
41289795 CD O O
6085758 CD O O
0/19/2003 CD O O
12:00:00 CD O O
AM NNP B-NP O
atypical JJ B-NP O
noncardiac NN I-NP O
chest NN I-NP O
pain NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
0/19/2003 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
1/13/2003 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
KOSLOSKY NNP I-NP O
, , O O
ALEXANDER NNP B-NP O
580-29-32-0 CD O O
Denwood NNP B-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
8/4/03 CD O O
AT NNP B-NP O
02:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
WIESELER NNP I-NP O
, , O O
RUSSELL NNP B-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
9/3 CD O O
) ) O O
Instructions: NNP B-NP O
increased VBD B-VP O
dose NN B-NP O
for IN B-VP O
costochondritis NN B-NP B-r
, , O O
pt NN B-NP O
does VBZ O O
not RB O O
wish VB O O
to TO O O
take VB O O
650 CD O O
QID NNP B-NP O
dosing VBG O O
COLACE NNP B-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
ENALAPRIL NNP I-NP B-m
MALEATE NNP I-NP I-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ZOCOR NNP I-NP B-m
( ( O I-m
SIMVASTATIN NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
INSULIN NNP B-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
70/30 CD O I-m
70/30 CD O I-m
70/30 CD O I-m
70/30 CD O I-m
( ( O I-m
( ( O I-m
( ( O I-m
( ( O I-m
HUMAN NNP B-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
) ) O I-m
) ) O I-m
) ) O I-m
) ) O I-m
80 CD O B-do
UNITS NNP B-NP I-do
QAM; NNP I-NP B-f
60 CD O B-do
UNITS NNP B-NP I-do
QPM NNP I-NP B-f
SC NNP I-NP B-mo
SC NNP I-NP B-mo
80 CD O B-do
UNITS NNP B-NP I-do
QAM NNP I-NP B-f
60 CD O B-do
UNITS NNP B-NP I-do
QPM NNP I-NP B-f
Number NNP I-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ B-NP O
): NN I-NP O
6 CD O O
PLAVIX NNP B-NP B-m
( ( O I-m
CLOPIDOGREL NNP B-NP I-m
) ) O I-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
PSYLLIUM NNP I-NP B-m
2 CD O B-do
TSP NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
TOPROL NNP I-NP B-m
XL NNP I-NP I-m
( ( O I-m
METOPROLOL NNP B-NP I-m
( ( O I-m
SUST NNP B-NP I-m
REL NNP I-NP I-m
) ) O I-m
) ) O I-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
FAMOTIDINE NNP I-NP B-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
DIET: NNP I-NP O
Patient NNP I-NP O
should MD O O
measure VB O O
weight JJ B-NP O
daily JJ I-NP O
DIET: NNP I-NP O
Fluid NNP I-NP O
restriction: VBD B-VP O
2 CD O O
liters NNS B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
2 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Curts NNP I-NP O
1-2 JJ B-NP O
weeks NNS I-NP O
, , O O
ALLERGY: NNP B-NP O
Codeine NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
chest JJS B-NP O
pain NN I-NP O
, , O O
cad NN B-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
atypical JJ B-NP O
noncardiac JJ I-NP O
chest NN I-NP O
pain NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
HTN NNP I-NP O
( ( O O
hypertension NN B-NP O
) ) O O
CAD NNP B-NP O
( ( O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
) ) O O
s/p NN B-NP O
cabg NN I-NP O
( ( O O
S/P NNP B-NP O
cardiac JJ B-NP O
bypass NN I-NP O
graft NN I-NP O
surgery NN I-NP O
) ) O O
IDDM NNP B-NP O
( ( O O
) ) O O
hypercholesterolemia NN B-NP O
( ( O O
elevated VBN O O
cholesterol NN B-NP O
) ) O O
peripheral NN B-NP O
neuropathy JJ O O
( ( O O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
none NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
adenosine VBP O B-m
MIBI NNP B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
62M CD O O
with IN B-VP O
history NN B-NP O
of IN B-VP O
CAD NNP B-NP O
and CC O O
prior RB O O
MI NNP B-NP O
leading VBG O O
to TO O O
CABG NNP B-NP O
in IN B-VP O
5/23 CD O O
Frequent JJ B-NP O
chest NN I-NP O
pain NN I-NP O
since IN B-VP O
on IN B-VP O
exertion NN B-NP O
and CC O O
in IN B-VP O
times NNS B-NP O
of IN B-VP O
stress NN B-NP O
Admitted VBN O O
to TO O O
RCH VB O O
6/17 CD O O
with IN B-VP O
CP NNP B-NP O
and CC O O
ruled VBD B-VP O
out RP O O
for IN B-VP O
MI NNP B-NP O
Cath NNP I-NP O
showed VBD B-VP O
non-occlusive JJ B-NP O
disease NN I-NP O
( ( O O
70% CD O O
) ) O O
an DT B-NP O
OM NNP I-NP O
which WDT O O
was VBD B-VP O
stented VBN O O
Well NNP B-NP O
since IN B-VP O
with IN B-VP O
frequent JJ B-NP O
CP NNP I-NP O
with IN B-VP O
very RB O O
minimal JJ B-NP O
exertion NN I-NP O
Today NNP I-NP O
walking VBG O O
outside RB O O
after IN B-VP O
dinner NN B-NP O
had VBD B-VP O
another DT B-NP O
episode NN I-NP O
of IN B-VP O
his PRP$ O O
usual JJ B-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
+SOB NNP B-NP O
, , O O
5/10 CD O O
, , O O
no DT B-NP O
radiation/LH/ NN I-NP O
palpitations NNS I-NP O
, , O O
c/o NN B-NP O
nausea NN I-NP O
and CC O O
vomiting; NN B-NP O
called VBN O O
EMS NNP B-NP O
-&gt; NNP I-NP O
BSMH NNP I-NP O
EW NNP I-NP O
, , O O
given VBN O O
2 CD O B-do
NTG NNP B-NP B-m
with IN B-VP O
resolution NN B-NP O
of IN B-VP O
symptoms NNS B-NP O
Concerning VBG O O
for IN B-VP O
increasing VBG O O
frequency NN B-NP O
of IN B-VP O
CP NNP B-NP O
OUTPT NNP I-NP O
MEDS: NNP I-NP O
plavix VBD B-VP B-m
75/lasix CD O B-m
75/lasix CD O B-do
20/enalapril CD O B-m
20/enalapril CD O B-do
5/pepcid CD O B-do
5/pepcid CD O B-m
20/toprol CD O B-m
20/toprol CD O B-do
xl NN B-NP I-m
25/ASA CD O B-do
25/ASA CD O B-m
325/insulin CD O B-do
325/insulin CD O B-m
325/insulin CD O B-m
70/30/ CD O I-m
70/30/ CD O I-m
80units CD O B-do
am VBP O B-f
, , O O
60 CD O B-do
units NNS B-NP I-do
pm/zocor VBP O B-f
pm/zocor JJ B-NP B-m
Hospital NNP I-NP O
course: NN I-NP O
1 CD O O
Card NNP B-NP O
- : O O
ruled VBD B-VP O
out RP O O
for IN B-VP O
MI NNP B-NP O
, , O O
repeated VBD B-VP O
Adenosine NNP B-NP B-m
MIBI NNP I-NP O
which WDT O O
confirmed VBD B-VP O
no DT B-NP O
ischemia NN I-NP O
continue VBP O O
outpt JJ B-NP O
regimen NNS I-NP O
of IN B-VP O
enalapril/lasix/toprol/zocor NN B-NP B-m
2 CD O O
GI: NNP B-NP O
pt NN I-NP O
with IN B-VP O
rapid JJ B-NP O
new JJ I-NP O
rise NN I-NP O
in IN B-VP O
transaminases NNS B-NP O
ddx: VBP O O
most RBS O O
likely JJ O O
due JJ O O
to TO O O
relative JJ B-NP O
hypotension NN I-NP O
early RB O O
in IN B-VP O
admission NN B-NP O
per IN B-VP O
GI NNP B-NP O
c/s NN I-NP O
, , O O
vs NN B-NP O
NASH NNP I-NP O
( ( O O
fatt JJ B-NP O
y NN I-NP O
infiltrate NN I-NP O
on IN B-VP O
RUQ NNP B-NP O
US NNP I-NP O
, , O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
stones NNS B-NP O
) ) O O
also RB O O
on IN B-VP O
ddx NNS B-NP O
are VBP O O
ETOH NNP B-NP O
, , O O
viral JJ B-NP O
hepatitis NN I-NP O
, , O O
hepatic JJ B-NP O
congestion NN I-NP O
, , O O
hemochromatosis NN B-NP O
- : O O
labs NN B-NP O
not RB O O
c/w VB O O
those DT B-NP O
Finally NNP I-NP O
, , O O
pt NN B-NP O
experienced VBD B-VP O
droplets NNS B-NP O
of IN B-VP O
bright JJ B-NP O
red JJ I-NP O
blood NN I-NP O
when WRB O O
straining VBG O O
for IN B-VP O
BM NNP B-NP O
Have NNP I-NP O
advised VBN O O
pt NN B-NP O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Kump NNP I-NP O
regarding VBG O O
this DT O O
to TO O O
determine VB O O
the DT B-NP O
need NN I-NP O
for IN B-VP O
a DT B-NP O
GI NNP I-NP O
work NN I-NP O
up RB O O
Have NNP B-NP O
left VBN O O
message NN B-NP O
with IN B-VP O
OGMC NNP B-NP O
answering VBG O O
service NN B-NP O
to TO O O
advise VB O O
the DT B-NP O
nurse JJ I-NP O
practitioner NN I-NP O
and CC O O
primary JJ B-NP O
care NN I-NP O
phy NN I-NP O
sician NN I-NP O
of IN B-VP O
these DT B-NP O
issues NNS I-NP O
FULL NNP I-NP O
CODE NNP I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
1 CD O O
See NNP B-NP O
Dr NNP I-NP O
Sixkiller NNP I-NP O
to TO O O
follow VB O O
up RP O O
on IN B-VP O
your PRP$ O O
liver NN B-NP O
function NN I-NP O
tests NNS I-NP O
that WDT O O
were VBD B-VP O
elevated VBN O O
when WRB O O
you PRP O O
were VBD B-VP O
admitted VBN O O
2 CD O O
See NNP B-NP O
Dr NNP I-NP O
Tippen NNP I-NP O
to TO O O
evaluate VB O O
the DT B-NP O
bleeding NN I-NP O
you PRP O O
experience VBP O O
with IN B-VP O
bowel NN B-NP O
movements NNS I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
1 CD O O
Call NNP B-NP O
to TO O O
make VB O O
an DT B-NP O
appointment NN I-NP O
with IN B-VP O
your PRP$ O O
primary JJ B-NP O
care NN I-NP O
doctor NN I-NP O
within IN B-VP O
a DT B-NP O
week NN I-NP O
of IN B-VP O
your PRP$ O O
discharge NN B-NP O
No RB O O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
GUTTMAN NNP I-NP O
, , O O
AUGUST NNP B-NP O
DAMIAN NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
OQ00 NNP B-NP O
) ) O O
8/4/03 CD O O
@ $ O O
01:36 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#968181 VBZ O O
812857745 CD O O
LCFH NNP B-NP O
10364873 CD O O
521624 CD O O
6/10/1994 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
9/20/1994 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
3/9/1994 CD O O
PRINCIPLE NNP B-NP O
DIAGNOSIS: NNP I-NP O
PLEURISY NNP I-NP O
, , O O
POSSIBLY NNP B-NP O
SECONDARY NNP I-NP O
TO NNP I-NP O
A NNP I-NP O
POST NNP I-NP O
VIRAL NNP I-NP O
SYNDROME NNP I-NP O
SECONDARY NNP I-NP O
DIAGNOSIS: NNP I-NP O
1 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PULMONARY NNP I-NP O
EMBOLI NNP I-NP O
IN NNP I-NP O
1971 CD O O
AND NNP B-NP O
IN NNP I-NP O
1988 CD O O
2 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
STREP NNP I-NP B-r
PHARYNGITIS NNP I-NP I-r
IN NNP I-NP O
August NNP I-NP O
OF IN B-VP O
1994 CD O O
, , O O
TREATED NNP B-NP O
WITH NNP I-NP O
PENICILLIN NNP I-NP B-m
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT O O
54 CD O O
year NN B-NP O
old JJ B-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
pulmonary JJ B-NP O
emboli NN I-NP O
in IN B-VP O
the DT O O
past JJ O O
, , O O
now RB O O
with IN B-VP O
complaint NN B-NP O
of IN B-VP O
four CD O O
days NNS B-NP O
of IN B-VP O
pleuritic JJ B-NP O
chest NN I-NP O
pain NN I-NP O
and CC O O
left VBD B-VP O
arm NN B-NP O
heaviness NN I-NP O
Coronary NNP I-NP O
risk NN I-NP O
factors NNS I-NP O
include VBP O O
a DT B-NP O
positive JJ I-NP O
family NN I-NP O
history NN I-NP O
, , O O
no DT B-NP O
smoking NN I-NP O
, , O O
diabetes VBZ O O
mellitus NN B-NP O
, , O O
hypertension NN B-NP O
or CC O O
elevated VBN O O
cholesterol NN B-NP O
The DT B-NP O
patient's JJ I-NP O
history NN I-NP O
begins VBZ O O
in IN B-VP O
1971 CD O O
when WRB O O
, , O O
after IN B-VP O
a DT B-NP O
tubal JJ I-NP O
ligation NN I-NP O
, , O O
she PRP O O
had VBD B-VP O
a DT B-NP B-r
pulmonary JJ I-NP I-r
emboli NN I-NP I-r
which WDT O O
was VBD B-VP O
felt VBN O O
to TO O O
be VB O O
secondary JJ O O
to TO O O
prolonged VB O O
bedrest JJS O O
She PRP O O
received VBD B-VP O
Heparin NNP B-NP B-m
and CC O O
was VBD B-VP O
coumadinized VBN O O
for IN B-VP O
one CD O O
year NN B-NP O
In IN B-VP O
1988 CD O O
she PRP O O
had VBD B-VP O
lower JJR B-NP O
abdominal JJ I-NP O
pain NN I-NP O
, , O O
extensive JJ B-NP O
work NN I-NP O
up IN B-VP O
of IN B-VP O
which WDT O O
revealed VBD B-VP O
a DT B-NP O
pulmonary JJ I-NP O
emboli NN I-NP O
, , O O
and CC O O
again RB O O
she PRP O O
was VBD B-VP O
heparinized VBN O O
and CC O O
coumadinized VBN O O
for IN B-VP O
one CD O O
year NN B-NP O
On IN B-VP O
July NNP B-NP O
, , O O
1994 CD O O
she PRP O O
developed VBD B-VP O
the DT B-NP O
acute JJ I-NP O
onset NN I-NP O
of IN B-VP O
intermittent JJ B-NP O
chest NN I-NP O
pressure NN I-NP O
and CC O O
left VBD B-VP O
arm NN B-NP O
heaviness NN I-NP O
, , O O
associated VBN O O
with IN B-VP O
night NN B-NP O
sweats NNS I-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
, , O O
palpitations NNS B-NP O
, , O O
light-headedness JJ O O
, , O O
nausea NN B-NP O
or CC O O
vomiting VBG O O
The DT B-NP O
pain NN I-NP O
was VBD B-VP O
exacerbated VBN O O
by IN B-VP O
deep JJ B-NP O
breaths NNS I-NP O
as RB O O
well RB O O
as IN B-VP O
yawning NN B-NP O
and CC O O
movement NN B-NP O
It PRP O O
was VBD B-VP O
not RB O O
relieved VBN O O
by IN B-VP O
any DT B-NP O
factors NNS I-NP O
On IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
admission NN B-NP O
the DT B-NP B-r
discomfort NN I-NP I-r
progressed VBD B-VP O
from IN B-VP O
intermittent NN B-NP O
to TO O O
constant VB O O
and CC O O
was VBD B-VP O
unrelieved VBN O O
with IN B-VP O
two CD O B-do
Advils NNS B-NP B-m
, , O O
at IN B-VP O
which WDT O O
time NN B-NP O
she PRP O O
subsequently RB O O
presented VBD B-VP O
to TO O O
the DT B-NP O
W.coness- NNP I-NP O
County NNP I-NP O
General NNP I-NP O
Hospital NNP I-NP O
Emergency NNP I-NP O
Ward NNP I-NP O
In IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Ward NNP I-NP O
her PRP$ O O
examination NN B-NP O
was VBD B-VP O
negative JJ B-NP O
Chest NNP I-NP O
x-ray NN I-NP O
was VBD B-VP O
negative JJ B-NP O
VQ NNP I-NP O
scan NN I-NP O
was VBD B-VP O
with IN B-VP O
intermediate JJ B-NP O
probability NN I-NP O
She PRP O O
received VBD B-VP O
Heparin NNP B-NP B-m
and CC O O
was VBD B-VP O
subsequently RB O O
transferred VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
She PRP O O
denied VBD B-VP O
any DT B-NP O
fevers NNS I-NP O
, , O O
chills NNS B-NP O
, , O O
cough NN B-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
diarrhea NN B-NP O
, , O O
constipation NN B-NP O
, , O O
abdominal JJ B-NP O
pain NN I-NP O
or CC O O
dysuria NN B-NP O
It PRP O O
is VBZ O O
noteworthy JJ O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
an DT B-NP O
Emergency NNP I-NP O
Ward NNP I-NP O
visit NN I-NP O
on IN B-VP O
May NNP B-NP O
at IN B-VP O
which WDT O O
time NN B-NP O
she PRP O O
complained VBD B-VP O
of IN B-VP O
sore NN B-NP O
throat NN I-NP O
Rapid NNP I-NP O
Strep NNP I-NP O
test NN I-NP O
was VBD B-VP O
positive JJ O O
for IN B-VP O
Strep NNP B-NP B-r
pharyngitis NN I-NP I-r
She PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
a DT B-NP O
course NN I-NP O
of IN B-VP O
Penicillin NNP B-NP B-m
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Her NNP I-NP O
past JJ B-NP O
medical JJ I-NP O
history NN I-NP O
is VBZ O O
as IN B-VP O
above IN B-VP O
She PRP O O
also RB O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
dysfunctional JJ B-NP O
uterine JJ I-NP O
bleeding NN I-NP O
, , O O
iron NN B-NP O
deficiency NN I-NP O
anemia NN I-NP O
, , O O
lumbosacral JJ B-NP O
disc NN I-NP O
disease NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
laminectomy NN I-NP O
times NNS I-NP O
three CD O O
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Medications NNP I-NP O
on IN B-VP O
admission NN B-NP O
are VBP O O
Motrin NNP B-NP B-m
prn NN I-NP B-f
ALLERGIES: NNP I-NP O
She PRP O O
has VBZ O O
no DT O O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
Her NNP I-NP O
mother NN I-NP O
died VBD B-VP O
from IN B-VP O
complications NNS B-NP O
from IN B-VP O
hypertension NN B-NP O
Her PRP$ O O
father NN B-NP O
died VBD B-VP O
from IN B-VP O
a DT B-NP O
cerebrovascular JJ I-NP O
accident NN I-NP O
She PRP O O
has VBZ O O
one CD O O
sister NN B-NP O
who WP O O
is VBZ O O
deceased VBN O O
from IN B-VP O
burn NN B-NP O
injuries NNS I-NP O
, , O O
one CD O O
brother NN B-NP O
who WP O O
passed VBD B-VP O
away RB O O
from IN B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
at IN B-VP O
age NN B-NP O
57 CD O O
, , O O
and CC O O
two CD O O
brothers NNS B-NP O
who WP O O
passed VBD B-VP O
away RB O O
from IN B-VP O
natural JJ B-NP O
causes NNS I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
She PRP O O
is VBZ O O
a DT B-NP O
clerk NN I-NP O
She PRP O O
is VBZ O O
divorced VBN O O
with IN B-VP O
five CD O O
children NNS B-NP O
She PRP O O
never RB O O
smoked VBD B-VP O
She PRP O O
drinks VBZ O O
alcohol NN B-NP O
occasionally RB O O
She PRP O O
has VBZ O O
no DT B-NP O
HIV NNP I-NP O
risk NN I-NP O
factors NNS I-NP O
and CC O O
no DT O O
known VBN O O
TB NNP B-NP O
exposures VBZ O O
PHYSICAL NNP B-NP O
EXAMINATION: NNP I-NP O
On IN B-VP O
physical JJ B-NP O
examination NN I-NP O
she PRP O O
is VBZ O O
a DT O O
well-developed JJ O O
, , O O
well-nourished JJ B-NP O
female NN I-NP O
appearing VBG O O
her PRP$ O O
stated JJ B-NP O
age NN I-NP O
and CC O O
in IN B-VP O
no DT B-NP O
apparent JJ I-NP O
distress NN I-NP O
Temperature NNP I-NP O
is VBZ O O
98 CD O O
, , O O
pulse RB O O
94 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
140/88 CD O O
, , O O
and CC O O
respirations NNS B-NP O
16 CD O O
Heent NNP B-NP O
shows NNS I-NP O
extraocular JJ B-NP O
movements NNS I-NP O
were VBD B-VP O
intact JJ B-NP O
Oropharynx NNP I-NP O
revealed VBD B-VP O
no DT B-NP O
erythema NN I-NP O
, , O O
edema NN B-NP O
or CC O O
exudate VBP O O
Mucous JJ B-NP O
membranes NNS I-NP O
were VBD B-VP O
moist JJ B-NP O
Neck NNP I-NP O
was VBD B-VP O
supple JJ O O
with IN B-VP O
no DT B-NP O
lymphadenopathy JJ I-NP O
Carotids NNS I-NP O
were VBD B-VP O
2+ CD O O
bilaterally RB O O
Lungs NNP B-NP O
revealed VBD B-VP O
right JJ B-NP O
basilar NN I-NP O
rales NNS I-NP O
Coronary NNP I-NP O
examination NN I-NP O
revealed VBD B-VP O
a DT B-NP O
regular JJ I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
positive JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
and CC O O
no DT B-NP O
S3 NNP I-NP O
or CC O O
S4 NNP B-NP O
There EX O O
were VBD B-VP O
no DT B-NP O
murmurs NNS I-NP O
, , O O
rubs NNS B-NP O
or CC O O
gallops NNS B-NP O
Abdomen NNP I-NP O
is VBZ O O
soft JJ O O
and CC O O
non-tender JJ O O
with IN B-VP O
positive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
hepatosplenomegaly NN I-NP O
or CC O O
masses NNS B-NP O
noted VBD B-VP O
Rectal NNP B-NP O
was VBD B-VP O
guaiac JJ O O
negative JJ O O
in IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Ward NNP I-NP O
Extremities NNP I-NP O
revealed VBD B-VP O
no DT B-NP O
clubbing NN I-NP O
, , O O
cyanosis NN B-NP O
or CC O O
edema VB O O
Neurological JJ B-NP O
examination NN I-NP O
was VBD B-VP O
non-focal JJ B-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Sodium NNP I-NP O
was VBD B-VP O
142 CD O O
, , O O
potassium NN B-NP O
4.1 CD O O
, , O O
BUN NNP B-NP O
15 CD O O
, , O O
creatinine NN B-NP O
.8 NN I-NP O
, , O O
and CC O O
glucose VB O O
74 CD O O
Liver NNP B-NP O
function NN I-NP O
tests NNS I-NP O
were VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
CK NNP I-NP O
was VBD B-VP O
697 CD O O
with IN B-VP O
an DT B-NP O
MB NNP I-NP O
of IN B-VP O
8.5 CD O O
White NNP B-NP O
count NN I-NP O
was VBD B-VP O
4.1 CD O O
, , O O
hematocrit NN B-NP O
37 CD O O
and CC O O
platelet NN B-NP O
count NN I-NP O
was VBD B-VP O
252 CD O O
, , O O
000 CD O O
PT NNP B-NP O
was VBD B-VP O
12.5 CD O O
, , O O
PTT NNP B-NP O
29.3 CD O O
Chest NNP B-NP O
x-ray NN I-NP O
, , O O
which WDT O O
was VBD B-VP O
a DT B-NP O
portable JJ I-NP O
film NN I-NP O
, , O O
was VBD B-VP O
clear JJ B-NP O
VQ NNP I-NP O
scan NN I-NP O
was VBD B-VP O
read VBN O O
as IN B-VP O
intermediate JJ B-NP O
probability NN I-NP O
EKG NNP I-NP O
revealed VBD B-VP O
a DT B-NP O
sinus JJ I-NP O
bradycardia NN I-NP O
at IN B-VP O
54 CD O O
with IN B-VP O
normal JJ B-NP O
axis NNS I-NP O
and CC O O
intervals NNS B-NP O
She PRP O O
had VBD B-VP O
flipped VBN O O
T NNP B-NP O
waves NNS I-NP O
in IN B-VP O
leads NNS B-NP O
3 CD O O
, , O O
F NNP B-NP O
, , O O
and CC O O
V1 NNP B-NP O
through IN B-VP O
V3 NNP B-NP O
, , O O
biphasic JJ B-NP O
T NNP I-NP O
waves NNS I-NP O
in IN B-VP O
V4 NNP B-NP O
, , O O
flat JJ B-NP O
T NNP I-NP O
waves NNS I-NP O
in IN B-VP O
V5 NNP B-NP O
and CC O O
V6 NNP B-NP O
There EX O O
was VBD B-VP O
poor JJ B-NP O
R NNP I-NP O
wave NN I-NP O
progression NN I-NP O
and CC O O
Q NNP B-NP O
waves NNS I-NP O
in IN B-VP O
1 CD O O
and CC O O
L NNP B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
It PRP O O
was VBD B-VP O
felt VBN O O
that IN B-VP O
during IN B-VP O
the DT B-NP O
patient's JJ I-NP O
presentation NN I-NP O
the DT O O
most RBS O O
likely JJ B-NP O
diagnosis NN I-NP O
was VBD B-VP O
a DT B-NP O
pulmonary JJ I-NP O
embolus NN I-NP O
, , O O
given VBN O O
her PRP$ O O
clinical JJ B-NP O
history NN I-NP O
and CC O O
her PRP$ O O
intermediate JJ B-NP O
probability NN I-NP O
of IN B-VP O
VQ NNP B-NP O
scan VBD B-VP O
The DT B-NP O
elevated JJ I-NP O
CK NNP I-NP O
with IN B-VP O
the DT O O
very RB O O
low JJ B-NP O
MB NNP I-NP O
was VBD B-VP O
felt VBN O O
not RB O O
to TO O O
represent VB O O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
but CC O O
to TO O O
represent VB O O
a DT B-NP O
CK NNP I-NP O
leak NN I-NP O
from IN B-VP O
presumed JJ B-NP O
pulmonary JJ I-NP O
infarction NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
heparinized VBN O O
with IN B-VP O
the DT B-NP O
goal NN I-NP O
of IN B-VP O
maintaining VBG O O
her PRP$ O O
PTT NN B-NP O
in IN B-VP O
the DT O O
60 CD O O
to TO O O
80 CD O O
range NN B-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
thrombotic JJ I-NP O
work NN I-NP O
up RB O O
sent VBD B-VP O
off RP O O
, , O O
namely RB O O
an DT B-NP O
antithrombin NN I-NP O
3 CD O O
, , O O
protein NN B-NP O
C NNP I-NP O
and CC O O
protein NN B-NP O
S NNP I-NP O
, , O O
all DT O O
of IN B-VP O
which WDT O O
, , O O
with IN B-VP O
the DT B-NP O
exception NN I-NP O
of IN B-VP O
the DT B-NP O
Russell NNP I-NP O
viper NNP I-NP O
venom NN I-NP O
, , O O
returned VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
The DT B-NP O
Russell NNP I-NP O
viper IN B-VP O
venom NN B-NP O
is VBZ O O
pending VBG O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
dictation NN B-NP O
The DT B-NP O
patient NN I-NP O
underwent NN I-NP O
lower JJR B-NP O
extremity NN I-NP O
noninvasives NNS I-NP O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
number NN I-NP O
one CD O O
which WDT O O
returned VBD B-VP O
as IN B-VP O
negative JJ O O
She PRP O O
had VBD B-VP O
a DT B-NP O
D NNP I-NP O
dimer NN I-NP O
sent VBD B-VP O
which WDT O O
was VBD B-VP O
also RB O O
normal JJ O O
At IN B-VP O
this DT B-NP O
point NN I-NP O
the DT B-NP O
DVT NNP I-NP O
Team NNP I-NP O
here RB O O
at IN B-VP O
the DT B-NP O
Otver NNP I-NP O
Hospital NNP I-NP O
was VBD B-VP O
consulted VBN O O
, , O O
given VBN O O
the DT O O
conflicted VBN O O
data NN B-NP O
for IN B-VP O
pulmonary JJ B-NP O
emboli NN I-NP O
The DT B-NP O
team NN I-NP O
felt VBD B-VP O
that IN B-VP O
, , O O
given VBN O O
the DT B-NP O
patient's JJ I-NP O
clinical JJ I-NP O
history NN I-NP O
and CC O O
the DT B-NP O
implications NNS I-NP O
of IN B-VP O
chronic JJ B-NP O
Coumadin NNP I-NP B-m
therapy NN I-NP O
, , O O
that IN B-VP O
a DT B-NP O
pulmonary JJ I-NP O
embolus NN I-NP O
should MD O O
be VB O O
definitely RB O O
ruled VBN O O
out RP O O
by IN B-VP O
pulmonary JJ B-NP O
arteriogram NN I-NP O
On IN B-VP O
hospital JJ B-NP O
day NN I-NP O
number NN I-NP O
two CD O O
the DT B-NP O
patient NN I-NP O
underwent NN I-NP O
a DT B-NP O
PA NNP I-NP O
gram NN I-NP O
which WDT O O
revealed VBD B-VP O
a DT B-NP O
mean JJ I-NP O
RA NNP I-NP O
pressure NN I-NP O
of IN B-VP O
7 CD O O
mm NN B-NP O
of IN B-VP O
mercury NN B-NP O
, , O O
a DT B-NP O
mean JJ I-NP O
RV NNP I-NP O
pressure NN I-NP O
of IN B-VP O
12 CD O O
mm NN B-NP O
of IN B-VP O
mercury NN B-NP O
, , O O
and CC O O
no DT B-NP O
filling NN I-NP O
defects VBZ O O
to TO O O
suggest VB O O
a DT B-NP O
pulmonary JJ I-NP O
embolus NN I-NP O
At IN B-VP O
this DT B-NP O
point NN I-NP O
the DT B-NP O
patient's NN I-NP O
Heparin NNP I-NP B-m
was VBD B-VP O
discontinued VBN O O
The DT B-NP O
day NN I-NP O
prior RB O O
to TO O O
obtaining VBG O O
the DT B-NP O
pulmonary JJ I-NP O
arteriogram NN I-NP O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
good JJ I-NP O
PA NNP I-NP O
and CC O O
lateral JJ B-NP O
film NN I-NP O
, , O O
which WDT O O
revealed VBD B-VP O
no DT B-NP O
focal JJ I-NP O
infiltrates NNS I-NP O
and CC O O
no DT B-NP O
effusions NNS I-NP O
On IN B-VP O
hospital JJ B-NP O
day NN I-NP O
number NN I-NP O
three CD O O
the DT B-NP O
patient NN I-NP O
underwent VBD B-VP O
an DT B-NP O
echocardiogram NN I-NP O
which WDT O O
revealed VBD B-VP O
normal JJ O O
left VBD B-VP O
ventricular JJ B-NP O
size NN I-NP O
and CC O O
mild NN B-NP O
left VBD B-VP O
ventricular JJ B-NP O
hypertrophy NN I-NP O
with IN B-VP O
vigorous JJ B-NP O
function NN I-NP O
and CC O O
no DT B-NP O
regional JJ I-NP O
wall NN I-NP O
motion NN I-NP O
abnormalities NNS I-NP O
She PRP O O
had VBD B-VP O
no DT B-NP O
pericardial JJ I-NP O
thickening NN I-NP O
or CC O O
pericardial JJ B-NP O
effusion NN I-NP O
to TO O O
suggest VB O O
pericarditis NN B-NP O
She PRP O O
had VBD B-VP O
structurally RB O O
normal JJ B-NP O
cardiac JJ I-NP O
valves NNS I-NP O
, , O O
no DT B-NP O
significant JJ I-NP O
mitral NN I-NP O
or CC O O
tricuspid JJ B-NP O
regurge NN I-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
minimal JJ I-NP O
amount NN I-NP O
of IN B-VP O
aortic JJ B-NP O
regurgitation NN I-NP O
and CC O O
normal JJ B-NP O
right JJ I-NP O
heart NN I-NP O
size NN I-NP O
and CC O O
function NN B-NP O
At IN B-VP O
this DT B-NP O
point NN I-NP O
, , O O
given VBN O O
the DT B-NP O
fact NN I-NP O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
not RB O O
felt VBN O O
to TO O O
have VB O O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
, , O O
given VBN O O
her PRP$ O O
low JJ B-NP O
MB NNP I-NP O
total NN I-NP O
CK NNP I-NP O
ratio NN I-NP O
, , O O
and CC O O
also RB O O
that IN B-VP O
she PRP O O
was VBD B-VP O
not RB O O
felt VBN O O
to TO O O
have VB O O
a DT B-NP O
pulmonary JJ I-NP O
embolus NN I-NP O
, , O O
given VBN O O
the DT B-NP O
negative JJ I-NP O
PA NNP I-NP O
gram NN I-NP O
, , O O
the DT B-NP O
diagnosis NN I-NP O
of IN B-VP O
pleurisy NN B-NP O
secondary JJ O O
to TO O O
possible JJ B-NP O
close JJ I-NP O
viral JJ I-NP O
syndrome NN I-NP O
was VBD B-VP O
considered VBN O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
Naprosyn NNP B-NP B-m
at IN B-VP O
500 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
number NN I-NP O
three CD O O
, , O O
to TO O O
which WDT O O
she PRP O O
responded VBD B-VP O
quite RB O O
well RB O O
After IN B-VP O
discussion NN B-NP O
with IN B-VP O
the DT B-NP O
patient's NN I-NP O
primary JJ B-NP O
doctor NN I-NP O
it PRP O O
was VBD B-VP O
felt VBN O O
that IN B-VP O
, , O O
given VBN O O
the DT B-NP O
fact NN I-NP O
that IN B-VP O
serious JJ B-NP O
causes NNS I-NP O
for IN B-VP O
pleuritic JJ B-NP O
chest NN I-NP O
pain NN I-NP O
had VBD B-VP O
been VBN O O
ruled VBN O O
out RP O O
, , O O
the DT B-NP O
patient's NN I-NP O
management NN I-NP O
could MD O O
be VB O O
followed VBN O O
in IN B-VP O
an DT B-NP O
outpatient JJ I-NP O
setting NN I-NP O
On IN B-VP O
hospital JJ B-NP O
day NN I-NP O
number NN I-NP O
four CD O O
it PRP O O
was VBD B-VP O
felt VBN O O
that IN B-VP O
she PRP O O
was VBD B-VP O
safe JJ O O
to TO O O
be VB O O
discharged VBN O O
to TO O O
home VB O O
Operations NNP B-NP O
and CC O O
procedures NNS B-NP O
performed VBN O O
during IN B-VP O
this DT B-NP O
hospitalization NN I-NP O
were VBD B-VP O
pulmonary JJ B-NP O
arteriogram NN I-NP O
by IN B-VP O
Pa NNP B-NP O
Hospital NNP I-NP O
on IN B-VP O
May NNP B-NP O
, , O O
1994 CD O O
There EX O O
were VBD B-VP O
no DT B-NP O
complications NNS I-NP O
DISPOSITION: NNP I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
Discharge NNP I-NP O
medications NNS I-NP O
include VBP O O
Naprosyn NNP B-NP B-m
500 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
with IN B-VP I-f
meals NNS B-NP I-f
The DT B-NP O
patient NN I-NP O
is VBZ O O
being VBG O O
discharged VBN O O
to TO O O
home VB O O
FOLLOW NNP B-NP O
UP: NNP I-NP O
She PRP O O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Owen NNP I-NP O
Albertine NNP I-NP O
on IN B-VP O
November NNP B-NP O
, , O O
1994 CD O O
at IN B-VP O
1:30 CD O O
p.m RB O O
Dictated NNP B-NP O
By: NNP I-NP O
RUDY NNP I-NP O
EZZO NNP I-NP O
, , O O
M.D NNP B-NP O
XA96 NNP I-NP O
Attending: NNP I-NP O
BRITT NNP I-NP O
FOGAL NNP I-NP O
, , O O
M.D NNP B-NP O
IB3 NNP I-NP O
YQ458/6388 NNP I-NP O
Batch: NNP I-NP O
9990 CD O O
Index NNP B-NP O
No NNP I-NP O
IDIB931ZD NNP I-NP O
D: NNP I-NP O
6/26/94 CD O O
T: NNP B-NP O
6/30/94 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#970511 VBZ O O
098098801 CD O O
RGH NNP B-NP O
04710426 CD O O
3809298 CD O O
8/14/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
bone NN I-NP O
cancer NN I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
8/14/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Unsigned NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
4/17/2006 CD O O
ATTENDING: NNP B-NP O
KOLLING NNP I-NP O
, , O O
OREN NNP B-NP O
ROMEO NNP I-NP O
MD NNP I-NP O
PRIMARY NNP I-NP O
ADMITTING NNP I-NP O
DIAGNOSIS: NNP I-NP O
Pulmonary NNP I-NP O
embolism NN I-NP O
SECONDARY NNP I-NP O
DIAGNOSES: NNP I-NP O
Diabetes NNP I-NP O
, , O O
hypertension NN B-NP O
, , O O
hypothyroid NN B-NP O
and CC O O
GERD NNP B-NP O
ADMISSION NNP I-NP O
MEDICATIONS: NNP I-NP O
Atenolol NNP I-NP B-m
50 CD O B-do
daily RB O B-f
, , O O
lisinopril VBD B-VP B-m
5 CD O B-do
daily RB O B-f
, , O O
Protonix NNP B-NP B-m
40 CD O B-do
daily RB O B-f
, , O O
metformin JJ O B-m
1500 CD O B-do
daily RB O B-f
, , O O
Lantus NNP B-NP B-m
60 CD O B-do
daily RB O B-f
, , O O
Humalog NNP B-NP B-m
20 CD O B-do
before IN B-VP B-f
meals NNS B-NP I-f
, , O O
Byetta NNP B-NP B-m
5 CD O B-do
mcg NN B-NP I-do
twice RB O B-f
daily RB O I-f
, , O O
levothyroxine NN B-NP B-m
( ( O O
dose JJ B-NP O
unknown NN I-NP O
) ) O O
, , O O
OxyContin NNP B-NP B-m
40 CD O B-do
every DT O B-f
eight CD O I-f
hours NNS B-NP I-f
, , O O
Percocet NNP B-NP B-m
two CD O B-do
tabs NN B-NP I-do
every DT O B-f
3 CD O O
hours NNS B-NP O
as IN B-VP O
needed VBN O O
for IN B-VP O
pain NN B-NP B-r
and CC O O
gabapentin NN B-NP B-m
( ( O O
dose JJ B-NP O
unknown NN I-NP O
) ) O O
CHIEF NNP B-NP O
COMPLAINT: NNP I-NP O
Syncope NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
66-year-old JJ I-NP O
man NN I-NP O
with IN B-VP O
diabetes NNS B-NP O
, , O O
hypertension NN B-NP O
, , O O
obesity NN B-NP O
and CC O O
non-Hodgkin's JJ B-NP B-r
lymphoma NN I-NP I-r
of IN B-VP O
the DT B-NP O
right JJ I-NP O
hip NN I-NP O
on IN B-VP O
chemotherapy NN B-NP O
( ( O O
R-CHOP NNP B-NP B-m
) ) O O
, , O O
which WDT O O
began VBD B-VP O
on IN B-VP O
4/10/06 CD O O
and CC O O
will MD O O
continue VB O O
for IN B-VP B-du
18 CD O I-du
weeks NNS B-NP I-du
He PRP O O
reported VBD B-VP O
no DT B-NP O
complications NNS I-NP O
from IN B-VP O
ischemic JJ B-NP O
chemotherapy NN I-NP O
At IN B-VP O
baseline NN B-NP O
he PRP O O
cannot VBD B-VP O
bear JJ B-NP O
weight NN I-NP O
on IN B-VP O
his PRP$ O O
right JJ B-NP O
leg NN I-NP O
and CC O O
he PRP O O
devised VBD B-VP O
this DT B-NP O
complicated JJ I-NP O
system NN I-NP O
where WRB O O
he PRP O O
shifts VBZ O O
himself PRP O O
down RP O O
the DT B-NP O
stairs NN I-NP O
to TO O O
the DT B-NP O
bottom NN I-NP O
of IN B-VP O
the DT B-NP O
steps NNS I-NP O
using VBG O O
his PRP$ O O
upper JJ B-NP O
body NN I-NP O
strength NN I-NP O
and CC O O
a DT B-NP O
family NN I-NP O
member NN I-NP O
to TO O O
assist VB O O
him PRP O O
All DT O O
during IN B-VP O
this DT B-NP O
maneuver NN I-NP O
he PRP O O
felt VBD B-VP O
unusually RB O O
short JJ O O
of IN B-VP O
breath NN B-NP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
and CC O O
in IN B-VP O
the DT B-NP O
context NN I-NP O
of IN B-VP O
breathing VBG O O
heavily RB O O
began VBD B-VP O
to TO O O
sweat VB O O
and CC O O
feel VB O O
lightheaded VBN O O
and CC O O
then RB O O
lost VBD B-VP O
consciousness JJ O O
temporarily RB O O
Sister NNP B-NP O
was VBD B-VP O
present JJ O O
and CC O O
called VBD B-VP O
EMS NNP B-NP O
On IN B-VP O
arrival NN B-NP O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
, , O O
he PRP O O
was VBD B-VP O
hypotensive JJ O B-r
and CC O O
received JJ B-NP O
IV NNP I-NP B-mo
normal JJ B-NP B-m
saline NN I-NP I-m
as IN B-VP O
volume NN B-NP O
resuscitations NNS I-NP O
His PRP$ O O
pressures NNS B-NP O
initially RB O O
were VBD B-VP O
noted VBN O O
to TO O O
be VB O O
in IN B-VP O
the DT O O
70s CD O O
to TO O O
80s CD O O
systolic NN B-NP O
and CC O O
improved VBN O O
to TO O O
90 CD O O
systolic NN B-NP O
after IN B-VP O
4 CD O O
L NNP B-NP O
of IN B-VP O
fluid NN B-NP O
from IN B-VP O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
syncope NN B-NP O
On IN B-VP O
admission NN B-NP O
as IN B-VP O
part NN B-NP O
of IN B-VP O
the DT B-NP O
workup NN I-NP O
for IN B-VP O
syncope NN B-NP O
an DT B-NP O
initial JJ I-NP O
set NN I-NP O
of IN B-VP O
cardiac JJ B-NP O
enzymes NNS I-NP O
was VBD B-VP O
negative JJ B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
On IN B-VP O
physical JJ B-NP O
exam NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
afebrile RB O O
, , O O
heart NN B-NP O
rate NN I-NP O
in IN B-VP O
the DT O O
90s CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
systolic JJ O O
100 CD O O
, , O O
respirations NNS B-NP O
20 CD O O
and CC O O
O2 NNP B-NP O
sat VBD B-VP O
94% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
Pupils NNPS I-NP O
were VBD B-VP O
equal JJ O O
, , O O
round NN B-NP O
and CC O O
reactive JJ O O
to TO O O
light VB O O
There EX O O
was VBD B-VP O
no DT B-NP O
cervical JJ I-NP O
lymphadenopathy NN I-NP O
JVP NNP I-NP O
was VBD B-VP O
not RB O O
visualized VBN O O
due JJ O O
to TO O O
large JJ B-NP O
neck NN I-NP O
Lungs NNS I-NP O
were VBD B-VP O
clear JJ O O
The DT B-NP O
heart NN I-NP O
was VBD B-VP O
regular JJ O O
There EX O O
was VBD B-VP O
an DT B-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
with IN B-VP O
a DT B-NP O
loud NN I-NP O
and CC O O
widened VBD B-VP O
split NN B-NP O
P2 NNP I-NP O
component NN I-NP O
of IN B-VP O
the DT B-NP O
second JJ I-NP O
heart NN I-NP O
sound NN I-NP O
Abdomen NNP I-NP O
was VBD B-VP O
soft JJ O O
and CC O O
nontender VBP O O
The DT B-NP O
right JJ I-NP O
hip NN I-NP O
was VBD B-VP O
tender NN B-NP O
to TO O O
palpation VB O O
The DT B-NP O
extremities NNS I-NP O
had VBD B-VP O
1+ CD O O
edema NN B-NP O
bilaterally RB O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
with IN B-VP O
a DT B-NP O
preliminary JJ I-NP O
diagnosis NN I-NP O
of IN B-VP O
syncope NN B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
second JJ I-NP O
set NN I-NP O
of IN B-VP O
cardiac JJ B-NP O
enzymes NNS I-NP O
was VBD B-VP O
positive JJ O O
with IN B-VP O
a DT B-NP O
troponin NN I-NP O
of IN B-VP O
2 CD O O
Echocardiogram NNP B-NP O
the DT B-NP O
morning NN I-NP O
following VBG O O
admission NN B-NP O
showed VBD B-VP O
a DT B-NP O
dilated JJ I-NP O
right JJ I-NP O
ventricle NN I-NP O
consistent JJ O O
with IN B-VP O
right JJ B-NP O
ventricular NN I-NP O
strain NN I-NP O
This DT O O
was VBD B-VP O
followed VBN O O
by IN B-VP O
a DT B-NP O
PE NNP I-NP O
protocol NN I-NP O
CT NNP I-NP O
scan NN I-NP O
, , O O
which WDT O O
showed VBD B-VP O
a DT O O
large JJ O O
saddle JJ O O
embolus CC O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
treated VBN O O
initially RB O O
with IN B-VP O
IV NNP B-NP B-mo
heparin NN I-NP B-m
, , O O
transitioned VBD B-VP O
to TO O O
Coumadin NNP B-NP B-m
and CC O O
then RB O O
the DT B-NP O
decision NN I-NP O
was VBD B-VP O
made VBN O O
to TO O O
try VB O O
Lovenox NNP B-NP B-m
therapy NN I-NP O
for IN B-VP O
long-term JJ B-NP B-r
anticoagulation NN I-NP O
Cardiac NNP I-NP O
enzymes VBZ O O
normalized JJ B-NP O
Repeat NNP I-NP O
echocardiogram NN I-NP O
showed VBD B-VP O
mild JJ B-NP O
improvement NN I-NP O
in IN B-VP O
right JJ B-NP O
heart NN I-NP O
function NN I-NP O
eScription NN I-NP O
document: VBZ O O
5-3408110 JJ B-NP O
CSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
REFF NNP I-NP O
, , O O
ELBERT NNP B-NP O
Attending: NNP I-NP O
HACKEL NNP I-NP O
, , O O
MICAH NNP B-NP O
ED NNP I-NP O
Dictation NNP I-NP O
ID NNP I-NP O
7113327 CD O O
D: NNP B-NP O
2/29/06 CD O O
T: NNP B-NP O
2/29/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#973184 VBZ O O
097075110 CD O O
NMH NNP B-NP O
26639961 CD O O
9095112 CD O O
4/20/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
UNSTABLE NNP I-NP O
ANGINA NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
11/15/2004 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
7/1/2004 CD O O
ATTENDING: NNP B-NP O
WM NNP I-NP O
BRYANT NNP I-NP O
STENT NNP I-NP O
MD NNP I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS: NNP I-NP O
Status NNP I-NP O
post NN I-NP O
AVR NNP I-NP O
, , O O
CABG NNP B-NP O
x3 NNP I-NP O
OTHER NNP I-NP O
DIAGNOSIS: NNP I-NP O
Diagnoses NNP I-NP O
hypertension NN I-NP O
, , O O
diabetes VBZ O O
mellitus VBP O O
type NN B-NP O
I PRP O O
, , O O
dyslipidemia NN B-NP O
, , O O
COPD NNP B-NP O
and CC O O
asthma JJ B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
55-year-old JJ I-NP O
female NN I-NP O
who WP O O
was VBD B-VP O
admitted VBN O O
to TO O O
Hend NNP B-NP O
Ratal/creek NNP I-NP O
Hospital NNP I-NP O
on IN B-VP O
6/2/04 CD O O
complaining NN B-NP O
of IN B-VP O
chest NN B-NP O
pain NN I-NP O
on IN B-VP O
exertion NN B-NP O
and CC O O
was VBD B-VP O
ruled VBN O O
in IN B-VP O
for IN B-VP O
NSTEMI NNP B-NP O
by IN B-VP O
enzymes NNS B-NP O
peaking VBG O O
on IN B-VP O
8/21/04 CD O O
CK NNP B-NP O
381 CD O O
and CC O O
TNI NNP B-NP O
0.18 CD O O
No NNP B-NP O
acute NN I-NP O
EKG NNP I-NP O
changes NNS I-NP O
were VBD B-VP O
noted VBN O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
Woduatesit NNP B-NP O
General NNP I-NP O
Hospital NNP I-NP O
for IN B-VP O
catheterization NN B-NP O
and CC O O
possible JJ B-NP O
CABG NNP I-NP O
Preoperative NNP I-NP O
cardiac NN I-NP O
status NN I-NP O
myocardial JJ B-NP O
infarction NN I-NP O
6/2/04 CD O O
requiring VBG O O
hospitalization NN B-NP O
associated VBN O O
with IN B-VP O
prolonged JJ B-NP O
chest NN I-NP O
pain NN I-NP O
Peak NNP I-NP O
CK NNP I-NP O
389 CD O O
, , O O
troponin VBD B-VP O
0.18 CD O O
PREOPERATIVE NNP B-NP O
CARDIAC NNP I-NP O
STATUS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
class NN B-NP O
II NNP I-NP O
angina NN I-NP O
There EX O O
has VBZ O O
been VBN O O
no DT B-NP O
recent JJ I-NP O
angina NN I-NP O
There EX O O
is VBZ O O
history NN B-NP O
of IN B-VP O
class NN B-NP O
II NNP I-NP O
heart NN I-NP O
failure NN I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
in IN B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm VBP O O
PREVIOUS NNP B-NP O
CARDIOVASCULAR NNP I-NP O
INTERVENTIONS: NNP I-NP O
None NNP I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Hypertension NNP I-NP O
, , O O
diabetes VBZ O O
mellitus NN B-NP O
, , O O
insulin NN B-NP O
therapy NN I-NP O
, , O O
dyslipidemia NN B-NP O
, , O O
COPD NNP B-NP O
, , O O
bronchodilator NN B-NP O
therapy NN I-NP O
, , O O
asthma NN B-NP O
for IN B-VP O
the DT B-NP O
last JJ I-NP O
7-10 JJ I-NP O
years NNS I-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
Knees NNP I-NP O
bilateral JJ B-NP O
arthroscopy NN I-NP O
6/18 CD O O
, , O O
10/14 CD O O
FAMILY NNP B-NP O
HISTORY: NNP I-NP O
Family NNP I-NP O
history NN I-NP O
of IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
Mother NNP I-NP O
with IN B-VP O
MI NNP B-NP O
Father NNP I-NP O
died VBD B-VP O
at IN B-VP O
an DT B-NP O
early JJ I-NP O
age NN I-NP O
due JJ O O
to TO O O
questionable JJ B-NP O
PE NNP I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
A NNP I-NP O
history NN I-NP O
of IN B-VP O
tobacco NN B-NP O
use NN I-NP O
70-pack-year JJ B-NP O
cigarette NN I-NP O
smoking VBG O O
history NN B-NP O
, , O O
quit NN B-NP O
smoking NN I-NP O
30 CD O O
years NNS B-NP O
ago RB O O
Single NNP B-NP O
, , O O
lives VBZ O O
with IN B-VP O
her PRP$ O O
children NNS B-NP O
ALLERGIES: NNP I-NP O
To TO O O
lisinopril VB O O
and CC O O
metformin VB O O
PREOP NNP B-NP O
MEDICATIONS: NNP I-NP O
Verapamil NNP I-NP B-m
80 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Avapro NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
aspirin RB O B-m
325 CD O B-do
mg NNS B-NP I-do
q.d JJ B-NP B-f
IV NNP I-NP B-mo
heparin NN I-NP B-m
, , O O
hydrochlorothiazide RB O B-m
50 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
albuterol VBP O B-m
2 CD O B-do
puffs NNS B-NP I-do
b.i.d RB O B-f
, , O O
fluticasone RB O B-m
2 CD O B-do
puffs NNS B-NP I-do
q.i.d RB O B-f
, , O O
atorvastatin VBD B-VP B-m
10 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Celexa NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
ibuprofen JJ O B-m
800 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
NPH NNP I-NP B-m
insulin NN I-NP I-m
30 CD O B-do
units NNS B-NP I-do
b.i.d RB O B-f
PHYSICAL NNP B-NP O
EXAMINATION: NNP I-NP O
Height NNP I-NP O
and CC O O
weight: $ O O
5 CD O O
feet NNS B-NP O
1 CD O O
inches NNS B-NP O
, , O O
103 CD O O
kilograms NNS B-NP O
Vital NNP I-NP O
signs: VBD B-VP O
Temperature NNP B-NP O
96 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
80 CD O O
, , O O
BP NNP B-NP O
right VBD B-VP O
arm NN B-NP O
140/80 CD O O
HEENT: NNP B-NP O
PERRLA NNP I-NP O
, , O O
dentition NN B-NP O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
infection NN B-NP O
, , O O
left VBD B-VP O
carotid JJ B-NP O
bruits NNS I-NP O
, , O O
right JJ B-NP O
carotid NN I-NP O
bruit NN I-NP O
Carotid NNP I-NP O
bruits VBZ O O
hard JJ O O
to TO O O
distinguish VB O O
from IN B-VP O
radiated VBN O O
systolic JJ B-NP O
murmur NN I-NP O
into IN B-VP O
carotids NNS B-NP O
Chest: NNP I-NP O
No NNP I-NP O
incisions NNS I-NP O
Cardiovascular: NNP I-NP O
Regular NNP I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
systolic JJ B-NP O
III/VI NNP I-NP O
murmur NN I-NP O
radiating VBG O O
to TO O O
carotids VB O O
Pulses: NNP B-NP O
Carotid NNP I-NP O
2+ CD O O
bilaterally RB O O
, , O O
femoral JJ O O
2+ CD O O
bilaterally RB O O
, , O O
radial JJ O O
2+ CD O O
bilaterally RB O O
, , O O
dorsalis JJ B-NP O
pedis NN I-NP O
present NN I-NP O
by IN B-VP O
Doppler NNP B-NP O
bilaterally RB O O
, , O O
posterior JJ B-NP O
tibial JJ I-NP O
present NN I-NP O
by IN B-VP O
Doppler NNP B-NP O
bilaterally RB O O
Allen's NNP B-NP O
test NN I-NP O
left VBD B-VP O
upper JJ B-NP O
extremity NN I-NP O
normal JJ O O
, , O O
right JJ B-NP O
upper JJ I-NP O
extremity NN I-NP O
normal JJ O O
, , O O
left VBD B-VP O
handed VBN O O
patient JJ B-NP O
Please NNP I-NP O
use NN I-NP O
right JJ B-NP O
forearm NN I-NP O
for IN B-VP O
graft NN B-NP O
takedown NN I-NP O
Respiratory: NNP I-NP O
Breath NNP I-NP O
sounds VBZ O O
clear JJ O O
bilaterally RB O O
Abdomen: NNP B-NP O
No NNP I-NP O
incisions NNS I-NP O
, , O O
soft JJ O O
, , O O
no DT B-NP O
masses NNS I-NP O
Extremities NNS I-NP O
without IN B-VP O
scarring VBG O O
, , O O
varicosities NNS B-NP O
or CC O O
edema VB O O
Neuro: NNP B-NP O
Alert NNP I-NP O
and CC O O
oriented VBN O O
, , O O
no DT B-NP O
focal JJ I-NP O
deficits NNS I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Chemistry NNP I-NP O
sodium NN I-NP O
138 CD O O
, , O O
potassium NN B-NP O
3.9 CD O O
, , O O
chloride RB O O
103 CD O O
, , O O
CO2 NNP B-NP O
26 CD O O
, , O O
BUN NNP B-NP O
16 CD O O
, , O O
creatinine NN B-NP O
0.7 CD O O
, , O O
glucose VBD B-VP O
164 CD O O
Hematology NNP B-NP O
WBC NNP I-NP O
9.58 CD O O
, , O O
hematocrit NN B-NP O
30.9 CD O O
, , O O
hemoglobin NN B-NP O
10.7 CD O O
, , O O
platelets NNS B-NP O
287 CD O O
, , O O
PT NNP B-NP O
13.6 CD O O
, , O O
INR NNP B-NP O
1.0 CD O O
, , O O
PTT NNP B-NP O
36.9 CD O O
Carotid NNP B-NP O
imaging: NN I-NP O
CNIS NNP I-NP O
Ultrasound NNP I-NP O
left VBD B-VP O
internal JJ B-NP O
carotid NN I-NP O
artery NN I-NP O
, , O O
zero CD O O
percent NN B-NP O
occlusion NN I-NP O
, , O O
right JJ B-NP O
internal JJ I-NP O
carotid NN I-NP O
artery NN I-NP O
zero CD O O
percent NN B-NP O
occlusion NN I-NP O
Cardiac NNP I-NP O
catheterization NN I-NP O
data NNS I-NP O
from IN B-VP O
3/0/04 CD O O
showed VBD B-VP O
coronary JJ B-NP O
anatomy NN I-NP O
, , O O
95% CD O O
osteo NN B-NP O
LAD NNP I-NP O
, , O O
40% CD O O
proximal JJ B-NP O
LAD NNP I-NP O
, , O O
60% CD O O
proximal JJ B-NP O
ramus NN I-NP O
, , O O
90% CD O O
mid NN B-NP O
circumflex NN I-NP O
, , O O
90% CD O O
mid NN B-NP O
OM1 NNP I-NP O
, , O O
right JJ B-NP O
dominant JJ I-NP O
circulation NN I-NP O
Echo NNP I-NP O
from IN B-VP O
0/20/04 CD O O
showed VBD B-VP O
57% CD O O
ejection NN B-NP O
fraction NN I-NP O
, , O O
aortic JJ B-NP O
stenosis NN I-NP O
mean JJ B-NP O
gradient NN I-NP O
22 CD O O
mmHg NN B-NP O
, , O O
peak JJ B-NP O
gradient NN I-NP O
37 CD O O
mmHg NN B-NP O
, , O O
calculated VBD B-VP O
valve JJ B-NP O
area NN I-NP O
of IN B-VP O
1 CD O O
cm2 NN B-NP O
, , O O
mild JJ B-NP O
mitral JJ I-NP O
insufficiency NN I-NP O
, , O O
trivial JJ B-NP O
tricuspid JJ I-NP O
insufficiency NN I-NP O
, , O O
mid NN B-NP O
and CC O O
inferior JJ B-NP O
septal JJ I-NP O
hypokinesis NN I-NP O
, , O O
normal JJ B-NP O
RV NNP I-NP O
function NN I-NP O
EKG NNP I-NP O
from IN B-VP O
3/0/04 CD O O
showed VBD B-VP O
normal JJ B-NP O
sinus NNS I-NP O
rhythm VBP O O
rate NN B-NP O
of IN B-VP O
69 CD O O
, , O O
ST NNP B-NP O
depression NN I-NP O
in IN B-VP O
I PRP O O
, , O O
V4 NNP B-NP O
, , O O
V5 NNP B-NP O
, , O O
V6 NNP B-NP O
, , O O
inverted VBD B-VP O
T's NNP B-NP O
in IN B-VP O
I PRP O O
AVL NNP B-NP O
, , O O
V4 NNP B-NP O
, , O O
V5 NNP B-NP O
, , O O
V6 NNP B-NP O
Chest NNP I-NP O
x-ray NN I-NP O
from IN B-VP O
3/0/04 CD O O
showed VBD B-VP O
increased VBN O O
pulmonary JJ B-NP O
vascular JJ I-NP O
markings NNS I-NP O
, , O O
otherwise RB O O
clear JJ B-NP O
Right NNP I-NP O
ICA NNP I-NP O
proximal JJ B-NP O
65-70% JJ I-NP O
stenosis NN I-NP O
, , O O
left VBD B-VP O
ICA NNP B-NP O
proximal JJ B-NP O
75-80% JJ I-NP O
stenosis NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
our PRP$ O O
service NN B-NP O
and CC O O
stabilized VBN O O
for IN B-VP O
surgery NN B-NP O
Date NNP I-NP O
of IN B-VP O
surgery NN B-NP O
4/15/04 CD O O
PREOPERATIVE NNP B-NP O
STATUS: NNP I-NP O
Urgent NNP I-NP O
The DT B-NP O
patient NN I-NP O
presented VBN O O
with IN B-VP O
AMI NNP B-NP O
critical JJ B-NP O
coronary NN I-NP O
anatomy NN I-NP O
, , O O
rest NN B-NP O
angina NN I-NP O
, , O O
valve FW O O
dysfunction NN B-NP O
PREOPERATIVE NNP I-NP O
DIAGNOSIS: NNP I-NP O
CAD NNP I-NP O
, , O O
aortic JJ B-NP O
stenosis NN I-NP O
PROCEDURE: NNP I-NP O
An DT B-NP O
AVR NNP I-NP O
with IN B-VP O
a DT O O
21 CD O O
Carpentier-Edwards JJ B-NP O
pericardial JJ I-NP O
valve NN I-NP O
and CC O O
a DT B-NP O
CABG NNP I-NP O
x3 NNP I-NP O
LIMA NNP I-NP O
to TO O O
LAD NNP B-NP O
, , O O
SVG1 NNP B-NP O
to TO O O
PDA NNP B-NP O
, , O O
SVG2-OM2 NNP B-NP O
with IN B-VP O
a DT B-NP O
Robichek NNP I-NP O
closure NN I-NP O
Bypass NNP I-NP O
time NN I-NP O
201 CD O O
minutes NNS B-NP O
, , O O
crossclamp JJ B-NP O
time NN I-NP O
156 CD O O
minutes NNS B-NP O
FINDINGS: NNP I-NP O
Obesity NNP I-NP O
, , O O
heart NN B-NP O
fused VBD B-VP O
pericardium NN B-NP O
which WDT O O
had VBD B-VP O
severe JJ B-NP O
calcification NN I-NP O
, , O O
adhesions NNS B-NP O
between IN B-VP O
heart NN B-NP O
and CC O O
pericardium NN B-NP O
taken VBN O O
down RP O O
on IN B-VP O
CPB NNP B-NP O
There EX O O
are VBP O O
no DT B-NP O
complications NNS I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
unit NN I-NP O
in IN B-VP O
stable JJ B-NP O
fashion NN I-NP O
with IN B-VP O
lines NNS B-NP O
and CC O O
tubes NNS B-NP O
intact JJ B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
Initial NNP I-NP O
postoperative JJ B-NP O
period: NN I-NP O
Rufus NNP I-NP O
Leanard NNP I-NP O
was VBD B-VP O
extubated VBN O O
without IN B-VP O
difficulty NN B-NP O
and CC O O
had VBD B-VP O
reasonable JJ B-NP O
saturations NNS I-NP O
on IN B-VP O
nasal JJ B-NP O
cannula JJ I-NP O
Chest NNP I-NP O
x-ray NN I-NP O
appeared VBD B-VP O
wet JJ O O
and CC O O
diuresis NN B-NP O
was VBD B-VP O
increased VBN O O
The DT B-NP O
history NN I-NP O
of IN B-VP O
COPD NNP B-NP O
and CC O O
thus RB O O
preoperative JJ B-NP O
COPD NNP I-NP B-m
medications NNS I-NP O
were VBD B-VP O
restarted VBN O O
She PRP O O
was VBD B-VP O
in IN B-VP O
sinus JJ B-NP O
rhythm NN I-NP O
with IN B-VP O
a DT B-NP B-r
systolic JJ I-NP O
blood NN I-NP O
pressure NN I-NP O
of IN B-VP O
110 CD O O
and CC O O
started VBD B-VP O
on IN B-VP O
beta-blocker NN B-NP B-m
She PRP O O
was VBD B-VP O
given VBN O O
Toradol NNP B-NP B-m
initially RB O O
for IN B-VP O
pain NN B-NP B-r
and CC O O
Percocet NNP B-NP B-m
for IN B-VP O
break NN B-NP B-r
through IN B-VP O
pain NN B-NP O
Gentle NNP I-NP O
diuresis NN I-NP O
was VBD B-VP O
initiated VBN O O
and CC O O
in IN B-VP O
the DT B-NP O
initial JJ I-NP O
postoperative JJ I-NP O
period NN I-NP O
she PRP O O
was VBD B-VP O
on IN B-VP O
the DT B-NP O
Portland NNP I-NP O
protocol NN I-NP O
for IN B-VP O
elevated JJ B-NP O
postoperative JJ I-NP O
blood NN I-NP O
sugars NNS I-NP O
She PRP O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
step-down JJ I-NP O
unit NN I-NP O
on IN B-VP O
9/2/04 CD O O
where WRB O O
she PRP O O
continued VBD B-VP O
to TO O O
improve VB O O
Diuresis NNP B-NP O
was VBD B-VP O
continued VBN O O
and CC O O
increased VBN O O
as IN B-VP O
needed JJ O O
She PRP O O
was VBD B-VP O
on IN B-VP O
96% CD O O
saturation NN B-NP O
with IN B-VP O
3 CD O B-do
liters NNS B-NP I-do
of IN B-VP O
oxygen NN B-NP B-m
delivered VBN O O
via IN B-VP O
nasal NN B-NP B-mo
cannula VBZ O I-mo
Her PRP$ O O
hematocrit NN B-NP O
postoperative NN I-NP O
fluctuated VBD B-VP O
between IN B-VP O
23-25 JJ O O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
asymptomatic JJ O O
She PRP O O
continued VBD B-VP O
to TO O O
be VB O O
followed VBN O O
by IN B-VP O
cardiology NN B-NP O
for IN B-VP O
the DT B-NP O
duration NN I-NP O
of IN B-VP O
her PRP$ O O
hospital JJ B-NP O
course NN I-NP O
Gentle NNP I-NP O
ambulation NN I-NP O
was VBD B-VP O
increased VBN O O
She PRP O O
remained VBD B-VP O
in IN B-VP O
sinus NN B-NP O
rhythm NN I-NP O
in IN B-VP O
the DT O O
80's CD O O
and CC O O
pressure NN B-NP O
was VBD B-VP O
stable JJ O O
120's/80's CD O O
and CC O O
oxygen NN B-NP B-m
was VBD B-VP O
progressively RB O O
weaned VBN O O
Her NNP B-NP O
temporary JJ B-NP O
pacing NN I-NP O
wires NNS I-NP O
were VBD B-VP O
DC'd NNP B-NP O
without IN B-VP O
incident NN B-NP O
on IN B-VP O
3/28/04 CD O O
She PRP O O
was VBD B-VP O
followed VBN O O
by IN B-VP O
Diabetes NNP B-NP O
Management NNP I-NP O
Service NNP I-NP O
for IN B-VP O
the DT B-NP O
duration NN I-NP O
of IN B-VP O
her PRP$ O O
hospital JJ B-NP O
course NN I-NP O
Chest NNP I-NP O
tubes NNS I-NP O
were VBD B-VP O
DC'd NNP B-NP O
without IN B-VP O
incident NN B-NP O
on IN B-VP O
7/12/04 CD O O
Physical JJ B-NP O
therapy NN I-NP O
was VBD B-VP O
consulted VBN O O
and CC O O
they PRP O O
cleared VBD B-VP O
her PRP O O
for IN B-VP O
home NN B-NP O
discharge NN I-NP O
secondary JJ O O
to TO O O
elevated VBN O O
white JJ B-NP O
count NN I-NP O
and CC O O
low-grade JJ B-NP O
temperatures NNS I-NP O
on IN B-VP O
9/7/04 CD O O
She PRP O O
was VBD B-VP O
pan RB O O
cultured VBN O O
Resultant JJ B-NP O
culture NN I-NP O
showed VBD B-VP O
a DT B-NP O
UTI NNP I-NP O
and CC O O
all DT B-NP O
cultures NNS I-NP O
were VBD B-VP O
negative JJ B-NP O
Wounds NNS I-NP O
were VBD B-VP O
stable JJ B-NP O
Diuresis NN I-NP O
was VBD B-VP O
continued VBN O O
and CC O O
increased VBN O O
Sid NNP B-NP O
Loving NNP I-NP O
had VBD B-VP O
a DT B-NP O
postoperative JJ I-NP O
echocardiogram NN I-NP O
on IN B-VP O
2/18/04 CD O O
which WDT O O
showed VBD B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
55-60% JJ O O
, , O O
trace NN B-NP O
MR NNP I-NP O
, , O O
trace NN B-NP O
TR NNP I-NP O
and CC O O
no DT B-NP O
AI NNP I-NP O
and CC O O
no DT B-NP O
regional JJ I-NP O
wall NN I-NP O
motion NN I-NP O
abnormalities VBZ O O
She PRP O O
continued VBD B-VP O
to TO O O
progress VB O O
well RB O O
and CC O O
was VBD B-VP O
evaluated VBN O O
by IN B-VP O
cardiac JJ B-NP O
surgery NN I-NP O
service NN I-NP O
to TO O O
be VB O O
stable JJ O O
to TO O O
discharge VB O O
to TO O O
home NN B-NP O
with IN B-VP O
VNA NNP B-NP O
service NN I-NP O
on IN B-VP O
3/8/04 CD O O
with IN B-VP O
the DT O O
following VBG O O
discharge NN B-NP O
instructions NNS I-NP O
Diet: NNP I-NP O
Low-cholesterol NNP I-NP O
low JJ O O
saturated VBD B-VP O
fat NN B-NP O
, , O O
ADA NNP B-NP O
2100 CD O O
calories NNS B-NP O
per IN B-VP O
day NN B-NP O
FOLLOWUP NNP I-NP O
APPOINTMENTS: NNP I-NP O
With IN B-VP O
Dr NNP B-NP O
Feder NNP I-NP O
652 CD O O
042-3264 NN B-NP O
in IN B-VP O
5-6 JJ B-NP O
weeks NNS I-NP O
, , O O
Dr NNP B-NP O
Burkhead NNP I-NP O
364-329-0928 JJ O O
in IN B-VP O
1-2 JJ B-NP O
weeks NNS I-NP O
, , O O
and CC O O
Dr NNP B-NP O
Saltmarsh NNP I-NP O
262-598-9932 JJ O O
in IN B-VP O
1-2 JJ B-NP O
weeks NNS I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Please NNP I-NP O
have VBP O O
PCP/cardiologist NNP B-NP O
draw VB O O
CBC NNP B-NP O
at IN B-VP O
first JJ B-NP O
office NN I-NP O
visit NN I-NP O
and CC O O
repeat NN B-NP O
UA NNP I-NP O
and CC O O
culture NN B-NP O
to TO O O
determine VB O O
need NN B-NP O
for IN B-VP O
treatment NN B-NP O
of IN B-VP O
possible JJ B-NP O
UTI NNP I-NP O
, , O O
is VBZ O O
completing VBG O O
antibiotic JJ B-NP B-m
course NN I-NP O
as IN B-VP O
outpatient NN B-NP O
TO NNP I-NP O
DO NNP I-NP O
PLAN: NNP I-NP O
Make NNP I-NP O
all DT O O
follow VBP O O
up RP O O
appointments NNS B-NP O
Local NNP I-NP O
wound NN I-NP O
care: NN I-NP O
Wash NNP I-NP O
all DT B-NP O
wounds NNS I-NP O
daily RB O O
with IN B-VP O
soap NN B-NP O
and CC O O
water NN B-NP O
Watch NNP I-NP O
all DT B-NP O
wounds NNS I-NP O
for IN B-VP O
signs NNS B-NP O
of IN B-VP O
infection NN B-NP O
, , O O
redness NN B-NP O
, , O O
drainage NN B-NP O
, , O O
pain NN B-NP O
, , O O
swelling VBG O O
, , O O
fever RB O O
Keep NNP B-NP O
legs NNS I-NP O
elevated VBD B-VP O
while IN B-VP O
sitting/in JJ B-NP O
bed NN I-NP O
Call NNP I-NP O
PCP/cardiologist NNP I-NP O
or CC O O
Ole NNP B-NP O
Health NNP I-NP O
Of IN B-VP O
cardiac JJ B-NP O
surgery NN I-NP O
service NN I-NP O
282-008-4347 JJ O O
with IN B-VP O
any DT B-NP O
questions NNS I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Enteric-coated NNP I-NP B-m
aspirin VBZ O I-m
325 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Lasix NNP B-NP B-m
Lasix NNP I-NP B-m
60 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
for IN B-VP B-du
3 CD O I-du
days NNS B-NP I-du
then RB O O
40 CD O B-do
mg NNS B-NP I-do
b.i.d NN I-NP B-f
for IN B-VP B-du
3 CD O I-du
days NNS B-NP I-du
, , O O
ibuprofen JJ O B-m
600 CD O B-do
mg NN B-NP I-do
q.6h NN I-NP B-f
p.r.n NN I-NP I-f
pain NN I-NP B-r
, , O O
Lopressor NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
, , O O
niferex RB O B-m
150 CD O I-m
150 CD O B-do
mg NN B-NP O
b.i.d NN I-NP B-f
, , O O
simvastatin VBD B-VP B-m
20 CD O B-do
mg NN B-NP I-do
q.h.s NN I-NP B-f
, , O O
K-Dur NNP B-NP B-m
K-Dur NNP I-NP B-m
30 CD O B-do
mEq NN B-NP I-do
b.i.d NN I-NP B-f
and CC O O
then RB O O
20 CD O B-do
mEq NNS B-NP I-do
b.i.d NN I-NP B-f
, , O O
fluticasone RB O B-m
44 CD O B-do
mcg NNS B-NP I-do
inhaled VBN O B-mo
b.i.d NN B-NP B-f
, , O O
levofloxacin VBZ O B-m
500 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
for IN B-VP B-du
2 CD O I-du
days NNS B-NP I-du
to TO O O
complete JJ B-NP O
course NN I-NP O
for IN B-VP O
UTI NNP B-NP B-r
, , O O
Humalog NNP B-NP B-m
, , O O
insulin NN B-NP B-m
on IN B-VP O
sliding VBG O B-do
scale NN B-NP I-do
, , O O
Humalog NNP B-NP B-m
insulin VBZ O I-m
12 CD O B-do
units NNS B-NP I-do
subq VBN O B-mo
with IN B-VP B-f
lunch NN B-NP O
and CC O O
dinner NN B-NP O
, , O O
Humalog NNP B-NP B-m
insulin VBZ O I-m
16 CD O B-do
units NNS B-NP I-do
subcutaneous JJ O B-mo
with IN B-VP B-f
breakfast NN B-NP O
, , O O
Celexa NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Combivent NNP B-NP B-m
2 CD O B-do
puffs NNS B-NP I-do
inhaled VBD B-VP B-mo
q.i.d NN B-NP B-f
, , O O
Nexium NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
and CC O O
Lantus NNP B-NP B-m
insulin VBP O I-m
62 CD O B-do
units NNS B-NP I-do
subcutaneous JJ B-NP B-mo
q.h.s JJ I-NP B-f
eScription NN I-NP O
document: VBZ O O
7-6609130 JJ B-NP O
DBSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
ROEHR NNP I-NP O
, , O O
BILLIE NNP B-NP O
LUPE NNP I-NP O
Attending: NNP I-NP O
VELAQUEZ NNP I-NP O
, , O O
TYSON NNP B-NP O
ALAN NNP I-NP O
Dictation NNP I-NP O
ID NNP I-NP O
1243617 CD O O
D: NNP B-NP O
7/15/04 CD O O
T: NNP B-NP O
7/15/04 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#974209 VBZ O O
338403609 CD O O
GMHAMC NNP B-NP O
30508109 CD O O
8380058 CD O O
11/27/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
" NNP I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
11/8/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
3/5/2005 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
KARPINSKY NNP I-NP O
, , O O
LOYD NNP B-NP O
O NNP I-NP O
033-89-98-3 JJ B-NP O
Midbluff NNP I-NP O
Drive NNP I-NP O
Service: NNP I-NP O
GGI NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
4/15/05 CD O O
AT NNP B-NP O
02:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
NIEDERMAYER NNP I-NP O
, , O O
ARMAND NNP B-NP O
KERMIT NNP I-NP O
, , O O
M.D NNP B-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
LANTUS NNP I-NP B-m
( ( O I-m
INSULIN NNP B-NP I-m
GLARGINE NNP I-NP I-m
) ) O I-m
10 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
QD NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
FS NNP I-NP O
&lt;150 NNP I-NP O
RANITIDINE NNP I-NP B-m
HCL NNP I-NP I-m
SYRUP NNP I-NP I-m
150 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
ROXICET NNP I-NP B-m
ELIXIR NNP I-NP I-m
( ( O I-m
OXYCODONE+APAP NNP B-NP I-m
LIQUID NNP I-NP I-m
) ) O I-m
5-10 JJ B-NP B-do
MILLILITERS NNP I-NP I-do
PO NNP I-NP B-mo
Q4H NNP I-NP B-f
PRN NNP I-NP I-f
Pain NNP I-NP B-r
COLACE NNP I-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
diarrhea VBZ O O
Instructions: NNP B-NP O
as IN B-VP O
elixir NN B-NP O
PHENERGAN NNP I-NP B-m
( ( O I-m
PROMETHAZINE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
25 CD O B-do
MG NNP B-NP I-do
PR NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP I-f
Nausea NNP I-NP B-r
AUGMENTIN NNP I-NP B-m
SUSP NNP I-NP I-m
250MG/62.5 CD O I-m
MG NNP B-NP I-m
( ( O I-m
5ML CD O I-m
) ) O I-m
( ( O I-m
AMOXICIL NNP B-NP I-m
) ) O I-m
10 CD O B-do
MILLILITERS NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
Instructions: NNP I-NP O
for IN B-VP B-du
five CD O I-du
days NNS B-NP I-du
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
May NNP I-NP O
be VB O O
taken VBN O O
without IN B-VP O
regard NN B-NP O
to TO O O
meals NNS B-NP O
DIET: NNP I-NP O
stage NN I-NP O
2 CD O O
post NN B-NP O
band NN I-NP O
diet JJ B-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Hinsley NNP I-NP O
1-2 JJ B-NP O
weeks NNS I-NP O
, , O O
Diabetes NNP B-NP O
Management NNP I-NP O
Service NNP I-NP O
3 CD O O
weeks NNS B-NP O
, , O O
ALLERGY: NNP B-NP O
Sulfa NNP I-NP O
, , O O
Erythromycins NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
s/p VBD B-VP O
lap RBR O O
gastic JJ B-NP O
band NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
" VBZ O O
OTHER NNP B-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
11/12/05 CD O O
GIACCIO NNP B-NP O
, , O O
HARLEY NNP B-NP O
JARROD NNP I-NP O
, , O O
M.D NNP B-NP O
LAPARO NNP I-NP O
PLACEMENT NNP I-NP O
ADJUSTABLE NNP I-NP O
GASTRIC NNP I-NP O
BAND NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
upper IN B-VP O
GI NNP B-NP O
series NN I-NP O
- : O O
negative JJ B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
this DT O O
very RB O O
pleasant JJ O O
54yo CD O O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
NIDDM NNP B-NP O
failure NN I-NP O
of IN B-VP O
other JJ B-NP O
conventional JJ I-NP O
methods NNS I-NP O
of IN B-VP O
weight JJ B-NP O
loss NN I-NP O
, , O O
underwent VBD B-VP O
a DT B-NP O
laparoscopic NN I-NP O
adjustable JJ B-NP O
gastric JJ I-NP O
band NN I-NP O
placement NN I-NP O
without IN B-VP O
complication NN B-NP O
The DT B-NP O
pt NN I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
PACU NNP I-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
Her NNP I-NP O
pain NN I-NP B-r
was VBD B-VP O
well RB O O
controlled VBN O O
with IN B-VP O
PCA NNP B-NP B-m
analgesia NN I-NP O
on IN B-VP O
POD0 NNP B-NP O
and CC O O
transitioned VBD B-VP O
to TO O O
po VB O B-mo
elixir JJ B-NP B-m
analgesia NN I-NP I-m
following VBG O O
a DT B-NP O
negative JJ I-NP O
upper JJ I-NP O
GI NNP I-NP O
studfy NN I-NP O
exhibiting VBG O O
no DT O O
leaks FW O O
Her PRP$ O O
diet NN B-NP O
was VBD B-VP O
advanced VBN O O
from IN B-VP O
NPO NNP B-NP O
to TO O O
stage VB O O
2 CD O O
post NN B-NP O
gastric JJ B-NP O
banding NN I-NP O
diet NN I-NP O
, , O O
which WDT O O
she PRP O O
tolerated VBD B-VP O
with IN B-VP O
no DT O O
nausea/vomiting VBG O O
On IN B-VP O
POD NNP B-NP O
1 CD O O
the DT B-NP O
surgical JJ I-NP O
site NN I-NP O
was VBD B-VP O
examined VBN O O
and CC O O
there EX O O
were VBD B-VP O
no DT B-NP O
signs NNS I-NP O
of IN B-VP O
hematoma NN B-NP O
The DT B-NP O
pt NN I-NP O
remained VBD B-VP O
hemodynamically RB O O
stable JJ O O
and CC O O
was VBD B-VP O
making VBG O O
good JJ B-NP O
urine NN I-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
the DT B-NP O
pt's NN I-NP O
pain NN I-NP O
was VBD B-VP O
well RB O O
controlled VBN O O
and CC O O
she PRP O O
was VBD B-VP O
tolerating VBG O O
a DT B-NP O
stage NN I-NP O
2 CD O O
diet JJ O O
and CC O O
was VBD B-VP O
afebrile VBN O O
with IN B-VP O
all DT B-NP O
incisions NNS I-NP O
were VBD B-VP O
clean JJ O O
dry JJ O O
and CC O O
intact JJ B-NP O
Pt NNP I-NP O
is VBZ O O
being VBG O O
sent VBN O O
home NN B-NP O
on IN B-VP O
roxicet NN B-NP B-m
and CC O O
ranitidine NN B-NP B-m
elixir NN I-NP I-m
as RB O O
wel NN B-NP O
as IN B-VP O
a DT B-NP O
course NN I-NP O
of IN B-VP O
qugmentin JJ B-NP B-m
suspension NN I-NP I-m
as RB O O
well RB O O
as IN B-VP O
previous JJ B-NP B-m
home NN I-NP I-m
medications NNS I-NP I-m
She PRP O O
will MD O O
follow VB O O
up RP O O
her PRP$ O B-r
diabetes NNS B-NP I-r
in IN B-VP O
DM NNP B-NP O
clinic NN I-NP O
as IN B-VP O
previously RB O O
arranged VBN O O
and CC O O
will MD O O
take VB O O
only RB O O
her PRP$ O O
lantus NN B-NP B-m
in IN B-VP O
the DT B-NP O
interim JJ I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Please NNP I-NP O
call VB O O
your PRP$ O O
physician NN B-NP O
or CC O O
go VB O O
to TO O O
the DT B-NP O
ER NNP I-NP O
if IN B-VP O
you PRP O O
develop VBP O O
abdominal JJ B-NP O
pain NN I-NP O
, , O O
vomiting VBG O O
or CC O O
overt JJ B-NP O
distension NN I-NP O
increased VBD B-VP O
pain NN B-NP O
, , O O
increased VBD B-VP O
swelling NN B-NP O
, , O O
bruising NN B-NP O
, , O O
fever&gt;101.2/chills NNS B-NP O
, , O O
change NN B-NP O
in IN B-VP O
wound NN B-NP O
appearance NN I-NP O
( ( O O
increased JJ B-NP O
redness NN I-NP O
or CC O O
discharge NN B-NP O
) ) O O
or CC O O
chest JJS B-NP O
pain NN I-NP O
&amp; JJ B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
Please NNP I-NP O
avoid VBZ O O
strenuous JJ B-NP O
activity NN I-NP O
You PRP O O
may MD O O
take VB O O
dressings NNS B-NP O
off IN B-VP O
and CC O O
shower VB O O
48 CD O O
hours NNS B-NP O
after IN B-VP O
surgery NN B-NP O
Do NNP I-NP O
not RB O O
go VB O O
swimming NN B-NP O
, , O O
bathing VBG O O
or CC O O
hot JJ O O
tubbing VBG O O
Do NNP B-NP O
not RB O O
drive VB O O
or CC O O
drink VB O O
alcohol NN B-NP O
while IN B-VP O
taking VBG O O
prescription NN B-NP O
narcotic JJ O B-m
( ( O I-m
pain NN B-NP I-m
) ) O I-m
medications NNS B-NP I-m
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
KELCOURSE NNP I-NP O
, , O O
JOHN NNP B-NP O
, , O O
M.B.B.S NNP B-NP O
( ( O O
CQ451 NNP B-NP O
) ) O O
4/15/05 CD O O
@ $ O O
01:35 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#975588 VBZ O O
039777095 CD O O
GCH NNP B-NP O
19126555 CD O O
0135055 CD O O
4/29/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
chest JJS B-NP O
discomfort NN I-NP O
unclear JJ B-NP O
etiology NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
2/17/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
2/17/2005 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
KRATZ NNP I-NP O
, , O O
DEANGELO NNP B-NP O
Z NNP I-NP O
993-80-55-1 CD O O
Grovemont NNP B-NP O
Ton NNP I-NP O
A NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
5/28/05 CD O O
AT NNP B-NP O
06:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
CHAPMAN NNP I-NP O
, , O O
CLAIR NNP B-NP O
S NNP I-NP O
, , O O
M.D NNP B-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ECASA NNP I-NP B-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
3x/Week CD O B-f
M-W-F NNP B-NP I-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
5/28/05 CD O O
by IN B-VP O
CALEMINE NNP B-NP O
, , O O
HUGH NNP B-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
ECASA NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
65555559 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
DEFINITE NNP I-NP O
allergy NN I-NP O
to TO O O
Aspirin; NNP B-NP O
reaction NN I-NP O
is VBZ O O
GI NNP B-NP O
upset JJ B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
Takes NNP I-NP O
as IN B-VP O
outpatient JJ B-NP O
LISINOPRIL NNP I-NP B-m
1.25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
5/28/05 CD O O
by IN B-VP O
BARKE NNP B-NP O
, , O O
LEANDRO NNP B-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
LISINOPRIL NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
Aware NNP I-NP O
PLAVIX NNP I-NP B-m
( ( O I-m
CLOPIDOGREL NNP B-NP I-m
) ) O I-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ATENOLOL NNP I-NP B-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
LIPITOR NNP I-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
GLYBURIDE NNP I-NP B-m
1.25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
2100 CD O O
cals/dy NN B-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
pcp SYM O O
- : O O
Dr NN B-NP O
Claudio NNP I-NP O
Conorich NNP I-NP O
( ( O O
329-1910 JJ B-NP O
1-2 JJ I-NP O
weeks NNS I-NP O
, , O O
cardiology NN B-NP O
- : O O
Truman NNP B-NP O
Shinoda NNP I-NP O
8/10 CD O O
3.20p CD O O
, , O O
vascular NN B-NP O
surgery NN I-NP O
- : O O
Travillian JJ O O
( ( O O
603-819-2768 JJ O O
) ) O O
9/13 CD O O
( ( O O
call VB O O
for IN B-VP O
time NN B-NP O
) ) O O
, , O O
ALLERGY: NNP B-NP O
Penicillins NNP I-NP O
, , O O
IV NNP B-NP O
Contrast NNP I-NP O
, , O O
AZITHROMYCIN NNP B-NP O
, , O O
Shellfish NNP B-NP O
, , O O
Aspirin NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
atypical JJ B-NP O
chest NN I-NP O
pain NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
chest JJS B-NP O
discomfort NN I-NP O
unclear JJ B-NP O
etiology NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
unstable JJ B-NP O
angina NNS I-NP O
hypercholesterol VBP O O
s/p JJ B-NP O
TAH NNP I-NP O
, , O O
RSO NNP B-NP O
s/p VBZ O O
splenectomy JJ O O
- : O O
stab NN B-NP O
woun NN I-NP O
asthma NN I-NP O
h/o NN I-NP O
hepatitis NN I-NP O
s/p NN I-NP O
L NNP I-NP O
hemicolectomy NN I-NP O
- : O O
polyp NN B-NP O
r/o NN I-NP O
for IN B-VP O
mi NN B-NP O
4/7 CD O O
8/15 CD O O
GIB NNP B-NP O
from IN B-VP O
diverticuli NN B-NP O
, , O O
7/24 CD O O
MIBI NNP B-NP O
old JJ B-NP O
scar NN I-NP O
inf/lat JJ B-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
none NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
prelim NN B-NP O
STRESS NNP I-NP O
MIBI NNP I-NP O
- : O O
negative JJ O O
for IN B-VP O
acute NN B-NP O
or CC O O
reversible JJ B-NP O
defects NNS I-NP O
non-reversible JJ B-NP O
scar NN I-NP O
inf/lat JJ B-NP O
final JJ I-NP O
read NN I-NP O
P NNP I-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
Pt NNP I-NP O
is VBZ O O
a DT O O
64F JJ O O
with IN B-VP O
hx NN B-NP O
of IN B-VP O
CAD NNP B-NP O
( ( O O
NSTEMIs NNP B-NP O
x VBZ O O
2 CD O O
in IN B-VP O
1997/2001 CD O O
, , O O
cath NN B-NP O
2000 CD O O
RCA NNP B-NP O
, , O O
LCx NNP B-NP O
in IN B-VP O
2000 CD O O
, , O O
which WDT O O
were VBD B-VP O
complicated VBN O O
by IN B-VP O
in-stent JJ B-NP O
thrombosis NN I-NP O
?3 CD O O
years NNS B-NP O
ago RB O O
) ) O O
, , O O
HTN NNP B-NP O
, , O O
DM NNP B-NP O
( ( O O
hba1c VB O O
6.2 CD O O
) ) O O
, , O O
PVD NNP B-NP O
, , O O
recent JJ B-NP O
admit NN I-NP O
( ( O O
4/8 CD O O
) ) O O
for IN B-VP O
ROMI NNP B-NP O
( ( O O
negative JJ O O
and CC O O
declined VBD B-VP O
inpatient JJ B-NP O
stress NN I-NP O
) ) O O
, , O O
presents VBZ O O
with IN B-VP O
atypical JJ B-NP O
chest NN I-NP O
pain NN I-NP O
Constant NNP I-NP O
x VBZ O O
6 CD O O
days NNS B-NP O
SSCP NNP I-NP O
, , O O
no RB O O
associated VBN O O
sx VBZ O O
No DT B-NP O
pulm/infectious JJ I-NP O
component NN I-NP O
In IN B-VP O
the DT B-NP O
ED NNP I-NP O
, , O O
BP NNP B-NP O
159/69 CD O O
, , O O
P NNP B-NP O
60 CD O O
No NNP B-NP O
EKG NNP I-NP O
changes VBZ O O
new JJ B-NP O
first JJ I-NP O
set NN I-NP O
of IN B-VP O
enzymes NNS B-NP O
negative JJ B-NP O
d JJ I-NP O
dimer NN I-NP O
negative JJ B-NP O
********** NNP I-NP O
Hospital NNP I-NP O
Course NNP I-NP O
Pt NNP I-NP O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
observation NN B-NP O
and CC O O
ROMI NNP B-NP O
with IN B-VP O
stress JJ B-NP O
test NN I-NP O
There EX O O
was VBD B-VP O
low JJ B-NP O
suspicion NN I-NP O
for IN B-VP O
ACS NNP B-NP O
given VBN O O
her PRP$ O O
history NN B-NP O
However RB O O
, , O O
pt NN B-NP O
with IN B-VP O
multiple JJ B-NP O
CRF NNP I-NP O
and CC O O
felt VBD B-VP O
that IN B-VP O
inpatient NN B-NP O
stress NN I-NP O
was VBD B-VP O
warranted VBN O O
( ( O O
last JJ B-NP O
MIBI NNP I-NP O
2002 CD O O
) ) O O
Pt NNP B-NP O
underwent JJ B-NP O
chemical-MIBI NN I-NP O
on IN B-VP O
6/25 CD O O
( ( O O
hx NN B-NP O
of IN B-VP O
PVD NNP B-NP O
can MD O O
only RB O O
walk VB O O
2 CD O O
block NN B-NP O
equivalent NN I-NP O
) ) O O
that WDT O O
was VBD B-VP O
negative JJ O O
for IN B-VP O
any DT B-NP O
acute NN I-NP O
, , O O
reversible JJ B-NP O
changes NNS I-NP O
( ( O O
final JJ B-NP O
P NNP I-NP O
) ) O O
Unclear NNP B-NP O
etiology NN I-NP O
for IN B-VP O
her PRP$ O O
pain NN B-NP O
The DT B-NP O
diagnosis NN I-NP O
of IN B-VP O
potential JJ B-NP O
pericarditis NN I-NP O
was VBD B-VP O
entertained VBN O O
, , O O
but CC O O
again RB O O
, , O O
the DT B-NP O
history NN I-NP O
was VBD B-VP O
not RB O O
consistent JJ O O
, , O O
no DT B-NP O
viral JJ I-NP O
prodome NN I-NP O
, , O O
no DT B-NP O
EKG NNP I-NP O
changes NNS I-NP O
, , O O
no DT B-NP O
pulsus/rub NN I-NP O
appreciated VBD B-VP O
No DT B-NP O
reproducible/MSK NN I-NP O
pain VB O O
Her NNP B-NP O
pain NN I-NP B-r
was VBD B-VP O
only RB O O
controlled VBN O O
with IN B-VP O
oxycodone NN B-NP B-m
She PRP O O
was VBD B-VP O
pain-free JJ O O
at IN B-VP O
discharge.Pt NN B-NP O
was VBD B-VP O
continued VBN O O
on IN B-VP O
all DT O O
her PRP$ O O
outpatient JJ B-NP O
medications NNS I-NP O
no DT B-NP O
changes NNS I-NP O
Pt NNP I-NP O
will MD O O
be VB O O
discharged VBN O O
to TO O O
home NN B-NP O
with IN B-VP O
follow-up JJ O O
already RB O O
scheduled VBN O O
with IN B-VP O
Dr NNP B-NP O
Hassenger NNP I-NP O
, , O O
her PRP$ O O
cardiologist NN B-NP O
at IN B-VP O
the DT B-NP O
end NN I-NP O
of IN B-VP O
the DT B-NP O
month NN I-NP O
Of IN B-VP O
note NN B-NP O
pt NN I-NP O
had VBD B-VP O
an DT O O
elevated VBN O O
WBC NNP B-NP O
( ( O O
15.2 CD O O
) ) O O
which WDT O O
seems VBZ O O
to TO O O
be VB O O
chronic JJ O O
in IN B-VP O
nature NN B-NP O
No NNP I-NP O
fevers NNS I-NP O
, , O O
localizing VBG O O
signs/symptoms NNS B-NP O
of IN B-VP O
infection NN B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
please NN I-NP O
continue NN I-NP O
to TO O O
take VB O O
the DT B-NP O
same JJ I-NP O
medications NNS I-NP O
as IN B-VP O
you PRP O O
were VBD B-VP O
before IN B-VP O
this DT B-NP O
admission NN I-NP O
call VB O O
your PRP$ O O
PCP NN B-NP O
to TO O O
make VB O O
an DT B-NP O
appointment NN I-NP O
in IN B-VP O
1-2 JJ B-NP O
weeks NNS I-NP O
( ( O O
number NN B-NP O
above IN B-VP O
) ) O O
Your PRP$ O O
cardiology NN B-NP O
appts NNS I-NP O
with IN B-VP O
dr JJ B-NP O
nik NNS I-NP O
and CC O O
surgery NN B-NP O
appointment NN I-NP O
with IN B-VP O
dr NN B-NP O
prosonic NN I-NP O
, , O O
also RB O O
listed VBN O O
above IN B-VP O
your PRP$ O O
stress JJ B-NP O
test NN I-NP O
was VBD B-VP O
negative JJ O O
for IN B-VP O
any DT B-NP O
new JJ I-NP O
heart NN I-NP O
disease NN I-NP O
- : O O
your PRP$ O O
chest JJS B-NP O
pain NN I-NP O
was VBD B-VP O
unlikely JJ O O
due JJ O O
to TO O O
heart NN B-NP O
disease VB O O
return NN B-NP O
to TO O O
the DT B-NP O
ED NNP I-NP O
or CC O O
call VB O O
your PRP$ O O
PCP NNP B-NP O
with IN B-VP O
new JJ B-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
palpitations NNS B-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
1 CD O O
pt NN B-NP O
has VBZ O O
follow VBN O O
up RP O O
with IN B-VP O
cardiology NN B-NP O
and CC O O
vascular JJ B-NP O
surgery NN I-NP O
scheduled VBN O O
no DT B-NP O
new JJ I-NP O
medications NNS I-NP O
this DT B-NP O
admission NN I-NP O
No RB O O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
GETCHMAN NNP I-NP O
, , O O
MAN NNP B-NP O
DAREN NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
FE09 NNP B-NP O
) ) O O
5/28/05 CD O O
@ $ O O
05 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#976089 VBZ O O
450657129 CD O O
PMH NNP B-NP O
92496595 CD O O
007885 CD O O
8/22/1990 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
11/10/1990 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Unsigned NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
2/17/1990 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT O O
58 CD O O
year NN B-NP O
old JJ B-NP O
woman NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
CABG NNP I-NP O
times NNS I-NP O
three CD O O
in IN B-VP O
9/9 CD O O
, , O O
status NN B-NP O
post NN I-NP O
inferior JJ B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
in IN B-VP O
1/28 CD O O
with IN B-VP O
a DT B-NP O
peak JJ I-NP O
CPK NNP I-NP O
of IN B-VP O
714 CD O O
She PRP O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
chest NN B-NP O
pain NN I-NP O
since IN B-VP O
the DT B-NP O
CABG NNP I-NP O
The DT B-NP O
CABG NNP I-NP O
consisted VBD B-VP O
of IN B-VP O
a DT B-NP O
LIMA NNP I-NP O
to TO O O
the DT B-NP O
LAD NNP I-NP O
, , O O
saphenous JJ B-NP O
vein NN I-NP O
grafts NNS I-NP O
to TO O O
the DT B-NP O
OMB-2 NNP I-NP O
and CC O O
RCA NNP B-NP O
In IN B-VP O
8/2 CD O O
, , O O
she PRP O O
had VBD B-VP O
been VBN O O
cathed VBN O O
and CC O O
a DT O O
70% CD O O
RCA NNP B-NP O
occlusion NN I-NP O
with IN B-VP O
a DT B-NP O
question NN I-NP O
of IN B-VP O
thrombus NN B-NP O
was VBD B-VP O
seen VBN O O
A DT O O
90% CD O O
OMB-2 NN B-NP O
was VBD B-VP O
seen; VBN O O
a DT B-NP O
circumflex NN I-NP O
of IN B-VP O
60% CD O O
was VBD B-VP O
seen; VBN O O
an DT B-NP O
LAD NNP I-NP O
of IN B-VP O
70% CD O O
was VBD B-VP O
seen VBN O O
An DT O O
LV-gram JJ O O
showed VBD B-VP O
inferior JJ B-NP O
akinesis NN I-NP O
and CC O O
posterior JJ B-NP O
hypokinesis NN I-NP O
with IN B-VP O
a DT B-NP O
left JJ I-NP O
ventricular JJ I-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
78% CD O O
Post NNP B-NP O
CABG NNP I-NP O
at IN B-VP O
baseline NN B-NP O
, , O O
she PRP O O
had VBD B-VP O
substernal JJ B-NP B-r
chest NN I-NP I-r
pain NN I-NP I-r
at IN B-VP O
rest NN B-NP O
with IN B-VP O
rare JJ B-NP O
use NN I-NP O
of IN B-VP O
sublingual JJ B-NP B-mo
nitroglycerin NN I-NP B-m
She PRP O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
peptic JJ B-NP O
ulcer NN I-NP O
disease NN I-NP O
which WDT O O
was VBD B-VP O
a DT B-NP O
duodenal JJ I-NP O
ulcer NN I-NP O
with IN B-VP O
melena NN B-NP O
She PRP O O
had VBD B-VP O
an DT B-NP O
EGD NNP I-NP O
in IN B-VP O
8/27 CD O O
which WDT O O
showed VBD B-VP O
mild JJ B-NP O
antral JJ I-NP O
gastritis NN I-NP O
without IN B-VP O
ulcers NNS B-NP O
She PRP O O
is VBZ O O
status NN B-NP O
post NN I-NP O
colonoscopy NN I-NP O
in IN B-VP O
8/2 CD O O
which WDT O O
showed VBD B-VP O
diverticulitis NN B-NP O
She PRP O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
anemia NN B-NP B-r
anemia NN I-NP B-r
with IN B-VP O
a DT B-NP O
hematocrit NN I-NP O
of IN B-VP O
29 CD O O
, , O O
MCV NNP B-NP O
of IN B-VP O
68 CD O O
She PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
iron NN B-NP B-m
sulfate NN I-NP I-m
and CC O O
H2 NNP B-NP B-m
blockers NNS I-NP I-m
She PRP O O
noted VBD B-VP O
a DT B-NP O
history NN I-NP O
in IN B-VP O
two CD O O
months NNS B-NP O
of IN B-VP O
a DT O O
20 CD O O
pound NN B-NP O
weight VBD B-VP O
loss NN B-NP O
One CD O O
week NN B-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
she PRP O O
had VBD B-VP O
melena NN B-NP O
of IN B-VP O
loose JJ B-NP O
stool NN I-NP O
She PRP O O
felt VBD B-VP O
light-headed JJ O O
She PRP O O
had VBD B-VP O
a DT B-NP O
cough NN I-NP O
and CC O O
nocturia NNS B-NP O
Three NNP I-NP O
days NNS I-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
she PRP O O
noted VBD B-VP O
a DT O O
stabbing VBG O O
periodic JJ B-NP O
epigastric JJ I-NP O
pain NN I-NP O
with IN B-VP O
nausea NN B-NP O
and CC O O
vomiting VBG O O
twice; NN B-NP O
no DT B-NP O
coffee NN I-NP O
grounds VBZ O O
or CC O O
hematemesis NN B-NP O
She PRP O O
had VBD B-VP O
dysphagia NN B-NP O
for IN B-VP O
months NNS B-NP O
to TO O O
liquids NNS B-NP O
and CC O O
solids NNS B-NP O
with IN B-VP O
the DT B-NP O
sensation NN I-NP O
of IN B-VP O
aspiration NN B-NP O
on IN B-VP O
swallowing VBG O O
She PRP O O
had VBD B-VP O
a DT B-NP O
sharp JJ I-NP O
pain NN I-NP O
radiating VBG O O
to TO O O
the DT B-NP O
left JJ I-NP O
arm NN I-NP O
and CC O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
The DT B-NP O
pain NN I-NP O
was VBD B-VP O
similar JJ O O
to TO O O
the DT B-NP O
inferior JJ I-NP O
MI NNP I-NP O
in IN B-VP O
1988 CD O O
On IN B-VP O
0/16 CD O O
, , O O
she PRP O O
came VBD B-VP O
to TO O O
the DT B-NP O
emergency NN I-NP O
ward NN I-NP O
, , O O
where WRB O O
her PRP$ O O
blood NN B-NP O
pressure NN I-NP O
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
110/68 CD O O
lying VBG O O
and CC O O
90/palp CD O O
sitting VBG O O
O2 NNP B-NP O
sat VBD B-VP O
was VBD B-VP O
97% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
Her NNP I-NP O
JVP NNP I-NP O
was VBD B-VP O
9 CD O O
cm NN B-NP O
with IN B-VP O
crackles NNS B-NP O
at IN B-VP O
the DT B-NP O
right JJ I-NP O
base NN I-NP O
She PRP O O
was VBD B-VP O
given VBN O O
three CD O B-do
sublingual JJ B-NP B-mo
nitroglycerins NNS I-NP B-m
and CC O O
Maalox NNP B-NP B-m
Her NNP I-NP O
hematocrit NN I-NP O
was VBD B-VP O
20.8 CD O O
She PRP O O
was VBD B-VP O
given VBN O O
10 CD O B-do
mg NN B-NP I-do
of IN B-VP O
IV NNP B-NP B-mo
Lopressor NNP I-NP B-m
from IN B-VP O
which WDT O O
she PRP O O
became VBD B-VP O
hypotensive JJ O O
, , O O
but CC O O
this DT O O
resolved VBD B-VP O
She PRP O O
was VBD B-VP O
transfused VBN O O
three CD O B-do
units NNS B-NP I-do
of IN B-VP O
packed JJ B-NP B-m
red JJ I-NP I-m
blood NN I-NP I-m
cells NNS I-NP I-m
, , O O
given VBN O O
Lasix NNP B-NP B-m
and CC O O
IV NNP B-NP B-mo
H2 NNP I-NP B-m
blockers NNS I-NP I-m
She PRP O O
went VBD B-VP O
to TO O O
the DT B-NP O
unit NN I-NP O
and CC O O
ruled VBD B-VP O
out RP O O
for IN B-VP O
an DT B-NP O
MI NNP I-NP O
by IN B-VP O
EKG NNP B-NP O
and CC O O
enzymes VBZ O O
The DT B-NP O
A-set NNP I-NP O
revealed VBD B-VP O
a DT B-NP O
CPK NNP I-NP O
of IN B-VP O
54; CD O O
B-set NNP B-NP O
was VBD B-VP O
48; CD O O
C-set NNP B-NP O
was VBD B-VP O
36 CD O O
An DT B-NP O
ABG NNP I-NP O
was VBD B-VP O
132 CD O O
, , O O
99 CD O O
, , O O
7.43 CD O O
, , O O
33 CD O O
Potassium NN B-NP O
was VBD B-VP O
4.2 CD O O
, , O O
BUN NNP B-NP O
20 CD O O
, , O O
creatinine NN B-NP O
0.9 CD O O
ALLERGIES: NNP B-NP O
None NNP I-NP O
known VBN O O
PHYSICAL NNP B-NP O
EXAMINATION: NNP I-NP O
JVD NNP I-NP O
was VBD B-VP O
9 CD O O
cm NN B-NP O
on IN B-VP O
admission NN B-NP O
and CC O O
decreased; NN B-NP O
scar NN I-NP O
at IN B-VP O
the DT B-NP O
left JJ I-NP O
base NN I-NP O
of IN B-VP O
the DT B-NP O
neck NN I-NP O
secondary JJ O O
to TO O O
a DT B-NP O
basal NN I-NP O
cell NN I-NP O
resection; NN I-NP O
II/VI NNP I-NP O
systolic JJ B-NP O
ejection NN I-NP O
murmur NN I-NP O
at IN B-VP O
the DT B-NP O
left JJ I-NP O
sternal JJ I-NP O
border NN I-NP O
without IN B-VP O
gallop PDT O O
The DT B-NP O
lungs NNS I-NP O
revealed VBD B-VP O
crackles NNS B-NP O
at IN B-VP O
the DT B-NP O
right JJ I-NP O
base NN I-NP O
one CD O O
quarter NN B-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
kyphoscoliosis NN I-NP O
The DT B-NP O
abdomen NNS I-NP O
was VBD B-VP O
benign IN B-VP O
The DT B-NP O
neuro JJ I-NP O
exam NN I-NP O
was VBD B-VP O
nonfocal JJ O O
, , O O
though IN B-VP O
she PRP O O
had VBD B-VP O
some DT B-NP O
past JJ I-NP O
pointing NN I-NP O
secondary NN I-NP O
to TO O O
poor JJ B-NP O
eyesight JJ I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
On IN B-VP O
10/17 CD O O
, , O O
she PRP O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
She PRP O O
complained VBD B-VP O
of IN B-VP O
some DT B-NP O
left JJ I-NP O
arm NN I-NP O
pain NN I-NP O
secondary JJ O O
to TO O O
her PRP$ O O
IV NNP B-NP O
, , O O
but CC O O
she PRP O O
had VBD B-VP O
no DT B-NP O
EKG NNP I-NP O
changes NNS I-NP O
and CC O O
this DT O O
improved VBN O O
with IN B-VP O
hot JJ B-NP O
compresses NNS I-NP O
She PRP O O
was VBD B-VP O
guaiac JJ O O
negative JJ O O
On IN B-VP O
the DT B-NP O
evening NN I-NP O
of IN B-VP O
0/12 CD O O
, , O O
she PRP O O
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
trace JJ O O
guaiac JJ O O
positive JJ O O
in IN B-VP O
the DT B-NP O
stool NN I-NP O
On IN B-VP O
9/9 CD O O
at IN B-VP O
7:30 CD O O
AM NNP B-NP O
, , O O
she PRP O O
complained VBD B-VP O
of IN B-VP O
substernal JJ B-NP B-r
substernal JJ I-NP B-r
substernal JJ I-NP B-r
chest NN I-NP I-r
chest NN I-NP I-r
chest NN I-NP I-r
pain NN I-NP I-r
pain NN I-NP I-r
pain NN I-NP I-r
which WDT O O
radiated VBD B-VP O
to TO O O
both DT B-NP O
upper JJ I-NP O
extremities NNS I-NP O
with IN B-VP O
tingling VBG O O
bilaterally RB O O
This DT O O
did VBD B-VP O
not RB O O
resolve VB O O
, , O O
even RB O O
after IN B-VP O
giving VBG O O
Maalox NNP B-NP B-m
, , O O
four CD O B-do
sublinguals NNS B-NP B-mo
and CC O O
12 CD O B-do
mg NN B-NP I-do
of IN B-VP O
morphine NN B-NP B-m
and CC O O
three CD O B-do
inches NNS B-NP I-do
of IN B-VP O
Nitropaste NNP B-NP B-m
Her NNP I-NP O
blood NN I-NP O
pressure NN I-NP O
was VBD B-VP O
stable JJ O O
at IN B-VP O
130/80 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
was VBD B-VP O
68 CD O O
, , O O
and CC O O
she PRP O O
was VBD B-VP O
afebrile IN B-VP O
Her NNP B-NP O
substernal JJ B-NP O
chest NN I-NP O
pain NN I-NP O
ranged VBD B-VP O
between IN B-VP O
7-3 NNP B-NP O
, , O O
and CC O O
she PRP O O
was VBD B-VP O
given VBN O O
20 CD O B-do
mEq NN B-NP I-do
of IN B-VP O
Kay NNP B-NP B-m
Ciel NNP I-NP O
Her NNP I-NP O
potassium NN I-NP O
was VBD B-VP O
3.8 CD O O
, , O O
hematocrit NN B-NP O
32.8 CD O O
and CC O O
stable JJ O O
She PRP O O
was VBD B-VP O
given VBN O O
two CD O B-do
more JJR B-NP I-do
units NNS I-NP I-do
of IN B-VP O
packed JJ B-NP B-m
red JJ I-NP I-m
blood NN I-NP I-m
cells NNS I-NP I-m
after IN B-VP O
having VBG O O
been VBN O O
given VBN O O
two CD O B-do
more JJR B-NP I-do
units NNS I-NP I-do
of IN B-VP O
packed JJ B-NP B-m
red JJ I-NP I-m
blood NN I-NP I-m
cells NNS I-NP I-m
between IN B-VP O
10/17 CD O O
and CC O O
2/10 CD O O
IV NNP B-NP B-mo
IV NNP I-NP B-mo
nitroglycerin VBD B-VP B-m
nitroglycerin JJ O B-m
50 CD O B-do
units NNS B-NP I-do
was VBD B-VP O
started VBN O O
after IN B-VP O
one CD O O
hour NN B-NP O
and CC O O
15 CD O O
minutes NNS B-NP O
of IN B-VP O
pain NN B-NP B-r
pain NN I-NP B-r
This DT O O
was VBD B-VP O
increased VBN O O
to TO O O
100 CD O B-do
units NNS B-NP I-do
EKG NNP I-NP O
changes NNS I-NP O
were VBD B-VP O
noted VBN O O
as IN B-VP O
a DT B-NP O
flattening NN I-NP O
in IN B-VP O
V4 NNP B-NP O
through IN B-VP O
V6 NNP B-NP O
with IN B-VP O
no DT B-NP O
ST NNP I-NP O
depressions NNS I-NP O
, , O O
and CC O O
she PRP O O
had VBD B-VP O
a DT B-NP O
T NNP I-NP O
wave VBP O O
down RP O O
in IN B-VP O
V3 NNP B-NP O
which WDT O O
was VBD B-VP O
new JJ O O
since IN B-VP O
admission NN B-NP O
On IN B-VP O
9/9 CD O O
, , O O
she PRP O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
unit NN I-NP O
Her PRP$ O O
CKs NNP B-NP O
were VBD B-VP O
negative; JJ B-NP O
A-set NNP I-NP O
was VBD B-VP O
27 CD O O
, , O O
B-set NNP B-NP O
was VBD B-VP O
29 CD O O
, , O O
C-set NNP B-NP O
was VBD B-VP O
57 CD O O
and CC O O
D-set NNP B-NP O
was VBD B-VP O
65 CD O O
A NNP B-NP O
catheterization NN I-NP O
showed VBD B-VP O
right JJ B-NP O
atrial JJ I-NP O
pressures NNS I-NP O
of IN B-VP O
12 CD O O
, , O O
PCWP NNP B-NP O
of IN B-VP O
16 CD O O
, , O O
SVR NNP B-NP O
1 CD O O
, , O O
000 CD O O
, , O O
PVR NNP B-NP O
76 CD O O
, , O O
PA NNP B-NP O
34/14 CD O O
, , O O
cardiac JJ B-NP O
output NN I-NP O
6.8 CD O O
Grafts NNP B-NP O
from IN B-VP O
the DT B-NP O
aorta NN I-NP O
to TO O O
the DT B-NP O
OM NNP I-NP O
, , O O
aorta NN B-NP O
to TO O O
the DT B-NP O
RCA NNP I-NP O
and CC O O
LIMA NNP B-NP O
to TO O O
the DT B-NP O
LAD NNP I-NP O
were VBD B-VP O
all DT B-NP O
patent NN I-NP O
LAD NNP I-NP O
showed VBD B-VP O
100% CD O O
proximal JJ B-NP O
occlusion NN I-NP O
, , O O
LAD NNP B-NP O
diagonal NN I-NP O
showed VBD B-VP O
a DT O O
50% CD O O
long JJ B-NP O
proximal NN I-NP O
and CC O O
circumflex NN B-NP O
showed VBD B-VP O
a DT O O
50% CD O O
proximal NN B-NP O
, , O O
OM-2 NNP B-NP O
showed VBD B-VP O
a DT O O
70% CD O O
occlusion NN B-NP O
at IN B-VP O
the DT B-NP O
origin NN I-NP O
There EX O O
was VBD B-VP O
a DT B-NP O
mild JJ I-NP O
increase NN I-NP O
in IN B-VP O
right JJ O O
and CC O O
left VBD B-VP O
sided VBN O O
pressures NNS B-NP O
She PRP O O
was VBD B-VP O
readmitted VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
and CC O O
watched VBD B-VP O
Her NNP B-NP O
hematocrit NN I-NP O
remained VBD B-VP O
stable JJ O O
She PRP O O
had VBD B-VP O
an DT B-NP O
endoscopy NN I-NP O
done VBN O O
on IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
3/28 CD O O
, , O O
and CC O O
the DT B-NP O
impression NN I-NP O
was VBD B-VP O
of IN B-VP O
a DT B-NP O
large JJ I-NP O
hiatal JJ I-NP O
hernia NN I-NP O
with IN B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
GI NNP B-NP O
bleeding VBG O O
at IN B-VP O
this DT B-NP O
time NN I-NP O
It PRP O O
was VBD B-VP O
recommended VBN O O
that IN B-VP O
she PRP O O
had VBD B-VP O
an DT B-NP O
upper JJ I-NP O
GI NNP I-NP O
and CC O O
small JJ B-NP O
bowel NN I-NP O
follow VBP O O
through IN B-VP O
or CC O O
repeat VB O O
colonoscopy NN B-NP O
in IN B-VP O
the DT B-NP O
future NN I-NP O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
Her NNP I-NP O
hematocrit NN I-NP O
remained VBD B-VP O
stable JJ O O
at IN B-VP O
approximately RB O O
33 CD O O
for IN B-VP O
the DT O O
past JJ O O
four CD O O
days NNS B-NP O
The DT B-NP O
sed JJ I-NP O
rate NN I-NP O
was VBD B-VP O
25 CD O O
, , O O
PT NNP B-NP O
and CC O O
PTT NNP B-NP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
, , O O
potassium NN B-NP O
4.2 CD O O
, , O O
iron NN B-NP O
182 CD O O
, , O O
TIBC NNP B-NP O
432 CD O O
, , O O
vitamin VBD B-VP O
B-12 NNP B-NP O
371 CD O O
, , O O
folate NN B-NP O
3.9 CD O O
, , O O
ferritin RB O O
16 CD O O
, , O O
cholesterol NN B-NP O
153 CD O O
, , O O
triglyceride RB O O
112 CD O O
DISPOSITION: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
home NN B-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
Pepcid NNP I-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d.; NN I-NP B-f
metoprolol VBD B-VP B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d.; NN I-NP B-f
nitroglycerin VBD B-VP B-m
1/150 CD O I-m
0.4 CD O B-do
mg NNS B-NP I-do
sublingual JJ B-NP B-mo
p.r.n NN I-NP B-f
FOLLOW NNP I-NP O
UP NNP I-NP O
will MD O O
be VB O O
with IN B-VP O
Dr NNP B-NP O
Pichard NNP I-NP O
and CC O O
with IN B-VP O
the DT B-NP O
GI NNP I-NP O
service NN I-NP O
DISCHARGE NNP I-NP O
DIAGNOSES: NNP I-NP O
1 CD O O
UPPER NNP B-NP O
GASTROINTESTINAL NNP I-NP O
BLEED NNP I-NP O
2 CD O O
CORONARY NNP B-NP O
ARTERY NNP I-NP O
DISEASE NNP I-NP O
, , O O
STATUS NNP B-NP O
POST NNP I-NP O
CORONARY NNP I-NP O
ARTERY NNP I-NP O
BYPASS NNP I-NP O
GRAFTING NNP I-NP O
3 CD O O
PEPTIC NNP B-NP O
ULCER NNP I-NP O
DISEASE NNP I-NP O
4 CD O O
IRON NNP B-NP O
DEFICIENCY NNP I-NP O
ANEMIA NNP I-NP O
5 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
CHOLELITHIASIS NNP I-NP O
________________________________ NNP I-NP O
FV787/1724 NNP I-NP O
THEO NNP I-NP O
GARRINGER NNP I-NP O
, , O O
M.D NNP B-NP O
VP05 NNP I-NP O
D: NNP I-NP O
3/0/90 CD O O
Batch: NNP B-NP O
7012 CD O O
Report: NNP B-NP O
Z5468N7 NNP I-NP O
T: NNP I-NP O
5/23/90 CD O O
Dictated NNP B-NP O
By: NNP I-NP O
WILL NNP I-NP O
HEINECK NNP I-NP O
, , O O
M.D NNP B-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#978271 VBZ O O
484126147 CD O O
CCH NNP B-NP O
55327920 CD O O
9437699 CD O O
1/24/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
PPM NNP I-NP O
placement NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/18/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
1/7/2005 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
POBRE NNP I-NP O
, , O O
JACOB NNP B-NP O
M NNP I-NP O
647-60-35-2 JJ B-NP O
Atl NNP I-NP O
Sey NNP I-NP O
Prodo NNP I-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
7/7/05 CD O O
AT NNP B-NP O
01:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Attending NNP I-NP O
evaluation NN I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
MCCLEVE NNP I-NP O
, , O O
SON NNP B-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ECASA NNP I-NP B-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ZESTRIL NNP I-NP B-m
( ( O I-m
LISINOPRIL NNP B-NP I-m
) ) O I-m
2.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ZOLOFT NNP I-NP B-m
( ( O I-m
SERTRALINE NNP B-NP I-m
) ) O I-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
KEFLEX NNP I-NP B-m
( ( O I-m
CEPHALEXIN NNP B-NP I-m
) ) O I-m
250 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QID NNP I-NP B-f
X NNP I-NP B-du
12 CD O I-du
doses NNS B-NP I-du
Starting VBG O O
when WRB O O
IV NNP B-NP B-mo
ANTIBIOTICS NNP I-NP B-m
END NNP I-NP O
Number NNP I-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ B-NP O
): NN I-NP O
20 CD O O
ARICEPT NNP B-NP B-m
( ( O I-m
DONEPEZIL NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QPM NNP I-NP B-f
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
1 CD O I-du
PLAVIX NNP B-NP B-m
( ( O I-m
CLOPIDOGREL NNP B-NP I-m
) ) O I-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
TOPROL NNP I-NP B-m
XL NNP I-NP I-m
( ( O I-m
METOPROLOL NNP B-NP I-m
( ( O I-m
SUST NNP B-NP I-m
REL NNP I-NP I-m
) ) O I-m
) ) O I-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
LIPITOR NNP I-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
GLUCOPHAGE NNP I-NP B-m
( ( O I-m
METFORMIN NNP B-NP I-m
) ) O I-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
GLYBURIDE NNP I-NP B-m
1.25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
2 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Local NNP I-NP O
cardiologist NN I-NP O
1-2 JJ B-NP O
weeks NNS I-NP O
, , O O
ALLERGY: NNP B-NP O
NKA NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
CHB NNP I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
PPM NNP B-NP O
placement NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
DM NNP I-NP O
( ( O O
diabetes VBZ O O
mellitus VBP O O
type JJ O O
2 CD O O
) ) O O
HTN NNP B-NP O
( ( O O
hypertension NN B-NP O
) ) O O
CAD NNP B-NP O
( ( O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
) ) O O
CRI NNP B-NP O
( ( O O
chronic JJ B-NP O
renal JJ I-NP O
dysfunction NN I-NP O
) ) O O
mild NN B-NP O
dementia NN I-NP O
( ( O O
dementia NN B-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
PPM NNP I-NP O
placed VBD B-VP O
0/7/05 CD O O
without IN B-VP O
complications NNS B-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC: NNP I-NP O
PPM NNP I-NP O
placement NN I-NP O
HPI: NNP I-NP O
74M CD O O
w NN B-NP O
3VD CD O O
s/p JJ B-NP O
recent JJ I-NP O
MI NNP I-NP O
in IN B-VP O
11/2 CD O O
( ( O O
w JJ B-NP O
subsequent JJ I-NP O
stent NN I-NP O
of IN B-VP O
100% CD O O
RCA NNP B-NP O
, , O O
but CC O O
residual JJ B-NP O
LAD NNP I-NP O
dz NN I-NP O
) ) O O
transferred VBD B-VP O
from IN B-VP O
RAMH NNP B-NP O
for IN B-VP O
PPM NNP B-NP O
placement NN I-NP O
for IN B-VP O
symptomatic JJ B-NP O
bradycardia NN I-NP O
PPM NNP I-NP O
placed VBD B-VP O
w JJ O O
no DT B-NP O
cx JJ I-NP O
DAILY NNP I-NP O
STATUS/EXAM: NNP I-NP O
arm NN I-NP O
in IN B-VP O
sling NN B-NP O
, , O O
ox3 NN B-NP O
, , O O
sleepy NN B-NP O
but CC O O
easily RB O O
rousible JJ O O
, , O O
cn JJ B-NP O
intact NN I-NP O
, , O O
rrr VB O O
s1s2 JJ O O
no DT B-NP O
m/r/g NN I-NP O
, , O O
ctab NN B-NP O
, , O O
no DT B-NP O
LEE NNP I-NP O
, , O O
distal JJ B-NP O
pulses NNS I-NP O
2+ CD O O
, , O O
PPM NNP B-NP O
site NN I-NP O
bandage NN I-NP O
C/D/I NNP I-NP O
TESTS: NNP I-NP O
CXR NNP I-NP O
- : O O
clear JJ O O
, , O O
no DT B-NP O
PTX NNP I-NP O
post NN I-NP O
procedure NN I-NP O
*********PROBLEM NNP I-NP O
LIST************** NNP I-NP O
1 CD O O
BRADYCARDIA NNP B-NP O
s/p NN I-NP O
PPM NNP I-NP O
placement NN I-NP O
PPM NNP I-NP O
appears VBZ O O
to TO O O
be VB O O
working VBG O O
well RB O O
cont VB O O
standard NN B-NP O
care NN I-NP O
( ( O O
post JJ B-NP O
procedure NN I-NP O
abx NN I-NP O
, , O O
overnight JJ B-NP O
observation NN I-NP O
, , O O
cxr NN B-NP O
to TO O O
r/o VB O O
PTX NNP B-NP O
) ) O O
2 CD O O
3VD: CD O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
active JJ B-NP O
ischemia NN I-NP O
cont NN I-NP O
home NN I-NP O
meds NNS I-NP O
incl JJ B-NP O
plavix NN I-NP B-m
, , O O
asa NN B-NP B-m
, , O O
highdose JJ B-NP B-do
statin NN I-NP B-m
, , O O
bb NN B-NP B-m
, , O O
acei RB O B-m
3 CD O O
DM: NNP B-NP O
we PRP O O
held VBD B-VP O
oral JJ B-NP B-mo
hypoglycemics NNS I-NP B-m
in IN B-VP O
house NN B-NP O
and CC O O
used VBD B-VP O
a DT B-NP O
RISS NNP I-NP B-m
Pt NNP I-NP O
to TO O O
resume VB O O
meds NNS B-NP O
on IN B-VP O
dispo JJ B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
Follow NNP I-NP O
up RP O O
as RB O O
arranged VBN O O
by IN B-VP O
cardiology NN B-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
GADLIN NNP I-NP O
, , O O
TOMAS NNP B-NP O
LOGAN NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
KW10 NNP B-NP O
) ) O O
7/7/05 CD O O
@ $ O O
01:23 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#980280 VBZ O O
322074815 CD O O
CBMC NNP B-NP O
49432110 CD O O
299002 CD O O
9/1/2000 CD O O
12:00:00 CD O O
AM NNP B-NP O
ABDOMINAL NNP I-NP O
PAIN NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
10/26/2000 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
0/25/2000 CD O O
SERVICE: NNP B-NP O
Coll NNP I-NP O
Lum NNP I-NP O
All NNP I-NP O
PRINCIPAL NNP I-NP O
DIAGNOSIS: NNP I-NP O
Pyelonephritis NNP I-NP O
SECONDARY NNP I-NP O
DIAGNOSES: NNP I-NP O
Urinary NNP I-NP O
tract NN I-NP O
infection NN I-NP O
Bilateral NNP I-NP O
adnexal NN I-NP O
masses NNS I-NP O
Diabetes VBZ O O
mellitus JJ B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Cristopher NNP I-NP O
Ottilige NNP I-NP O
is VBZ O O
a DT O O
53 CD O O
year NN B-NP O
old JJ B-NP O
woman NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
diabetes NNS B-NP O
mellitus NNS I-NP O
who WP O O
presents VBP O O
with IN B-VP O
abdominal JJ B-NP O
pain NN I-NP O
and CC O O
fevers NNS B-NP O
over IN B-VP O
two CD O O
weeks NNS B-NP O
duration VBP O O
Two CD O O
weeks NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
headaches NNS B-NP O
, , O O
nausea NN B-NP O
, , O O
vomiting VBG O O
, , O O
presyncope NN B-NP O
, , O O
anorexia NN B-NP O
with IN B-VP O
mild JJ B-NP O
periumbilical JJ I-NP O
pain NN I-NP O
She PRP O O
also RB O O
had VBD B-VP O
fevers NNS B-NP O
to TO O O
101 CD O O
degrees NNS B-NP O
F NNP I-NP O
with IN B-VP O
associated JJ B-NP O
chills NNS I-NP O
and CC O O
diaphoresis VB O O
The DT B-NP O
patient NN I-NP O
presented VBD B-VP O
to TO O O
her PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician JJ O O
three CD O O
days NNS B-NP O
before IN B-VP O
admission NN B-NP O
and CC O O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
elevated VBN O O
liver JJ B-NP O
function NN I-NP O
tests NNS I-NP O
with IN B-VP O
AST NNP B-NP O
of IN B-VP O
39 CD O O
, , O O
ALT NNP B-NP O
of IN B-VP O
108 CD O O
At IN B-VP O
that DT B-NP O
time NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
presumed VBN O O
to TO O O
have VB O O
a DT B-NP O
viral JJ I-NP O
syndrome NN I-NP O
Two CD O O
days NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
developed VBD B-VP O
worsening VBG O O
abdominal JJ B-NP O
pain NN I-NP O
The DT B-NP O
pain NN I-NP O
was VBD B-VP O
described VBN O O
as IN B-VP O
sharp JJ O O
, , O O
constant JJ O O
in IN B-VP O
character NN B-NP O
with IN B-VP O
radiation NN B-NP O
to TO O O
the DT O O
back RP O O
The DT B-NP O
pain NN I-NP O
was VBD B-VP O
more JJR O O
intense JJ O O
in IN B-VP O
the DT B-NP O
right NN I-NP O
lower RBR O O
quadrant VB O O
The DT B-NP O
pain NN I-NP O
was VBD B-VP O
also RB O O
noted VBN O O
to TO O O
be VB O O
in IN B-VP O
the DT B-NP O
lower JJR I-NP O
flanks NNS I-NP O
and CC O O
the DT B-NP O
costovertebral JJ I-NP O
angle NN I-NP O
area NN I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
noted VBN O O
no DT B-NP O
change NN I-NP O
in IN B-VP O
her PRP$ O O
usual JJ B-NP O
bowel NN I-NP O
habits NNS I-NP O
of IN B-VP O
one CD O O
stool NN B-NP O
per IN B-VP O
week NN B-NP O
She PRP O O
has VBZ O O
had VBD B-VP O
no DT B-NP O
diarrhea NN I-NP O
, , O O
constipation NN B-NP O
, , O O
melena NN B-NP O
, , O O
or CC O O
hematochezia NN B-NP O
She PRP O O
has VBZ O O
had VBD B-VP O
no DT B-NP O
hematemesis NN I-NP O
She PRP O O
denies VBZ O O
any DT B-NP O
urinary JJ I-NP O
symptoms NNS I-NP O
but CC O O
only RB O O
has VBZ O O
nocturia NNS B-NP O
Of IN B-VP O
note NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
menopause RBR O O
approximately RB O O
eight CD O O
years NNS B-NP O
ago RB O O
, , O O
but CC O O
in IN B-VP O
each DT O O
of IN B-VP O
the DT O O
last JJ O O
three CD O O
months NNS B-NP O
she PRP O O
has VBZ O O
noticed VBN O O
monthly JJ B-NP O
vaginal NN I-NP O
bleeding NN I-NP O
which WDT O O
she PRP O O
believes VBZ O O
are VBP O O
a DT B-NP O
resumption NN I-NP O
of IN B-VP O
menstrual JJ B-NP O
cycles NNS I-NP O
The DT B-NP O
last JJ I-NP O
episode NN I-NP O
was VBD B-VP O
about IN B-VP O
one CD O O
month NN B-NP O
ago IN B-VP O
The DT B-NP O
patient NN I-NP O
also RB O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
nephrolithiasis NN B-NP O
but CC O O
feels VBZ O O
that IN B-VP O
this DT B-NP O
current JJ I-NP O
pain NN I-NP O
is VBZ O O
different JJ O O
from IN B-VP O
the DT O O
one CD O O
she PRP O O
has VBZ O O
had VBN O O
in IN B-VP O
the DT B-NP O
past JJ I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
hypertension NN B-NP O
, , O O
diabetes VBZ O O
mellitus NNS B-NP O
diagnosed VBN O O
two CD O O
years NNS B-NP O
ago RB O O
, , O O
obesity NN B-NP O
, , O O
obstructive JJ B-NP O
sleep NN I-NP O
apnea NN I-NP O
, , O O
nephrolithiasis NN B-NP O
, , O O
osteoarthritis NN B-NP O
, , O O
glaucoma NN B-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
Notable NNP I-NP O
for IN B-VP O
cesarean JJ B-NP O
section NN I-NP O
20 CD O O
years NNS B-NP O
ago RB O O
that IN B-VP O
was VBD B-VP O
complicated VBN O O
by IN B-VP O
pulmonary JJ B-NP O
embolism NN I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
1 CD O O
Lasix NNP B-NP B-m
60 CD O B-do
mg NN B-NP I-do
q JJ B-NP B-f
day NN I-NP I-f
2 CD O O
Glyburide NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
q JJ B-NP B-f
day NN I-NP I-f
3 CD O O
Labetalol NNP B-NP B-m
200 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
4 CD O O
Timoptic NNP B-NP B-m
, , O O
Xylatan NNP B-NP B-m
drops VBZ O I-m
for IN B-VP O
glaucoma NN B-NP B-r
glaucoma NN I-NP B-r
ALLERGIES: NNP I-NP O
Lidocaine NNP I-NP O
leads VBZ O O
to TO O O
rash VB O O
Lisinopril NNP B-NP O
leads VBZ O O
to TO O O
cough VB O O
Diltiazem NNP B-NP O
leads VBZ O O
to TO O O
edema VB O O
Nifedipine NNP B-NP O
leads VBZ O O
to TO O O
edema VB O O
Intravenous NNP B-NP O
contrast NN I-NP O
leads VBZ O O
to TO O O
hives VB O O
FAMILY NNP B-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
cardiovascular JJ B-NP O
disease NN I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
married VBN O O
and CC O O
has VBZ O O
two CD O O
children NNS B-NP O
She PRP O O
denies VBZ O O
any DT B-NP O
use NN I-NP O
of IN B-VP O
alcohol NN B-NP O
or CC O O
tobacco NN B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Temperature NNP I-NP O
102 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
90 CD O O
, , O O
respiratory NN B-NP O
rate NN I-NP O
34 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
143/48 CD O O
Oxygen NNP B-NP O
saturation NN I-NP O
91% CD O O
on IN B-VP O
2 CD O O
liters NNS B-NP O
nasal JJ O O
cannula VBP O O
HEENT: NNP B-NP O
Pupils NNP I-NP O
equal JJ O O
, , O O
round NN B-NP O
, , O O
reactive JJ O O
to TO O O
light JJ O O
and CC O O
accommodation NN B-NP O
Extraocular NNP I-NP O
muscles NNS I-NP O
intact JJ B-NP O
Anicteric NNP I-NP O
sclerae NN I-NP O
Oropharynx NNP I-NP O
clear JJ B-NP O
No NNP I-NP O
jugular NN I-NP O
venous JJ B-NP O
distension NN I-NP O
CHEST: NNP I-NP O
Clear NNP I-NP O
to TO O O
auscultation VB O O
bilaterally RB O O
HEART: NNP B-NP O
Regular NNP I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
Normal NNP I-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
, , O O
no DT B-NP O
murmurs NNS I-NP O
ABDOMEN: NNP I-NP O
Obese NNP I-NP O
and CC O O
fairly RB O O
firm JJ O O
Diffusely RB O O
tender NN B-NP O
to TO O O
palpation NN B-NP O
Increased VBD B-VP O
right JJ B-NP O
lower JJR I-NP O
quadrant NN I-NP O
pain NN I-NP O
Rebound NNP I-NP O
tenderness NN I-NP O
and CC O O
mild JJ O O
guarding VBG O O
Bowel NNP B-NP O
sounds NNS I-NP O
are VBP O O
present JJ O O
but CC O O
decreased VBD B-VP O
BACK: NNP B-NP O
No NNP I-NP O
costovertebral JJ O O
angle RB O O
tenderness JJ B-NP O
CERVIX: NNP I-NP O
Cervical NNP I-NP O
motion NN I-NP O
tenderness NN I-NP O
is VBZ O O
present JJ B-NP O
NEUROLOGIC: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
alert JJ O O
and CC O O
oriented JJ B-NP O
x3 NNP I-NP O
LABORATORY: NNP I-NP O
Chemistries NNP I-NP O
revealed VBD B-VP O
sodium NN B-NP O
132 CD O O
, , O O
potassium NN B-NP O
4.2 CD O O
, , O O
chloride RB O O
94 CD O O
, , O O
CO2 NNP B-NP O
32 CD O O
, , O O
BUN NNP B-NP O
13 CD O O
, , O O
creatinine NN B-NP O
1 CD O O
Glucose NNP B-NP O
315 CD O O
, , O O
calcium NN B-NP O
9.9 CD O O
Liver NNP B-NP O
function NN I-NP O
tests NNS I-NP O
showed VBD B-VP O
ALT NNP B-NP O
58 CD O O
, , O O
AST NNP B-NP O
23 CD O O
, , O O
ALK NNP B-NP O
127 CD O O
, , O O
total JJ B-NP O
bilirubin NN I-NP O
1.2 CD O O
, , O O
albumin RB O O
4.6 CD O O
, , O O
globulin NN B-NP O
3.1 CD O O
, , O O
amylase NN B-NP O
28 CD O O
, , O O
lipase NN B-NP O
145 CD O O
, , O O
total JJ B-NP O
protein NN I-NP O
7.7 CD O O
The DT B-NP O
complete JJ I-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
revealed VBD B-VP O
a DT B-NP O
white JJ I-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
of IN B-VP O
23.91 CD O O
, , O O
hemoglobin NN B-NP O
14.1 CD O O
, , O O
hematocrit NN B-NP O
41.8 CD O O
, , O O
platelets NNS B-NP O
520 CD O O
The DT B-NP O
differential NN I-NP O
showed VBD B-VP O
77 CD O O
polys NN B-NP O
, , O O
7 CD O O
bands NNS B-NP O
, , O O
6 CD O O
lymphocytes NNS B-NP O
, , O O
and CC O O
6 CD O O
monocytes NNS B-NP O
The DT B-NP O
urinalysis NN I-NP O
was VBD B-VP O
notable JJ O O
for IN B-VP O
pH NN B-NP O
5.5 CD O O
, , O O
protein RB O O
1+ CD O O
, , O O
glucose RB O O
1+ CD O O
, , O O
leukocytes VBZ O O
1+ CD O O
, , O O
nitrite RB O O
positive JJ O O
, , O O
trace JJ B-NP O
ketones NNS I-NP O
, , O O
and CC O O
no DT B-NP O
blood NN I-NP O
Sediments NNS I-NP O
showed VBD B-VP O
white JJ B-NP O
blood NN I-NP O
cells NNS I-NP O
45 CD O O
- : O O
50 CD O O
, , O O
4+ CD O O
bacteria NNS B-NP O
, , O O
1+ CD O O
squamous JJ B-NP O
epithelial JJ I-NP O
cells NNS I-NP O
, , O O
1 CD O O
- : O O
2 CD O O
casts NNS B-NP O
Abdominal NNP I-NP O
CT NNP I-NP O
was VBD B-VP O
notable JJ O O
for IN B-VP O
a DT O O
7 CD O O
x NN B-NP O
8 CD O O
cm NN B-NP O
low JJ B-NP O
density NN I-NP O
fluid NN I-NP O
collection NN I-NP O
in IN B-VP O
the DT B-NP O
region NN I-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
adnexa NN I-NP O
and CC O O
a DT O O
4 CD O O
x NN B-NP O
8 CD O O
cm NN B-NP O
low JJ B-NP O
density NN I-NP O
fluid NN I-NP O
collection NN I-NP O
in IN B-VP O
the DT B-NP O
left NN I-NP O
adnexa VBZ O O
A DT B-NP O
UCG NNP I-NP O
was VBD B-VP O
negative JJ B-NP O
PROCEDURES: NNP I-NP O
July NNP I-NP O
, , O O
2000 CD O O
, , O O
endometrial JJ B-NP O
biopsy NN I-NP O
The DT B-NP O
procedure NN I-NP O
was VBD B-VP O
limited VBN O O
due JJ O O
to TO O O
the DT B-NP O
patient's NN I-NP O
body NN I-NP O
habitus VBZ O O
The DT B-NP O
biopsy NN I-NP O
revealed VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
malignancy NN B-NP O
Complications NNP I-NP O
none NN I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
By IN B-VP O
systems: JJ O O
1 CD O O
GENITOURINARY NNP B-NP O
The DT B-NP O
patient's NN I-NP O
presenting NN I-NP O
symptoms NNS I-NP O
and CC O O
abdominal JJ B-NP O
CT NNP I-NP O
findings NNS I-NP O
of IN B-VP O
bilateral JJ B-NP O
adnexal NN I-NP O
masses NNS I-NP O
were VBD B-VP O
suspicious JJ O O
for IN B-VP O
a DT B-NP O
tubo-ovarian JJ I-NP O
abscess NN I-NP O
However RB O O
, , O O
the DT B-NP O
patient NN I-NP O
did VBD B-VP O
not RB O O
have VB O O
any DT O O
of IN B-VP O
the DT O O
associated VBN O O
risk NN B-NP O
factors NNS I-NP O
, , O O
given VBN O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
is VBZ O O
not RB O O
sexually RB O O
active JJ O O
and CC O O
denied VBD B-VP O
introducing VBG O O
any DT B-NP O
foreign JJ I-NP O
objects NNS I-NP O
into IN B-VP O
the DT B-NP O
vagina NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
initially RB O O
managed VBN O O
on IN B-VP O
triple JJ B-NP B-m
antibiotics NNS I-NP O
, , O O
ampicillin NN B-NP B-m
, , O O
gentamicin NN B-NP B-m
, , O O
and CC O O
Clindamycin NNP B-NP B-m
Since IN B-VP O
a DT B-NP O
CT NNP I-NP O
scan NN I-NP O
is VBZ O O
not RB O O
the DT B-NP O
optimal JJ I-NP O
test NN I-NP O
to TO O O
evaluate VB O O
the DT B-NP O
adnexa NN I-NP O
, , O O
a DT B-NP O
transvaginal JJ I-NP O
ultrasound NN I-NP O
was VBD B-VP O
ordered VBN O O
which WDT O O
revealed VBD B-VP O
endometrial JJ B-NP O
thickness NN I-NP O
of IN B-VP O
3.6 CD O O
mm NNS B-NP O
and CC O O
bilateral JJ B-NP O
cystic JJ I-NP O
masses NNS I-NP O
The DT B-NP O
patient's NN I-NP O
right JJ B-NP O
upper JJ I-NP O
quadrant NN I-NP O
pain NN I-NP O
and CC O O
tenderness NN B-NP O
persisted VBN O O
for IN B-VP O
several JJ B-NP O
days NNS I-NP O
during IN B-VP O
the DT B-NP O
admission NN I-NP O
with IN B-VP O
periodic JJ B-NP O
exacerbations NNS I-NP O
and CC O O
was VBD B-VP O
increasingly RB O O
suspicious JJ O O
for IN B-VP O
cholelithiasis NN B-NP O
or CC O O
pancreatitis VB O O
The DT B-NP O
patient NN I-NP O
then RB O O
had VBD B-VP O
an DT B-NP O
abdominal JJ I-NP O
ultrasound NN I-NP O
which WDT O O
was VBD B-VP O
essentially RB O O
was VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
and CC O O
showed VBD B-VP O
no DT B-NP O
abnormal JJ I-NP O
viscera NN I-NP O
The DT B-NP O
bilateral JJ I-NP O
adnexal NN I-NP O
masses NNS I-NP O
continued VBD B-VP O
to TO O O
be VB O O
of IN B-VP O
major JJ B-NP O
concern NN I-NP O
, , O O
and CC O O
interventional JJ B-NP O
radiology NN I-NP O
was VBD B-VP O
consulted VBN O O
for IN B-VP O
possible JJ B-NP O
aspiration NN I-NP O
Given NNP I-NP O
that IN B-VP O
the DT B-NP O
etiology NN I-NP O
of IN B-VP O
the DT B-NP O
masses NNS I-NP O
was VBD B-VP O
unclear JJ O O
and CC O O
the DT B-NP O
risk NN I-NP O
of IN B-VP O
malignancy NN B-NP O
in IN B-VP O
a DT B-NP O
post NN I-NP O
menopausal NN I-NP O
woman NN I-NP O
, , O O
it PRP O O
was VBD B-VP O
decided VBN O O
that IN B-VP O
the DT B-NP O
best JJS I-NP O
approach NN I-NP O
would MD O O
be VB O O
open JJ B-NP O
tissue NN I-NP O
sampling VBG O O
It PRP O O
was VBD B-VP O
then RB O O
decided VBD B-VP O
to TO O O
postpone VB O O
this DT B-NP O
procedure NN I-NP O
pending VBG O O
further JJ B-NP O
evaluation NN I-NP O
of IN B-VP O
the DT B-NP O
patient NN I-NP O
Of IN B-VP O
note NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
CA-125 NNP I-NP O
drawn NN I-NP O
which WDT O O
77 CD O O
Serum NNP B-NP O
HCG NNP I-NP O
was VBD B-VP O
negative JJ O O
The DT B-NP O
patient's JJ I-NP O
report NN I-NP O
of IN B-VP O
new JJ B-NP O
onset NN I-NP O
of IN B-VP O
post NN B-NP O
menopausal NN I-NP O
bleeding NN I-NP O
was VBD B-VP O
concerning VBG O O
Considering VBG O O
the DT B-NP O
high JJ I-NP O
likelihood NN I-NP O
of IN B-VP O
malignancy NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
being VBG O O
followed VBN O O
by IN B-VP O
the DT B-NP O
gynecology NN I-NP O
oncology NN I-NP O
service NN I-NP O
and CC O O
underwent JJ B-NP O
endometrial JJ I-NP O
biopsy NN I-NP O
for IN B-VP O
tissue NN B-NP O
sampling VBG O O
The DT B-NP O
biopsy NN I-NP O
revealed VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
malignancy NN B-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
repeat NN I-NP O
CT NNP I-NP O
scan NN I-NP O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
number NN I-NP O
seven CD O O
which WDT O O
was VBD B-VP O
essentially RB O O
unchanged JJ O O
from IN B-VP O
admission NN B-NP O
showing VBG O O
persistent JJ B-NP O
bilateral JJ I-NP O
adnexal NN I-NP O
masses NNS I-NP O
and CC O O
no DT B-NP O
free JJ I-NP O
fluid NN I-NP O
The DT B-NP O
patient's NN I-NP O
symptoms NNS I-NP O
of IN B-VP O
right JJ B-NP O
lower JJR I-NP O
quadrant NN I-NP O
pain NN I-NP O
persisted VBD B-VP O
but CC O O
became VBD B-VP O
more RBR O O
responsive JJ O O
to TO O O
treatment NN B-NP O
toward IN B-VP O
the DT B-NP O
end NN I-NP O
of IN B-VP O
the DT B-NP O
admission NN I-NP O
Throughout IN B-VP O
the DT B-NP O
admission NN I-NP O
the DT B-NP O
actual JJ I-NP O
etiology NN I-NP O
of IN B-VP O
the DT B-NP O
bilateral JJ I-NP O
adnexal NN I-NP O
masses NNS I-NP O
was VBD B-VP O
never RB O O
discerned VBN O O
As IN B-VP O
a DT B-NP O
result NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
referred VBN O O
to TO O O
the DT B-NP O
gynecology NN I-NP O
oncology NN I-NP O
service NN I-NP O
for IN B-VP O
continued VBN O O
follow VBP O O
up RP O O
as IN B-VP O
an DT O O
outpatient JJ O O
2 CD O O
INFECTIOUS NNP B-NP O
DISEASE NNP I-NP O
The DT B-NP O
patient's JJ I-NP O
presentation NN I-NP O
of IN B-VP O
fevers NNS B-NP O
, , O O
chills NNS B-NP O
, , O O
and CC O O
diaphoresis NN B-NP O
was VBD B-VP O
certainly RB O O
suspicious JJ O O
for IN B-VP O
infectious JJ B-NP O
process NN I-NP O
Initially RB O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
covered VBN O O
with IN B-VP O
ampicillin NN B-NP B-m
, , O O
gentamicin NN B-NP B-m
, , O O
and CC O O
Clindamycin NNP B-NP B-m
for IN B-VP O
empiric JJ B-NP B-r
empiric JJ I-NP B-r
empiric JJ I-NP B-r
antimicrobial JJ I-NP I-r
antimicrobial JJ I-NP I-r
antimicrobial JJ I-NP I-r
coverage NN I-NP I-r
coverage NN I-NP I-r
coverage NN I-NP I-r
The DT B-NP O
urine JJ I-NP O
culture NN I-NP O
was VBD B-VP O
notable JJ O O
for IN B-VP O
greater JJR O O
than IN B-VP O
100 CD O O
, , O O
000 CD O O
Escherichia NNP B-NP O
coli NN I-NP O
which WDT O O
was VBD B-VP O
pan RBS O O
sensitive JJ O O
All DT B-NP O
blood NN I-NP O
cultures NNS I-NP O
at IN B-VP O
initial JJ B-NP O
presentation NN I-NP O
had VBD B-VP O
been VBN O O
negative JJ O O
On IN B-VP O
March NNP B-NP O
, , O O
the DT B-NP O
creatinine JJ I-NP O
level NN I-NP O
increased VBD B-VP O
to TO O O
1.8 CD O O
As IN B-VP O
a DT B-NP O
result NN I-NP O
, , O O
gentamicin NN B-NP B-m
was VBD B-VP O
then RB O O
switched VBN O O
to TO O O
Levofloxacin VB O B-m
The DT B-NP B-r
patient's NN I-NP I-r
fever NN I-NP I-r
initially RB O O
defervesced VBD B-VP O
from IN B-VP O
102.2 CD O O
to TO O O
99.3 CD O O
, , O O
but CC O O
spiked VBD B-VP O
to TO O O
100.1 CD O O
after IN B-VP O
six CD O B-du
days NNS B-NP I-du
of IN B-VP O
antibiotics NNS B-NP B-m
Her NNP I-NP O
white JJ B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
remained VBD B-VP O
elevated JJ O O
and CC O O
ranged VBD B-VP O
from IN B-VP O
24 CD O O
to TO O O
32 CD O O
However RB O O
, , O O
by IN B-VP O
discharge NN B-NP O
the DT B-NP O
white JJ I-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
was VBD B-VP O
10 CD O O
Because IN B-VP O
of IN B-VP O
the DT B-NP O
patient's JJ I-NP O
initial JJ I-NP O
minimal JJ I-NP O
response NN I-NP O
to TO O O
antibiotics NNS B-NP B-m
, , O O
repeat NN B-NP O
blood NN I-NP O
cultures NNS I-NP O
and CC O O
urine JJ B-NP O
cultures NNS I-NP O
were VBD B-VP O
sent VBN O O
which WDT O O
were VBD B-VP O
negative JJ O O
In IN B-VP O
addition NN B-NP O
, , O O
ID NNP B-NP O
was VBD B-VP O
consulted VBN O O
to TO O O
provide VB O O
further JJ B-NP O
guidance NN I-NP O
regarding VBG O O
antimicrobial JJ B-NP O
management NN I-NP O
They PRP O O
recommended VBD B-VP O
to TO O O
continue VB O O
ampicillin NN B-NP B-m
and CC O O
Levofloxacin NNP B-NP B-m
Clindamycin NNP I-NP B-m
was VBD B-VP O
changed VBN O O
to TO O O
Flagyl NNP B-NP B-m
By IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
afebrile JJ O O
3 CD O O
CARDIOVASCULAR NNP B-NP O
By IN B-VP O
hospital JJ B-NP O
day NN I-NP O
number NN I-NP O
two CD O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
increased VBN O O
lower JJR B-NP O
extremity NN I-NP O
swelling VBG O O
and CC O O
new JJ B-NP O
bibasilar JJ I-NP O
crackles NNS I-NP O
The DT B-NP O
symptoms NNS I-NP O
were VBD B-VP O
suggestive JJ O O
of IN B-VP O
volume NN B-NP O
overload NN I-NP O
and CC O O
possibly RB O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
A DT B-NP O
chest NN I-NP O
x-ray NN I-NP O
was VBD B-VP O
notable JJ O O
for IN B-VP O
bilateral JJ B-NP O
atelectasis NN I-NP O
in IN B-VP O
the DT B-NP O
lower JJR I-NP O
lobes NNS I-NP O
but CC O O
no DT B-NP O
pulmonary JJ I-NP O
edema NN I-NP O
or CC O O
pleural JJ B-NP O
effusions NNS I-NP O
A DT B-NP O
cardiac JJ I-NP O
echocardiogram NN I-NP O
revealed VBD B-VP O
normal JJ B-NP O
systolic JJ I-NP O
function NN I-NP O
with IN B-VP O
ejection NN B-NP O
fraction NN I-NP O
of IN B-VP O
approximately RB O O
60% CD O O
and CC O O
mild JJ O O
left VBD B-VP O
ventricular JJ B-NP O
hypertrophy NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
treated VBN O O
with IN B-VP O
Lasix NNP B-NP B-m
and CC O O
was VBD B-VP O
aggressively RB O O
diuresed VBN O O
She PRP O O
responded VBD B-VP O
well RB O O
to TO O O
treatment NN B-NP O
4 CD O O
NEUROLOGIC NNP B-NP O
The DT B-NP O
patient NN I-NP O
presented VBN O O
with IN B-VP O
abdominal JJ B-NP B-r
abdominal JJ I-NP B-r
pain NN I-NP I-r
pain NN I-NP I-r
and CC O O
was VBD B-VP O
initially RB O O
with IN B-VP O
Demerol NNP B-NP B-m
and CC O O
Vistaril NNP B-NP B-m
Initially NNP I-NP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
only RB O O
minimally RB O O
responsive JJ O O
to TO O O
treatment NN B-NP O
, , O O
but CC O O
over IN B-VP O
time NN B-NP O
she PRP O O
became VBD B-VP O
more RBR O O
responsive JJ O O
By IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
without IN B-VP O
pain NN B-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
Lasix NNP I-NP B-m
60 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.i.d VBD B-VP B-f
Glyburide NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
Labetalol NNP I-NP B-m
200 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
Flagyl NNP I-NP B-m
500 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q VBD B-VP B-f
8 CD O I-f
hours NNS B-NP I-f
Levofloxacin NNP I-NP B-m
500 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q VBD B-VP B-f
24 CD O O
hours NNS B-NP O
Xalatan VBD B-VP B-m
1 CD O B-do
drop NN B-NP I-do
OU NNP I-NP B-mo
q NN I-NP B-f
p.m NN I-NP I-f
Timoptic NNP I-NP B-m
0.5% CD O I-m
1 CD O B-do
drop NN B-NP I-do
OS NNP I-NP B-mo
q NNP I-NP B-f
day NN I-NP I-f
CONDITION NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
Stable NNP I-NP O
DISPOSITION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
and CC O O
required VBN O O
no DT B-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
INSTRUCTIONS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
advised VBN O O
to TO O O
call VB O O
her PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
for IN B-VP O
fevers NNS B-NP O
greater JJR O O
than IN B-VP O
100.5 CD O O
, , O O
chills NNS B-NP O
, , O O
nausea NN B-NP O
, , O O
vomiting VBG O O
, , O O
abdominal JJ O O
pain VBP O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
also RB O O
advised VBN O O
to TO O O
take VB O O
her PRP$ O O
temperature NN B-NP O
every DT B-NP O
day NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
scheduled VBN O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
her PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
in IN B-VP O
one CD O O
week NN B-NP O
She PRP O O
will MD O O
also RB O O
follow VB O O
up RP O O
with IN B-VP O
the DT B-NP O
gynecology NN I-NP O
oncology NN I-NP O
service NN I-NP O
for IN B-VP O
further JJ B-NP O
evaluation NN I-NP O
of IN B-VP O
bilateral JJ B-NP O
adnexal NN I-NP O
masses NNS I-NP O
and CC O O
post NN B-NP O
menopausal NN I-NP O
bleeding VBG O O
Dictated NNP B-NP O
By: NNP I-NP O
PACO NNP I-NP O
, , O O
KEVIN NNP B-NP O
RENALDO NNP I-NP O
DEANDRE NNP I-NP O
Attending: NNP I-NP O
ARLIE NNP I-NP O
S NNP I-NP O
PAGANI NNP I-NP O
, , O O
M.D NNP B-NP O
ZA2 NNP I-NP O
RP290/8974 NNP I-NP O
Batch: NNP I-NP O
21380 CD O O
Index NNP B-NP O
No NNP I-NP O
OZTFSV9PK3 NNP I-NP O
D: NNP I-NP O
10/6 CD O O
T: NNP B-NP O
10/6 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#981662 VBZ O O
603746432 CD O O
PCHAMC NNP B-NP O
12716509 CD O O
8078262 CD O O
0/23/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
3/16/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
4/4/2005 CD O O
ATTENDING: NNP B-NP O
JASPER NNP I-NP O
WISCOMBE NNP I-NP O
MD NNP I-NP O
PROCEDURES NNP I-NP O
DURING NNP I-NP O
ADMISSION: NNP I-NP O
1 CD O O
Insertion NNP B-NP O
of IN B-VP O
a DT B-NP O
pacemaker NN I-NP O
, , O O
4/0/05 CD O O
2 CD O O
Electrophysiology NNP B-NP O
study NN I-NP O
, , O O
4/0/05 CD O O
3 CD O O
Cardiac NNP B-NP O
catheterization NN I-NP O
, , O O
6/11/05 CD O O
ADMITTING NNP B-NP O
DIAGNOSES: NNP I-NP O
1 CD O O
Third-degree JJ B-NP O
heart NN I-NP O
block NN I-NP O
2 CD O O
Syncope NNP B-NP O
3 CD O O
Status NNP B-NP O
post NN I-NP O
motor NN I-NP O
vehicle NN I-NP O
collision NN I-NP O
4 CD O O
Rule NN B-NP O
out IN B-VP O
stroke NN B-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSES: NNP I-NP O
1 CD O O
Third-degree JJ B-NP O
heart NN I-NP O
block; VBZ O O
resolved VBD B-VP O
2 CD O O
Status NNP B-NP O
post NN I-NP O
motor NN I-NP O
vehicle NN I-NP O
collision NN I-NP O
3 CD O O
Lateral NNP B-NP O
and CC O O
medial JJ B-NP O
menisci NN I-NP O
tears NNS I-NP O
, , O O
left VBD B-VP O
knee NN B-NP O
4 CD O O
Old NNP B-NP O
CVA NNP I-NP O
SECONDARY NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSES: NNP I-NP O
1 CD O O
Coronary NNP B-NP O
artery NN I-NP O
disease NN I-NP O
2 CD O O
Diabetes VBZ O O
3 CD O O
Hypertension NNP B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Mr NNP I-NP O
Barriger NNP I-NP O
is VBZ O O
a DT B-NP O
73-year-old JJ I-NP O
gentleman NN I-NP O
who WP O O
is VBZ O O
a DT B-NP O
restrained JJ I-NP O
driver NN I-NP O
in IN B-VP O
a DT B-NP O
single JJ I-NP O
car NN I-NP O
motor NN I-NP O
vehicle NN I-NP O
collision NN I-NP O
, , O O
in IN B-VP O
which WDT O O
the DT B-NP O
car NN I-NP O
went VBD B-VP O
off IN B-VP O
the DT B-NP O
road NN I-NP O
at IN B-VP O
a DT B-NP O
moderate JJ I-NP O
rate NN I-NP O
of IN B-VP O
speed NN B-NP O
( ( O O
approximately RB O O
45 CD O O
miles NNS B-NP O
an DT B-NP O
hour NN I-NP O
) ) O O
, , O O
and CC O O
struck VBD B-VP O
a DT B-NP O
telephone NN I-NP O
pole NN I-NP O
There EX O O
are VBP O O
no DT B-NP O
skin JJ I-NP O
marks NNS I-NP O
noted VBD B-VP O
at IN B-VP O
the DT B-NP O
scene NN I-NP O
There EX O O
was VBD B-VP O
airbag JJ B-NP O
deployment NN I-NP O
, , O O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
wearing VBG O O
a DT B-NP O
seatbelt NN I-NP O
The DT B-NP O
patient NN I-NP O
reports NNS I-NP O
feeling VBG O O
"fine" JJ O O
prior RB O O
to TO O O
the DT B-NP O
motor NN I-NP O
vehicle NN I-NP O
collision NN I-NP O
However RB O O
, , O O
he PRP O O
has VBZ O O
no DT B-NP O
recollection NN I-NP O
of IN B-VP O
the DT B-NP O
motor NN I-NP O
vehicle NN I-NP O
collision NN I-NP O
itself PRP O O
, , O O
and CC O O
the DT B-NP O
next JJ I-NP O
thing NN I-NP O
he PRP O O
remembers VBZ O O
is VBZ O O
waking VBG O O
up RP O O
and CC O O
finding VBG O O
the DT B-NP O
airbag NN I-NP O
is VBZ O O
deployed VBN O O
, , O O
and CC O O
being VBG O O
in IN B-VP O
severe JJ B-NP O
pain NN I-NP O
He PRP O O
does VBZ O O
remember VB O O
EMS NNP B-NP O
arriving VBG O O
Upon NNP B-NP O
arrival NN I-NP O
of IN B-VP O
the DT B-NP O
EMS NNP I-NP O
, , O O
he PRP O O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
a DT B-NP O
heart NN I-NP O
rate NN I-NP O
of IN B-VP O
30 CD O O
in IN B-VP O
a DT B-NP O
third-degree JJ I-NP O
AV NNP I-NP O
block NN I-NP O
The DT B-NP O
patient NN I-NP O
denies VBZ O O
any DT B-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
nausea NN B-NP O
or CC O O
vomiting NN B-NP O
before IN B-VP O
the DT B-NP O
motor NN I-NP O
vehicle NN I-NP O
collision NN I-NP O
He PRP O O
also RB O O
denies VBZ O O
any DT B-NP O
fevers NNS I-NP O
, , O O
chills NNS B-NP O
, , O O
night NN B-NP O
sweats NNS I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
headaches NNS B-NP O
or CC O O
visual JJ B-NP O
changes NNS I-NP O
either CC O O
before IN B-VP O
or CC O O
after IN B-VP O
He PRP O O
had VBD B-VP O
no DT B-NP O
recent JJ I-NP O
changes NNS I-NP O
in IN B-VP O
any DT B-NP O
doses NNS I-NP O
of IN B-VP O
his PRP$ O O
medications NNS B-NP O
He PRP O O
was VBD B-VP O
also RB O O
complaining VBG O O
of IN B-VP O
knee NN B-NP O
pain NN I-NP O
ED NNP I-NP O
COURSE: NNP I-NP O
In IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
, , O O
he PRP O O
was VBD B-VP O
seen VBN O O
by IN B-VP O
the DT B-NP O
Trauma NNP I-NP O
Team NNP I-NP O
A NNP I-NP O
full JJ B-NP O
dictation NN I-NP O
of IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
courses VBZ O O
has VBZ O O
been VBN O O
completed VBN O O
Please NNP B-NP O
see VB O O
the DT B-NP O
computer NN I-NP O
for IN B-VP O
further JJ B-NP O
details NNS I-NP O
of IN B-VP O
this DT B-NP O
dictation NN I-NP O
However RB O O
, , O O
in IN B-VP O
brief NN B-NP O
, , O O
he PRP O O
had VBD B-VP O
numerous JJ B-NP O
CAT NNP I-NP O
scans NNS I-NP O
performed VBN O O
while IN B-VP O
in IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
These DT O O
included VBD B-VP O
a DT B-NP O
CAT NNP I-NP O
scan NN I-NP O
of IN B-VP O
the DT B-NP O
abdomen NNS I-NP O
and CC O O
pelvis NN B-NP O
, , O O
head NN B-NP O
, , O O
and CC O O
chest JJS O O
There EX O O
was VBD B-VP O
also RB O O
a DT B-NP O
CT NNP I-NP O
of IN B-VP O
the DT B-NP O
cervicothoracic NN I-NP O
and CC O O
lumbar NN B-NP O
spine NN I-NP O
, , O O
with IN B-VP O
reconstructions NNS B-NP O
performed VBN O O
As RB O O
well RB O O
as IN B-VP O
plain JJ B-NP O
x-rays JJ I-NP O
films NNS I-NP O
of IN B-VP O
the DT B-NP O
lower JJR I-NP O
extremity NN I-NP O
as RB O O
well RB O O
a DT B-NP O
pelvis NN I-NP O
, , O O
C-spine NNP B-NP O
, , O O
and CC O O
chest JJS O O
Of IN B-VP O
significance NN B-NP O
, , O O
the DT B-NP O
plain NN I-NP O
films NNS I-NP O
of IN B-VP O
the DT B-NP O
knee NN I-NP O
were VBD B-VP O
negative JJ O O
The DT B-NP O
CAT NNP I-NP O
scan NN I-NP O
of IN B-VP O
the DT B-NP O
chest NN I-NP O
demonstrated VBD B-VP O
a DT B-NP O
right JJ I-NP O
frontal NN I-NP O
periventricular JJ B-NP O
hypodensity NN I-NP O
, , O O
which WDT O O
was VBD B-VP O
thought VBN O O
to TO O O
represent VB O O
a DT B-NP O
subacute NN I-NP O
infarct NN I-NP O
He PRP O O
was VBD B-VP O
subsequently RB O O
admitted VBN O O
to TO O O
the DT B-NP O
Cardiac NNP I-NP O
Step-Down NNP I-NP O
Floor NNP I-NP O
He PRP O O
was VBD B-VP O
seen VBN O O
by IN B-VP O
the DT B-NP O
Neurology NNP I-NP O
Service NNP I-NP O
( ( O O
Dr NNP B-NP O
Orban NNP I-NP O
, , O O
who WP O O
is VBZ O O
the DT B-NP O
Neurology NNP I-NP O
resident NN I-NP O
) ) O O
, , O O
who WP O O
initially RB O O
saw VBD B-VP O
him PRP O O
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Significant NNP B-NP O
for IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
, , O O
eight CD O O
years NNS B-NP O
ago RB O O
He PRP O O
received VBD B-VP O
cardiac JJ B-NP O
stents NNS I-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
2 CD O O
Hypertension NNP B-NP O
3 CD O O
Hypercholesterolemia NNP B-NP O
4 CD O O
Diabetes VBZ O O
5 CD O O
Renal NNP B-NP O
cyst NN I-NP O
6 CD O O
Cataract NNP B-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Significant NNP B-NP O
for IN B-VP O
coronary JJ B-NP O
stenting; NN I-NP O
two CD O O
were VBD B-VP O
placed VBN O O
eight CD O O
years NNS B-NP O
ago RB O O
during IN B-VP O
his PRP$ O O
MI NNP B-NP O
, , O O
and CC O O
he PRP O O
had VBD B-VP O
an DT O O
additional JJ O O
two CD O O
stents NNS B-NP O
placed VBN O O
in IN B-VP O
July NNP B-NP O
of IN B-VP O
2004 CD O O
2 CD O O
Cataract NNP B-NP O
removal JJ B-NP O
MEDICATIONS NNP I-NP O
AT NNP I-NP O
HOME: NNP I-NP O
1 CD O O
Glyburide NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
2 CD O O
Metformin NNP B-NP B-m
500 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
3 CD O O
Aspirin NNP B-NP B-m
81 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
4 CD O O
Zocor NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
5 CD O O
Plavix NNP B-NP B-m
75 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
6 CD O O
Prilosec NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
7 CD O O
Isosorbide NNP B-NP B-m
dinitrate NN I-NP I-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d VBD B-VP B-f
8 CD O O
Atenolol NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
ALLERGIES: NNP I-NP O
He PRP O O
has VBZ O O
no DT O O
known VBN O O
allergies NNS B-NP O
PHYSICAL NNP I-NP O
EXAMINATION NNP I-NP O
UPON NNP I-NP O
ADMISSION: NNP I-NP O
Blood NNP I-NP O
pressure NN I-NP O
of IN B-VP O
123/51 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
of IN B-VP O
48 CD O O
, , O O
respiratory JJ B-NP O
rate NN I-NP O
of IN B-VP O
16 CD O O
General NNP B-NP O
appearance: NN I-NP O
He PRP O O
is VBZ O O
a DT O O
well-developed JJ O O
, , O O
well-nourished JJ O O
, , O O
and CC O O
well-hydrated JJ B-NP O
male NN I-NP O
, , O O
in IN B-VP O
mildly RB O O
acute JJ B-NP O
distress NN I-NP O
HEENT: NNP I-NP O
Normocephalic NNP I-NP O
and CC O O
atraumatic JJ B-NP O
Extraocular NNP I-NP O
motions NNS I-NP O
are VBP O O
intact JJ B-NP O
Pupils NNP I-NP O
are VBP O O
equal JJ O O
, , O O
round NN B-NP O
, , O O
and CC O O
reactive JJ O O
to TO O O
light JJ O O
and CC O O
accommodation NN B-NP O
at IN B-VP O
4 CD O O
mm NN B-NP O
The DT B-NP O
conjunctivae NN I-NP O
are VBP O O
pink VBN O O
and CC O O
the DT B-NP O
sclera NN I-NP O
is VBZ O O
anicteric JJ O O
The DT B-NP O
oropharynx NN I-NP O
is VBZ O O
significant JJ O O
for IN B-VP O
a DT B-NP O
slight JJ I-NP O
bite NN I-NP O
mark NN I-NP O
on IN B-VP O
the DT B-NP O
tongue NN I-NP O
, , O O
without IN B-VP O
any DT B-NP O
active JJ I-NP O
bleeding NN I-NP O
There EX O O
are VBP O O
moist JJ B-NP O
mucosal NN I-NP O
membranes VBZ O O
The DT B-NP O
neck NN I-NP O
is VBZ O O
supple JJ O O
, , O O
and CC O O
there EX O O
is VBZ O O
no DT B-NP O
midline NN I-NP O
tenderness NN I-NP O
There EX O O
is VBZ O O
no DT B-NP O
JVD NNP I-NP O
The DT B-NP O
chest NN I-NP O
is VBZ O O
clear JJ O O
to TO O O
auscultation VB O O
There EX O O
is VBZ O O
tenderness NN B-NP O
over IN B-VP O
the DT B-NP O
right JJ I-NP O
ribs NN I-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
mild JJ B-NP O
sternal JJ I-NP O
tenderness NN I-NP O
The DT B-NP O
heart NN I-NP O
is VBZ O O
regular JJ B-NP O
rhythm NN I-NP O
, , O O
although IN B-VP O
markedly RB O O
bradycardiac VBZ O O
The DT B-NP O
abdomen NNS I-NP O
is VBZ O O
soft JJ O O
, , O O
nontender NN B-NP O
, , O O
and CC O O
nondistended VBD B-VP O
There EX O O
are VBP O O
good JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
in IN B-VP O
all DT O O
four CD O O
quadrants NNS B-NP O
There EX O O
is VBZ O O
no DT B-NP O
CVA NNP I-NP O
tenderness VBD B-VP O
The DT B-NP O
pelvis NN I-NP O
is VBZ O O
stable JJ O O
to TO O O
rock VB O O
Extremities: NNP B-NP O
There EX O O
is VBZ O O
tenderness NN B-NP O
in IN B-VP O
the DT B-NP O
abrasions NNS I-NP O
over IN B-VP O
the DT B-NP O
left JJ I-NP O
knee NN I-NP O
The DT B-NP O
left NN I-NP O
knee NN I-NP O
is VBZ O O
in IN B-VP O
an DT B-NP O
immobilizer NN I-NP O
, , O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
to TO O O
the DT B-NP O
floor NN I-NP O
He PRP O O
has VBZ O O
full JJ B-NP O
range NN I-NP O
of IN B-VP O
motion NN B-NP O
in IN B-VP O
ankles NNS B-NP O
, , O O
shoulders NNS B-NP O
, , O O
and CC O O
elbows VBZ O O
bilaterally RB O O
There EX O O
is VBZ O O
decreased JJ B-NP O
range NN I-NP O
of IN B-VP O
motion NN B-NP O
in IN B-VP O
the DT B-NP O
left JJ I-NP O
knee NN I-NP O
There EX O O
is VBZ O O
no DT B-NP O
bony NN I-NP O
tenderness RB O O
along IN B-VP O
any DT O O
of IN B-VP O
the DT B-NP O
long JJ I-NP O
bones NNS I-NP O
of IN B-VP O
the DT O O
upper JJ O O
or CC O O
lower JJR B-NP O
extremities NNS I-NP O
, , O O
with IN B-VP O
exception NN B-NP O
of IN B-VP O
the DT B-NP O
knee JJ I-NP O
Peripheral NNP I-NP O
vascular NN I-NP O
, , O O
dorsalis NN B-NP O
pedis NN I-NP O
, , O O
posterior RB O O
, , O O
tibial JJ O O
, , O O
and CC O O
radial JJ B-NP O
pulses NNS I-NP O
are VBP O O
all DT O O
equal JJ O O
bilaterally RB O O
Neuro NNP B-NP O
exam: NN I-NP O
He PRP O O
is VBZ O O
awake JJ O O
, , O O
alert JJ O O
, , O O
and CC O O
oriented VBD B-VP O
x3 NNP B-NP O
Cranial NNP I-NP O
nerves NNS I-NP O
II-XII NNP I-NP O
are VBP O O
intact JJ B-NP O
Motor NNP I-NP O
is VBZ O O
5/5 CD O O
in IN B-VP O
the DT O O
upper JJ O O
and CC O O
lower JJR B-NP O
extremities NNS I-NP O
bilaterally RB O O
Sensation NNP B-NP O
is VBZ O O
equal JJ O O
bilaterally RB O O
, , O O
in IN B-VP O
the DT B-NP O
upper JJ I-NP O
extremities NNS I-NP O
, , O O
lower JJR B-NP O
extremities NNS I-NP O
, , O O
and CC O O
face NN B-NP O
There EX O O
is VBZ O O
no DT B-NP O
dysmetria NN I-NP O
or CC O O
dysarthria VB O O
Finger-to-nose NNP B-NP O
is VBZ O O
fast JJ O O
and CC O O
accurate JJ O O
bilaterally RB O O
There EX O O
is VBZ O O
no DT B-NP O
drift NN I-NP O
Skin NNP I-NP O
is VBZ O O
warm JJ O O
, , O O
dry JJ O O
, , O O
and CC O O
well-perfused JJ B-NP O
LABORATORY NNP I-NP O
DATA NNP I-NP O
UPON NNP I-NP O
ADMISSION: NNP I-NP O
CT NNP I-NP O
C-spine NNP I-NP O
negative JJ B-NP O
CT NNP I-NP O
head NN I-NP O
shows VBZ O O
a DT B-NP O
right JJ I-NP O
frontal NN I-NP O
subacute NN I-NP O
infarct NN I-NP O
CT NNP I-NP O
chest NN I-NP O
shows VBZ O O
anterior JJ B-NP O
fifth JJ I-NP O
rib NN I-NP O
fractures NNS I-NP O
bilaterally RB O O
There EX O O
was VBD B-VP O
also RB O O
some DT B-NP O
supraclavicular JJ I-NP O
stranding NN I-NP O
along IN B-VP O
the DT B-NP O
left JJ I-NP O
side NN I-NP O
, , O O
without IN B-VP O
any DT B-NP O
evidence NN I-NP O
of IN B-VP O
vessel JJ B-NP O
injury NN I-NP O
CT NNP I-NP O
of IN B-VP O
the DT B-NP O
abdomen NNS I-NP O
and CC O O
pelvis NN B-NP O
is VBZ O O
negative JJ O O
, , O O
except IN B-VP O
for IN B-VP O
a DT B-NP O
ruptured JJ I-NP O
renal JJ I-NP O
cyst NN I-NP O
He PRP O O
was VBD B-VP O
also RB O O
incidentally RB O O
noted VBN O O
to TO O O
show VB O O
diverticulosis NN B-NP O
, , O O
without IN B-VP O
any DT B-NP O
diverticulitis NN I-NP O
The DT B-NP O
CT NNP I-NP O
of IN B-VP O
the DT B-NP O
thoracic NN I-NP O
and CC O O
lumbar NN B-NP O
spines NNS I-NP O
also RB O O
demonstrated VBD B-VP O
no DT B-NP O
fractures NNS I-NP O
, , O O
although IN B-VP O
there EX O O
were VBD B-VP O
incidentally RB O O
noted VBN O O
to TO O O
be VB O O
anterior JJ B-NP O
osteophytes NNS I-NP O
in IN B-VP O
numerous JJ B-NP O
levels NNS I-NP O
CT NNP I-NP O
of IN B-VP O
the DT B-NP O
chest NN I-NP O
demonstrated VBD B-VP O
the DT B-NP O
rib NN I-NP O
fractures NNS I-NP O
, , O O
but CC O O
was VBD B-VP O
otherwise RB O O
negative JJ B-NP O
Laboratory NNP I-NP O
, , O O
sodium NN B-NP O
138 CD O O
, , O O
potassium NN B-NP O
4.4 CD O O
, , O O
chloride RB O O
103 CD O O
, , O O
bicarbonate NN B-NP O
25 CD O O
, , O O
BUN NNP B-NP O
28 CD O O
, , O O
creatinine NN B-NP O
1.3 CD O O
, , O O
glucose RB O O
185 CD O O
, , O O
and CC O O
anion NN B-NP O
gap NN I-NP O
is VBZ O O
10 CD O O
, , O O
AST NNP B-NP O
and CC O O
ALT NNP B-NP O
are VBP O O
20 CD O O
and CC O O
25 CD O O
respectively RB O O
Alkaline JJ B-NP O
phosphatase NN I-NP O
is VBZ O O
80 CD O O
Lipase NNP B-NP O
is VBZ O O
51 CD O O
Calcium NN B-NP O
is VBZ O O
8.8 CD O O
, , O O
the DT B-NP O
albumin NN I-NP O
is VBZ O O
4.6 CD O O
, , O O
the DT B-NP O
CK NNP I-NP O
is VBZ O O
89 CD O O
, , O O
CKMB NNP B-NP O
is VBZ O O
3.6 CD O O
, , O O
and CC O O
troponin NN B-NP O
was VBD B-VP O
less JJR O O
than IN B-VP O
assay VB O O
His PRP$ O O
serum NN B-NP O
toxicology NN I-NP O
screen NN I-NP O
was VBD B-VP O
negative JJ O O
for IN B-VP O
aspirin NN B-NP O
, , O O
Tylenol NNP B-NP O
, , O O
benzodiazepine NN B-NP O
, , O O
barbiturates NNS B-NP O
, , O O
and CC O O
tricyclics NNS B-NP O
Urine NNP I-NP O
drug NN I-NP O
screen NN I-NP O
is VBZ O O
also RB O O
negative JJ B-NP O
PT NNP I-NP O
, , O O
PTT NNP B-NP O
, , O O
and CC O O
INR NNP B-NP O
were VBD B-VP O
13 CD O O
, , O O
25.8 CD O O
, , O O
and CC O O
0.9 CD O O
respectively RB O O
CBC NNP B-NP O
was VBD B-VP O
significant JJ O O
for IN B-VP O
white JJ B-NP O
count NN I-NP O
of IN B-VP O
12.0 CD O O
, , O O
hemoglobin NN B-NP O
and CC O O
hematocrit NN B-NP O
were VBD B-VP O
14.6 CD O O
and CC O O
42.2 CD O O
, , O O
and CC O O
platelets NNS B-NP O
are VBP O O
250 CD O O
Urinalysis NNP B-NP O
was VBD B-VP O
negative JJ B-NP O
Review NNP I-NP O
of IN B-VP O
the DT B-NP O
prehospital JJ I-NP O
EKG NNP I-NP O
demonstrated VBD B-VP O
a DT O O
complete JJ O O
( ( O O
third-degree JJ O O
) ) O O
heart NN B-NP O
block NN I-NP O
However RB O O
, , O O
EKG NNP B-NP O
done VBN O O
immediately RB O O
upon JJ B-NP O
admission NN I-NP O
to TO O O
the DT B-NP O
Trauma NNP I-NP O
Bay NNP I-NP O
demonstrated VBD B-VP O
a DT B-NP O
bifascicular JJ I-NP O
block NN I-NP O
, , O O
with IN B-VP O
a DT B-NP O
rate NN I-NP O
in IN B-VP O
the DT O O
40s CD O O
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
BY NNP I-NP O
SYSTEMS: NNP I-NP O
1 CD O O
Cardiovascular: NNP B-NP O
He PRP O O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Cardiac NNP I-NP O
Step-Down NNP I-NP O
Unit NNP I-NP O
He PRP O O
had VBD B-VP O
Zoll NNP B-NP O
pacer NN I-NP O
pads NNS I-NP O
were VBD B-VP O
placed VBN O O
upon IN B-VP O
his PRP$ O O
chest NN B-NP O
, , O O
and CC O O
atropine NN B-NP O
remained VBN O O
at IN B-VP O
his PRP$ O O
bedside NN B-NP O
He PRP O O
also RB O O
had VBD B-VP O
an DT B-NP O
additional JJ I-NP O
Zoll NNP I-NP O
pacer NN I-NP O
pads NNS I-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
the DT B-NP O
pacemaker NN I-NP O
standby NN I-NP O
at IN B-VP O
the DT B-NP O
bedside NN I-NP O
, , O O
however RB O O
, , O O
these DT O O
were VBD B-VP O
not RB O O
needed VBN O O
, , O O
as IN B-VP O
he PRP O O
has VBZ O O
completed VBN O O
asymptomatic JJ O O
with IN B-VP O
his PRP$ O O
bifascicular JJ B-NP O
block NN I-NP O
He PRP O O
had VBD B-VP O
serial JJ B-NP O
enzymes NNS I-NP O
, , O O
which WDT O O
were VBD B-VP O
performed VBN O O
, , O O
he PRP O O
was VBD B-VP O
ruled VBN O O
out RP O O
for IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
He PRP O O
went VBD B-VP O
to TO O O
the DT B-NP O
Cardiac NNP I-NP O
Cath NNP I-NP O
Lab NNP I-NP O
, , O O
which WDT O O
demonstrated VBD B-VP O
some DT B-NP O
coronary JJ I-NP O
artery NN I-NP O
disease NN I-NP O
Please NNP I-NP O
see VB O O
the DT B-NP O
dictated JJ I-NP O
cardiology NN I-NP O
reports NNS I-NP O
for IN B-VP O
the DT B-NP O
findings NNS I-NP O
of IN B-VP O
the DT B-NP O
Cath NNP I-NP O
Lab NNP I-NP O
It PRP O O
was VBD B-VP O
felt VBN O O
, , O O
however RB O O
, , O O
this DT O O
was VBD B-VP O
unchanged JJ O O
from IN B-VP O
prior JJ B-NP O
studies NNS I-NP O
He PRP O O
also RB O O
went VBD B-VP O
to TO O O
the DT B-NP O
Electrophysiology NNP I-NP O
Lab NNP I-NP O
They PRP O O
were VBD B-VP O
unable JJ O O
to TO O O
induce VB O O
any DT B-NP O
ventricular JJ I-NP O
tachycardia NN I-NP O
or CC O O
other JJ B-NP O
dysrhythmias NN I-NP O
during IN B-VP O
the DT B-NP O
prolonged JJ I-NP O
EP NNP I-NP O
studies NNS I-NP O
He PRP O O
had VBD B-VP O
a DT B-NP O
pacemaker NN I-NP O
inserted VBD B-VP O
The DT B-NP O
pacemaker NN I-NP O
was VBD B-VP O
followed VBN O O
by IN B-VP O
the DT B-NP O
Electrophysiology NNP I-NP O
Service NNP I-NP O
, , O O
and CC O O
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
working VBG O O
adequately RB O O
The DT B-NP O
attending NN I-NP O
was VBD B-VP O
Dr NNP B-NP O
Matt NNP I-NP O
Duropan NNP I-NP O
, , O O
with IN B-VP O
the DT B-NP O
Electrophysiology NNP I-NP O
Service NNP I-NP O
Dr NNP I-NP O
Caires VBZ O O
with IN B-VP O
the DT B-NP O
Cardiology NNP I-NP O
Service NNP I-NP O
saw VBD B-VP O
him PRP O O
and CC O O
was VBD B-VP O
attending VBG O O
on IN B-VP O
record NN B-NP O
2 CD O O
Neurology: NNP B-NP O
He PRP O O
was VBD B-VP O
seen VBN O O
by IN B-VP O
the DT B-NP O
Neurology NNP I-NP O
Service NNP I-NP O
So NNP I-NP O
, , O O
this DT O O
was VBD B-VP O
under IN B-VP O
Dr NNP B-NP O
Edgardo NNP I-NP O
Mccorison NNP I-NP O
, , O O
the DT O O
attending VBG O O
neurologist NN B-NP O
on IN B-VP O
the DT B-NP O
case NN I-NP O
He PRP O O
had VBD B-VP O
an DT B-NP O
MRI/MRA NNP I-NP O
performed NN I-NP O
of IN B-VP O
his PRP$ O O
head NN B-NP O
and CC O O
neck VB O O
The DT B-NP O
diffusion-weighted JJ I-NP O
images NNS I-NP O
demonstrated VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
any DT B-NP O
abnormality NN I-NP O
There EX O O
was VBD B-VP O
a DT B-NP O
region NN I-NP O
of IN B-VP O
increase NN B-NP O
signal JJ B-NP O
intensity NN I-NP O
on IN B-VP O
the DT B-NP O
T2 NNP I-NP O
and CC O O
FLAIR NNP B-NP O
images NNS I-NP O
, , O O
involving VBG O O
the DT B-NP O
vasoganglion NN I-NP O
, , O O
extending VBG O O
the DT B-NP O
corona NN I-NP O
radiata NN I-NP O
Therefore NNP I-NP O
, , O O
given VBN O O
the DT B-NP O
fact NN I-NP O
that IN B-VP O
signal NN B-NP O
was VBD B-VP O
seen VBN O O
on IN B-VP O
the DT B-NP O
T2 NNP I-NP O
and CC O O
FLAIR NNP B-NP O
, , O O
not RB O O
on IN B-VP O
the DT O O
diffusion-weighted JJ O O
, , O O
it PRP O O
was VBD B-VP O
felt VBN O O
that IN B-VP O
this DT O O
was VBD B-VP O
at IN B-VP O
least JJS O O
10 CD O O
days NNS B-NP O
old JJ O O
Therefore RB O O
, , O O
this DT O O
was VBD B-VP O
not RB O O
felt VBN O O
to TO O O
be VB O O
either RB O O
the DT B-NP O
cause NN I-NP O
nor CC O O
an DT B-NP O
affect NN I-NP O
of IN B-VP O
the DT B-NP O
motor NN I-NP O
vehicle NN I-NP O
collision NN I-NP O
It PRP O O
was VBD B-VP O
most RBS O O
likely JJ O O
represented VBD B-VP O
an DT B-NP O
old JJ I-NP O
CVA NNP I-NP O
, , O O
which WDT O O
was VBD B-VP O
not RB O O
previously RB O O
detected VBN O O
Given NNP B-NP O
the DT B-NP O
fact NN I-NP O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
remained VBD B-VP O
asymptomatic JJ O O
, , O O
and CC O O
had VBD B-VP O
a DT B-NP O
normal JJ I-NP O
neurological JJ I-NP O
exam NN I-NP O
, , O O
and CC O O
radiographic JJ B-NP O
data NNS I-NP O
demonstrated VBD B-VP O
that IN B-VP O
this DT B-NP O
infarct NN I-NP O
was VBD B-VP O
more JJR O O
than IN B-VP O
10 CD O O
days NNS B-NP O
old JJ O O
, , O O
and CC O O
this DT O O
was VBD B-VP O
not RB O O
further RB O O
addressed VBD B-VP O
An DT B-NP O
MRA NNP I-NP O
of IN B-VP O
his PRP$ O O
head NN B-NP O
and CC O O
neck NN B-NP O
demonstrated VBD B-VP O
tortuous JJ B-NP O
vertebrobasilar NN I-NP O
system NN I-NP O
The DT B-NP O
MRI/MRA NNP I-NP O
of IN B-VP O
the DT B-NP O
neck NN I-NP O
was VBD B-VP O
essentially RB O O
normal JJ O O
, , O O
however RB O O
, , O O
the DT B-NP O
left JJ I-NP O
bifurcation NN I-NP O
was VBD B-VP O
thought VBN O O
to TO O O
be VB O O
without IN B-VP O
any DT B-NP O
significant JJ I-NP O
stenosis NN I-NP O
The DT B-NP O
right JJ I-NP O
bifurcation NN I-NP O
is VBZ O O
probably RB O O
without IN B-VP O
significant JJ B-NP O
stenosis NN I-NP O
, , O O
however RB O O
, , O O
could MD O O
not RB O O
be VB O O
completed VBN O O
excluded JJ B-NP O
Given NNP I-NP O
artifact NN I-NP O
, , O O
this DT O O
could MD O O
be VB O O
further RB O O
followed VBN O O
up RP O O
with IN B-VP O
an DT B-NP O
outpatient NN I-NP O
venous JJ B-NP O
duplex NN I-NP O
of IN B-VP O
the DT B-NP O
carotid NN I-NP O
arteries VBZ O O
3 CD O O
Musculoskeletal: NNP B-NP O
He PRP O O
was VBD B-VP O
seen VBN O O
by IN B-VP O
the DT B-NP O
Orthopedic NNP I-NP O
Service NNP I-NP O
in IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
the DT B-NP O
trauma NN I-NP O
, , O O
he PRP O O
ultimately RB O O
had VBD B-VP O
an DT B-NP O
MRI NNP I-NP O
that WDT O O
was VBD B-VP O
performed VBN O O
of IN B-VP O
his PRP$ O O
knee NN B-NP O
This DT O O
showed VBD B-VP O
tears NNS B-NP O
of IN B-VP O
the DT O O
medial JJ O O
and CC O O
lateral JJ B-NP O
menisci NN I-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
fracture NN B-NP O
He PRP O O
remained VBD B-VP O
in IN B-VP O
a DT B-NP O
knee NN I-NP O
immobilizer NN I-NP O
He PRP O O
saw VBD B-VP O
Physical NNP B-NP O
Therapy NNP I-NP O
, , O O
which WDT O O
felt VBD B-VP O
that IN B-VP O
further JJ B-NP O
therapy NN I-NP O
would MD O O
be VB O O
indicated VBN O O
With IN B-VP O
the DT B-NP O
impression NN I-NP O
of IN B-VP O
the DT B-NP O
Orthopedic NNP I-NP O
Service NNP I-NP O
that IN B-VP O
no DT B-NP O
acute JJ I-NP O
intervention NN I-NP O
was VBD B-VP O
needed VBN O O
, , O O
and CC O O
that IN B-VP O
he PRP O O
should MD O O
follow-up VB O O
with IN B-VP O
Sports NNP B-NP O
Medicine NNP I-NP O
or CC O O
Orthopedics NNPS B-NP O
in IN B-VP O
approximately RB O O
3-4 JJ B-NP O
weeks NNS I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
he PRP O O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
several JJ B-NP O
rib NN I-NP O
fractures VBZ O O
The DT B-NP O
rib NN I-NP O
fractures NNS I-NP O
were VBD B-VP O
felt VBN O O
to TO O O
be VB O O
the DT B-NP O
source NN I-NP O
of IN B-VP O
his PRP$ O O
pain NN B-NP O
, , O O
he PRP O O
continue VBP O O
to TO O O
complain VB O O
of IN B-VP O
some DT B-NP O
inspiratory NN I-NP O
pain NN I-NP O
throughout IN B-VP O
his PRP$ O O
chest NN B-NP O
However RB O O
, , O O
he PRP O O
adamantly RB O O
denied VBD B-VP O
any DT B-NP O
pain NN I-NP O
throughout IN B-VP O
his PRP$ O O
chest JJS B-NP O
wall NN I-NP O
upon IN B-VP O
inspiring VBG O O
It PRP O O
was VBD B-VP O
therefore RB O O
felt VBD B-VP O
that IN B-VP O
given VBN O O
the DT B-NP O
negative JJ I-NP O
enzymes NNS I-NP O
and CC O O
the DT B-NP O
negative JJ I-NP O
Cath NNP I-NP O
, , O O
and CC O O
the DT O O
known VBN O O
rib NN B-NP O
fractures NNS I-NP O
that IN B-VP O
the DT B-NP O
chest JJS I-NP O
pain NN I-NP O
was VBD B-VP O
strictly RB O O
a DT B-NP O
result NN I-NP O
of IN B-VP O
a DT B-NP O
musculoskeletal JJ I-NP O
pain NN I-NP O
This DT B-NP O
pain NN I-NP B-r
pain NN I-NP B-r
was VBD B-VP O
well RB O O
controlled VBN O O
with IN B-VP O
the DT B-NP O
combination NN I-NP O
of IN B-VP O
Dilaudid NNP B-NP B-m
and CC O O
oxycodone NN B-NP B-m
He PRP O O
was VBD B-VP O
encouraged VBN O O
to TO O O
take VB O O
several JJ B-NP O
deep JJ I-NP O
breaths NNS I-NP O
per IN B-VP O
hour NN B-NP O
to TO O O
reduce VB O O
the DT B-NP O
risk NN I-NP O
of IN B-VP O
atelectasis NN B-NP O
or CC O O
pneumonia NN B-NP O
4 CD O O
Infectious JJ B-NP O
Disease: NNP I-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
any DT B-NP O
acute JJ I-NP O
infection NN I-NP O
Of IN B-VP O
note NN B-NP O
, , O O
his PRP$ O O
white JJ B-NP O
count NN I-NP O
was VBD B-VP O
trending VBG O O
upwards NNS B-NP O
, , O O
on IN B-VP O
the DT O O
last JJ O O
two CD O O
days NNS B-NP O
of IN B-VP O
admission NN B-NP O
It PRP O O
was VBD B-VP O
felt VBN O O
that IN B-VP O
this DT O O
probably RB O O
represented VBN O O
stress NN B-NP O
, , O O
given VBN O O
all PDT O O
the DT B-NP O
recent JJ I-NP O
procedures NNS I-NP O
that WDT O O
were VBD B-VP O
done VBN O O
, , O O
including VBG O O
the DT B-NP O
catheterization NN I-NP O
and CC O O
the DT B-NP O
electrophysiology NN I-NP O
studies NNS I-NP O
, , O O
rather RB O O
than IN B-VP O
A2 NNP B-NP O
infection NN I-NP O
The DT B-NP O
chest JJS I-NP O
x-ray NN I-NP O
was VBD B-VP O
performed VBN O O
on IN B-VP O
the DT O O
25th CD O O
, , O O
which WDT O O
demonstrated VBD B-VP O
no DT B-NP O
infiltrate NN I-NP O
This DT O O
was VBD B-VP O
reviewed VBN O O
with IN B-VP O
an DT O O
attending VBG O O
radiologist NN B-NP O
who WP O O
reported VBD B-VP O
low JJ B-NP O
lung NN I-NP O
volumes NNS I-NP O
Otherwise RB O O
, , O O
it PRP O O
was VBD B-VP O
essentially RB O O
negative JJ O O
In IN B-VP O
addition NN B-NP O
, , O O
a DT B-NP O
repeat NN I-NP O
urinalysis NN I-NP O
was VBD B-VP O
performed VBN O O
The DT B-NP O
results NNS I-NP O
are VBP O O
pending VBG O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
dictation NN B-NP O
, , O O
however RB O O
, , O O
will MD O O
be VB O O
followed VBN O O
up RP O O
prior RB O O
to TO O O
the DT B-NP O
patient's NN I-NP O
discharge NN I-NP O
from IN B-VP O
the DT B-NP O
hospital NN I-NP O
The DT B-NP O
patient NN I-NP O
appears VBZ O O
well RB O O
, , O O
and CC O O
states NNS B-NP O
that IN B-VP O
he PRP O O
is VBZ O O
feeling VBG O O
at IN B-VP O
his PRP$ O O
best JJS O O
since IN B-VP O
the DT B-NP O
accident NN I-NP O
However RB O O
, , O O
further JJ B-NP O
workup NN I-NP O
for IN B-VP O
his PRP$ O O
white JJ B-NP O
count NN I-NP O
is VBZ O O
not RB O O
performed VBN O O
at IN B-VP O
the DT B-NP O
present JJ I-NP O
time NN I-NP O
, , O O
however RB O O
, , O O
the DT B-NP O
patient NN I-NP O
is VBZ O O
informed VBN O O
, , O O
as IN B-VP O
the DT B-NP O
No NNP I-NP O
Hospital NNP I-NP O
and CC O O
the DT B-NP O
discharge NN I-NP O
summary NN I-NP O
, , O O
which WDT O O
show VBP O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
seem VBP O O
to TO O O
develop VB O O
any DT B-NP O
evidence NN I-NP O
of IN B-VP O
infection NN B-NP O
that IN B-VP O
he PRP O O
should MD O O
be VB O O
reevaluated VBN O O
by IN B-VP O
a DT O O
physician JJ O O
5 CD O O
Nutrition: NNP B-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
able JJ O O
to TO O O
eat VB O O
without IN B-VP O
any DT B-NP O
difficulty NN I-NP O
He PRP O O
was VBD B-VP O
eating VBG O O
regular JJ B-NP O
house NN I-NP O
diabetic/cardiac NN I-NP O
diet JJ O O
6 CD O O
Hypercholesterolemia: NNP B-NP B-r
He PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
his PRP$ O O
Zocor NN B-NP B-m
throughout IN B-VP O
the DT B-NP O
hospitalization NN I-NP O
7 CD O O
Prophylaxis: NNP B-NP O
He PRP O O
was VBD B-VP O
initially RB O O
treated VBN O O
with IN B-VP O
Lovenox NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
sub-Q JJ B-NP B-mo
q JJ I-NP B-f
day NN I-NP I-f
for IN B-VP O
a DT B-NP O
prophylaxis NN I-NP B-r
against IN B-VP I-r
DVTs NNP B-NP I-r
He PRP O O
is VBZ O O
also RB O O
on IN B-VP O
aspirin NNS B-NP B-m
and CC O O
Plavix NNP B-NP B-m
for IN B-VP O
secondary JJ B-NP B-r
secondary JJ I-NP B-r
cardiac NN I-NP O
and CC O O
neurological JJ B-NP O
prophylaxis NN I-NP O
The DT B-NP O
Lovenox NNP I-NP B-m
is VBZ O O
discontinued VBN O O
, , O O
at IN B-VP O
the DT B-NP O
request NN I-NP O
of IN B-VP O
the DT B-NP O
Electrophysiology NNP I-NP O
Service NNP I-NP O
on IN B-VP O
the DT O O
24th CD O O
8 CD O O
Endocrine: NNP B-NP O
Given NNP I-NP O
the DT B-NP O
numerous JJ I-NP O
contrast NN I-NP O
studies NNS I-NP O
, , O O
initially RB O O
his PRP$ O O
metformin NN B-NP B-m
was VBD B-VP O
held VBN O O
However RB O O
, , O O
he PRP O O
was VBD B-VP O
later RB O O
restarted VBN O O
on IN B-VP O
this DT O O
In IN B-VP O
addition NN B-NP O
, , O O
he PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
his PRP$ O O
glyburide NN B-NP B-m
and CC O O
covered VBN O O
with IN B-VP O
sliding VBG O B-do
scale JJ B-NP I-do
insulin NN I-NP B-m
His PRP$ O O
blood NN B-NP O
sugar NN I-NP O
was VBD B-VP O
never RB O O
any DT B-NP O
significant JJ I-NP O
problem NN I-NP O
during IN B-VP O
his PRP$ O O
hospitalization NN B-NP O
9 CD O O
Disposition: NNP B-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
be VB O O
going VBG O O
to TO O O
Missp NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
, , O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
At IN B-VP O
the DT B-NP O
Rehab NNP I-NP O
, , O O
he PRP O O
will MD O O
continue VB O O
to TO O O
get VB O O
physical JJ B-NP O
therapy NN I-NP O
, , O O
which WDT O O
he PRP O O
has VBZ O O
received VBN O O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
It PRP O O
was VBD B-VP O
felt VBN O O
that IN B-VP O
a DT B-NP O
short JJ I-NP O
course NN I-NP O
of IN B-VP O
rehab NN B-NP O
would MD O O
benefit VB O O
the DT B-NP O
patient NN I-NP O
to TO O O
allow VB O O
him PRP O O
to TO O O
go VB O O
back RB O O
living VBG O O
independently RB O O
again RB O O
He PRP O O
will MD O O
be VB O O
discharged VBN O O
to TO O O
the DT B-NP O
Rehab NNP I-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
MEDICATIONS NNP I-NP O
AT NNP I-NP O
DISCHARGE: NNP I-NP O
1 CD O O
Tylenol NNP B-NP B-m
650 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.4h NN I-NP B-f
p.r.n NN I-NP I-f
pain VBP O B-r
2 CD O O
Aspirin NNP B-NP B-m
81 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
3 CD O O
Atenolol NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
4 CD O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
5 CD O O
Glyburide NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
6 CD O O
Dilaudid NNP B-NP B-m
1-2 JJ B-NP B-do
mg NN I-NP I-do
IV NNP I-NP B-mo
q.4h NN I-NP B-f
p.r.n NN I-NP I-f
pain VBP O B-r
7 CD O O
Isosorbide NNP B-NP B-m
dinitrate NN I-NP I-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d VBD B-VP B-f
8 CD O O
Ativan NNP B-NP B-m
1-2 JJ B-NP B-do
mg NN I-NP I-do
IV NNP I-NP B-mo
p.r.n NN I-NP B-f
anxiety NN I-NP B-r
9 CD O O
Oxycodone NNP B-NP B-m
5-10 JJ B-NP B-do
mg NN I-NP I-do
p.o NN I-NP B-mo
q.6h NN I-NP B-f
p.r.n NN I-NP I-f
pain VBP O B-r
10 CD O O
Senna NNP B-NP B-m
tablets NNS I-NP I-m
2 CD O B-do
p.o NN B-NP B-mo
b.i.d NN I-NP B-f
11 CD O O
Keflex NNP B-NP B-m
250 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.i.d NN I-NP B-f
x12 NN I-NP B-du
doses VBZ O I-du
Keflex NNP B-NP B-m
should MD O O
be VB O O
completed VBN O B-du
on IN B-VP I-du
Monday NNP B-NP I-du
night NN I-NP I-du
12 CD O O
Zocor NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s VBD B-VP B-f
13 CD O O
Ambien NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s VBD B-VP B-f
14 CD O O
Tessalon NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
p.r.n VBD B-VP I-f
cough JJ O B-r
15 CD O O
Plavix NNP B-NP B-m
75 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
16 CD O O
Novalog NNP B-NP B-m
slides NNS I-NP B-do
17 CD O O
Prilosec NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
18 CD O O
Maalox NNP B-NP B-m
1-2 JJ B-NP B-do
tabs NNS I-NP I-do
p.o VBP O B-mo
q.6h JJ B-NP B-f
p.r.n NN I-NP I-f
pain VBP O B-r
The DT B-NP O
patient NN I-NP O
has VBZ O O
following VBG O O
discharge NN B-NP O
appointments NNS I-NP O
He PRP O O
has VBZ O O
appointments NNS B-NP O
with IN B-VP O
Dr NNP B-NP O
Jc NNP I-NP O
Rizzo NNP I-NP O
, , O O
with IN B-VP O
Sports NNP B-NP O
Medicine NNP I-NP O
, , O O
Dr NNP B-NP O
Mac NNP I-NP O
Gladwin NNP I-NP O
in IN B-VP O
10-14 JJ B-NP O
days NNS I-NP O
, , O O
and CC O O
Dr NNP B-NP O
Aldo NNP I-NP O
Helger NNP I-NP O
in IN B-VP O
one CD O O
week NN B-NP O
Appointment NN I-NP O
with IN B-VP O
Dr NNP B-NP O
Mittman NNP I-NP O
is VBZ O O
in IN B-VP O
3 CD O O
weeks NNS B-NP O
ADDENDUM: NNP I-NP O
Mr NNP I-NP O
Flentge NNP I-NP O
had VBD B-VP O
this DT B-NP O
pacemaker NN I-NP O
placed VBD B-VP O
and CC O O
was VBD B-VP O
recovering VBG O O
uneventfully RB O O
However RB O O
, , O O
it PRP O O
was VBD B-VP O
noted VBN O O
that IN B-VP O
he PRP O O
started VBD B-VP O
having VBG O O
increasing VBG O O
white JJ B-NP O
count NN I-NP O
It PRP O O
was VBD B-VP O
felt VBN O O
this DT O O
was VBD B-VP O
perhaps RB O O
due JJ O O
to TO O O
a DT B-NP O
mild JJ I-NP B-r
urine JJ I-NP I-r
infection NN I-NP I-r
and CC O O
was VBD B-VP O
started VBN O O
on IN B-VP O
Levaquin NNP B-NP B-m
However RB O O
, , O O
he PRP O O
started VBD B-VP O
the DT B-NP O
next JJ I-NP O
day NN I-NP O
complaining VBG O O
increasing VBG O O
pain NN B-NP O
in IN B-VP O
his PRP$ O O
knee NN B-NP O
At IN B-VP O
this DT B-NP O
time NN I-NP O
, , O O
his PRP$ O O
white JJ B-NP O
count NN I-NP O
had VBD B-VP O
risen VBN O O
to TO O O
23 CD O O
, , O O
000 CD O O
The DT B-NP O
knee NN I-NP O
was VBD B-VP O
obviously RB O O
a DT B-NP O
concern NN I-NP O
for IN B-VP O
possible JJ B-NP O
infection NN I-NP O
His PRP$ O O
knee NN B-NP O
was VBD B-VP O
warm JJ O O
, , O O
was VBD B-VP O
tender NN B-NP O
and CC O O
was VBD B-VP O
erythematous JJ O O
, , O O
compared VBN O O
to TO O O
the DT B-NP O
contralateral JJ I-NP O
side NN I-NP O
As IN B-VP O
a DT B-NP O
result NN I-NP O
, , O O
the DT B-NP O
Orthopedic NNP I-NP O
Service NNP I-NP O
was VBD B-VP O
again RB O O
consulted VBN O O
An DT B-NP O
arthrocentesis NN I-NP O
was VBD B-VP O
performed VBN O O
on IN B-VP O
his PRP$ O O
left JJ B-NP O
knee NN I-NP O
, , O O
this DT O O
was VBD B-VP O
a DT B-NP O
dry JJ I-NP O
tap; NN I-NP O
no DT B-NP O
fluid NN I-NP O
was VBD B-VP O
able JJ O O
to TO O O
be VB O O
obtained VBN O O
The DT B-NP O
subsequent JJ I-NP O
day NN I-NP O
, , O O
he PRP O O
was VBD B-VP O
complaining VBG O O
of IN B-VP O
increasing VBG O O
pain NN B-NP O
, , O O
and CC O O
the DT B-NP O
sed JJ I-NP O
rate NN I-NP O
returned VBN O O
in IN B-VP O
the DT O O
99 CD O O
with IN B-VP O
a DT B-NP O
CRP NNP I-NP O
of IN B-VP O
190 CD O O
The DT B-NP O
EP NNP I-NP O
Service NNP I-NP O
again RB O O
evaluated VBD B-VP O
the DT B-NP O
patient NN I-NP O
, , O O
and CC O O
felt VBD B-VP O
that IN B-VP O
there EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
any DT B-NP O
clear JJ I-NP O
infection NN I-NP O
from IN B-VP O
the DT B-NP O
pacer NN I-NP O
site NN I-NP O
He PRP O O
continued VBD B-VP O
to TO O O
have VB O O
no DT B-NP O
erythema NN I-NP O
or CC O O
tenderness NN B-NP O
around IN B-VP O
the DT B-NP O
pacer NN I-NP O
site NN I-NP O
His PRP$ O O
chest JJS B-NP O
x-ray NN I-NP O
was VBD B-VP O
essentially RB O O
unremarkable JJ O O
The DT B-NP O
next JJ I-NP O
day NN I-NP O
( ( O O
5/1/05 CD O O
) ) O O
, , O O
he PRP O O
was VBD B-VP O
seen VBN O O
by IN B-VP O
the DT B-NP O
Rheumatology NNP I-NP O
Service NNP I-NP O
, , O O
under IN B-VP O
Dr NNP B-NP O
Burris NNP I-NP O
who WP O O
also RB O O
felt VBD B-VP O
this DT O O
was VBD B-VP O
most RBS O O
likely JJ O O
to TO O O
be VB O O
prepatellar JJ B-NP O
bursitis NN I-NP O
, , O O
probably RB O O
septic JJ O O
in IN B-VP O
nature NN B-NP O
, , O O
with IN B-VP O
a DT B-NP O
hematoma NN I-NP O
He PRP O O
was VBD B-VP O
asked VBN O O
to TO O O
seen VBN O O
by IN B-VP O
the DT B-NP O
Infectious NNP I-NP O
Disease NNP I-NP O
Service NNP I-NP O
, , O O
under IN B-VP O
Dr NNP B-NP O
Ferlic NNP I-NP O
and CC O O
Lou NNP B-NP O
Marzinske NNP I-NP O
He PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
Ancef NNP B-NP B-m
1 CD O B-do
gm NN B-NP I-do
q.8h VBD B-VP B-f
A NNP B-NP O
PICC NNP I-NP O
line NN I-NP O
will MD O O
be VB O O
placed VBN O O
later RB O O
today NN B-NP O
on IN B-VP O
the DT O O
2/22/05 CD O O
and CC O O
he PRP O O
will MD O O
be VB O O
discharged VBN O O
to TO O O
rehab VB O O
Of IN B-VP O
note NN B-NP O
, , O O
he PRP O O
has VBZ O O
been VBN O O
afebrile RB O O
for IN B-VP O
more JJR O O
than IN B-VP O
48 CD O O
hours NNS B-NP O
while IN B-VP O
on IN B-VP O
the DT B-NP O
Ancef NNP I-NP B-m
, , O O
and CC O O
his PRP$ O O
white JJ B-NP O
count NN I-NP O
has VBZ O O
improved VBN O O
dramatically RB O O
, , O O
into IN B-VP O
the DT O O
approximately RB O O
10000 CD O O
range NN B-NP O
He PRP O O
will MD O O
continue VB O O
to TO O O
get VB O O
IV NNP B-NP B-mo
Ancef NNP I-NP B-m
q.8h NN I-NP B-f
for IN B-VP B-du
an DT O I-du
additional JJ O I-du
12 CD O I-du
days NNS B-NP I-du
New NNP I-NP O
consultants NNS I-NP O
on IN B-VP O
the DT B-NP O
case NN I-NP O
, , O O
again RB O O
Dr NNP B-NP O
Hempe NNP I-NP O
and CC O O
Dr NNP B-NP O
Bradford NNP I-NP O
Mcguigan NNP I-NP O
with IN B-VP O
Infectious NNP B-NP O
Disease NNP I-NP O
, , O O
Dr NNP B-NP O
Borde NNP I-NP O
and CC O O
Dr NNP B-NP O
Frances NNP I-NP O
Thackston NNP I-NP O
with IN B-VP O
Orthopedics NNP B-NP O
and CC O O
Dr NNP B-NP O
Gangwer NNP I-NP O
with IN B-VP O
Rheumatology NNP B-NP O
eScription NN I-NP O
document: NN I-NP O
5-0149629 JJ B-NP O
IS NNP I-NP O
CC: NNP I-NP O
Claudio NNP I-NP O
Shreve NNP I-NP O
M.D NNP I-NP O
Ynealwell NNP I-NP O
Healthcare NNP I-NP O
Medicine NNP I-NP O
CC: NNP I-NP O
Fredrick NNP I-NP O
Paciorek NNP I-NP O
MD NNP I-NP O
O NNP I-NP O
H NNP I-NP O
Athensph NNP I-NP O
CC: NNP I-NP O
Jonathan NNP I-NP O
Counterman NNP I-NP O
M.D NNP I-NP O
Stockfay NNP I-NP O
CC: NNP I-NP O
Michel NNP I-NP O
Patera NNP I-NP O
MD NNP I-NP O
La NNP I-NP O
A NNP I-NP O
Ver NNP I-NP O
Coln NNP I-NP O
CC: NNP I-NP O
Brian NNP I-NP O
Vecellio NNP I-NP O
MD NNP I-NP O
Cardiac NNP I-NP O
Arrhythmia NNP I-NP O
Service NNP I-NP O
Statesson NNP I-NP O
Rankwarmchusetts NNP I-NP O
Burg NNP I-NP O
Medical NNP I-NP O
Andvirg NNP I-NP O
E NNP I-NP O
Ha NNP I-NP O
Son NNP I-NP O
St NNP I-NP O
, , O O
Ette NNP B-NP O
Villelau NNP I-NP O
Jack NNP I-NP O
, , O O
Indiana NNP B-NP O
51422 CD O O
CC: NNP B-NP O
Thomas NNP I-NP O
Skelly NNP I-NP O
MD NNP I-NP O
Ette NNP I-NP O
A NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
SHANDS NNP I-NP O
, , O O
WILSON NNP B-NP O
Attending: NNP I-NP O
RAISBECK NNP I-NP O
, , O O
CONRAD NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
0461398 CD O O
D: NNP B-NP O
6/13/05 CD O O
T: NNP B-NP O
3/23/05 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#983185 VBZ O O
044103237 CD O O
MHMC NNP B-NP O
31613051 CD O O
887222 CD O O
2/1/1990 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
7/12/1990 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Unsigned NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
10/10/1990 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Patient NNP I-NP O
is VBZ O O
a DT O O
40 CD O O
year NN B-NP O
old JJ B-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
cholelithiasis NN B-NP O
who WP O O
was VBD B-VP O
recently RB O O
discharged VBN O O
from IN B-VP O
Asce NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
on IN B-VP O
June NNP B-NP O
, , O O
l990 NN B-NP O
after IN B-VP O
an DT B-NP O
incisional JJ I-NP O
hernia NN I-NP O
repair NN I-NP O
who WP O O
, , O O
soon RB O O
after IN B-VP O
, , O O
noted VBD B-VP O
onset NN B-NP O
of IN B-VP O
right JJ B-NP O
upper JJ I-NP O
quadrant NN I-NP O
pain NN I-NP O
, , O O
vomiting NN B-NP O
, , O O
and CC O O
fever NN B-NP O
and CC O O
was VBD B-VP O
readmitted VBN O O
with IN B-VP O
an DT B-NP O
ultrasound NN I-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
showing VBG O O
two CD O O
8-9 JJ B-NP O
mm NN I-NP O
gallstones NNS I-NP O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
upper JJ I-NP O
quadrant JJ I-NP O
Patient NNP I-NP O
was VBD B-VP O
treated VBN O O
with IN B-VP O
intravenous JJ B-NP B-mo
antibiotics NNS I-NP B-m
but CC O O
deferred VBD B-VP O
surgery NN B-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
and CC O O
was VBD B-VP O
discharged VBN O O
home NN B-NP O
after IN B-VP O
defervescing VBG O O
Approximately RB O O
six CD O O
weeks NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
seen VBN O O
in IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Ward NNP I-NP O
for IN B-VP O
recurrent NN B-NP O
right JJ B-NP O
upper JJ I-NP O
quadrant NN I-NP O
pain NN I-NP O
without IN B-VP O
nausea NN B-NP O
, , O O
vomiting VBG O O
, , O O
or CC O O
fever VB O O
The DT B-NP O
patient NN I-NP O
then RB O O
was VBD B-VP O
subsequently RB O O
seen VBN O O
by IN B-VP O
Dr NNP B-NP O
Bellman NNP I-NP O
in IN B-VP O
the DT B-NP O
Chica NNP I-NP O
Onant NNP I-NP O
Hospital NNP I-NP O
and CC O O
a DT B-NP O
cholecystectomy NN I-NP O
was VBD B-VP O
scheduled VBN O O
on IN B-VP O
a DT B-NP O
routine JJ I-NP O
basis NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Non-contributory NNP I-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
Includes VBZ O O
a DT B-NP O
cesarean JJ I-NP O
section NN I-NP O
in IN B-VP O
l988 NN B-NP O
and CC O O
a DT B-NP O
ventral JJ I-NP O
hernia NN I-NP O
repair NN I-NP O
in IN B-VP O
March NNP B-NP O
of IN B-VP O
l990 JJ B-NP O
CURRENT NNP I-NP O
MEDICATIONS: NNP I-NP O
Naprosyn NNP I-NP B-m
as IN B-VP B-f
needed VBN O I-f
for IN B-VP O
right JJ B-NP B-r
upper JJ I-NP I-r
quadrant NN I-NP I-r
pain NN I-NP I-r
ALLERGIES: NNP I-NP O
Include NNP I-NP O
Penicillin NNP I-NP O
which WDT O O
gives VBZ O O
her PRP O O
a DT B-NP O
rash NN I-NP O
and CC O O
Compazine NNP B-NP O
which WDT O O
leads VBZ O O
to TO O O
a DT B-NP O
dystonic JJ I-NP O
reaction NN I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
She PRP O O
does VBZ O O
not RB O O
smoke VB O O
or CC O O
drink VB O O
PHYSICAL NNP B-NP O
EXAMINATION: NNP I-NP O
Patient NNP I-NP O
was VBD B-VP O
afebrile JJ O O
with IN B-VP O
stable JJ B-NP O
vital JJ I-NP O
signs NNS I-NP O
SKIN: NNP I-NP O
Scattered NNP I-NP O
skin NN I-NP O
tags NN I-NP O
on IN B-VP O
her PRP$ O O
trunk NN B-NP O
NODES: NNP I-NP O
Negative NNP I-NP O
HEAD/NECK: NNP I-NP O
Benign NNP I-NP O
BREASTS: NNP I-NP O
Without NNP I-NP O
masses NNS I-NP O
, , O O
tenderness NN B-NP O
, , O O
or CC O O
axillary JJ B-NP O
adenopathy JJ I-NP O
LUNGS: NNP I-NP O
Clear NNP I-NP O
to TO O O
auscultation VB O O
HEART: NNP B-NP O
Regular NNP I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
no DT B-NP O
murmurs NNS I-NP O
, , O O
gallops NNS B-NP O
, , O O
or CC O O
rubs VB O O
PULSES: NNP B-NP O
2+ CD O O
bilaterally RB O O
ABDOMEN: NNP B-NP O
Obese NNP I-NP O
, , O O
positive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
and CC O O
non-tender NN B-NP O
with IN B-VP O
a DT B-NP O
small JJ I-NP O
fascial JJ I-NP O
defect NN I-NP O
at IN B-VP O
the DT B-NP O
umbilicus NN I-NP O
and CC O O
a DT O O
well RB O O
healed VBN O O
midline NN B-NP O
scar NN I-NP O
NEUROLOGICAL: NNP I-NP O
Non-focal JJ B-NP O
LABORATORY NNP I-NP O
EXAMINATION: NNP I-NP O
Her NNP I-NP O
EKG NNP I-NP O
showed VBD B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
7l CD O O
beats NNS B-NP O
per IN B-VP O
minute NN B-NP O
with IN B-VP O
an DT B-NP O
axis NN I-NP O
of IN B-VP O
positive JJ O O
40 CD O O
degrees NNS B-NP O
, , O O
normal JJ B-NP O
intervals NNS I-NP O
, , O O
and CC O O
no DT B-NP O
ischemic JJ I-NP O
changes NNS I-NP O
Her PRP$ O O
chest JJS B-NP O
X-Ray NN I-NP O
was VBD B-VP O
clear JJ B-NP O
Her NNP I-NP O
electrolytes NNS I-NP O
were VBD B-VP O
all DT O O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
, , O O
her PRP$ O O
BUN NNP B-NP O
was VBD B-VP O
22 CD O O
, , O O
and CC O O
her PRP$ O O
creatinine NN B-NP O
was VBD B-VP O
l.0 JJ B-NP O
Her NNP I-NP O
glucose NN I-NP O
was VBD B-VP O
88 CD O O
Her NNP B-NP O
white JJ B-NP O
count NN I-NP O
was VBD B-VP O
6.4 CD O O
, , O O
her PRP$ O O
hematocrit NN B-NP O
was VBD B-VP O
33.l CD O O
, , O O
and CC O O
her PRP$ O O
platelets NNS B-NP O
were VBD B-VP O
259 CD O O
Her NNP B-NP O
PT NNP I-NP O
was VBD B-VP O
l2.3 JJ O O
and CC O O
her PRP$ O O
PTT NNP B-NP O
was VBD B-VP O
29.9 CD O O
Her NNP B-NP O
urinalysis NN I-NP O
showed VBD B-VP O
3-4 JJ B-NP O
white JJ I-NP O
blood NN I-NP O
cells NNS I-NP O
and CC O O
l+ JJ B-NP O
bacteria NNS I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
arrived VBD B-VP O
the DT B-NP O
same JJ I-NP O
day NN I-NP O
as IN B-VP O
her PRP$ O O
surgery NN B-NP O
and CC O O
was VBD B-VP O
taken VBN O O
directly RB O O
to TO O O
the DT B-NP O
Operating NN I-NP O
Room NNP I-NP O
Patient NNP I-NP O
was VBD B-VP O
placed VBN O O
under IN B-VP O
general JJ B-NP B-m
anesthesia NN I-NP I-m
and CC O O
her PRP$ O O
intubation NN B-NP O
was VBD B-VP O
particularly RB O O
difficult JJ O O
secondary JJ O O
to TO O O
obesity VB O O
requiring VBG O O
fiberoptic JJ B-NP O
intubation NN I-NP O
and CC O O
Anesthesia NNP B-NP O
elected VBD B-VP O
, , O O
at IN B-VP O
this DT B-NP O
time NN I-NP O
, , O O
to TO O O
place VB O O
both DT O O
an DT B-NP O
A-line NNP I-NP O
and CC O O
a DT B-NP O
central JJ I-NP O
venous JJ I-NP O
access NN I-NP O
in IN B-VP O
order NN B-NP O
to TO O O
be VB O O
able JJ O O
to TO O O
optimally RB O O
monitor VB O O
this DT B-NP O
difficult JJ I-NP O
obese JJ I-NP O
patient NN I-NP O
Patient NNP I-NP O
then RB O O
underwent VBD B-VP O
a DT O O
very RB O O
uncomplicated JJ B-NP O
cholecystectomy NN I-NP O
at IN B-VP O
which WDT O O
time NN B-NP O
a DT B-NP O
distended JJ I-NP O
gallbladder NN I-NP O
with IN B-VP O
several JJ B-NP O
stones NNS I-NP O
was VBD B-VP O
found VBN O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
Recovery NNP I-NP O
Room NNP I-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
after IN B-VP O
being VBG O O
extubated VBD B-VP O
Her NNP B-NP O
O2 NNP I-NP O
saturation NN I-NP O
on IN B-VP O
40% CD O O
facemask NN B-NP O
was VBD B-VP O
96% CD O O
in IN B-VP O
the DT B-NP O
Recovery NNP I-NP O
Room NNP I-NP O
and CC O O
both DT O O
her PRP$ O O
nasogastric JJ B-NP O
tube NN I-NP O
and CC O O
Foley NNP B-NP O
tube NN I-NP O
were VBD B-VP O
removed VBN O O
without IN B-VP O
incident NN B-NP O
Her PRP$ O O
A-line NNP B-NP O
was VBD B-VP O
also RB O O
removed VBN O O
before RB O O
transfer NN B-NP O
to TO O O
the DT B-NP O
floor NN I-NP O
but CC O O
her PRP$ O O
central JJ B-NP O
line NN I-NP O
remained VBN O O
in IN B-VP O
place NN B-NP O
until IN B-VP O
the DT B-NP O
following JJ I-NP O
day NN I-NP O
Patient NNP I-NP O
received VBD B-VP O
two CD O B-do
doses NNS B-NP I-do
of IN B-VP O
Gentamicin NNP B-NP B-m
as IN B-VP O
prophylaxis JJ O B-r
post-operatively RB O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
an DT B-NP O
unremarkable JJ I-NP O
post-operative JJ I-NP O
course NN I-NP O
with IN B-VP O
a DT B-NP O
post-operative JJ I-NP O
hematocrit NN I-NP O
of IN B-VP O
3l.5 CD O O
and CC O O
white JJ B-NP O
count NN I-NP O
of IN B-VP O
8.4 CD O O
Her PRP$ O O
diet NN B-NP O
was VBD B-VP O
slowly RB O O
advanced JJ O O
and CC O O
she PRP O O
remained VBD B-VP O
afebrile JJ O O
with IN B-VP O
good JJ B-NP O
oxygen NN I-NP O
saturations NNS I-NP O
on IN B-VP O
room NN B-NP O
air NN I-NP O
and CC O O
good JJ B-NP O
urine NN I-NP O
output NN I-NP O
DISOSITION: NNP I-NP O
She PRP O O
was VBD B-VP O
discharged VBN O O
to TO O O
home VB O O
on IN B-VP O
post-operative JJ B-NP O
day NN I-NP O
number NN I-NP O
five CD O O
with IN B-VP O
an DT B-NP O
appointment NN I-NP O
to TO O O
follow-up NN B-NP O
in IN B-VP O
the DT B-NP O
Ingtondi NNP I-NP O
Community NNP I-NP O
Healthcare NNP I-NP O
on IN B-VP O
Thursday NNP B-NP O
, , O O
March NNP B-NP O
, , O O
for IN B-VP O
a DT B-NP O
wound NN I-NP O
check NN I-NP O
________________________________ NNP I-NP O
EO942/9894 NNP I-NP O
QUENTIN NNP I-NP O
A NNP I-NP O
MENDELSOHN NNP I-NP O
, , O O
JR NNP B-NP O
, , O O
M.D NNP B-NP O
BP9 NNP I-NP O
D: NNP I-NP O
2/20/90 CD O O
Batch: NNP B-NP O
8112 CD O O
Report: NNP B-NP O
J2215G66 NNP I-NP O
T: NNP I-NP O
6/1/90 CD O O
Dictated NNP B-NP O
By: NNP I-NP O
THADDEUS NNP I-NP O
LORCH NNP I-NP O
, , O O
M.D NNP B-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#984247 VBZ O O
742668784 CD O O
IHC NNP B-NP O
48808234 CD O O
703320 CD O O
1/27/1993 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
0/29/1993 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
3/7/1993 CD O O
ADMISSION NNP B-NP O
DIAGNOSIS: NNP I-NP O
COMPLETE NNP I-NP O
HEART NNP I-NP O
BLOCK NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Mr NNP I-NP O
Lahm NNP I-NP O
is VBZ O O
a DT O O
43 CD O O
year NN B-NP O
old JJ B-NP O
male NN I-NP O
with IN B-VP O
Down's NNP B-NP O
syndrome NN I-NP O
who WP O O
was VBD B-VP O
admitted VBN O O
with IN B-VP O
multiple JJ B-NP O
episodes NNS I-NP O
of IN B-VP O
syncope NN B-NP O
over IN B-VP O
the DT B-NP O
prior JJ I-NP O
8-10 JJ I-NP O
years NNS I-NP O
These DT O O
were VBD B-VP O
characterized VBN O O
by IN B-VP O
emesis NN B-NP O
followed VBN O O
by IN B-VP O
loss NN B-NP O
of IN B-VP O
consciousness NN B-NP O
with IN B-VP O
a DT B-NP O
question NN I-NP O
of IN B-VP O
seizure NN B-NP O
like IN B-VP O
activity NN B-NP O
This DT O O
had VBD B-VP O
occurred VBN O O
on IN B-VP O
a DT B-NP O
yearly JJ I-NP O
basis NN I-NP O
for IN B-VP O
8-10 JJ B-NP O
years NNS I-NP O
Such JJ O O
an DT B-NP O
episode NN I-NP O
occurred VBD B-VP O
on IN B-VP O
March NNP B-NP O
At IN B-VP O
that DT B-NP O
time NN I-NP O
, , O O
his PRP$ O O
mother NN B-NP O
brought VBD B-VP O
him PRP O O
to TO O O
the DT B-NP O
Harwelliew NNP I-NP O
Oker NNP I-NP O
Medical NNP I-NP O
Centers NNP I-NP O
Emergency NNP I-NP O
Room NNP I-NP O
because IN B-VP O
he PRP O O
developed VBD B-VP O
a DT B-NP O
facial JJ I-NP O
hematoma NN I-NP O
after IN B-VP O
one CD O O
of IN B-VP O
these DT B-NP O
episodes NNS I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
In IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Room NNP I-NP O
he PRP O O
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
somewhat RB O O
groggy JJ O O
with IN B-VP O
a DT B-NP O
brief JJ I-NP O
episode NN I-NP O
of IN B-VP O
apparent JJ B-NP O
loss NN I-NP O
of IN B-VP O
consciousness NN B-NP O
with IN B-VP O
a DT B-NP O
question NN I-NP O
of IN B-VP O
apnea NN B-NP O
He PRP O O
was VBD B-VP O
sent VBN O O
to TO O O
head VB O O
CT NNP B-NP O
for IN B-VP O
a DT O O
scan JJ O O
and CC O O
at IN B-VP O
that DT B-NP O
time NN I-NP O
he PRP O O
vomiting VBG O O
with IN B-VP O
loss NN B-NP O
of IN B-VP O
consciousness NN B-NP O
and CC O O
a DT B-NP O
decrease NN I-NP O
in IN B-VP O
heart NN B-NP O
rate NN I-NP O
to TO O O
30 CD O O
beats NNS B-NP O
per IN B-VP O
minute NN B-NP O
He PRP O O
was VBD B-VP O
intubated VBN O O
in IN B-VP O
the DT B-NP O
CT NNP I-NP O
scan JJ B-NP O
room NN I-NP O
, , O O
sedated VBN O O
and CC O O
paralyzed VBN O O
while IN B-VP O
the DT B-NP O
study NN I-NP O
was VBD B-VP O
completed VBN O O
When WRB O O
he PRP O O
arrived VBD B-VP O
in IN B-VP O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
, , O O
he PRP O O
had VBD B-VP O
a DT B-NP O
heart NN I-NP O
beat NN I-NP O
in IN B-VP O
the DT O O
20s CD O O
with IN B-VP O
complete JJ B-NP O
heart NN I-NP O
block NN I-NP O
, , O O
which WDT O O
was VBD B-VP O
transient NN B-NP O
and CC O O
with IN B-VP O
subsequent JJ B-NP O
return NN I-NP O
to TO O O
normal JJ B-NP O
sinus NN I-NP O
rhythm VBD B-VP O
The DT B-NP O
remainder NN I-NP O
of IN B-VP O
his PRP$ O O
exam NN B-NP O
was VBD B-VP O
remarkable JJ O O
for IN B-VP O
an DT B-NP O
S4 NNP I-NP O
and CC O O
I/VI NNP B-NP O
systolic JJ B-NP O
ejection NN I-NP O
murmur NN I-NP O
NEURO: NNP I-NP O
The DT B-NP O
neurological JJ I-NP O
exam NN I-NP O
was VBD B-VP O
nonfocal JJ B-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Electrolytes NNP I-NP O
were VBD B-VP O
normal JJ O O
His PRP$ O O
EKG NN B-NP O
showed VBD B-VP O
sinus JJ B-NP O
tachycardia NN I-NP O
with IN B-VP O
an DT B-NP O
axis NN I-NP O
of IN B-VP O
0 CD O O
, , O O
ST NNP B-NP O
flattening VBG O O
in IN B-VP O
leads NNS B-NP O
V5 NNP I-NP O
and CC O O
V6 NNP B-NP O
, , O O
I PRP O O
in IN B-VP O
L NNP B-NP O
and CC O O
a DT B-NP O
question NN I-NP O
of IN B-VP O
a DT B-NP O
Q NNP I-NP O
in IN B-VP O
III NNP B-NP O
Chest NNP I-NP O
X-ray NN I-NP O
raised VBD B-VP O
the DT B-NP O
question NN I-NP O
of IN B-VP O
an DT B-NP O
infiltrate NN I-NP O
in IN B-VP O
the DT B-NP O
left JJ I-NP O
base NN I-NP O
The DT B-NP O
head NN I-NP O
CT NNP I-NP O
was VBD B-VP O
negative JJ O O
His PRP$ O O
course NN B-NP O
in IN B-VP O
the DT B-NP O
MICU NNP I-NP O
was VBD B-VP O
as IN B-VP O
follows: NN B-NP O
He PRP O O
ruled VBD B-VP O
out RP O O
for IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
, , O O
despite IN B-VP O
an DT B-NP O
elevated JJ I-NP O
CK NNP I-NP O
The DT B-NP O
MB NNP I-NP O
fraction NN I-NP O
was VBD B-VP O
negative JJ O O
on IN B-VP O
electrophoresis NN B-NP O
On IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
February NNP B-NP O
, , O O
he PRP O O
spiked VBD B-VP O
a DT B-NP O
temperature NN I-NP O
to TO O O
102.3 CD O O
and CC O O
was VBD B-VP O
begun VBN O O
on IN B-VP O
Penicillin NNP B-NP B-m
Later NNP I-NP O
on IN B-VP O
February NNP B-NP O
he PRP O O
had VBD B-VP O
an DT B-NP O
episode NN I-NP O
of IN B-VP O
complete JJ B-NP O
heart NN I-NP O
block NN I-NP O
with IN B-VP O
asystole NN B-NP O
for IN B-VP O
9 CD O O
seconds NNS B-NP O
Otherwise RB O O
, , O O
he PRP O O
alternated VBD B-VP O
sinus JJ B-NP O
tachycardia NN I-NP O
and CC O O
second JJ B-NP O
degree JJ I-NP O
heart NN I-NP O
block NN I-NP O
with IN B-VP O
runs NNS B-NP O
of IN B-VP O
bradycardia NN B-NP O
at IN B-VP O
the DT B-NP O
rate NN I-NP O
of IN B-VP O
30-40 JJ O O
and CC O O
also RB O O
tachycardia JJ B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
A NNP I-NP O
temporary JJ B-NP O
pacemaker NN I-NP O
was VBD B-VP O
placed VBN O O
on IN B-VP O
February NNP B-NP O
through IN B-VP O
the DT B-NP O
left NN I-NP O
subclavian JJ B-NP O
approach NN I-NP O
At IN B-VP O
that DT B-NP O
time NN I-NP O
, , O O
he PRP O O
was VBD B-VP O
hemodynamically RB O O
stable JJ O O
, , O O
except IN B-VP O
for IN B-VP O
intermittent JJ B-NP B-r
hypertension NN I-NP O
, , O O
which WDT O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
Nifedipine NNP B-NP B-m
He PRP O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Cardiology NNP I-NP O
Wa NNP I-NP O
Nas NNP I-NP O
O NNP I-NP O
on IN B-VP O
March NNP B-NP O
, , O O
1993 CD O O
to TO O O
await VB O O
pacemaker NN B-NP O
placement NN I-NP O
He PRP O O
was VBD B-VP O
switched VBN O O
from IN B-VP O
Nifedipine NNP B-NP B-m
to TO O O
Captopril NNP B-NP B-m
for IN B-VP O
treatment NN B-NP O
of IN B-VP O
his PRP$ O B-r
his PRP$ O B-r
hypertension NN B-NP I-r
hypertension NN I-NP I-r
and CC O O
his PRP$ O O
fever NN B-NP O
was VBD B-VP O
treated VBN O O
with IN B-VP O
Cefotetan NNP B-NP B-m
for IN B-VP O
presumed JJ B-NP B-r
aspiration NN I-NP I-r
pneumonia NN I-NP I-r
This DT O O
has VBZ O O
resulted VBN O O
in IN B-VP O
a DT B-NP O
delay NN I-NP O
in IN B-VP O
his PRP$ O O
pacemaker NN B-NP O
placement NN I-NP O
He PRP O O
intermittently RB O O
had VBD B-VP O
a DT B-NP O
pericardial JJ I-NP O
friction NN I-NP O
rub NN I-NP O
on IN B-VP O
physical JJ B-NP O
examination NN I-NP O
that WDT O O
was VBD B-VP O
thought VBN O O
to TO O O
be VB O O
most RBS O O
likely JJ O O
due JJ O O
to TO O O
myocardial JJ B-NP O
irritation NN I-NP O
by IN B-VP O
the DT B-NP O
pacing NN I-NP O
wire NN I-NP O
implantation NN I-NP O
One CD O O
echocardiogram NN B-NP O
in IN B-VP O
a DT B-NP O
series NN I-NP O
did VBD B-VP O
reveal VB O O
a DT B-NP O
regional JJ I-NP O
wall NN I-NP O
motion NN I-NP O
abnormality NN I-NP O
that WDT O O
may MD O O
have VB O O
been VBN O O
a DT B-NP O
function NN I-NP O
of IN B-VP O
the DT B-NP O
pacemaker NN I-NP O
wire NN I-NP O
as RB O O
well RB O O
He PRP O O
remained VBD B-VP O
afebrile JJ O O
and CC O O
completed VBD B-VP O
a DT B-NP O
course NN I-NP O
of IN B-VP O
antibiotics NNS B-NP B-m
for IN B-VP O
his PRP$ O B-r
presumed JJ B-NP I-r
aspiration NN I-NP I-r
pneumonia NN I-NP I-r
, , O O
although IN B-VP O
subsequent JJ B-NP O
chest JJS I-NP O
x-rays NNS I-NP O
did VBD B-VP O
not RB O O
support VB O O
that IN B-VP O
diagnosis NN B-NP O
He PRP O O
required VBD B-VP O
replacement NN B-NP O
of IN B-VP O
his PRP$ O O
temporary JJ B-NP O
pacemaker NN I-NP O
wire NN I-NP O
while IN B-VP O
awaiting VBG O O
permanent JJ B-NP O
pacemaker NN I-NP O
placement NN I-NP O
to TO O O
decrease VB O O
the DT B-NP O
risk NN I-NP O
of IN B-VP O
infection NN B-NP O
He PRP O O
underwent JJ B-NP O
permanent JJ I-NP O
pacemaker NN I-NP O
placement NN I-NP O
in IN B-VP O
the DT B-NP O
Operating NN I-NP O
Room NN I-NP O
with IN B-VP O
anesthesia JJ B-NP O
backup NN I-NP O
in IN B-VP O
case NN B-NP O
there EX O O
was VBD B-VP O
need NN B-NP O
for IN B-VP O
intubation NN B-NP O
because IN B-VP O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
difficulty NN B-NP O
remaining VBG O O
still RB O O
The DT B-NP O
pacemaker NN I-NP O
replacement NN I-NP O
was VBD B-VP O
performed VBN O O
on IN B-VP O
August NNP B-NP O
, , O O
1993 CD O O
Intubation NNP B-NP O
was VBD B-VP O
not RB O O
necessary JJ B-NP O
DISPOSITION: NNP I-NP O
He PRP O O
tolerated VBD B-VP O
the DT B-NP O
procedure NN I-NP O
well RB O O
and CC O O
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
on IN B-VP O
March NNP B-NP O
, , O O
1993 CD O O
MEDICATIONS: NNP B-NP O
The DT B-NP O
medications NNS I-NP O
at IN B-VP O
discharge NN B-NP O
were: NN I-NP O
Kefzol NNP I-NP B-m
500mg CD O B-do
q.i.d NN B-NP B-f
for IN B-VP B-du
3 CD O I-du
days NNS B-NP I-du
, , O O
and CC O O
Lisinopril NNP B-NP B-m
10mg CD O B-do
p.o NN B-NP B-mo
q NN I-NP B-f
day NN I-NP I-f
He PRP O O
will MD O O
followup VB O O
with IN B-VP O
Dr NNP B-NP O
Antis NNP I-NP O
on IN B-VP O
January NNP B-NP O
, , O O
1993 CD O O
and CC O O
in IN B-VP O
TYTAZE NNP B-NP O
TH NNP I-NP O
IONO NNP I-NP O
VALLEY NNP I-NP O
HEALTH NNP I-NP O
with IN B-VP O
Dr NNP B-NP O
Filiberto NNP I-NP O
Schie NNP I-NP O
Secondary NNP I-NP O
Diagnoses NNP I-NP O
were VBD B-VP O
pacemaker VBN O O
placement NN B-NP O
and CC O O
Down's NNP B-NP O
syndrome VBP O O
Dictated NNP B-NP O
By: NNP I-NP O
OLIN NNP I-NP O
E NNP I-NP O
ZELEDON NNP I-NP O
, , O O
M.D NNP B-NP O
HJ25 NNP I-NP O
Attending: NNP I-NP O
ULYSSES NNP I-NP O
J NNP I-NP O
DRANE NNP I-NP O
, , O O
M.D NNP B-NP O
TS0 NNP I-NP O
SO547/1452 NNP I-NP O
Batch: NNP I-NP O
2399 CD O O
Index NNP B-NP O
No NNP I-NP O
D5GQOZ62V6 NNP I-NP O
D: NNP I-NP O
3/5/93 CD O O
T: NNP B-NP O
3/5/93 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#984424 VBZ O O
929972643 CD O O
LOH NNP B-NP O
49110992 CD O O
3533188 CD O O
8/3/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
COPD NNP I-NP O
flare NN I-NP O
, , O O
right JJ B-NP O
heart NN I-NP O
failure NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
9/0/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
2/17/2005 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
SCARBERRY NNP I-NP O
, , O O
DION NNP B-NP O
926-57-39-3 CD O O
A NNP B-NP O
Clearland NNP I-NP O
Cale NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
5/28/05 CD O O
AT NNP B-NP O
02:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
PRASAD NNP I-NP O
, , O O
AMOS NNP B-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting NNP I-NP O
IN NNP I-NP O
AM NNP I-NP O
( ( O O
7/17 CD O O
) ) O O
ELAVIL NNP B-NP B-m
( ( O I-m
AMITRIPTYLINE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
ATENOLOL NNP I-NP B-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting NNP I-NP O
IN NNP I-NP O
AM NNP I-NP O
( ( O O
7/17 CD O O
) ) O O
COLACE NNP B-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
FUROSEMIDE NNP I-NP B-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
6/25 CD O O
) ) O O
GUAIFENESIN NNP B-NP B-m
10 CD O B-do
MILLILITERS NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP O
Starting VBG O O
Today NNP B-NP O
( ( O O
6/25 CD O O
) ) O O
PRN NNP B-NP O
Other:cough NNP I-NP O
OXYCODONE NNP I-NP B-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP O
Starting VBG O O
Today NNP B-NP O
( ( O O
6/25 CD O O
) ) O O
PRN NNP B-NP B-f
Pain NNP I-NP B-r
Instructions: NNP I-NP O
please NN I-NP O
give VB O O
am VBP O O
and CC O O
pm VBP O O
dose NN B-NP O
with IN B-VP O
his PRP$ O O
doses NNS B-NP O
of IN B-VP O
morphine NN B-NP B-m
midday NN I-NP O
dose VB O O
2-3pm.thank JJ O O
you PRP O O
QUININE VBP O B-m
SULFATE JJ O I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
HS NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
6/25 CD O O
) ) O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
with IN B-VP O
food NN B-NP O
SENNA NNP I-NP B-m
TABLETS NNP I-NP I-m
( ( O I-m
SENNOSIDES NNP B-NP I-m
) ) O I-m
2 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
MVI NNP I-NP B-m
THERAPEUTIC NNP I-NP I-m
( ( O I-m
THERAPEUTIC NNP B-NP I-m
MULTIVITAMINS NNP I-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
2/11/05 CD O O
by IN B-VP O
BURKS NNP B-NP O
, , O O
LEVI NNP B-NP O
A NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
monitor VB O O
ZOCOR NNP B-NP B-m
( ( O I-m
SIMVASTATIN NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
Override NNP B-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
2/11/05 CD O O
by IN B-VP O
PITTELKOW NNP B-NP O
, , O O
TUAN NNP B-NP O
B NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
MVI NNP B-NP O
THERAPEUTIC NNP I-NP O
PO NNP I-NP O
( ( O O
ref JJ O O
# # O O
17152641 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
monitor VB O O
MORPHINE NNP B-NP B-m
CONTROLLED NNP I-NP I-m
RELEASE NNP I-NP I-m
15 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q12H NNP I-NP B-f
FELODIPINE NNP I-NP B-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs VBZ O O
otherwise RB O O
Number NNP B-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
5 CD O I-du
FLONASE NNP B-NP B-m
( ( O I-m
FLUTICASONE NNP B-NP I-m
NASAL NNP I-NP I-m
SPRAY NNP I-NP I-m
) ) O I-m
1 CD O B-do
SPRAY NNP B-NP I-do
INH NNP I-NP B-mo
QD NNP I-NP B-f
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
5 CD O I-du
ADVAIR NNP B-NP B-m
DISKUS NNP I-NP I-m
500/50 CD O I-m
( ( O I-m
FLUTICASONE NNP B-NP I-m
PROPIONATE/ NNP I-NP I-m
) ) O I-m
1 CD O B-do
PUFF NNP B-NP I-do
INH NNP I-NP O
BID NNP I-NP O
CALTRATE NNP I-NP B-m
+ NNP I-NP I-m
D NNP I-NP I-m
( ( O I-m
CALCIUM NNP B-NP I-m
CARBONATE NNP I-NP I-m
1 CD O I-m
, , O I-m
500 CD O I-m
MG NNP B-NP I-m
( ( O I-m
600 CD O I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
NOVOLOG NNP I-NP B-m
NOVOLOG NNP I-NP B-m
NOVOLOG NNP I-NP B-m
MIX NNP I-NP I-m
MIX NNP I-NP I-m
MIX NNP I-NP I-m
70/30 CD O I-m
70/30 CD O I-m
70/30 CD O I-m
( ( O I-m
( ( O I-m
( ( O I-m
INSULIN NNP B-NP I-m
INSULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
70/30 CD O I-m
70/30 CD O I-m
70/30 CD O I-m
) ) O I-m
) ) O I-m
) ) O I-m
35 CD O B-do
UNITS NNP B-NP I-do
QAM; NNP I-NP B-f
22 CD O B-do
UNITS NNP B-NP I-do
QPM NNP I-NP B-f
SC NNP I-NP B-mo
SC NNP I-NP B-mo
35 CD O B-do
UNITS NNP B-NP I-do
QAM NNP I-NP B-f
22 CD O O
UNITS NNP B-NP O
QPM NNP I-NP O
PREDNISONE NNP I-NP B-m
PREDNISONE NNP I-NP B-m
PREDNISONE NNP I-NP B-m
PREDNISONE NNP I-NP B-m
PREDNISONE NNP I-NP B-m
PREDNISONE NNP I-NP B-m
PREDNISONE NNP I-NP B-m
Taper NNP I-NP O
PO NNP I-NP B-mo
Give NNP I-NP O
60 CD O B-do
mg NN B-NP I-do
q NN I-NP B-f
24 CD O I-f
h NN B-NP I-f
X NNP I-NP B-du
5 CD O I-du
dose( NN B-NP I-du
s NN I-NP I-du
) ) O I-du
, , O O
then RB O O
Give VB O O
50 CD O B-do
mg NN B-NP I-do
q NN I-NP B-f
24 CD O I-f
h NN B-NP I-f
X NNP I-NP B-du
3 CD O I-du
dose( NN B-NP I-du
s NN I-NP I-du
) ) O I-du
, , O O
then RB O O
Give VB O O
40 CD O B-do
mg NN B-NP I-do
q NN I-NP B-f
24 CD O I-f
h NN B-NP I-f
X NNP I-NP B-du
3 CD O I-du
dose( NN B-NP I-du
s NN I-NP I-du
) ) O I-du
, , O O
then RB O O
Give VB O O
30 CD O B-do
mg NN B-NP I-do
q NN I-NP B-f
24 CD O I-f
h NN B-NP I-f
X NNP I-NP B-du
3 CD O I-du
dose( NN B-NP I-du
s NN I-NP I-du
) ) O I-du
, , O O
then RB O O
Give VB O O
20 CD O B-do
mg NN B-NP I-do
q NN I-NP B-f
24 CD O I-f
h NN B-NP I-f
X NNP I-NP B-du
3 CD O I-du
dose( NN B-NP I-du
s NN I-NP I-du
) ) O I-du
, , O O
then RB O O
Give VB O O
10 CD O B-do
mg NN B-NP I-do
q NN I-NP B-f
24 CD O I-f
h NN B-NP I-f
X NNP I-NP B-du
3 CD O I-du
dose( NN B-NP I-du
s NN I-NP I-du
) ) O I-du
, , O O
then RB O O
Give VB O O
5 CD O B-do
mg NN B-NP I-do
q NN I-NP B-f
24 CD O I-f
h NN B-NP I-f
X NNP I-NP B-du
3 CD O I-du
dose( NN B-NP I-du
s NN I-NP I-du
) ) O I-du
, , O O
then RB O O
Starting VBG O O
Today NNP B-NP O
( ( O O
6/25 CD O O
) ) O O
COMBIVENT NNP B-NP B-m
( ( O I-m
IPRATROPIUM NNP B-NP I-m
AND NNP I-NP I-m
ALBUTEROL NNP I-NP I-m
SULFATE NNP I-NP I-m
) ) O I-m
2 CD O B-do
PUFF NNP B-NP I-do
INH NNP I-NP B-mo
QID NNP I-NP B-f
DIET: NNP I-NP O
4 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Please NNP I-NP O
schedule NN I-NP O
appointment NN I-NP O
with IN B-VP O
primary JJ B-NP O
care NN I-NP O
doctor NN I-NP O
at IN B-VP O
the DT B-NP O
BCCMC NNP I-NP O
early JJ B-NP O
next JJ I-NP O
week NN I-NP O
, , O O
ALLERGY: NNP B-NP O
Erythromycins NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
pneumonia NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
COPD NNP B-NP O
flare NN I-NP O
, , O O
right JJ B-NP O
heart NN I-NP O
failure NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
prostate NN I-NP O
CA NNP I-NP O
, , O O
DM NNP B-NP O
, , O O
hypertension NN B-NP O
, , O O
R NNP B-NP O
breast NN I-NP O
cancer NN I-NP O
, , O O
recurrent NN B-NP O
pneumothorax NN I-NP O
, , O O
COPD NNP B-NP O
on IN B-VP O
home NN B-NP O
O2 NNP I-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
OA NNP B-NP O
, , O O
chronic JJ B-NP O
pain NN I-NP O
BPH NNP I-NP O
, , O O
peripheral JJ B-NP O
neuopathy JJ I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
none NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
cardiac VBP O O
MR NNP B-NP O
v/q FW O O
scan JJ B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
--HPI: NNP I-NP O
Mr NNP I-NP O
Gump NNP I-NP O
is VBZ O O
a DT B-NP O
77yo JJ I-NP O
African JJ I-NP O
American JJ I-NP O
male NN I-NP O
with IN B-VP O
PMH NNP B-NP O
notable JJ O O
for IN B-VP O
COPD NNP B-NP O
, , O O
HTN NNP B-NP O
, , O O
NIDDM NNP B-NP O
and CC O O
recent JJ B-NP O
PNA NNP I-NP O
who WP O O
presented VBD B-VP O
to TO O O
SHH NNP B-NP O
ED NNP I-NP O
on IN B-VP O
7/26/05 CD O O
via IN B-VP O
EMS NNP B-NP O
with IN B-VP O
a DT B-NP O
CC NNP I-NP O
of IN B-VP O
SOB NNP B-NP O
x NNP I-NP O
3d CD O O
He PRP O O
was VBD B-VP O
seen VBN O O
2 CD O O
days NNS B-NP O
earlier RBR O O
at IN B-VP O
the DT B-NP O
Dis.ry NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
where WRB O O
he PRP O O
was VBD B-VP O
diagosed VBN O O
with IN B-VP O
pneumonia NN B-NP O
and CC O O
given VBN O O
Azithromycin NNP B-NP B-m
The DT B-NP O
day NN I-NP O
of IN B-VP O
admissio NN B-NP O
he PRP O O
said VBD B-VP O
his PRP$ O O
breathing NN B-NP O
felt VBD B-VP O
more RBR O O
labored JJ O O
and CC O O
he PRP O O
contacted VBD B-VP O
EMS NNP B-NP O
to TO O O
take VB O O
him PRP O O
to TO O O
the DT B-NP O
CHA NNP I-NP O
ED NNP I-NP O
He PRP O O
also RB O O
reported VBD B-VP O
worsening VBG O O
exercise NN B-NP O
tolerance NN I-NP O
and CC O O
an DT B-NP O
increase NN I-NP O
in IN B-VP O
bilateral JJ B-NP O
lower JJR I-NP O
extremity NN I-NP O
edema NN I-NP O
over IN B-VP O
the DT B-NP O
past JJ I-NP O
few JJ I-NP O
months NNS I-NP O
, , O O
accompanied VBN O O
by IN B-VP O
a DT O O
20lb CD O O
weight NN B-NP O
gain NN I-NP O
He PRP O O
also RB O O
noted VBD B-VP O
left VBD B-VP O
sided JJ B-NP O
pleuritic JJ I-NP O
pain NN I-NP O
made VBD B-VP O
worse JJR O O
by IN B-VP O
physical JJ B-NP O
movement NN I-NP O
and CC O O
deep JJ B-NP O
breathing NN I-NP O
He PRP O O
was VBD B-VP O
treated VBN O O
in IN B-VP O
the DT B-NP O
ED NNP I-NP O
with IN B-VP O
supplemental JJ B-NP O
O2 NNP I-NP B-m
and CC O O
Levofloxacin NNP B-NP B-m
and CC O O
admitted VBN O O
with IN B-VP O
a DT B-NP O
diagnosis NN I-NP O
of IN B-VP O
COPD NNP B-NP O
flare NN I-NP O
and CC O O
right JJ B-NP O
heart NN I-NP O
failure NN I-NP O
--Home NNP I-NP O
meds: NN I-NP O
atenolol VBD B-VP B-m
25mg CD O B-do
PO NNP B-NP O
qd NN I-NP B-f
, , O O
HCTZ NNP B-NP B-m
25mg CD O B-do
PO NNP B-NP B-mo
PO NNP I-NP B-mo
qd NN I-NP B-f
, , O O
felodipine VBP O B-m
5mg CD O B-do
PO NNP B-NP B-mo
qd NN I-NP B-f
, , O O
zocor NN B-NP B-m
20mg CD O B-do
PO NNP B-NP B-mo
qhs NN I-NP B-f
, , O O
ASA NNP B-NP B-m
81mg CD O B-do
PO NNP B-NP B-mo
qd NN I-NP B-f
, , O O
Advair NNP B-NP B-m
1 CD O B-do
puff NN B-NP I-do
bid NN I-NP B-f
, , O O
Combivent NNP B-NP B-m
2 CD O B-do
puffs NNS B-NP I-do
qid RB O B-f
, , O O
loratidine JJ O B-m
10mg CD O B-do
PO NNP B-NP B-mo
qd NN I-NP B-f
, , O O
guqifenesin NN B-NP B-m
600mg CD O B-do
PO NNP B-NP B-mo
q12h NN I-NP B-f
, , O O
morphine VBP O B-m
15mg CD O B-do
PO NNP B-NP B-mo
q8-12h NN I-NP B-f
, , O O
Percocet NNP B-NP B-m
1-2 JJ B-NP B-do
tab NN I-NP I-do
PO NNP I-NP B-mo
q6h NN I-NP B-f
, , O O
quinine JJ B-NP B-m
sulfate NN I-NP I-m
325mg CD O B-do
PO NNP B-NP B-mo
qhs NN I-NP B-f
, , O O
Colace NNP B-NP B-m
100mg CD O B-do
PO NNP B-NP B-mo
bid NN I-NP B-f
, , O O
Senna NNP B-NP B-m
2 CD O B-do
tab NN B-NP I-do
PO NNP I-NP B-mo
qd NN I-NP B-f
, , O O
calcium+vim NN B-NP B-m
D NNP I-NP I-m
125 CD O B-do
units NNS B-NP I-do
PO NNP I-NP B-mo
qd NN I-NP B-f
, , O O
Elavil NNP B-NP B-m
10mg CD O B-do
PO NNP B-NP B-mo
qhs NN I-NP B-f
--Allergies: NNP I-NP O
NKDA NNP I-NP O
--Social NNP I-NP O
Hx: NNP I-NP O
veteran NN I-NP O
and CC O O
retired JJ B-NP O
school NN I-NP O
bus NN I-NP O
driver NN I-NP O
lives VBZ O O
with IN B-VP O
close JJ B-NP O
friend NN I-NP O
in IN B-VP O
Thou NNP B-NP O
son NN I-NP O
checks NNS I-NP O
in IN B-VP O
on IN B-VP O
him PRP O O
multiple JJ B-NP O
times NNS I-NP O
during IN B-VP O
the DT B-NP O
week NN I-NP O
--PE NNP I-NP O
upon IN B-VP O
admission: NN B-NP O
afebrile NN I-NP O
, , O O
P NNP B-NP O
101 CD O O
, , O O
R NNP B-NP O
28 CD O O
, , O O
BP NNP B-NP O
150/70 CD O O
, , O O
O2 NNP B-NP O
sat VBD B-VP O
99% CD O O
2L CD O O
NC NNP B-NP O
Pulm- NNP I-NP O
labored VBD B-VP O
breathing NN B-NP O
, , O O
accessory JJ B-NP O
muscle NN I-NP O
use NN I-NP O
, , O O
rhonchi NN B-NP O
and CC O O
expiratory NN B-NP O
wheezes NNS I-NP O
present JJ O O
throughout IN B-VP O
both DT B-NP O
lung NN I-NP O
fields NNS I-NP O
egophony VBP O O
in IN B-VP O
LLL NNP B-NP O
CV- NNP I-NP O
normal JJ B-NP O
PMI NNP I-NP O
, , O O
no DT B-NP O
RV NNP I-NP O
heave VBP O O
RRR NNP B-NP O
Unable NNP I-NP O
to TO O O
appreciate VB O O
heart NN B-NP O
sounds VBZ O O
weak JJ B-NP O
peripheral JJ I-NP O
pulses NNS I-NP O
12cm CD O O
JVD NNP B-NP O
Abd- NNP I-NP O
+BS NNP I-NP O
, , O O
nontender NN B-NP O
, , O O
nondistended VBD B-VP O
hepatomegaly JJ O O
Ext- JJ O O
2+ CD O O
bilateral JJ O O
pitting VBG O O
edema JJ B-NP O
Neuro- JJ I-NP O
AAOx3 NNP I-NP O
CN NNP I-NP O
intact JJ B-NP O
strength NN I-NP O
5/5 CD O O
, , O O
symmetric JJ O O
unable JJ O O
to TO O O
elicit VB O O
reflexes NNS B-NP O
--Sig NNP I-NP O
labs NN I-NP O
and CC O O
tests NNS B-NP O
upon IN B-VP O
admission: JJ B-NP O
BUN NNP I-NP O
17 CD O O
, , O O
Cr NNP B-NP O
1.4 CD O O
, , O O
Glucose NNP B-NP O
179 CD O O
WBC NNP B-NP O
8.7 CD O O
, , O O
Hct NNP B-NP O
38 CD O O
, , O O
MCV NNP B-NP O
84 CD O O
LFTs NNP B-NP O
normal JJ B-NP O
Albumin NNP I-NP O
4.3 CD O O
, , O O
Amylast NNP B-NP O
83 CD O O
, , O O
Lipase NNP B-NP O
33 CD O O
Cardiac NNP B-NP O
enzymes- JJ B-NP O
negative JJ I-NP O
CXR NNP I-NP O
showed VBD B-VP O
old JJ B-NP O
RLL NNP I-NP O
infiltrate NN I-NP O
unchanged JJ O O
from IN B-VP O
previous JJ B-NP O
tests NNS I-NP O
ECG NNP I-NP O
demonstrated VBD B-VP O
nonspecific JJ B-NP O
ST NNP I-NP O
changes NNS I-NP O
unchanged JJ O O
from IN B-VP O
previous JJ B-NP O
tests NNS I-NP O
--Hospital VBP O O
course: JJ O O
1 CD O O
) ) O O
Pulm- NNP B-NP O
Pt NNP I-NP O
treated VBD B-VP O
for IN B-VP O
COPD NNP B-NP B-r
COPD NNP I-NP B-r
COPD NNP I-NP B-r
flare NN I-NP I-r
flare NN I-NP I-r
flare NN I-NP I-r
with IN B-VP O
supplemental JJ B-NP O
O2 NNP I-NP B-m
, , O O
DuoNebs NNP B-NP B-m
, , O O
and CC O O
steroids NNS B-NP B-m
Since IN B-VP O
he PRP O O
reported VBD B-VP O
left RB O O
sided VBN O O
pleuritic JJ B-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
we PRP O O
evaluated VBD B-VP O
the DT B-NP O
possibility NN I-NP O
of IN B-VP O
PE NNP B-NP O
with IN B-VP O
a DT B-NP O
V/Q NNP I-NP O
scan NN I-NP O
that WDT O O
reported VBD B-VP O
a DT B-NP O
low JJ I-NP O
probability NN I-NP O
of IN B-VP O
PE NNP B-NP O
2 CD O O
) ) O O
CV- NNP B-NP O
Pt's NNP I-NP O
physical JJ B-NP O
exam NN I-NP O
demonstrated VBD B-VP O
signs NNS B-NP O
of IN B-VP O
right-sided JJ B-NP O
heart NN I-NP O
failure NN I-NP O
, , O O
notably RB O O
12 CD O O
cm NN B-NP O
JVD NNP I-NP O
, , O O
hepatomegaly NN B-NP O
and CC O O
later RB O O
hepatojugular JJ B-NP O
reflex NN I-NP O
, , O O
and CC O O
2+ CD O O
bilateral JJ B-NP O
lower JJR I-NP O
extremity NN I-NP O
pitting VBG O O
edema NN B-NP O
We PRP O O
proceeded VBD B-VP O
to TO O O
treat VB O O
his PRP$ O B-r
his PRP$ O B-r
heart NN B-NP O
failure NN I-NP O
by IN B-VP O
diuresis NN B-NP O
with IN B-VP O
Lasix NNP B-NP B-m
Lasix NNP I-NP B-m
, , O O
initially RB O O
PO NNP B-NP B-mo
and CC O O
then RB O O
IV NNP B-NP B-mo
Overall NNP I-NP O
, , O O
he PRP O O
diuresed VBD B-VP O
approximately RB O O
1L CD O O
fluid NN B-NP O
To TO O O
further JJ O O
evaluate VB O O
his PRP$ O O
heart NN B-NP O
failure NN I-NP O
, , O O
a DT B-NP O
cardiac JJ I-NP O
MRI NNP I-NP O
was VBD B-VP O
obtained VBN O O
and CC O O
demonstrated VBN O O
normal JJ B-NP O
cardiac JJ I-NP O
anatomy NN I-NP O
and CC O O
function NN B-NP O
His PRP$ O O
LVEF NNP B-NP O
was VBD B-VP O
73% CD O O
and CC O O
he PRP O O
had VBD B-VP O
no DT B-NP O
valvular JJ I-NP O
dysfunction NN I-NP O
3 CD O O
) ) O O
ID- NNP B-NP O
Sputum NNP I-NP O
was VBD B-VP O
cultured VBN O O
which WDT O O
showed VBD B-VP O
few JJ B-NP O
polys NNS I-NP O
, , O O
moderate JJ B-NP O
cocci NN I-NP O
, , O O
2+ CD O O
suspected VBD B-VP O
oral JJ B-NP O
flora NNS I-NP O
Since IN B-VP O
he PRP O O
remained VBD B-VP O
afebrile JJ O O
and CC O O
did VBD B-VP O
not RB O O
demonstrate VB O O
an DT B-NP O
elevated JJ I-NP O
WBC NNP I-NP O
, , O O
we PRP O O
did VBD B-VP O
not RB O O
treat VB O O
with IN B-VP O
antibiotics NNS B-NP O
4 CD O O
) ) O O
Endo- NNP B-NP O
His PRP$ O B-r
diabetes NN B-NP I-r
was VBD B-VP O
managed VBN O O
with IN B-VP O
his PRP$ O O
home NN B-NP O
regimen NNS I-NP O
of IN B-VP O
Novolog NNP B-NP B-m
Steroids NNP I-NP B-m
may MD O O
have VB O O
contributed VBN O O
to TO O O
his PRP$ O O
elevated JJ B-NP O
blood NN I-NP O
sugars NNS I-NP O
In IN B-VP O
a DT B-NP O
previous JJ I-NP O
discharge NN I-NP O
summary NN I-NP O
, , O O
it PRP O O
was VBD B-VP O
noted VBN O O
that IN B-VP O
he PRP O O
had VBD B-VP O
an DT O O
elevated VBN O O
TSH NNP B-NP O
level NN I-NP O
We PRP O O
followed VBD B-VP O
up RP O O
on IN B-VP O
this DT O O
by IN B-VP O
rechecking VBG O O
his PRP$ O O
TSH NNP B-NP O
, , O O
which WDT O O
was VBD B-VP O
normal JJ O O
5 CD O O
) ) O O
Renal- NN B-NP O
He PRP O O
an DT B-NP O
elevated JJ I-NP O
baseline NN I-NP O
level NN I-NP O
of IN B-VP O
Cr NNP B-NP O
We PRP O O
monitored VBD B-VP O
his PRP$ O O
Cr NNP B-NP O
and CC O O
BUN NNP B-NP O
for IN B-VP O
an DT B-NP O
increase NN I-NP O
with IN B-VP O
diuresis NN B-NP O
While IN B-VP O
the DT B-NP O
BUN NNP I-NP O
increased VBD B-VP O
to TO O O
the DT O O
low JJ O O
30s CD O O
, , O O
his PRP$ O O
Cr NNP B-NP O
was VBD B-VP O
stable JJ O O
6 CD O O
) ) O O
Prophylaxis- NNP B-NP O
Chronic NNP I-NP B-r
Chronic NNP I-NP B-r
pain NN I-NP I-r
pain NN I-NP I-r
and CC O O
insomnia NN B-NP B-r
insomnia NN I-NP B-r
were VBD B-VP O
managed VBN O O
with IN B-VP O
his PRP$ O O
out-pt JJ B-NP O
regimen NNS I-NP O
of IN B-VP O
morphine NN B-NP B-m
morphine NN I-NP B-m
and CC O O
oxycodone NN B-NP B-m
oxycodone NN I-NP B-m
He PRP O O
was VBD B-VP O
given VBN O O
Elavil NNP B-NP B-m
for IN B-VP O
sleep NN B-NP B-r
Because IN B-VP O
of IN B-VP O
his PRP$ O O
history NN B-NP O
of IN B-VP O
cancer NN B-NP O
, , O O
he PRP O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
Lovenox NNP B-NP B-m
for IN B-VP O
anticoagulation NN B-NP B-r
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Please NNP I-NP O
use VB O O
your PRP$ O O
home NN B-NP O
oxygen NN I-NP B-m
when WRB O O
you PRP O O
are VBP O O
sleeping VBG O O
at IN B-VP B-f
night NN B-NP I-f
We PRP O O
have VBP O O
added VBN O O
combivent NN B-NP B-m
inhalers NNS I-NP I-m
and CC O O
a DT B-NP O
steroid JJ I-NP B-m
taper NN I-NP O
to TO O O
your PRP$ O O
medicines NNS B-NP O
Please NNP I-NP O
stop VB O O
the DT B-NP O
hydrochlorathiazide NN I-NP B-m
( ( O I-m
hctz NN B-NP I-m
) ) O I-m
25mg CD O B-do
Instead RB O O
you PRP O O
will MD O O
be VB O O
taking VBG O O
lasix JJ O B-m
20mg CD O B-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
- : O O
Continue NNP B-NP O
Lasix NNP I-NP B-m
40mg CD O B-do
PO NNP B-NP B-mo
QD NNP I-NP B-f
at IN B-VP O
home NN B-NP O
and CC O O
D/C NNP B-NP O
home NN I-NP O
HTCZ NNP I-NP O
- : O O
Slow NNP B-NP O
Prednisone NNP I-NP B-m
taper NN I-NP O
over IN B-VP O
next JJ O O
20 CD O B-du
days NNS B-NP I-du
- : O O
Have VBP O O
PCP NNP B-NP O
address JJ B-NP O
management NN I-NP O
of IN B-VP O
HTN NNP B-NP B-m
medications NNS I-NP I-m
and CC O O
OSA NNP B-NP O
Check NNP I-NP O
lytes VBZ O O
on IN B-VP O
new JJ B-NP O
dose NN I-NP O
of IN B-VP O
lasix JJ B-NP B-m
Consider NNP I-NP O
adding VBG O O
ACE NNP B-NP B-m
inhibitor NN I-NP I-m
considering VBG O O
hx NN B-NP O
of IN B-VP O
NIDDM NNP B-NP O
Episodic NNP I-NP O
hypoxia NN I-NP O
while IN B-VP O
sleeping VBG O O
may MD O O
contribute VB O O
to TO O O
pulmonary JJ B-NP O
HTN NNP I-NP O
and CC O O
signs NNS B-NP O
of IN B-VP O
right JJ B-NP O
heart NN I-NP O
failure NN I-NP O
observed VBD B-VP O
No NNP B-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
WEIBEL NNP I-NP O
, , O O
RANDALL NNP B-NP O
R NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
TC12 NNP B-NP O
) ) O O
5/28/05 CD O O
@ $ O O
05 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#988921 VBZ O O
739139580 CD O O
DGMC NNP B-NP O
18296522 CD O O
304474 CD O O
7/2/2000 CD O O
12:00:00 CD O O
AM NNP B-NP O
CONGESTIVE NNP I-NP O
HEART NNP I-NP O
FAILURE NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
9/21/2000 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
3/0/2000 CD O O
SERVICE: NNP B-NP O
The DT B-NP O
service NN I-NP O
on IN B-VP O
which WDT O O
the DT B-NP O
patient NN I-NP O
received VBD B-VP O
care NN B-NP O
was VBD B-VP O
Cardiology NNP B-NP O
Broketroit NNP I-NP O
Ma NNP I-NP O
Ri NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Mrs NNP I-NP O
Wetterauer NNP I-NP O
is VBZ O O
a DT B-NP O
54-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
inferior JJ B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
in IN B-VP O
March NNP B-NP O
of IN B-VP O
1997 CD O O
, , O O
with IN B-VP O
sick JJ B-NP O
sinus NN I-NP O
syndrome NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
permanent JJ B-NP O
pacemaker NN I-NP O
placement NN I-NP O
, , O O
and CC O O
paroxysmal JJ B-NP B-r
atrial JJ I-NP I-r
fibrillation NN I-NP I-r
controlled VBN O O
with IN B-VP O
amiodarone; NN B-NP B-m
also RB O O
with IN B-VP O
history NN B-NP O
of IN B-VP O
diabetes NNS B-NP O
mellitus NNS I-NP O
and CC O O
hypertension NN B-NP O
She PRP O O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Crotamp NNP I-NP O
Hospital NNP I-NP O
for IN B-VP O
severe JJ B-NP O
respiratory NN I-NP O
distress NN I-NP O
on IN B-VP O
3/28 CD O O
The DT B-NP O
summary NN I-NP O
of IN B-VP O
clinical JJ B-NP O
events NNS I-NP O
is VBZ O O
as IN B-VP O
follows VBZ O O
The DT B-NP O
evening NN I-NP O
of IN B-VP O
1/11 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
having VBG O O
intercourse NN B-NP O
and CC O O
"collapsed." VB O O
She PRP O O
was VBD B-VP O
very RB O O
short JJ O O
of IN B-VP O
breath NN B-NP O
with IN B-VP O
this DT O O
, , O O
and CC O O
presented VBD B-VP O
to TO O O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
via IN B-VP O
the DT B-NP O
paramedics NNS I-NP O
They PRP O O
attempted VBD B-VP O
to TO O O
intubate VB O O
her PRP O O
on IN B-VP O
the DT B-NP O
field NN I-NP O
and CC O O
found VBD B-VP O
her PRP$ O O
pulse JJ B-NP O
oxygen NN I-NP O
to TO O O
be VB O O
about IN B-VP O
60 CD O O
percent NN B-NP O
on IN B-VP O
bag NN B-NP O
valve NN I-NP O
mask NN I-NP O
They PRP O O
were VBD B-VP O
unable JJ O O
to TO O O
do VB O O
so RB O O
She PRP O O
was VBD B-VP O
described VBN O O
during IN B-VP O
this DT B-NP O
episode NN I-NP O
by IN B-VP O
her PRP$ O O
husband NN B-NP O
as IN B-VP O
to TO O O
have VB O O
been VBN O O
"gurgling." NNP B-NP O
She PRP O O
began VBD B-VP O
to TO O O
describe VB O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
and CC O O
took VBD B-VP O
her PRP$ O O
inhalers NNS B-NP O
which WDT O O
did VBD B-VP O
not RB O O
help VB O O
She PRP O O
began VBD B-VP O
to TO O O
cough VB O O
quite RB O O
a DT B-NP O
bit NN I-NP O
and CC O O
coughed VBD B-VP O
up RP O O
some DT B-NP O
frothy JJ I-NP O
white JJ I-NP O
sputum NN I-NP O
At IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
, , O O
she PRP O O
was VBD B-VP O
immediately RB O O
intubated VBN O O
at IN B-VP O
Sirose NNP B-NP O
There EX O O
was VBD B-VP O
some DT B-NP O
difficulty NN I-NP O
intubating VBG O O
her PRP O O
, , O O
and CC O O
she PRP O O
was VBD B-VP O
ultimately RB O O
intubated VBN O O
by IN B-VP O
the DT O O
attending VBG O O
anesthesiologist NN B-NP O
there RB O O
An DT B-NP O
echocardiogram NN I-NP O
showed VBD B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
25 CD O O
to TO O O
30 CD O O
percent NN B-NP O
with IN B-VP O
flat JJ B-NP O
CKs NNP I-NP O
She PRP O O
was VBD B-VP O
diuresed VBN O O
six CD O O
liters NNS B-NP O
with IN B-VP O
a DT B-NP O
stable JJ I-NP O
BUN NNP I-NP O
and CC O O
creatinine NN B-NP O
and CC O O
was VBD B-VP O
extubated VBN O O
on IN B-VP O
1/19 CD O O
A NNP B-NP O
right JJ B-NP O
heart NN I-NP O
catheterization NN I-NP O
there RB O O
showed VBD B-VP O
a DT B-NP O
pulmonary JJ I-NP O
artery NN I-NP O
pressure NN I-NP O
of IN B-VP O
40/15 CD O O
, , O O
wedge NN B-NP O
of IN B-VP O
12 CD O O
, , O O
cardiac JJ B-NP O
output NN I-NP O
of IN B-VP O
5.2 CD O O
Hemodymanics NNS B-NP O
in IN B-VP O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
at IN B-VP O
Chebanks NNP B-NP O
Hospital NNP I-NP O
indicate VBP O O
the DT B-NP O
patient's NN I-NP O
cardiac NN I-NP O
output NN I-NP O
was VBD B-VP O
quite RB O O
dependent JJ O O
on IN B-VP O
her PRP$ O O
SVR NNP B-NP O
Her NNP I-NP O
cardiac JJ B-NP O
index NN I-NP O
fell VBD B-VP O
into IN B-VP O
the DT B-NP O
high JJ I-NP O
two's NN I-NP O
when WRB O O
her PRP$ O O
SVR NNP B-NP O
was VBD B-VP O
in IN B-VP O
the DT O O
1340 CD O O
range NN B-NP O
, , O O
but CC O O
jumped VBD B-VP O
up RB O O
into IN B-VP O
the DT B-NP O
high JJ I-NP O
three's NN I-NP O
at IN B-VP O
about RB O O
3.8 CD O O
when WRB O O
her PRP$ O O
SVR NNP B-NP O
was VBD B-VP O
much RB O O
lower JJR O O
down RP O O
in IN B-VP O
the DT O O
800s CD O O
At IN B-VP O
the DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
, , O O
a DT B-NP B-r
right JJ I-NP I-r
upper JJ I-NP I-r
lobe NN I-NP I-r
infiltrate NN I-NP I-r
was VBD B-VP O
also RB O O
noted VBN O O
and CC O O
she PRP O O
was VBD B-VP O
given VBN O O
gentamicin JJ O B-m
250 CD O B-do
mg NN B-NP I-do
times NNS I-NP B-du
one CD O I-du
, , O O
and CC O O
clindamycin VBZ O B-m
600 CD O B-do
mg NN B-NP I-do
She PRP O O
was VBD B-VP O
diagnosed VBN O O
with IN B-VP O
pneumonia NN B-NP B-r
and CC O O
treated VBN O O
with IN B-VP O
clindamycin NN B-NP B-m
, , O O
this DT B-NP O
caused JJ I-NP O
resolution NN I-NP O
of IN B-VP O
her PRP$ O O
white JJ B-NP O
count NN I-NP O
at IN B-VP O
the DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
She PRP O O
also RB O O
had VBD B-VP O
an DT B-NP O
increase NN I-NP O
in IN B-VP O
her PRP$ O O
Lasix NNP B-NP B-m
and CC O O
lisinopril RB O B-m
dose VB O O
there RB O O
, , O O
as RB O O
well RB O O
as IN B-VP O
her PRP$ O O
amiodarone NN B-NP B-m
She PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
Solu-Medrol NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
intravenous JJ B-NP B-mo
q.6 NN I-NP B-f
hours NNS I-NP I-f
for IN B-VP O
possible JJ B-NP B-r
asthma NN I-NP I-r
She PRP O O
did VBD B-VP O
quite RB O O
well RB O O
after IN B-VP O
her PRP$ O O
treatment NN B-NP O
for IN B-VP O
pneumonia NN B-NP O
and CC O O
treatment NN B-NP O
for IN B-VP O
pulmonary JJ B-NP O
edema NN I-NP O
, , O O
and CC O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Misutch NNP I-NP O
University NNP I-NP O
Hospital NNP I-NP O
for IN B-VP O
further JJ B-NP O
management NN I-NP O
Her NNP I-NP O
last JJ B-NP O
admission NN I-NP O
was VBD B-VP O
on IN B-VP O
10/6 CD O O
to TO O O
the DT B-NP O
Ceter NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
for IN B-VP O
atypical JJ B-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
when WRB O O
she PRP O O
had VBD B-VP O
a DT B-NP O
nondiagnostic JJ I-NP O
exercise NN I-NP O
tolerance NN I-NP O
test NN I-NP O
She PRP O O
went VBD B-VP O
6 CD O O
minutes NNS B-NP O
and CC O O
19 CD O O
seconds NNS B-NP O
with IN B-VP O
a DT B-NP O
maximum JJ I-NP O
heart NN I-NP O
rate NN I-NP O
of IN B-VP O
94 CD O O
Her PRP$ O O
chest NN B-NP O
pain NN I-NP O
then RB O O
was VBD B-VP O
ultimately RB O O
attributed VBN O O
to TO O O
a DT B-NP O
gastrointestinal JJ I-NP O
cause NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Coronary NNP I-NP O
artery NN I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
inferior JJ B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
on IN B-VP O
9/16 CD O O
She PRP O O
was VBD B-VP O
last JJ O O
admitted JJ O O
, , O O
as IN B-VP O
noted VBN O O
above IN B-VP O
, , O O
on IN B-VP O
10/6 CD O O
to TO O O
the DT B-NP O
Lordchild NNP I-NP O
Hospital NNP I-NP O
for IN B-VP O
atypical JJ B-NP O
chest NN I-NP O
pain NN I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
sick JJ B-NP O
sinus NN I-NP O
syndrome NN I-NP O
and CC O O
is VBZ O O
status NN B-NP O
post NN I-NP O
dual JJ B-NP O
chamber NN I-NP O
pacemaker NN I-NP O
in IN B-VP O
6/15 CD O O
Diabetes NNS B-NP O
mellitus JJ B-NP O
Hypertension NNP I-NP O
Paroxysmal NNP I-NP B-r
atrial JJ B-NP I-r
fibrillation NN I-NP I-r
, , O O
well-controlled JJ O O
in IN B-VP O
the DT B-NP O
past NN I-NP O
on IN B-VP O
amiodarone NN B-NP B-m
Past NNP I-NP O
rhythm NN I-NP O
monitoring NN I-NP O
has VBZ O O
revealed VBN O O
brief JJ B-NP O
runs NNS I-NP O
of IN B-VP O
ventricular JJ B-NP O
tachycardia NN I-NP O
Negative NNP I-NP O
breast NN I-NP O
biopsy NN I-NP O
in IN B-VP O
2/13 CD O O
MEDICATIONS: NNP B-NP O
Home NNP I-NP O
medications NNS I-NP O
include VBP O O
amiodarone RB O B-m
200 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q.d NN I-NP B-f
, , O O
Glyburide NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Lopressor NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Prempro NNP B-NP B-m
0.625/2.5 CD O B-do
p.o NN B-NP B-mo
q.d NN I-NP B-f
, , O O
lisinopril VBZ O B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Coumadin NNP B-NP B-m
, , O O
nitroglycerin JJ O B-m
sublingual JJ O B-mo
, , O O
Zantac NNP B-NP B-m
, , O O
beclomethasone NN B-NP B-m
, , O O
and CC O O
Ventolin NNP B-NP B-m
Medications NNP I-NP O
on IN B-VP O
transfer NN B-NP O
, , O O
Lovenox NNP B-NP B-m
60 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
aspirin RB O B-m
325 CD O B-do
p.o NN B-NP B-mo
q.d NN I-NP B-f
, , O O
lisinopril VBZ O B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
clindamycin VBP O B-m
600 CD O B-do
intravenous JJ B-NP B-mo
q.8 NNS I-NP B-f
, , O O
digoxin NN B-NP B-m
0.25 CD O B-do
, , O O
Lopressor NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Zantac NNP B-NP B-m
, , O O
Albuterol NNP B-NP B-m
, , O O
Flovent NNP B-NP B-m
, , O O
Solu-Medrol NNP B-NP B-m
, , O O
and CC O O
amiodarone RB O B-m
300 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
ALLERGIES: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
allergic JJ O O
to TO O O
penicillin VB O O
SOCIAL NNP B-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
ten NN I-NP O
pack NN I-NP O
year NN I-NP O
smoking VBG O O
history NN B-NP O
and CC O O
quit NN B-NP O
in IN B-VP O
1968 CD O O
No NNP B-NP O
intravenous JJ B-NP O
drug NN I-NP O
use NN I-NP O
She PRP O O
is VBZ O O
retired VBN O O
from IN B-VP O
Medical JJ B-NP O
Records NNS I-NP O
at IN B-VP O
SGH NNP B-NP O
She PRP O O
has VBZ O O
three CD O O
grown JJ B-NP O
children NNS I-NP O
and CC O O
she PRP O O
is VBZ O O
married JJ B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Physical NNP I-NP O
examination NN I-NP O
on IN B-VP O
admission NN B-NP O
is VBZ O O
significant JJ O O
for IN B-VP O
a DT B-NP O
blood NN I-NP O
pressure NN I-NP O
of IN B-VP O
114/93 CD O O
, , O O
this DT O O
is VBZ O O
down RB O O
from IN B-VP O
a DT O O
very RB O O
high JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
on IN B-VP O
admission NN B-NP O
at IN B-VP O
the DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
which WDT O O
was VBD B-VP O
in IN B-VP O
the DT O O
200s CD O O
Pulse NNP B-NP O
is VBZ O O
60 CD O O
, , O O
temperature NN B-NP O
is VBZ O O
96.5 CD O O
, , O O
saturating VBG O O
97 CD O O
percent NN B-NP O
on IN B-VP O
two CD O O
liters NNS B-NP O
General NNP I-NP O
, , O O
this DT O O
is VBZ O O
an DT B-NP O
agitated JJ I-NP O
woman NN I-NP O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
Her NNP I-NP O
neck NN I-NP O
veins NNS I-NP O
were VBD B-VP O
about RB O O
5.0 CD O O
to TO O O
6.0 CD O O
cm NN B-NP O
of IN B-VP O
water NN B-NP O
The DT B-NP O
lung NN I-NP O
examination NN I-NP O
showed VBD B-VP O
a DT B-NP O
few JJ I-NP O
crackles NNS I-NP O
in IN B-VP O
the DT B-NP O
left JJ I-NP O
base NN I-NP O
with IN B-VP O
the DT O O
right JJ O O
one CD O O
clear JJ B-NP O
Cardiovascular NNP I-NP O
examination NN I-NP O
revealed VBD B-VP O
a DT B-NP O
split NN I-NP O
S1 NNP I-NP O
and CC O O
normal JJ B-NP O
S2 NNP I-NP O
, , O O
also RB O O
a DT B-NP O
soft JJ I-NP O
S3 NNP I-NP O
, , O O
the DT B-NP O
presence NN I-NP O
of IN B-VP O
a DT O O
2/6 CD O O
systolic JJ B-NP O
ejection NN I-NP O
murmur NN I-NP O
at IN B-VP O
the DT B-NP O
right JJ I-NP O
upper JJ I-NP O
sternal JJ I-NP O
border NN I-NP O
was VBD B-VP O
noted VBN O O
The DT B-NP O
abdomen NNS I-NP O
was VBD B-VP O
benign JJ O O
, , O O
no DT B-NP O
hepatosplenomegaly NN I-NP O
noted VBD B-VP O
The DT B-NP O
extremities NNS I-NP O
showed VBD B-VP O
no DT B-NP O
edema NN I-NP O
, , O O
with IN B-VP O
intact JJ B-NP O
distal JJ I-NP O
pulses NNS I-NP O
Neurologically RB O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
alert JJ O O
and CC O O
oriented VBD B-VP O
times NNS B-NP O
three CD O O
with IN B-VP O
no DT B-NP O
focal JJ I-NP O
deficits NNS I-NP O
, , O O
but CC O O
careful JJ B-NP O
neurologic JJ I-NP O
examination NN I-NP O
was VBD B-VP O
impossible JJ O O
due JJ O O
to TO O O
severe JJ B-NP O
agitation NN I-NP O
and CC O O
anxiety NN B-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Laboratory NNP I-NP O
on IN B-VP O
admission NN B-NP O
was VBD B-VP O
significant JJ O O
for IN B-VP O
a DT B-NP O
Troponin NNP I-NP O
of IN B-VP O
0.02 CD O O
, , O O
CK NNP B-NP O
of IN B-VP O
80 CD O O
, , O O
INR NNP B-NP O
of IN B-VP O
1.3 CD O O
, , O O
hematocrit NN B-NP O
of IN B-VP O
38.0 CD O O
, , O O
BUN/creatinine NNP B-NP O
of IN B-VP O
24/0.6 CD O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
Mrs NNP I-NP O
Digerolamo NNP I-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Aley NNP I-NP O
Coness-o NNP I-NP O
Meoak NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
and CC O O
managed VBN O O
by IN B-VP O
problems NNS B-NP O
as IN B-VP O
follows VBZ O O
Flash NNP B-NP O
Pulmonary NNP I-NP O
Edema: NNP I-NP O
The DT B-NP O
initial JJ I-NP O
concern NN I-NP O
for IN B-VP O
Mrs NNP B-NP O
Kozicki NNP I-NP O
was VBD B-VP O
of IN B-VP O
this DT O O
being VBG O O
an DT B-NP O
ischemic JJ I-NP O
event NN I-NP O
causing VBG O O
her PRP O O
to TO O O
have VB O O
flash JJ B-NP O
pulmonary JJ I-NP O
edema NN I-NP O
However RB O O
, , O O
coronary JJ B-NP O
catheterization NN I-NP O
revealed VBD B-VP O
the DT B-NP O
patient NN I-NP O
to TO O O
have VB O O
clean JJ B-NP O
coronaries NNS I-NP O
Echocardiogram NNP I-NP O
revealed VBD B-VP O
a DT B-NP O
left JJ I-NP O
ventricular JJ I-NP O
hypertrophy NN I-NP O
with IN B-VP O
a DT B-NP O
low JJ I-NP O
normal JJ I-NP O
systolic JJ I-NP O
function NN I-NP O
, , O O
with IN B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
50 CD O O
to TO O O
55 CD O O
percent NN B-NP O
There EX O O
was VBD B-VP O
akinesis NN B-NP O
of IN B-VP O
the DT B-NP O
inferior JJ I-NP O
wall NN I-NP O
present JJ O O
She PRP O O
had VBD B-VP O
normal JJ B-NP O
right JJ I-NP O
ventricular NN I-NP O
size NN I-NP O
and CC O O
function NN B-NP O
She PRP O O
had VBD B-VP O
1 CD O O
to TO O O
2+ CD O O
mitral JJ B-NP O
regurgitation NN I-NP O
with IN B-VP O
mild JJ B-NP O
left JJ I-NP O
atrial JJ I-NP O
enlargement NN I-NP O
and CC O O
1+ CD O O
tricuspid JJ B-NP O
regurgitation NN I-NP O
with IN B-VP O
a DT B-NP O
regurgitive JJ I-NP O
velocity NN I-NP O
of IN B-VP O
about IN B-VP O
2.7 CD O O
meters NNS B-NP O
per IN B-VP O
second JJ B-NP O
consistent NN I-NP O
with IN B-VP O
minimal JJ B-NP O
pulmonary JJ I-NP O
systolic NN I-NP O
pressures NNS I-NP O
Subsequently RB O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
had VBN O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
hypothyroidism NN B-NP O
in IN B-VP O
the DT B-NP O
past NN I-NP O
, , O O
and CC O O
she PRP O O
had VBD B-VP O
normal JJ B-NP O
TSH NNP I-NP O
recently RB O O
checked VBD B-VP O
by IN B-VP O
her PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
, , O O
Dr NNP B-NP O
Slipper NNP I-NP O
, , O O
of IN B-VP O
TCH NNP B-NP O
However RB O O
, , O O
with IN B-VP O
no DT B-NP O
other JJ I-NP O
etiology NN I-NP O
present JJ O O
, , O O
we PRP O O
were VBD B-VP O
worried VBN O O
about IN B-VP O
the DT B-NP O
patient NN I-NP O
having VBG O O
had VBD B-VP O
tachyarrhythmia VBN O O
from IN B-VP O
some DT B-NP O
other JJ I-NP O
source NN I-NP O
causing VBG O O
this DT O O
The DT B-NP O
Electrophysiology NNP I-NP O
Service NNP I-NP O
interrogated VBD B-VP O
the DT B-NP O
patient's NN I-NP O
pacer NN I-NP O
which WDT O O
revealed VBD B-VP O
a DT B-NP O
number NN I-NP O
of IN B-VP O
tachyarrhythmias NN B-NP O
A NNP I-NP O
TSH NNP I-NP O
panel NN I-NP O
was VBD B-VP O
checked VBN O O
which WDT O O
revealed VBD B-VP O
a DT B-NP O
TSH NNP I-NP O
of IN B-VP O
less JJR O O
than IN B-VP O
assay NN B-NP O
, , O O
and CC O O
T4 NNP B-NP O
free JJ B-NP O
thyroxin NN I-NP O
index NN I-NP O
elevated VBD B-VP O
An DT B-NP O
Endocrinology NNP I-NP O
consultation NN I-NP O
was VBD B-VP O
obtained VBN O O
, , O O
and CC O O
they PRP O O
believed VBD B-VP O
that IN B-VP O
the DT B-NP O
patient's NN I-NP O
thyrotoxicosis NN I-NP O
was VBD B-VP O
amiodarone RB O O
induced JJ O O
She PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
Tapazole NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
They PRP O O
also RB O O
suggested VBD B-VP O
prednisone NN B-NP B-m
, , O O
but CC O O
the DT B-NP O
patient NN I-NP O
did VBD B-VP O
refuse VB O O
this DT O O
They PRP O O
recommended VBD B-VP O
follow-up NN B-NP O
with IN B-VP O
Endocrine NNP B-NP O
in IN B-VP O
about RB O O
four CD O O
to TO O O
six CD O O
weeks NNS B-NP O
Therefore RB O O
, , O O
the DT B-NP O
final JJ I-NP O
etiology NN I-NP O
for IN B-VP O
the DT B-NP O
patient's NN I-NP O
flash NN I-NP O
pulmonary JJ B-NP O
edema NN I-NP O
was VBD B-VP O
amiodarone RB O B-m
induced JJ B-NP O
thyrotoxicosis NN I-NP O
causing VBG O O
increased VBN O O
susceptibility NN B-NP O
to TO O O
tachyarrhythmia VB O O
, , O O
left VBD B-VP O
ventricular JJ B-NP O
hypertrophy NN I-NP O
, , O O
and CC O O
possible JJ B-NP O
diastolic JJ I-NP O
dysfunction NN I-NP O
, , O O
resulting VBG O O
in IN B-VP O
acute JJ B-NP O
pump NN I-NP O
dysfunction NN I-NP O
, , O O
causing VBG O O
flash JJ B-NP O
pulmonary JJ I-NP O
edema NN I-NP O
The DT B-NP O
final JJ I-NP O
therapy NN I-NP O
for IN B-VP O
this DT B-NP O
problem NN I-NP O
will MD O O
consist VB O O
of IN B-VP O
heavy JJ B-NP O
nodal NNS I-NP O
blockade VBD B-VP O
The DT B-NP O
patient NN I-NP O
will MD O O
be VB O O
blockaded VBN O O
with IN B-VP O
calcium NN B-NP B-m
channel NN I-NP I-m
blockers NNS I-NP I-m
, , O O
as RB O O
well RB O O
as IN B-VP O
Lopressor NNP B-NP B-m
Pneumonia: NNP I-NP B-r
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
treated VBN O O
with IN B-VP O
clindamycin NN B-NP B-m
and CC O O
did VBD B-VP O
quite RB O O
well RB O O
Her NNP B-NP O
white JJ B-NP O
count NN I-NP O
fully RB O O
resolved VBN O O
and CC O O
she PRP O O
had VBD B-VP O
no DT B-NP O
fever NN I-NP O
or CC O O
other JJ B-NP O
symptoms NNS I-NP O
of IN B-VP O
pneumonia NN B-NP O
She PRP O O
will MD O O
be VB O O
discharged VBN O O
without IN B-VP O
any DT B-NP O
further JJ I-NP O
antibiotics NNS I-NP B-m
Urinary JJ B-NP O
Tract NNP I-NP O
Infection: NNP I-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
lot NN I-NP O
of IN B-VP O
uric JJ B-NP B-r
crystals NNS I-NP I-r
, , O O
therefore IN B-VP O
she PRP O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
Bactrim NNP B-NP B-m
Double NNP I-NP I-m
Strength NNP I-NP I-m
b.i.d NN I-NP B-f
times VBZ O O
a DT B-NP B-du
total NN I-NP O
of IN B-VP O
seven CD O O
days NNS B-NP O
Psychiatry: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
clearly RB O O
severe JJ B-NP B-r
anxiety NN I-NP I-r
and CC O O
was VBD B-VP O
in IN B-VP O
a DT B-NP B-r
full JJ I-NP O
panic NN I-NP O
attack NN I-NP O
on IN B-VP O
admission NN B-NP O
She PRP O O
was VBD B-VP O
treated VBN O O
acutely RB O O
with IN B-VP O
Ativan NNP B-NP B-m
Ativan NNP I-NP B-m
and CC O O
her PRP$ O O
problem NN B-NP O
resolved VBD B-VP O
quite RB O O
well RB O O
, , O O
and CC O O
she PRP O O
became VBD B-VP O
more RBR O O
comfortable JJ O O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
Diabetes NNP I-NP B-r
Diabetes NNP I-NP B-r
Diabetes NNP I-NP B-r
Mellitus: NNP I-NP I-r
Mellitus: NNP I-NP I-r
Mellitus: NNP I-NP I-r
Glyburide NNP I-NP B-m
was VBD B-VP O
held VBN O O
initially RB O O
on IN B-VP O
admission NN B-NP O
She PRP O O
was VBD B-VP O
covered VBN O O
with IN B-VP O
insulin NN B-NP B-m
sliding VBG O B-do
scale JJ B-NP I-do
Glyburide NNP I-NP B-m
was VBD B-VP O
restarted VBN O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
relatively RB O O
high JJ B-NP O
blood NN I-NP O
sugars NNS I-NP O
, , O O
and CC O O
these DT O O
should MD O O
be VB O O
followed VBN O O
as IN B-VP O
an DT B-NP O
outpatient JJ I-NP O
Blood NNP I-NP O
sugars NNS I-NP O
as RB O O
high JJ O O
as IN B-VP O
the DT B-NP O
mid NN I-NP O
300s CD O O
were VBD B-VP O
noted VBN O O
Edema: NNP B-NP O
The DT B-NP O
patient NN I-NP O
clearly RB O O
had VBD B-VP O
some DT B-NP O
fluid NN I-NP B-r
accumulation NN I-NP I-r
which WDT O O
resolved VBD B-VP O
with IN B-VP O
20 CD O B-do
mg NNS B-NP I-do
of IN B-VP O
Lasix NNP B-NP B-m
p.o NN I-NP B-mo
q.d NN I-NP B-f
We PRP O O
will MD O O
continue VB O O
this DT O O
and CC O O
allow VB O O
outpatient JJ B-NP O
follow-up NN I-NP O
to TO O O
determine VB O O
whether IN B-VP O
or CC O O
not RB O O
she PRP O O
will MD O O
need VB O O
this DT O O
in IN B-VP O
the DT B-NP O
future NN I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS NNP I-NP O
INCLUDE: NNP I-NP O
Amiodarone NNP I-NP B-m
200 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
lisinopril VBZ O B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Tapazole NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Zantac NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Coumadin NNP B-NP B-m
5.0 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
q.p.m NN I-NP B-f
, , O O
Bactrim NNP B-NP B-m
Double NNP I-NP I-m
Strength NNP I-NP I-m
one CD O B-do
tablet NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
times NNS I-NP B-du
four CD O I-du
days NNS B-NP I-du
after IN B-VP O
discharge NN B-NP O
, , O O
Prempro NNP B-NP B-m
0.625/2.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Glyburide NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Lasix NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
atenolol RB O B-m
150 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q.d NN I-NP B-f
, , O O
diltiazem JJ B-NP B-m
CD NN I-NP I-m
240 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
DISPOSITION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
home NN B-NP O
in IN B-VP O
good JJ B-NP O
condition NN I-NP O
FINAL NNP I-NP O
DIAGNOSIS: NNP I-NP O
Thyrotoxicosis NNP I-NP O
FOLLOW-UP: NNP I-NP O
She PRP O O
will MD O O
follow-up VB O O
with IN B-VP O
Dr NNP B-NP O
Provins NNP I-NP O
on IN B-VP O
Monday NNP B-NP O
, , O O
3/22 CD O O
at IN B-VP O
9:30 CD O O
a.m NN B-NP O
, , O O
and CC O O
Dr NNP B-NP O
Orejel NNP I-NP O
of IN B-VP O
Chia NNP B-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
Endocrinology NNP I-NP O
at IN B-VP O
U NNP B-NP O
Hay NNP I-NP O
Rill NNP I-NP O
, , O O
on IN B-VP O
6/5 CD O O
at IN B-VP O
3:00 CD O O
p.m RB O O
Dictated NNP B-NP O
By: NNP I-NP O
MARKUS NNP I-NP O
TRAFICANTE NNP I-NP O
, , O O
M.D NNP B-NP O
TF37 NNP I-NP O
Attending: NNP I-NP O
OSVALDO NNP I-NP O
H NNP I-NP O
CONDUFF NNP I-NP O
, , O O
M.D NNP B-NP O
IK5 NNP I-NP O
WN271/0715 NNP I-NP O
Batch: NNP I-NP O
41277 CD O O
Index NNP B-NP O
No NNP I-NP O
H4SU0M28CE NNP I-NP O
D: NNP I-NP O
1/7 CD O O
T: NNP B-NP O
6/29 CD O O
CC: NNP B-NP O
1 CD O O
BOYCE NNP B-NP O
F NNP I-NP O
MARWICK NNP I-NP O
, , O O
M.D NNP B-NP O
VO67 NNP I-NP O
, , O O
BLOOBY NNP B-NP O
HONOR NNP I-NP O
HOSPITAL NNP I-NP O
, , O O
Ette NNP B-NP O
, , O O
Utah NNP B-NP O
08029 CD O O
2 CD O O
LENNY NNP B-NP O
M NNP I-NP O
PANNY NNP I-NP O
, , O O
M.D NNP B-NP O
FF0 NNP I-NP O
3 CD O O
COLUMBUS NNP B-NP O
SHIHADEH NNP I-NP O
, , O O
M.D NNP B-NP O
GC6 NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#992321 VBZ O O
419885223 CD O O
SVMC NNP B-NP O
11356075 CD O O
3131842 CD O O
2/2/2007 CD O O
12:00:00 CD O O
AM NNP B-NP O
atypical JJ B-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
hypertension NN B-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
9/12/2007 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
1/2/2007 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
SAGASER NNP I-NP O
, , O O
SCOT NNP B-NP O
105-81-88-0 CD O O
Ba NNP B-NP O
Ch NNP I-NP O
Wi NNP I-NP O
, , O O
West NNP B-NP O
Virginia NNP I-NP O
75512 CD O O
Service: NNP B-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
5/23/07 CD O O
AT NNP B-NP O
12:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
INGWELL NNP I-NP O
, , O O
MOSES NNP B-NP O
HERMAN NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.P.H NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
1 CD O O
FLUTICASONE NNP B-NP B-m
PROPIONATE/SALMETEROL NNP I-NP I-m
250/50 CD O I-m
1 CD O B-do
PUFF NNP B-NP I-do
INH NNP I-NP B-mo
BID NNP I-NP B-f
2 CD O O
ALBUTEROL NNP B-NP B-m
NEBULIZER NNP I-NP I-m
2.5 CD O B-do
MG NNP B-NP I-do
NEB NNP I-NP B-mo
Q4H NNP I-NP B-f
3 CD O O
ARTIFICIAL NNP B-NP B-m
TEARS NNP I-NP I-m
2 CD O B-do
DROP NNP B-NP I-do
OD NNP I-NP B-mo
TID NNP I-NP B-f
4 CD O O
LORATADINE NNP B-NP B-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
5 CD O O
HYDROCHLOROTHIAZIDE NNP B-NP B-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
6 CD O O
ALBUTEROL NNP B-NP B-m
INHALER NNP I-NP I-m
2 CD O B-do
PUFF NNP B-NP I-do
INH NNP I-NP B-mo
QID NNP I-NP B-f
MEDICATIONS NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
ALBUTEROL NNP I-NP B-m
INHALER NNP I-NP I-m
2 CD O B-do
PUFF NNP B-NP I-do
INH NNP I-NP B-mo
QID NNP I-NP B-f
PRN NNP I-NP I-f
Shortness NNP I-NP B-r
of IN B-VP I-r
Breath NNP B-NP I-r
ALBUTEROL NNP I-NP B-m
ALBUTEROL NNP I-NP B-m
NEBULIZER NNP I-NP I-m
NEBULIZER NNP I-NP I-m
2.5 CD O B-do
2.5 CD O B-do
MG NNP B-NP I-do
MG NNP I-NP I-do
NEB NNP I-NP B-mo
NEB NNP I-NP B-mo
Q2H NNP I-NP B-f
Q2H NNP I-NP B-f
PRN NNP I-NP O
Shortness NNP I-NP B-r
of IN B-VP I-r
Breath NNP B-NP I-r
, , O O
Wheezing NNP B-NP B-r
ATENOLOL NNP I-NP B-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
ADVAIR NNP I-NP B-m
DISKUS NNP I-NP I-m
500/50 CD O I-m
( ( O I-m
FLUTICASONE NNP B-NP I-m
PROPIONATE/ NNP I-NP I-m
) ) O I-m
1 CD O B-do
PUFF NNP B-NP I-do
INH NNP I-NP B-mo
BID NNP I-NP B-f
HYDROCHLOROTHIAZIDE NNP I-NP B-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
MICONAZOLE NNP I-NP B-m
NITRATE NNP I-NP I-m
2% CD O I-m
POWDER NNP B-NP I-m
TOPICAL NNP I-NP B-mo
TP NNP I-NP I-mo
DAILY NNP I-NP B-f
Instructions: NNP I-NP O
to TO O O
affected VB O O
areas NNS B-NP O
( ( O O
abdominal JJ B-NP O
folds NNS I-NP O
) ) O O
DIET: NNP B-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
2100 CD O O
cals/dy NN B-NP O
DIET: NNP I-NP O
2 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Blackledge NNP I-NP O
Cardiology NNP I-NP O
clinic JJ B-NP O
Worth NNP I-NP O
Yonkers NNP I-NP O
Juan NNP I-NP O
724-105-6354 JJ O O
11/0 CD O O
@ JJ O O
2pm CD O O
, , O O
Dr NNP B-NP O
Rownd NNP I-NP O
10/14 CD O O
at IN B-VP O
1:50pm CD O O
, , O O
Kendall NNP B-NP O
Burvine NNP I-NP O
nutrition NN I-NP O
10/14 CD O O
at IN B-VP O
1:15pm CD O O
, , O O
ALLERGY: NNP B-NP O
NKA NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
chest JJS B-NP O
pain NN I-NP O
, , O O
cough NN B-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
atypical JJ B-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
hypertension NN B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
Asthma NNP I-NP O
, , O O
Morbid NNP B-NP O
Obesity NNP I-NP O
, , O O
Pneumonia NNP B-NP O
, , O O
intertrigo NN B-NP O
, , O O
UTI NNP B-NP O
, , O O
otitis NN B-NP O
media NNS I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
none NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
Cardiac NNP B-NP O
PET NNP I-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC: NNP I-NP O
chest JJS B-NP O
pain NN I-NP O
, , O O
cough NN B-NP O
**** NNP I-NP O
HPI: NNP I-NP O
45 CD O O
yo NN B-NP O
male NN I-NP O
w/ NN I-NP O
morbid NN I-NP O
obesity NN I-NP O
and CC O O
asthma JJ B-NP O
presents NNS I-NP O
with IN B-VP O
chest NN B-NP O
pain NN I-NP O
and CC O O
cough NN B-NP O
Pt NNP I-NP O
c/o NN I-NP O
SSCP NNP I-NP O
x18h NNP I-NP O
, , O O
described VBD B-VP O
as IN B-VP O
tightness NN B-NP O
, , O O
radiating VBG O O
to TO O O
his PRP$ O O
back RP O O
that DT O O
began VBD B-VP O
at IN B-VP O
night NN B-NP O
while IN B-VP O
he PRP O O
was VBD B-VP O
sleeping VBG O O
Pain NNP B-NP O
is VBZ O O
worse JJR O O
with IN B-VP O
cough JJ B-NP O
Denies NNPS I-NP O
exertional JJ B-NP O
CP NNP I-NP O
but CC O O
very RB O O
limited JJ B-NP O
activity NN I-NP O
2/2 CD O O
obesityNo NN B-NP O
associated VBN O O
SOB NNP B-NP O
, , O O
but CC O O
mild JJ B-NP O
nausea NN I-NP O
and CC O O
+diaphoresis NN B-NP O
Denies NNP I-NP O
leg VBZ O O
swelling VBG O O
He PRP O O
c/o VBZ O O
worsening VBG O O
nonproductive JJ B-NP O
cough NN I-NP O
x1 NN I-NP O
day NN I-NP O
He PRP O O
often RB O O
has VBZ O O
nighttime JJ B-NP O
symptoms NNS I-NP O
of IN B-VP O
cough NN B-NP B-r
, , O O
relieved VBN O O
by IN B-VP O
nebulizer NN B-NP B-m
treatments NNS I-NP I-m
No DT B-NP O
fevers NNS I-NP O
, , O O
chills NNS B-NP O
, , O O
no DT B-NP O
other JJ I-NP O
URI NNP I-NP O
sx NN I-NP O
**** NNP I-NP O
ED NNP I-NP O
COURSE: NNP I-NP O
96.0 CD O O
p106 NN B-NP O
209/94 CD O O
rr20 NN B-NP O
95%RA CD O O
, , O O
CTA NNP B-NP O
Chest NNP I-NP O
peformed VBD B-VP O
and CC O O
was VBD B-VP O
neg VBN O O
for IN B-VP O
dissection NN B-NP O
, , O O
rx'd FW O O
nitro FW O B-m
gtt NN B-NP O
, , O O
labetalol NN B-NP B-m
, , O O
ASA NNP B-NP B-m
, , O O
nexium NN B-NP B-m
, , O O
albuterol NN B-NP B-m
neb JJ B-NP B-mo
Pt NNP I-NP O
had VBD B-VP O
emesis NN B-NP B-r
x1 NN I-NP O
, , O O
rx'd NN B-NP O
zofran NN I-NP B-m
**** NNP I-NP O
PMH: NNP I-NP O
Asthma NNP I-NP O
- : O O
Peak NNP B-NP O
flow VB O O
400 CD O O
at IN B-VP O
baseline NN B-NP O
No NNP I-NP O
intubations NNS I-NP O
, , O O
but CC O O
many JJ B-NP O
admissions NNS I-NP O
Obesity NNP I-NP O
- : O O
morbid NN B-NP O
Nephrolithiasis NNP I-NP O
Atypical NNP I-NP O
chest NN I-NP O
pain NN I-NP O
- : O O
negative JJ B-NP O
ETT NNP I-NP O
2002 CD O O
Umbilical NNP B-NP O
hernia NN I-NP O
repair NN I-NP O
2001 CD O O
-- : O O
incarcerated VBD B-VP B-r
HTN NNP B-NP I-r
-- : O O
recent JJ B-NP O
dx NN I-NP O
, , O O
started VBD B-VP O
on IN B-VP O
HCTZ NNP B-NP B-m
**** NNP I-NP O
EXAM: NNP I-NP O
afeb VBD B-VP O
p98 JJ O O
155/64 CD O O
rr18 NN B-NP O
93%RA CD O O
NAD NNP B-NP O
mmm NN I-NP O
, , O O
OP NNP B-NP O
clear JJ B-NP O
+diffuse NNP I-NP O
expiratory NN I-NP O
wheezes NNS I-NP O
and CC O O
rhonchi NN B-NP O
, , O O
+cough NN B-NP O
on IN B-VP O
forced JJ B-NP O
exhalation NN I-NP O
rrr NN I-NP O
, , O O
nl JJ B-NP O
S1S2 NNP I-NP O
, , O O
no DT B-NP O
m/g/r NN I-NP O
abd VBZ O O
obese JJ O O
, , O O
BS+ NNP B-NP O
, , O O
NT/ND NNP B-NP O
wwp NN I-NP O
, , O O
TR NNP B-NP O
edema VBZ O O
bilat JJ B-NP O
**** NNP I-NP O
LABS: NNP I-NP O
enzymes VBZ O O
neg JJ B-NP O
x3 NNP I-NP O
STUDIES: NNP I-NP O
EKG: NNP I-NP O
poor JJ B-NP O
study NN I-NP O
with IN B-VP O
wavering VBG O O
baseline NN B-NP O
, , O O
sinus JJ B-NP O
tach NN I-NP O
at IN B-VP O
100 CD O O
, , O O
no DT B-NP O
sig NN I-NP O
STTw NNP I-NP O
changes NNS I-NP O
, , O O
+low JJ B-NP O
voltage NN I-NP O
criteria NNS I-NP O
CTA NNP I-NP O
Chest: NNP I-NP O
negative JJ O O
for IN B-VP O
dissection NN B-NP O
Limited NNP I-NP O
study NN I-NP O
due JJ O O
to TO O O
body NN B-NP O
habitus JJ B-NP O
Incidental NNP I-NP O
finding NN I-NP O
of IN B-VP O
3 CD O O
subcentimeter NN B-NP O
nodules NNS I-NP O
in IN B-VP O
periphery NN B-NP O
of IN B-VP O
R NNP B-NP O
lung NNP I-NP O
Focal NNP I-NP O
thickening NN I-NP O
of IN B-VP O
lateral JJ B-NP O
limb NN I-NP O
of IN B-VP O
L NNP B-NP O
adrenal JJ B-NP O
gland NN I-NP O
**** NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
45 CD O O
yo NN B-NP O
M NNP I-NP O
w/ NN I-NP O
morbid NN I-NP O
obesity NN I-NP O
presents NNS I-NP O
with IN B-VP O
chest NN B-NP O
pain NN I-NP O
and CC O O
hypertensive JJ B-NP O
urgency NN I-NP O
* NNP I-NP O
CV: NNP I-NP O
Ischemia- NNP I-NP O
Pt NNP I-NP O
ruled VBD B-VP O
out RP O O
for IN B-VP O
MI NNP B-NP O
with IN B-VP O
negative JJ B-NP O
serial JJ I-NP O
enzymes NNS I-NP O
and CC O O
EKGs NNP B-NP O
Cardiac NNP I-NP O
PET NNP I-NP O
showed VBD B-VP O
2 CD O O
small JJ B-NP O
areas NNS I-NP O
of IN B-VP O
of IN B-VP O
reversible JJ B-NP O
ischemia NN I-NP O
in IN B-VP O
the DT B-NP O
mid NN I-NP O
PDA NNP I-NP O
and CC O O
distal JJ B-NP O
LAD NNP I-NP O
territory NN I-NP O
Cards NNP I-NP O
f/u NN I-NP O
was VBD B-VP O
arranged VBN O O
as IN B-VP O
an DT B-NP O
oupatient NN I-NP O
He PRP O O
was VBD B-VP O
given VBN O O
ASA NNP B-NP B-m
, , O O
and CC O O
beta NN B-NP B-m
blocker NN I-NP I-m
Total NNP I-NP O
cholesterol NN I-NP O
was VBD B-VP O
111 CD O O
, , O O
triglycerides NNS B-NP O
44 CD O O
, , O O
HDL NNP B-NP O
49 CD O O
, , O O
LDL NNP B-NP O
53 CD O O
Despites NNP B-NP O
evidence NN I-NP O
of IN B-VP O
CAD NNP B-NP O
on IN B-VP O
PET NNP B-NP O
, , O O
a DT B-NP O
statin NN I-NP B-m
was VBD B-VP O
not RB O O
started VBN O O
since IN B-VP O
patient NN B-NP O
has VBZ O O
a DT B-NP O
difficult JJ I-NP O
time NN I-NP O
with IN B-VP O
medication NN B-NP O
adherence NN I-NP O
and CC O O
understanding NN B-NP O
Will NNP I-NP O
defer VB O O
statin JJ B-NP B-m
initiation NN I-NP O
to TO O O
cardiology VB O O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
if IN B-VP O
necessary JJ O O
For IN B-VP O
HTN NNP B-NP B-r
HTN NNP I-NP B-r
control NN I-NP I-r
control NN I-NP I-r
, , O O
pt NN B-NP O
was VBD B-VP O
given VBN O O
HCTZ NNP B-NP B-m
and CC O O
lopressor NN B-NP B-m
which WDT O O
sufficiently RB O O
controlled VBD B-VP O
his PRP$ O O
BP NNP B-NP O
Pt NNP I-NP O
was VBD B-VP O
sent VBN O O
home NN B-NP O
on IN B-VP O
HCTZ NNP B-NP B-m
25mg CD O B-do
daily RB O B-f
and CC O O
atenolol VB O B-m
50mg CD O B-do
daily JJ B-NP B-f
Consider NNP I-NP O
outpatient NN I-NP O
w/u NN I-NP O
of IN B-VP O
thickened JJ B-NP O
adrenal JJ I-NP O
gland NN I-NP O
if IN B-VP O
BP NNP B-NP O
is VBZ O O
difficult JJ O O
to TO O O
control VB O O
* NNP B-NP O
PULM NNP I-NP O
- : O O
Pt NNP B-NP O
thought VBD B-VP O
to TO O O
have VB O O
very RB O B-r
very RB O B-r
very RB O B-r
mild JJ B-NP I-r
mild JJ I-NP I-r
mild JJ I-NP I-r
asthma NN I-NP I-r
asthma NN I-NP I-r
asthma JJ B-NP I-r
exacerbation NN I-NP I-r
exacerbation NN I-NP I-r
exacerbation NN I-NP I-r
and CC O O
likely RB O O
has VBZ O O
a DT B-NP B-r
restrictive JJ I-NP I-r
ventilatory NN I-NP I-r
defect NN I-NP I-r
from IN B-VP I-r
obesity NN B-NP I-r
Advair NNP I-NP B-m
Advair NNP I-NP B-m
Advair NNP I-NP B-m
was VBD B-VP O
increased VBN O O
to TO O O
500/50 CD O B-do
500/50 CD O B-do
BID NNP B-NP B-f
BID NNP I-NP B-f
Pt NNP I-NP O
was VBD B-VP O
given VBN O O
nebs JJ B-NP B-m
ATC NNP I-NP I-m
and CC O O
prednisone VB O B-m
prednisone NN B-NP B-m
60mg CD O B-do
60mg CD O B-do
qd NN B-NP B-f
qd NN I-NP B-f
x NNP I-NP B-du
x VBD B-VP I-f
3 CD O I-du
3 CD O I-f
doses NNS B-NP I-du
doses NNS I-NP I-f
and CC O O
then RB O O
stopped VBD B-VP O
when WRB O O
respiratory NN B-NP O
status NN I-NP O
significantly RB O O
improved VBN O O
* JJ B-NP O
GI: NNP I-NP O
Pt NNP I-NP O
had VBD B-VP O
trace NN B-NP O
guaiac NN I-NP O
+ NNP I-NP O
stool NN I-NP O
HCT NNP I-NP O
remained VBD B-VP O
stable JJ B-NP O
Outpt NNP I-NP O
colonoscopy NN I-NP O
is VBZ O O
recommended VBN O O
Pt NNP B-NP O
also RB O O
c/o VBP O O
loose JJ B-NP O
stool NN I-NP O
, , O O
c VB O O
diff NN B-NP O
was VBD B-VP O
negative JJ B-NP O
Pt NNP I-NP O
likely RB O O
has VBZ O O
a DT B-NP O
viral JJ I-NP O
gastroenteritis NN I-NP O
causing VBG O O
diarrhea NN B-NP O
and CC O O
some DT B-NP O
nausea NN I-NP O
* NNP I-NP O
ENDO: NNP I-NP O
A1C NNP I-NP O
was VBD B-VP O
7.4 CD O O
and CC O O
BS NNP B-NP O
was VBD B-VP O
in IN B-VP O
mid JJ O O
100s CD O O
multiple JJ B-NP O
times NNS I-NP O
during IN B-VP O
admit NN B-NP O
Pt NNP I-NP O
educated VBD B-VP O
on IN B-VP O
low JJ B-NP O
sugar NN I-NP O
, , O O
low JJ B-NP O
carbohydrate NN I-NP O
diet NN I-NP O
He PRP O O
was VBD B-VP O
seen VBN O O
by IN B-VP O
nutrition NN B-NP O
and CC O O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
his PRP$ O O
outpatient JJ B-NP O
nutritionist NN I-NP O
* NNP I-NP O
PPX: NNP I-NP O
lovenox VBZ O B-m
BID NNP B-NP B-f
( ( O O
for IN B-VP O
weight NN B-NP B-r
) ) O O
ADDITIONAL NNP B-NP O
COMMENTS: NNP I-NP O
1 CD O O
) ) O O
Take VB O O
hydrochlorothiazide JJ O B-m
25mg CD O B-do
daily JJ O B-f
and CC O O
atenolol JJ O B-m
50mg CD O B-do
daily JJ O B-f
for IN B-VP O
your PRP$ O B-r
your PRP$ O B-r
blood NN B-NP O
pressure NN I-NP O
You PRP O O
should MD O O
also RB O O
take VB O O
aspirin JJ O B-m
81mg CD O B-do
daily RB O B-f
2 CD O O
) ) O O
Your PRP$ O O
blood NN B-NP O
sugar NN I-NP O
has VBZ O O
been VBN O O
slightly RB O O
elevtaed IN B-VP O
You PRP O O
need VBP O O
to TO O O
eat VB O O
a DT B-NP O
low JJ I-NP O
sugar NN I-NP O
, , O O
low JJ B-NP O
carbohydrate NN I-NP O
diet JJ B-NP O
Please NNP I-NP O
discuss NN I-NP O
with IN B-VP O
your PRP$ O O
nutritionist JJ O O
3 CD O O
) ) O O
Follow NNP B-NP O
up RP O O
with IN B-VP O
cardiology NN B-NP O
( ( O O
heart NN B-NP O
clinic NN I-NP O
) ) O O
on IN B-VP O
11/0 CD O O
at IN B-VP O
Peobrid NNP B-NP O
Robrid NNP I-NP O
Clevery NNP I-NP O
Xand NNP I-NP O
O NNP I-NP O
Ee NNP I-NP O
on IN B-VP O
the DT B-NP O
Montcar NNP I-NP O
Erv NNP I-NP O
Pkwy NNP I-NP O
, , O O
Ton-ster NNP B-NP O
Fallsbi NNP I-NP O
Saant NNP I-NP O
, , O O
Minnesota NNP B-NP O
16637 CD O O
4 CD O O
) ) O O
Call VB O O
Dr NNP B-NP O
Lampkin NNP I-NP O
or CC O O
come VBN O O
back RB O O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
if IN B-VP O
you PRP O O
have VBP O O
chest VBN O O
pain NN B-NP O
, , O O
difficulty NN B-NP O
breathing NN I-NP O
, , O O
fever NN B-NP O
, , O O
or CC O O
lightheadedness JJ B-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
1 CD O O
) ) O O
Monitor NNP B-NP O
blood NN I-NP O
sugars NNS I-NP O
and CC O O
A1C- NNP B-NP O
pt NN I-NP O
is VBZ O O
borderline JJ O O
diabetic JJ O O
and CC O O
will MD O O
try VB O O
diet JJ B-NP O
modification NN I-NP O
2 CD O O
) ) O O
Recommend NNP B-NP O
outpatient NN I-NP O
colonoscopy NN I-NP O
3 CD O O
) ) O O
Consider NNP B-NP O
statin NN I-NP B-m
therapy NN I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
PICKELL NNP I-NP O
, , O O
MARKUS NNP B-NP O
L NNP I-NP O
( ( O O
GN51 NNP B-NP O
) ) O O
5/23/07 CD O O
@ $ O O
01:27 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#992839 VBZ O O
753215669 CD O O
KRCH NNP B-NP O
33656807 CD O O
3752166 CD O O
9/2/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
4/21/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
2/29/2005 CD O O
ATTENDING: NNP B-NP O
MACCARONE NNP I-NP O
, , O O
HERB NNP B-NP O
M.D NNP I-NP O
SERVICE: NNP I-NP O
General NNP I-NP O
Medical NNP I-NP O
Service NNP I-NP O
, , O O
Na NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
Congestive NNP I-NP O
heart NN I-NP O
failure NN I-NP O
DISCHARGE NNP I-NP O
DIAGNOSES: NNP I-NP O
Congestive NNP I-NP O
heart NN I-NP O
failure NN I-NP O
, , O O
aortic JJ B-NP O
valve NN I-NP O
and CC O O
mitral JJ B-NP O
valve NN I-NP O
dysfunction NN I-NP O
CHIEF NNP I-NP O
COMPLAINT: NNP I-NP O
Shortness NNP I-NP O
of IN B-VP O
breath JJ B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
59-year-old JJ B-NP O
female NN I-NP O
who WP O O
is VBZ O O
status NN B-NP O
post NN I-NP O
mitral JJ B-NP O
valve NN I-NP O
repair NN I-NP O
, , O O
aortic JJ B-NP O
valve NN I-NP O
repair NN I-NP O
, , O O
history NN B-NP O
of IN B-VP O
endocarditis NN B-NP O
, , O O
history NN B-NP O
of IN B-VP O
rheumatic JJ B-NP O
heart NN I-NP O
disease NN I-NP O
, , O O
hypertension NN B-NP O
, , O O
diabetes VBZ O O
mellitus NN B-NP O
, , O O
and CC O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
who WP O O
presents VBZ O O
with IN B-VP O
increasing VBG O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
nausea NN B-NP O
, , O O
vomiting NN B-NP O
, , O O
and CC O O
abdominal JJ B-NP O
pain NN I-NP O
She PRP O O
has VBZ O O
been VBN O O
under IN B-VP O
significant JJ B-NP O
stress NN I-NP O
at IN B-VP O
home NN B-NP O
since IN B-VP O
last JJ B-NP O
summer NN I-NP O
and CC O O
notes NNS B-NP O
slowly RB O O
declining VBG O O
health NN B-NP O
since IN B-VP O
that DT B-NP O
time NN I-NP O
She PRP O O
has VBZ O O
had VBD B-VP O
increasing VBG O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
as RB O O
well RB O O
as IN B-VP O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
since IN B-VP O
July NNP B-NP O
2004 CD O O
and CC O O
has VBZ O O
gotten VBN O O
worse RBR O O
in IN B-VP O
the DT O O
past JJ O O
one CD O O
month NN B-NP O
, , O O
and CC O O
even RB O O
significantly RB O O
worse JJR O O
in IN B-VP O
the DT B-NP O
past JJ I-NP O
week NN I-NP O
The DT B-NP O
patient NN I-NP O
notes NNS I-NP O
increasing VBG O O
lower JJR B-NP O
extremity NN I-NP O
edema NN I-NP O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
side NN I-NP O
greater JJR O O
than IN B-VP O
the DT O O
left JJ O O
She PRP O O
states VBZ O O
that IN B-VP O
this DT O O
is VBZ O O
her PRP$ O O
baseline NN B-NP O
with IN B-VP O
the DT B-NP O
right JJ I-NP O
side NN I-NP O
being VBG O O
more JJR O O
than IN B-VP O
the DT B-NP O
left NN I-NP O
She PRP O O
has VBZ O O
no DT B-NP O
increase NN I-NP O
in IN B-VP O
her PRP$ O O
abdominal JJ B-NP O
girth NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
has VBZ O O
two-to JJ B-NP O
three-pillow JJ I-NP O
orthopnea NN I-NP O
( ( O O
from IN B-VP O
one-pillow JJ B-NP O
orthopnea NN I-NP O
, , O O
one CD O O
month NN B-NP O
ago RB O O
) ) O O
, , O O
she PRP O O
does VBZ O O
have VB O O
some DT B-NP O
paroxysmal JJ I-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
, , O O
she PRP O O
has VBZ O O
no DT O O
increased VBN O O
nocturia RB O O
The DT B-NP O
patient NN I-NP O
notes VBZ O O
that IN B-VP O
the DT B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
is VBZ O O
"not JJ B-NP O
angina; NN I-NP O
I PRP O O
do VBP O O
not RB O O
have VB O O
that." VBN O O
She PRP O O
does VBZ O O
not RB O O
have VB O O
any DT B-NP O
lightheadedness NN I-NP O
, , O O
diaphoresis NN B-NP O
, , O O
or CC O O
radiation NN B-NP O
of IN B-VP O
pain NN B-NP O
The DT B-NP O
patient NN I-NP O
says VBZ O O
that IN B-VP O
she PRP O O
does VBZ O O
not RB O O
check VB O O
her PRP$ O O
weigh NN B-NP O
at IN B-VP O
home NN B-NP O
, , O O
but CC O O
"knows" NNP B-NP O
she PRP O O
is VBZ O O
in IN B-VP O
failure NN B-NP O
when WRB O O
she PRP O O
is VBZ O O
short JJ O O
of IN B-VP O
breath NN B-NP O
She PRP O O
also RB O O
notes VBZ O O
nausea NN B-NP O
, , O O
vomiting NN B-NP O
, , O O
and CC O O
some DT B-NP O
abdominal JJ I-NP O
pain NN I-NP O
stating VBG O O
that IN B-VP O
it PRP O O
started VBD B-VP O
about IN B-VP O
a DT B-NP O
week NN I-NP O
and CC O O
a DT B-NP O
half NN I-NP O
ago IN B-VP O
She PRP O O
had VBD B-VP O
gone VBN O O
to TO O O
see VB O O
the DT B-NP O
ED NNP I-NP O
on IN B-VP O
the DT B-NP O
Sunday NNP I-NP O
prior RB O O
to TO O O
admission VB O O
where WRB O O
the DT B-NP O
patient NN I-NP O
reportedly RB O O
had VBD B-VP O
a DT B-NP O
benign JJ I-NP O
exam NN I-NP O
, , O O
low-grade JJ B-NP O
temperature NN I-NP O
, , O O
given VBN O O
recent JJ B-NP O
Levaquin NNP I-NP B-m
for IN B-VP O
an DT B-NP B-r
upper JJ I-NP O
respiratory NN I-NP O
tract NN I-NP O
infection NN I-NP O
, , O O
she PRP O O
was VBD B-VP O
then RB O O
started VBN O O
on IN B-VP O
Flagyl NNP B-NP B-m
for IN B-VP O
a DT B-NP B-r
possible JJ I-NP I-r
C NNP I-NP I-r
difficile NN I-NP I-r
infection NN I-NP I-r
The DT B-NP O
patient's NN I-NP O
diarrhea NN I-NP O
stopped VBD B-VP O
, , O O
but CC O O
she PRP O O
had VBD B-VP O
still RB O O
remained VBN O O
some DT B-NP O
abdominal JJ I-NP O
pain NN I-NP O
and CC O O
increased VBD B-VP O
cough NN B-NP O
, , O O
which WDT O O
was VBD B-VP O
nonproductive JJ O O
She PRP O O
went VBD B-VP O
to TO O O
her PRP$ O O
PCP NNP B-NP O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
for IN B-VP O
increasing VBG O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
and CC O O
was VBD B-VP O
sent VBN O O
to TO O O
the DT B-NP O
ED NNP I-NP O
for IN B-VP O
diuresis NN B-NP O
In IN B-VP O
the DT B-NP O
ED NNP I-NP O
, , O O
she PRP O O
was VBD B-VP O
given VBN O O
60 CD O B-do
mg NN B-NP I-do
of IN B-VP O
IV NNP B-NP B-mo
Lasix NNP I-NP B-m
with IN B-VP O
good JJ B-NP O
output NN I-NP O
per IN B-VP O
report NN B-NP O
She PRP O O
did VBD B-VP O
have VB O O
some DT B-NP O
decrease NN I-NP O
in IN B-VP O
her PRP$ O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
shortly RB O O
thereafter RB O O
She PRP O O
also RB O O
complained VBD B-VP O
of IN B-VP O
10/10 CD O B-r
abdominal JJ B-NP I-r
pain NN I-NP I-r
and CC O O
was VBD B-VP O
given VBN O O
some DT B-NP O
Dilaudid NNP I-NP B-m
On IN B-VP O
the DT B-NP O
floor NN I-NP O
during IN B-VP O
the DT B-NP O
interview NN I-NP O
, , O O
she PRP O O
did VBD B-VP O
have VB O O
some DT B-NP O
projectile NN I-NP O
vomiting VBG O O
She PRP O O
was VBD B-VP O
able JJ O O
to TO O O
pass VB O O
gas NN B-NP O
She PRP O O
reported VBD B-VP O
no DT B-NP O
fevers NNS I-NP O
, , O O
chills NNS B-NP O
, , O O
or CC O O
night NN B-NP O
sweats NNS I-NP O
She PRP O O
reported VBD B-VP O
no DT B-NP O
bright JJ I-NP O
red JJ I-NP O
blood NN I-NP O
per IN B-VP O
rectum NN B-NP O
She PRP O O
reported VBD B-VP O
no DT B-NP O
change NN I-NP O
in IN B-VP O
her PRP$ O O
bowel NN B-NP O
, , O O
bladder NN B-NP O
, , O O
or CC O O
urinary JJ B-NP O
habits NNS I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Rheumatic NNP B-NP O
heart NN I-NP O
disease NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
mitral JJ B-NP O
valve NN I-NP O
repair NN I-NP O
and CC O O
aortic JJ B-NP O
valve NN I-NP O
repair NN I-NP O
In IN B-VP O
1981 CD O O
, , O O
she PRP O O
had VBD B-VP O
porcine JJ B-NP O
mitral JJ I-NP O
valve NN I-NP O
repair NN I-NP O
In IN B-VP O
1991 CD O O
, , O O
she PRP O O
had VBD B-VP O
St NNP B-NP O
Jude NNP I-NP O
valve NN I-NP O
, , O O
mitral JJ B-NP O
valve NN I-NP O
, , O O
and CC O O
AVR NNP B-NP O
2 CD O O
Endocarditis NNP B-NP O
in IN B-VP O
1991 CD O O
and CC O O
porcine VB O O
mitral JJ B-NP O
valve NNS I-NP O
3 CD O O
Diabetes NNPS B-NP O
mellitus VBD B-VP O
4 CD O O
Hypertension NNP B-NP O
5 CD O O
Status NNP B-NP O
post NN I-NP O
ankle NN I-NP O
fracture NN I-NP O
and CC O O
subsequent JJ B-NP O
ORIF NNP I-NP O
in IN B-VP O
2001 CD O O
6 CD O O
Status NNP B-NP O
post NN I-NP O
ventral JJ B-NP O
hernia NN I-NP O
repair NN I-NP O
7 CD O O
Status NNP B-NP O
post NN I-NP O
laparoscopic NN I-NP O
cholecystectomy VBD B-VP O
8 CD O O
Status NNP B-NP O
post NN I-NP O
breast NN I-NP O
biopsy NN I-NP O
9 CD O O
Congestive NNP B-NP O
heart NN I-NP O
failure NN I-NP O
10 CD O O
Atrial NNP B-NP O
fibrillation NN I-NP O
11 CD O O
TIA NNP B-NP O
ALLERGIES: NNP I-NP O
No NNP I-NP O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
Dove NNP I-NP O
soap NN I-NP O
does VBZ O O
give VB O O
her PRP$ O O
hives NNS B-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Lasix NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.o.d NN I-NP B-f
alternating VBG O O
with IN B-VP O
80 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
Lasix NNP I-NP B-m
q.o.d NN I-NP B-f
2 CD O O
Digoxin NNP B-NP B-m
Digoxin NNP I-NP B-m
0.125 CD O B-do
mg NN B-NP I-do
q.o.d NN I-NP B-f
alternating VBG O O
with IN B-VP O
0.25 CD O B-do
q.o.d NNS B-NP B-f
3 CD O O
Lisinopril NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
4 CD O O
Coumadin NNP B-NP B-m
Coumadin NNP I-NP B-m
6 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.o.d NN I-NP B-f
, , O O
alternating VBG O O
with IN B-VP O
4 CD O B-do
mg NNS B-NP I-do
q.o.d RB O B-f
5 CD O O
Omeprazole NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
6 CD O O
Metformin NNP B-NP B-m
500 CD O B-do
mg VBD B-VP I-do
daily RB O B-f
7 CD O O
Insulin NNP B-NP B-m
Insulin NNP I-NP B-m
70/30 CD O I-m
70/30 CD O I-m
65 CD O B-do
units NNS B-NP I-do
q.a.m RB O B-f
, , O O
35 CD O B-do
units NNS B-NP I-do
q.p.m RB O B-f
8 CD O O
Calcium NNP B-NP B-m
600 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
9 CD O O
Magnesium NNP B-NP B-m
400 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
10 CD O O
Multivitamin NNP B-NP B-m
11 CD O O
Iron NNP B-NP B-m
tablets NNS I-NP I-m
12 CD O O
Actonel NNP B-NP B-m
every DT B-NP B-f
Wednesday NNP I-NP I-f
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
quit NN I-NP O
smoking NN I-NP O
in IN B-VP O
2001 CD O O
Her NNP B-NP O
maximum NN I-NP O
was VBD B-VP O
three CD O O
to TO O O
four CD O O
packs NNS B-NP O
per IN B-VP O
day NN B-NP O
for IN B-VP O
35 CD O O
years NNS B-NP O
As RB O O
far RB O O
as IN B-VP O
her PRP$ O O
alcohol NN B-NP O
history NN I-NP O
, , O O
she PRP O O
drinks VBZ O O
occasional JJ B-NP O
alcohol NN I-NP O
She PRP O O
does VBZ O O
not RB O O
take VB O O
any DT B-NP O
illicit NN I-NP O
drugs NNS I-NP O
She PRP O O
used VBD B-VP O
to TO O O
work VB O O
as IN B-VP O
a DT B-NP O
hairdresser NN I-NP O
She PRP O O
has VBZ O O
had VBN O O
increased VBN O O
stress NN B-NP O
at IN B-VP O
home NN B-NP O
secondary NN I-NP O
to TO O O
a DT B-NP O
son NN I-NP O
who WP O O
has VBZ O O
schizophrenia NN B-NP O
and CC O O
another DT B-NP O
son NN I-NP O
who WP O O
abuses VBZ O O
drugs NNS B-NP O
and CC O O
has VBZ O O
violent JJ B-NP O
tendencies NNS I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
Noncontributory NNP I-NP O
PHYSICAL NNP I-NP O
EXAMINATION NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Vital NNP I-NP O
signs NNS I-NP O
are VBP O O
remarkable JJ O O
for IN B-VP O
temperature NN B-NP O
of IN B-VP O
98.7 CD O O
, , O O
pulse RB O O
60 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
111/61 CD O O
, , O O
respiratory NN B-NP O
rate NN I-NP O
30 CD O O
, , O O
O2 NNP B-NP O
saturation NN I-NP O
96% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
These DT O O
were VBD B-VP O
vitals NNS B-NP O
when WRB O O
the DT B-NP O
patient NN I-NP O
arrived VBD B-VP O
to TO O O
the DT B-NP O
floor NN I-NP O
General: NNP I-NP O
She PRP O O
is VBZ O O
alert JJ O O
and CC O O
oriented JJ B-NP O
x3 NN I-NP O
She PRP O O
is VBZ O O
anxious JJ O O
, , O O
but CC O O
pleasant NN B-NP O
in IN B-VP O
nature NN B-NP O
HEENT: NNP I-NP O
Her NNP I-NP O
left VBD B-VP O
eye NN B-NP O
is VBZ O O
artificial JJ B-NP O
Her NNP I-NP O
right NN I-NP O
eye NN I-NP O
is VBZ O O
approximately RB O O
3 CD O O
mm NN B-NP O
She PRP O O
has VBZ O O
moist RB O O
mucous JJ B-NP O
membrane NN I-NP O
She PRP O O
has VBZ O O
a DT B-NP O
small JJ I-NP O
erosion NN I-NP O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
upper JJ I-NP O
gum NN I-NP O
There EX O O
is VBZ O O
no DT B-NP O
erythema NN I-NP O
or CC O O
exudate NN B-NP O
seen VBN O O
within IN B-VP O
the DT B-NP O
tonsils NNS I-NP O
Neck: NNP I-NP O
JVP NNP I-NP O
noted VBD B-VP O
to TO O O
be VB O O
approximately RB O O
6 CD O O
cm NN B-NP O
Her NNP I-NP O
neck NN I-NP O
is VBZ O O
supple JJ O O
There EX O O
was VBD B-VP O
full JJ B-NP O
range NN I-NP O
of IN B-VP O
motion NN B-NP O
There EX O O
are VBP O O
no DT B-NP O
carotid JJ I-NP O
bruits NNS I-NP O
and CC O O
there EX O O
is VBZ O O
no DT B-NP O
lymphadenopathy JJ I-NP O
present JJ I-NP O
Cardiovascular: NNP I-NP O
Heart NNP I-NP O
is VBZ O O
of IN B-VP O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
occasional JJ B-NP O
premature NN I-NP O
beats VBZ O O
She PRP O O
has VBZ O O
a DT B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
that WDT O O
are VBP O O
mechanical JJ O O
in IN B-VP O
nature NN B-NP O
She PRP O O
has VBZ O O
a DT O O
3/6 CD O O
holosystolic JJ O O
murmur FW O O
heard NN B-NP O
at IN B-VP O
the DT B-NP O
apex NN I-NP O
There EX O O
are VBP O O
no DT B-NP O
rubs NN I-NP O
or CC O O
gallops NNS B-NP O
appreciated VBN O O
She PRP O O
additionally RB O O
has VBZ O O
a DT B-NP O
right JJ I-NP O
RV NNP I-NP O
heave VBP O O
Her NNP B-NP O
PMI NNP I-NP O
is VBZ O O
diffuse RB O O
, , O O
but CC O O
nondisplaced VBD B-VP O
Chest: NNP B-NP O
Faint NNP I-NP O
crackles NNS I-NP O
at IN B-VP O
the DT B-NP O
left JJ I-NP O
base NN I-NP O
, , O O
otherwise RB O O
clear JJ B-NP O
No NNP I-NP O
wheezes NN I-NP O
or CC O O
rhonchi NN B-NP O
are VBP O O
heard VBN O O
Abdomen: NNP B-NP O
Slightly NNP I-NP O
tympanic VBD B-VP O
Her PRP$ O O
right JJ B-NP O
lower JJR I-NP O
quadrant NN I-NP O
is VBZ O O
slightly RB O O
tender NN B-NP O
She PRP O O
has VBZ O O
active JJ B-NP O
bowel NN I-NP O
sounds VBZ O O
Her PRP$ O O
liver NN B-NP O
edge NN I-NP O
is VBZ O O
not RB O O
palpable JJ O O
The DT B-NP O
spleen JJ I-NP O
tip NN I-NP O
is VBZ O O
nonpalpable JJ B-NP O
Extremities: NNP I-NP O
Warm NNP I-NP O
, , O O
1+ CD O O
dorsalis NN B-NP O
pedis NN I-NP O
pulses VBZ O O
bilaterally RB O O
She PRP O O
does VBZ O O
have VB O O
some DT O O
1+ CD O O
lower JJR B-NP O
extremity NN I-NP O
edema NN I-NP O
on IN B-VP O
the DT B-NP O
right NN I-NP O
greater JJR O O
than IN B-VP O
the DT B-NP O
left NN I-NP O
It PRP O O
is VBZ O O
slightly RB O O
pitting VBG O O
LABORATORY NNP B-NP O
EXAM NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Sodium NNP I-NP O
126 CD O O
, , O O
potassium NN B-NP O
4.4 CD O O
, , O O
chloride RB O O
93 CD O O
, , O O
bicarbonate NN B-NP O
24 CD O O
, , O O
BUN NNP B-NP O
28 CD O O
, , O O
creatinine NN B-NP O
1.4 CD O O
with IN B-VP O
a DT B-NP O
baseline NN I-NP O
of IN B-VP O
1.2 CD O O
and CC O O
1.3 CD O O
, , O O
glucose VBD B-VP O
160 CD O O
CBC NNP B-NP O
is VBZ O O
notable JJ O O
for IN B-VP O
a DT B-NP O
white JJ I-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
of IN B-VP O
9.9 CD O O
, , O O
hematocrit NN B-NP O
27.9 CD O O
, , O O
platelet NN B-NP O
count NN I-NP O
274 CD O O
, , O O
000 CD O O
Her PRP$ O O
liver NN B-NP O
function NN I-NP O
tests NNS I-NP O
are VBP O O
notable JJ O O
for IN B-VP O
ALT NNP B-NP O
56 CD O O
, , O O
AST NNP B-NP O
83 CD O O
, , O O
alkaline JJ B-NP O
phosphatase NN I-NP O
is VBZ O O
52 CD O O
, , O O
total JJ B-NP O
bilirubin NN I-NP O
0.1 CD O O
, , O O
albumin RB O O
4.2 CD O O
, , O O
and CC O O
total JJ B-NP O
protein NN I-NP O
7.4 CD O O
STUDIES: NNP B-NP O
Her NNP I-NP O
EKG NNP I-NP O
showed VBD B-VP O
no DT B-NP O
change NN I-NP O
It PRP O O
was VBD B-VP O
in IN B-VP O
junctional JJ B-NP O
rhythm NN I-NP O
at IN B-VP O
65 CD O O
beats NNS B-NP O
per IN B-VP O
minute NN B-NP O
She PRP O O
had VBD B-VP O
frequent JJ B-NP O
PVCs NNP I-NP O
There EX O O
was VBD B-VP O
a DT B-NP O
normal JJ I-NP O
access NN I-NP O
There EX O O
were VBD B-VP O
some DT B-NP O
nonspecific JJ I-NP O
T-wave JJ I-NP O
inversions NNS I-NP O
CHEST NNP I-NP O
X-RAY: NN I-NP O
Showed NNP I-NP O
mild IN B-VP O
vascular JJ B-NP O
congestion NN I-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
any DT B-NP O
effusion NN I-NP O
IMPRESSION: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
59-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
rheumatic JJ I-NP O
heart NN I-NP O
disease NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
St NNP I-NP O
Jude's NNP I-NP O
MVR NNP I-NP O
and CC O O
AVR NNP B-NP O
, , O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
who WP O O
presents VBZ O O
with IN B-VP O
mild JJ B-NP O
volume NN I-NP O
overload NN I-NP O
and CC O O
abdominal JJ B-NP O
pain NN I-NP O
with IN B-VP O
nausea NN B-NP O
and CC O O
vomiting VBG O O
BRIEF NNP B-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
BY NNP I-NP O
SYSTEMS: NNP I-NP O
1 CD O O
Cardiovascular: NNP B-NP O
a DT B-NP O
Ischemia: NNP I-NP O
When WRB O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
, , O O
she PRP O O
was VBD B-VP O
ruled VBN O O
out RP O O
for IN B-VP O
an DT B-NP O
MI NNP I-NP O
She PRP O O
did VBD B-VP O
have VB O O
a DT B-NP O
slight JJ I-NP O
increase NN I-NP O
of IN B-VP O
her PRP$ O O
troponins NNS B-NP O
, , O O
which WDT O O
were VBD B-VP O
attributed VBN O O
to TO O O
mild VB O O
demand NN B-NP O
ischemia NN I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
she PRP O O
had VBD B-VP O
some DT B-NP O
slight JJ I-NP O
anemia NN I-NP O
, , O O
which WDT O O
could MD O O
also RB O O
be VB O O
contributed VBN O O
to TO O O
the DT B-NP O
demand NN I-NP O
as RB O O
well RB O O
in IN B-VP O
addition NN B-NP O
to TO O O
the DT B-NP O
clear JJ I-NP O
volume NN I-NP O
overload IN B-VP O
She PRP O O
did VBD B-VP O
fine VB O O
from IN B-VP O
the DT B-NP O
standpoint NN I-NP O
, , O O
had VBD B-VP O
no DT B-NP O
ST NNP I-NP O
changes NNS I-NP O
on IN B-VP O
any DT O O
of IN B-VP O
her PRP$ O O
EKGs NNP B-NP O
The DT B-NP O
patient NN I-NP O
laid VBD B-VP O
her PRP$ O O
head NN B-NP O
workup NN I-NP O
for IN B-VP O
future JJ B-NP O
AVR NNP I-NP O
and CC O O
MVR NNP B-NP O
with IN B-VP O
the DT B-NP O
Surgical NNP I-NP O
Service NNP I-NP O
, , O O
with IN B-VP O
Dr NNP B-NP O
Bio NNP I-NP O
Her NNP I-NP O
workup NN I-NP O
was VBD B-VP O
extensive JJ O O
and CC O O
included VBD B-VP O
a DT B-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
, , O O
which WDT O O
showed VBD B-VP O
no DT B-NP O
significant JJ I-NP O
coronary JJ I-NP O
artery NN I-NP O
disease NN I-NP O
The DT B-NP O
hemodynamics NNS I-NP O
were VBD B-VP O
notable JJ O O
for IN B-VP O
the DT B-NP O
following: JJ I-NP O
RA NNP I-NP O
of IN B-VP O
12 CD O O
, , O O
PA NNP B-NP O
of IN B-VP O
92/23/44 CD O O
, , O O
pulmonary JJ B-NP O
capillary JJ I-NP O
wedge NN I-NP O
pressure NN I-NP O
of IN B-VP O
22 CD O O
with IN B-VP O
V NNP B-NP O
waves NNS I-NP O
to TO O O
42 CD O O
The DT B-NP O
mitral JJ I-NP O
valve NN I-NP O
was VBD B-VP O
grossly RB O O
normal JJ O O
with IN B-VP O
appropriate JJ B-NP O
leaflet NN I-NP O
motion NN I-NP O
The DT B-NP O
AV NNP I-NP O
was VBD B-VP O
also RB O O
grossly RB O O
The DT B-NP O
overall JJ I-NP O
conclusion NN I-NP O
was VBD B-VP O
elevated VBN O O
right-sided JJ B-NP O
heart NN I-NP O
pressures VBZ O O
She PRP O O
had VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
major JJ B-NP O
atherosclerotic JJ I-NP O
disease NN I-NP O
of IN B-VP O
the DT B-NP O
coronary JJ I-NP O
arteries NNS I-NP O
b VBP O O
Pump: NNP B-NP O
Please NNP I-NP O
see VB O O
cath JJ B-NP O
report NN I-NP O
as IN B-VP O
above IN B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
and CC O O
diuresed VBN O O
with IN B-VP O
IV NNP B-NP B-mo
Lasix NNP I-NP B-m
, , O O
so IN B-VP O
she PRP O O
came VBD B-VP O
down RB O O
to TO O O
a DT B-NP O
euvolemic JJ I-NP O
state NN I-NP O
Her PRP$ O B-r
diuresis NN B-NP I-r
was VBD B-VP O
continued VBN O O
with IN B-VP O
80 CD O B-do
mg NNS B-NP I-do
IV NNP I-NP B-mo
Lasix NNP I-NP B-m
on IN B-VP O
a DT B-NP O
b.i.d JJ I-NP B-f
basis NN I-NP O
She PRP O O
was VBD B-VP O
diuresed VBN O O
until IN B-VP O
there EX O O
was VBD B-VP O
a DT B-NP O
subsequent JJ I-NP O
bump NN I-NP O
in IN B-VP O
her PRP$ O O
creatinine NN B-NP O
to TO O O
1.8 CD O O
, , O O
1.9 CD O O
After IN B-VP O
that DT B-NP O
point NN I-NP O
, , O O
diuresis NN B-NP O
was VBD B-VP O
slowly RB O O
modified VBN O O
She PRP O O
was VBD B-VP O
then RB O O
placed VBN O O
back RP O O
on IN B-VP O
a DT B-NP O
regimen NN I-NP O
of IN B-VP O
120 CD O B-do
mg NN B-NP I-do
of IN B-VP O
p.o NN B-NP B-mo
Lasix NNP I-NP B-m
q.o.d NN I-NP B-f
That WDT O O
is VBZ O O
the DT B-NP O
dosing NN I-NP O
of IN B-VP O
Lasix NNP B-NP B-m
on IN B-VP O
which WDT O O
she PRP O O
is VBZ O O
discharged VBN O O
c NNS B-NP O
Rhythm: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
paroxysmal JJ B-NP O
atrial JJ I-NP O
fibrillation NN I-NP O
that WDT O O
has VBZ O O
been VBN O O
rate NN B-NP O
controlled VBN O O
with IN B-VP O
a DT B-NP O
beta-blocker NN I-NP B-m
On IN B-VP O
admission NN B-NP O
, , O O
her PRP$ O O
digoxin NN B-NP B-m
was VBD B-VP O
stopped VBN O O
She PRP O O
was VBD B-VP O
evaluated VBN O O
by IN B-VP O
the DT B-NP O
EP NNP I-NP O
Service NNP I-NP O
They PRP O O
recommended VBD B-VP O
epicardial JJ B-NP O
lead NN I-NP O
placement NN I-NP O
at IN B-VP O
surgery NN B-NP O
due JJ O O
to TO O O
her PRP$ O O
tachybrady JJ O O
syndrome VB O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
on IN B-VP O
diltiazem NN B-NP B-m
30 CD O B-do
mg NN B-NP I-do
q.i.d NN I-NP B-f
She PRP O O
will MD O O
have VB O O
her PRP$ O O
medications NNS B-NP O
modified VBD B-VP O
status NN B-NP O
post NN I-NP O
her PRP$ O O
valvular JJ B-NP O
repair NN I-NP O
in IN B-VP O
the DT O O
very RB O O
near IN B-VP O
future JJ B-NP O
d JJ I-NP O
Presurgical NNP I-NP O
workup: NN I-NP O
In IN B-VP O
addition NN B-NP O
to TO O O
echo VB O O
, , O O
right JJ O O
and CC O O
left JJ B-NP O
heart NN I-NP O
cath NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
TEE NNP I-NP O
performed VBN O O
TEE NNP B-NP O
showed VBD B-VP O
normal JJ B-NP O
left JJ I-NP O
atrial JJ I-NP O
appendage NN I-NP O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
localized JJ B-NP O
thrombus NN I-NP O
St NNP I-NP O
Jude's NNP I-NP O
valve NN I-NP O
was VBD B-VP O
well RB O O
seated VBN O O
in IN B-VP O
the DT B-NP O
aortic JJ I-NP O
position NN I-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
significant JJ I-NP O
aortic JJ I-NP O
regurg NN I-NP O
that WDT O O
was VBD B-VP O
noted VBN O O
A NNP B-NP O
St NNP I-NP O
Jude's NNP I-NP O
valve NN I-NP O
was VBD B-VP O
well RB O O
seated VBN O O
in IN B-VP O
the DT B-NP O
mitral JJ I-NP O
position NN I-NP O
as RB O O
well RB O O
There EX O O
was VBD B-VP O
trace NN B-NP O
mild JJ B-NP O
regurgitation NN I-NP O
noted VBD B-VP O
There EX O O
was VBD B-VP O
slight JJ B-NP O
asynchronous JJ I-NP O
motion NN I-NP O
of IN B-VP O
the DT B-NP O
prosthetic JJ I-NP O
valve NN I-NP O
apparatus NN I-NP O
that WDT O O
was VBD B-VP O
noted VBN O O
The DT B-NP O
tricuspid JJ I-NP O
valve NN I-NP O
was VBD B-VP O
normal JJ O O
in IN B-VP O
appearance NN B-NP O
There EX O O
was VBD B-VP O
mild JJ B-NP O
regurgitation NN I-NP O
present JJ B-NP O
Visualized NNP I-NP O
portion NN I-NP O
of IN B-VP O
the DT B-NP O
thoracic NN I-NP O
aorta NN I-NP O
revealed VBD B-VP O
minimal JJ B-NP O
atheromatous JJ I-NP O
plaque NN I-NP O
2 CD O O
Pulmonary: NNP B-NP O
The DT B-NP O
patient NN I-NP O
remained VBD B-VP O
stable JJ O O
from IN B-VP O
her PRP$ O O
pulmonary JJ B-NP O
standpoint NN I-NP O
She PRP O O
continued VBD B-VP O
to TO O O
sat VB O O
well RB O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
She PRP O O
did VBD B-VP O
not RB O O
required VBN O O
any DT B-NP O
nebulizers NNS I-NP O
during IN B-VP O
her PRP$ O O
stay NN B-NP O
3 CD O O
GI: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
initially RB O O
admitted VBN O O
with IN B-VP O
some DT B-NP O
abdominal JJ I-NP O
pain NN I-NP O
and CC O O
also RB O O
nausea NN B-NP O
and CC O O
vomiting NN B-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
KUB NNP I-NP O
performed VBN O O
for IN B-VP O
a DT B-NP O
question NN I-NP O
of IN B-VP O
potential JJ B-NP O
bowel NN I-NP O
obstruction NN I-NP O
A NNP I-NP O
single JJ B-NP O
frontal JJ I-NP O
view NN I-NP O
of IN B-VP O
the DT B-NP O
abdomen NNS I-NP O
was VBD B-VP O
obtained VBN O O
and CC O O
is VBZ O O
reported VBN O O
in IN B-VP O
the DT B-NP O
final JJ I-NP O
radiology NN I-NP O
report NN I-NP O
There EX O O
was VBD B-VP O
gas NN B-NP O
seen VBN O O
within IN B-VP O
the DT B-NP O
loops NNS I-NP O
of IN B-VP O
small JJ B-NP O
bowel NN I-NP O
as RB O O
well RB O O
as IN B-VP O
the DT B-NP O
colon NN I-NP O
There EX O O
is VBZ O O
no DT B-NP O
bowel NN I-NP O
dilatation NN I-NP O
seen VBN O O
The DT B-NP O
overall JJ I-NP O
impression NN I-NP O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
any DT B-NP O
high-grade JJ I-NP O
bowel NN I-NP O
obstruction NN I-NP O
It PRP O O
is VBZ O O
likely JJ O O
that IN B-VP O
some DT O O
of IN B-VP O
her PRP$ O O
pain NN B-NP O
was VBD B-VP O
secondary JJ O O
to TO O O
hepatic JJ B-NP O
congestion NN I-NP O
The DT B-NP O
nausea NN I-NP O
and CC O O
vomiting VBG O O
eventually RB O O
resolved VBN O O
and CC O O
perhaps RB O O
this DT O O
is VBZ O O
some DT B-NP O
type NN I-NP O
of IN B-VP O
viral JJ B-NP O
illness NN I-NP O
or CC O O
gastroenteritis NN B-NP O
She PRP O O
did VBD B-VP O
have VB O O
some DT B-NP O
episode NN I-NP O
of IN B-VP O
diarrhea NN B-NP O
prior RB O O
to TO O O
admission VB O O
along RP O O
with IN B-VP O
some DT O O
abdominal JJ O O
cramping VBG O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
continued VBN O O
on IN B-VP O
her PRP$ O O
PPI NNP B-NP B-m
for IN B-VP O
GERD NNP B-NP B-r
prophylaxis NN I-NP I-r
At IN B-VP O
one CD O O
point NN B-NP O
, , O O
she PRP O O
required VBD B-VP O
increasing VBG O O
her PRP$ O O
dosage NN B-NP O
of IN B-VP O
Nexium NNP B-NP B-m
secondary JJ O O
to TO O O
GERD-like NNP B-NP B-r
symptoms NNS I-NP O
It PRP O O
seemed VBD B-VP O
that IN B-VP O
increasing VBG O O
the DT B-NP O
amount NN I-NP O
of IN B-VP O
Nexium NNP B-NP B-m
she PRP O O
received VBD B-VP O
, , O O
precipitated VBD B-VP O
some DT B-NP O
diarrhea NN I-NP O
She PRP O O
was VBD B-VP O
returned VBN O O
to TO O O
a DT B-NP O
normal JJ I-NP O
dosing NN I-NP O
of IN B-VP O
Nexium NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
while IN B-VP B-du
in-house NN B-NP I-du
She PRP O O
was VBD B-VP O
discharged VBN O O
on IN B-VP O
omeprazole JJ O B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
which WDT O O
she PRP O O
will MD O O
continue VB O O
to TO O O
take VB O O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
she PRP O O
was VBD B-VP O
given VBN O O
prescription NN B-NP O
for IN B-VP O
Colace NNP B-NP B-m
and CC O O
also RB O O
Senokot NNP B-NP B-m
today NN I-NP O
She PRP O O
should MD O O
continue VB O O
using VBG O O
4 CD O O
Heme: NNP B-NP O
Her NNP I-NP O
hematocrit NN I-NP O
remained VBD B-VP O
relatively RB O O
stable JJ O O
during IN B-VP O
her PRP$ O O
stay NN B-NP O
with IN B-VP O
averaging NN B-NP O
of IN B-VP O
26 CD O O
to TO O O
27 CD O O
as RB O O
far RB O O
as IN B-VP O
her PRP$ O O
hematocrit NN B-NP O
We PRP O O
were VBD B-VP O
not RB O O
concerned VBN O O
with IN B-VP O
keeping VBG O O
her PRP$ O O
hematocrit NN B-NP O
30 CD O O
or CC O O
above VB O O
at IN B-VP O
all DT B-NP O
times NNS I-NP O
given VBN O O
her PRP$ O O
clean JJ B-NP O
coronary JJ I-NP O
arteries NNS I-NP O
seen VBN O O
from IN B-VP O
the DT B-NP O
left NN I-NP O
and CC O O
also RB O O
right JJ B-NP O
heart NN I-NP O
catheterization NN I-NP O
She PRP O O
did VBD B-VP O
have VB O O
a DT B-NP O
slight JJ I-NP O
dip NN I-NP O
in IN B-VP O
her PRP$ O O
hematocrit NN B-NP O
at IN B-VP O
one CD O O
point NN B-NP O
requiring VBG O O
two CD O B-do
units NNS B-NP I-do
of IN B-VP O
packed JJ B-NP B-m
red JJ I-NP O
blood NN I-NP O
cells NNS I-NP O
Her PRP$ O O
hematocrit NN B-NP O
bumped VBD B-VP O
appropriately RB O O
to TO O O
30 CD O O
or CC O O
31 CD O O
She PRP O O
required VBD B-VP O
no DT B-NP O
subsequent JJ I-NP O
transfusions NNS I-NP O
thereafter RB O O
With IN B-VP O
regard NN B-NP O
to TO O O
anticoagulation NN B-NP B-r
, , O O
she PRP O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
the DT B-NP O
heparin NN I-NP B-m
drip NN I-NP I-m
at IN B-VP O
950 CD O B-do
units NNS B-NP O
per IN B-VP B-f
hour NN B-NP I-f
to TO O O
maintain VB O O
a DT B-NP O
PTT NNP I-NP O
between IN B-VP O
60 CD O O
and CC O O
80 CD O O
secondary JJ O O
to TO O O
her PRP$ O O
mechanical JJ B-NP O
valves NNS I-NP O
that WDT O O
are VBP O O
in IN B-VP O
place NN B-NP O
On IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
transitioned VBN O O
to TO O O
Lovenox VB O B-m
60 CD O B-do
mg NNS B-NP I-do
b.i.d NN I-NP B-f
with IN B-VP O
a DT B-NP O
renal JJ I-NP O
dosing NN I-NP O
She PRP O O
will MD O O
continue VB O O
to TO O O
take VB O O
this DT B-NP O
Lovenox NNP I-NP B-m
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
and CC O O
stop VB O O
it PRP O O
one CD O O
to TO O O
two CD O O
days NNS B-NP O
prior RB O O
to TO O O
her PRP$ O O
surgery NN B-NP O
as IN B-VP O
instructed VBN O O
She PRP O O
has VBZ O O
home NN B-NP O
VNA NNP I-NP O
in IN B-VP O
place NN B-NP O
5 CD O O
Renal: NNP B-NP O
Her NNP I-NP O
BUN NNP I-NP O
and CC O O
creatinine NN B-NP O
was VBD B-VP O
relatively RB O O
stable JJ O O
on IN B-VP O
admission NN B-NP O
It PRP O O
did VBD B-VP O
elevate VB O O
to TO O O
as RB O O
high JJ O O
as IN B-VP O
3.3 CD O O
, , O O
3.4 CD O O
on IN B-VP O
her PRP$ O O
admission NN B-NP O
secondary JJ O O
to TO O O
her PRP$ O O
ongoing JJ B-NP O
diuresis NN I-NP O
When WRB O O
diuresis NN B-NP O
was VBD B-VP O
held VBN O O
for IN B-VP O
several JJ B-NP O
days NNS I-NP O
given VBN O O
her PRP$ O O
markedly RB O O
increased JJ B-NP O
urine NN I-NP O
output NN I-NP O
and CC O O
as IN B-VP O
she PRP O O
became VBD B-VP O
more RBR O O
hydrated JJ O O
and CC O O
euvolemic JJ O O
, , O O
her PRP$ O O
creatinine NN B-NP O
returned VBN O O
to TO O O
its PRP$ O O
baseline NN B-NP O
of IN B-VP O
1.2 CD O O
, , O O
1.3 CD O O
She PRP O O
has VBZ O O
no DT B-NP O
active JJ I-NP O
issues NNS I-NP O
now RB O O
6 CD O O
Endocrine: NNP B-NP O
We PRP O O
appreciated VBD B-VP O
the DT B-NP O
Diabetes NNP I-NP O
Service NNP I-NP O
for IN B-VP O
following VBG O O
her PRP$ O O
very RB O O
closely RB O O
while IN B-VP O
in-house JJ B-NP O
Several JJ I-NP O
modifications NNS I-NP O
were VBD B-VP O
made VBN O O
to TO O O
her PRP$ O O
regimen NNS B-NP O
while IN B-VP O
here RB O O
to TO O O
get VB O O
good JJ B-NP O
control NN I-NP O
of IN B-VP O
her PRP$ O B-r
blood NN B-NP O
glucose NN I-NP O
She PRP O O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
a DT B-NP O
stable JJ I-NP O
regimen NN I-NP O
of IN B-VP O
NPH NNP B-NP B-m
60 CD O B-do
units NNS B-NP I-do
in IN B-VP B-f
the DT B-NP I-f
morning NN I-NP I-f
, , O O
NPH NNP B-NP B-m
30 CD O B-do
units NNS B-NP I-do
in IN B-VP B-f
the DT B-NP I-f
evening NN I-NP I-f
She PRP O O
also RB O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
a DT O O
sliding VBG O O
scale NN B-NP O
She PRP O O
also RB O O
received VBD B-VP O
NovoLog NNP B-NP B-m
of IN B-VP O
15 CD O B-do
units NNS B-NP I-do
in IN B-VP B-f
the DT B-NP O
morning NN I-NP O
with IN B-VP O
breakfast NN B-NP O
and CC O O
also RB O O
15 CD O O
at IN B-VP O
dinner NN B-NP O
She PRP O O
was VBD B-VP O
not RB O O
receiving VBG O O
any DT O O
of IN B-VP O
the DT B-NP O
NovoLog NNP I-NP B-m
while IN B-VP O
at IN B-VP O
lunch NN B-NP O
She PRP O O
will MD O O
continue VB O O
to TO O O
take VB O O
this DT B-NP O
regimen NNS I-NP O
in IN B-VP O
home NN B-NP O
All NNP I-NP O
of IN B-VP O
her PRP$ O O
prescriptions NNS B-NP O
were VBD B-VP O
provided VBN O O
by IN B-VP O
Carl NNP B-NP O
Mcclenahan NNP I-NP O
, , O O
who WP O O
is VBZ O O
following VBG O O
with IN B-VP O
the DT B-NP O
Diabetes NNP I-NP O
Service NNP I-NP O
They PRP O O
will MD O O
become VB O O
again RB O O
involved JJ O O
with IN B-VP O
her PRP$ O O
care NN B-NP O
as IN B-VP O
she PRP O O
plans VBZ O O
for IN B-VP O
surgery NN B-NP O
in IN B-VP O
the DT O O
very RB O O
near IN B-VP O
future JJ O O
7 CD O O
Infectious JJ O O
disease: VBD B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
stable JJ O O
from IN B-VP O
an DT B-NP O
ID NNP I-NP O
standpoint NN I-NP O
during IN B-VP O
her PRP$ O O
entire JJ B-NP O
admission NN I-NP O
On IN B-VP O
July NNP B-NP O
, , O O
2005 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
an DT B-NP O
increase NN I-NP O
in IN B-VP O
her PRP$ O O
white JJ B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
upwards NNS I-NP O
towards IN B-VP O
the DT O O
20 CD O O
, , O O
000 CD O O
This DT O O
was VBD B-VP O
one CD O O
day NN B-NP O
prior VBZ O O
to TO O O
a DT O O
planned VBN O O
surgery NN B-NP O
on IN B-VP O
May NNP B-NP O
, , O O
2005 CD O O
with IN B-VP O
Dr NNP B-NP O
Villata NNP I-NP O
to TO O O
repair VB O O
her PRP$ O O
aortic JJ B-NP O
valve NN I-NP O
and CC O O
also RB O O
her PRP$ O O
mitral JJ B-NP O
valve NN I-NP O
The DT B-NP O
surgery NN I-NP O
was VBD B-VP O
delayed VBN O O
as IN B-VP O
a DT B-NP O
result NN I-NP O
of IN B-VP O
this DT O O
, , O O
so IN B-VP O
an DT B-NP O
infectious JJ I-NP O
workup NN I-NP O
could MD O O
ensue VB O O
She PRP O O
had VBD B-VP O
a DT B-NP O
urine JJ I-NP O
sent NN I-NP O
that WDT O O
showed VBD B-VP O
, , O O
the DT B-NP O
suggestion NN I-NP O
of IN B-VP O
a DT B-NP O
urinary JJ I-NP O
tract NN I-NP O
infection NN I-NP O
Levaquin NNP I-NP B-m
was VBD B-VP O
given VBN O O
for IN B-VP O
treatment NN B-NP O
of IN B-VP O
her PRP$ O B-r
UTI NNP B-NP I-r
Surveillance NNP I-NP O
cultures NNS I-NP O
were VBD B-VP O
drawn VBN O O
daily RB O O
Given VBN O O
the DT B-NP O
fact NN I-NP O
that IN B-VP O
she PRP O O
had VBD B-VP O
a DT B-NP O
right JJ I-NP O
groin NN I-NP O
hematoma NN I-NP O
that WDT O O
performed VBD B-VP O
after IN B-VP O
the DT B-NP O
heart NN I-NP O
catheterization NN I-NP O
we PRP O O
questioned VBD B-VP O
whether IN B-VP O
or CC O O
not RB O O
this DT O O
could MD O O
be VB O O
some DT B-NP O
type NN I-NP O
of IN B-VP O
infectious JJ B-NP O
source NN I-NP O
She PRP O O
had VBD B-VP O
the DT B-NP O
hematoma NN I-NP O
aspirated VBD B-VP O
, , O O
it PRP O O
was VBD B-VP O
negative JJ O O
for IN B-VP O
any DT O O
organisms JJ O O
She PRP O O
had VBD B-VP O
no DT B-NP O
other JJ I-NP O
identified JJ I-NP O
places NNS I-NP O
as RB O O
far RB O O
as IN B-VP O
source NN B-NP O
of IN B-VP O
infection NN B-NP O
It PRP O O
was VBD B-VP O
believed VBN O O
that IN B-VP O
she PRP O O
could MD O O
potential VB O O
have VB O O
endocarditis VBN O O
as IN B-VP O
she PRP O O
has VBZ O O
had VBN O O
in IN B-VP O
the DT O O
past JJ O O
One CD O O
of IN B-VP O
her PRP$ O O
cultures NNS B-NP O
actually RB O O
grew VBD B-VP O
out RP O O
a DT B-NP O
species NNS I-NP O
of IN B-VP O
Abiotrophia NNP B-NP O
There EX O O
is VBZ O O
only RB O O
one CD O O
culture NN B-NP O
positive JJ O O
, , O O
that WDT O O
was VBD B-VP O
taken VBN O O
on IN B-VP O
February NNP B-NP O
She PRP O O
has VBZ O O
had VBD B-VP O
no DT B-NP O
subsequent JJ I-NP O
cultures NNS I-NP O
growing VBG O O
out RP O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
this DT B-NP O
dictation NN I-NP O
We PRP O O
appreciate VBP O O
the DT B-NP O
Infectious NNP I-NP O
Disease NNP I-NP O
Team NNP I-NP O
following VBG O O
Their PRP$ O O
recommendations NNS B-NP O
were VBD B-VP O
to TO O O
hold VB O O
antibiotics NNS B-NP B-m
unless IN B-VP O
subsequent JJ B-NP O
cultures NNS I-NP O
began VBD B-VP O
to TO O O
grow VB O O
out RP O O
Their PRP$ O O
recommendations NNS B-NP O
were VBD B-VP O
to TO O O
continue VB O O
to TO O O
follow VB O O
all DT B-NP O
cultures NNS I-NP O
and CC O O
to TO O O
perform VB O O
a DT B-NP O
TEE NNP I-NP O
A NNP I-NP O
repeat NN I-NP O
TEE NNP I-NP O
was VBD B-VP O
performed VBN O O
and CC O O
showed VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
any DT B-NP O
lesions NNS I-NP O
or CC O O
change NN B-NP O
in IN B-VP O
bowel NN B-NP O
function NN I-NP O
There EX O O
were VBD B-VP O
clearly RB O O
no DT B-NP O
vegetation NN I-NP O
seen VBN O O
on IN B-VP O
either DT O O
any DT B-NP O
transthoracic JJ I-NP O
echos NN I-NP O
or CC O O
TEEs NNP B-NP O
ID NNP I-NP O
made VBD B-VP O
recommendations NNS B-NP O
as RB O O
far RB O O
as IN B-VP O
perioperative JJ B-NP O
antibiotics NNS I-NP B-m
, , O O
which WDT O O
would MD O O
include VB O O
two CD O B-du
weeks NNS B-NP I-du
of IN B-VP O
ceftriaxone NN B-NP B-m
1 CD O B-do
g NN B-NP I-do
IV NNP I-NP B-mo
b.i.d NN I-NP B-f
under IN B-VP O
the DT B-NP O
assumption NN I-NP O
that IN B-VP O
this DT O O
would MD O O
be VB O O
completing VBG O O
a DT B-NP O
course NN I-NP O
of IN B-VP O
her PRP$ O O
therapy NN B-NP O
after IN B-VP O
SBE NNP B-NP O
They PRP O O
would MD O O
also RB O O
recommend VB O O
sending VBG O O
all DT B-NP O
valve NNS I-NP O
tissue NN I-NP O
for IN B-VP O
Gram NNP B-NP O
stain NN I-NP O
and CC O O
culture NN B-NP O
as RB O O
well RB O O
as IN B-VP O
pathology NN B-NP O
If IN B-VP O
the DT B-NP O
Gram NNP I-NP O
stain NN I-NP O
and CC O O
culture NN B-NP O
were VBD B-VP O
positive JJ O O
, , O O
they PRP O O
would MD O O
suggest VB O O
extending VBG O O
the DT B-NP O
course NN I-NP O
of IN B-VP O
the DT B-NP O
above-mentioned JJ I-NP O
antibiotic JJ I-NP B-m
therapy NN I-NP O
8 CD O O
Neurologic: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
given VBN O O
Darvon NNP B-NP B-m
and CC O O
also RB O O
codeine NN B-NP B-m
as IN B-VP B-f
needed VBN O O
for IN B-VP O
her PRP$ O B-r
pain NN B-NP I-r
She PRP O O
complained VBD B-VP O
of IN B-VP O
right JJ B-NP O
groin NN I-NP O
pain NN I-NP O
secondary JJ O O
to TO O O
the DT B-NP O
hematoma NN I-NP O
Her NNP I-NP O
pain NN I-NP O
is VBZ O O
much RB O O
improved VBN O O
that IN B-VP O
she PRP O O
is VBZ O O
able JJ O O
to TO O O
ambulate VB O O
easily RB O O
around IN B-VP O
the DT B-NP O
Tl NNP I-NP O
Brown NNP I-NP O
Vo NNP I-NP O
on IN B-VP O
discharge NN B-NP O
The DT B-NP O
hematoma NN I-NP O
is VBZ O O
resolving VBG O O
and CC O O
her PRP$ O O
pain NN B-NP O
is VBZ O O
resolving VBG O O
as RB O O
well RB O O
9 CD O O
Fluids NNS B-NP O
, , O O
electrolytes NNS B-NP O
, , O O
and CC O O
nutrition: VBZ O O
The DT B-NP O
patient NN I-NP O
is VBZ O O
tolerating VBG O O
p.o RB O O
well RB O O
Her PRP$ O O
electrolytes NNS B-NP O
were VBD B-VP O
repleted VBN O O
as IN B-VP O
needed VBN O O
daily RB O O
10 CD O O
Psychologic: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
seen VBN O O
by IN B-VP O
social JJ B-NP O
work NN I-NP O
It PRP O O
is VBZ O O
clear JJ O O
that IN B-VP O
she PRP O O
has VBZ O O
many JJ B-NP O
anxieties NNS I-NP O
about IN B-VP O
the DT B-NP O
surgery NN I-NP O
and CC O O
also RB O O
in IN B-VP O
going VBG O O
home NN B-NP O
and CC O O
returning VBG O O
to TO O O
her PRP$ O O
social JJ B-NP O
environment NN I-NP O
She PRP O O
necessitated VBD B-VP O
volume NN B-NP O
prior RB O O
to TO O O
many JJ B-NP O
procedures NNS I-NP O
given VBN O O
her PRP$ O O
severe JJ B-NP O
anxiety NN I-NP O
11 CD O O
Disposition: NNP B-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
stable JJ O O
from IN B-VP O
a DT B-NP O
medical JJ I-NP O
standpoint NN I-NP O
with IN B-VP O
all DT B-NP O
cultures NNS I-NP O
clear JJ O O
and CC O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
active JJ B-NP O
infection NN I-NP O
Her NNP I-NP O
white JJ B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
is VBZ O O
now RB O O
normal JJ O O
She PRP O O
is VBZ O O
now RB O O
awaiting VBG O O
surgical JJ B-NP O
repair NN I-NP O
of IN B-VP O
her PRP$ O O
valve NN B-NP O
and CC O O
will MD O O
have VB O O
a DT B-NP O
surgery NN I-NP O
scheduled VBN O O
with IN B-VP O
Dr NNP B-NP O
Berreth NNP I-NP O
office NN I-NP O
in IN B-VP O
the DT O O
next JJ O O
one CD O O
to TO O O
two CD O O
weeks NNS B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Diltiazem NNP B-NP B-m
30 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.6h VBD B-VP B-f
2 CD O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
3 CD O O
Lasix NNP B-NP B-m
120 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q NN I-NP B-f
other JJ B-NP I-f
day NN I-NP I-f
4 CD O O
NPH NNP B-NP B-m
60 CD O B-do
units NNS B-NP I-do
in IN B-VP B-f
the DT B-NP I-f
morning NN I-NP I-f
5 CD O O
NPH NNP B-NP B-m
30 CD O B-do
units NNS B-NP I-do
in IN B-VP B-f
the DT B-NP I-f
evening NN I-NP I-f
6 CD O O
Lisinopril NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
7 CD O O
Senokot NNP B-NP B-m
three CD O B-do
tablets NNS B-NP I-do
p.o VBP O B-mo
b.i.d RB O B-f
8 CD O O
Multivitamin NNP B-NP B-m
one CD O B-do
tablet NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
9 CD O O
Lovenox NNP B-NP B-m
60 CD O B-do
mg NN B-NP I-do
subcutaneously RB O B-mo
b.i.d VBZ O B-f
10 CD O O
Caltrate NNP B-NP B-m
plus CC O I-m
vitamin JJ B-NP I-m
D NNP I-NP I-m
600 CD O B-do
mg NN B-NP I-do
one CD O I-do
tablet NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
11 CD O O
NovoLog NNP B-NP B-m
NovoLog NNP I-NP B-m
sliding VBG O B-do
sliding VBG O B-do
scale JJ B-NP I-do
scale NN I-NP I-do
q.a.c NN I-NP B-f
and CC O O
h.s $ O B-f
12 CD O O
NovoLog NNP B-NP B-m
15 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
with IN B-VP B-f
breakfast NN B-NP I-f
and CC O I-f
dinner NN B-NP I-f
did VBD B-VP O
not RB O O
give VB O O
at IN B-VP O
lunch NN B-NP O
13 CD O O
Maalox NNP B-NP B-m
tablets NNS I-NP I-m
quick VBP O O
dissolve VB O O
14 CD O O
Codeine NNP B-NP B-m
15 CD O B-do
mg NN B-NP I-do
to TO O I-do
30 CD O I-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q.4h JJ I-NP B-f
p.r.n NN I-NP I-f
pain NN I-NP B-r
15 CD O O
Magnesium NNP B-NP B-m
oxide RB O I-m
400 CD O B-do
mg NNS B-NP I-do
p.o JJ O B-mo
b.i.d RB O B-f
16 CD O O
Omeprazole NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
17 CD O O
Niferex NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d IN B-VP B-f
FOLLOW-UP NNP B-NP O
PLANS: NNP I-NP O
1 CD O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
given VBN O O
instructions NNS B-NP O
to TO O O
call VB O O
Dr NNP B-NP O
Mccutchan NNP I-NP O
office NN I-NP O
to TO O O
coordinate VB O O
her PRP$ O O
appointment NN B-NP O
for IN B-VP O
her PRP$ O O
valve NN B-NP O
repair NN I-NP O
in IN B-VP O
the DT O O
next JJ O O
one CD O O
to TO O O
two CD O O
weeks NNS B-NP O
pending VBG O O
her PRP$ O O
surgeon's JJ B-NP O
return NN I-NP O
2 CD O O
The DT B-NP O
patient NN I-NP O
instructed VBD B-VP O
to TO O O
call VB O O
Dr NNP B-NP O
Doug NNP I-NP O
Schlanger NNP I-NP O
on IN B-VP O
March NNP B-NP O
, , O O
2005 CD O O
, , O O
to TO O O
discuss VB O O
surgical JJ B-NP O
plans NNS I-NP O
and CC O O
also RB O O
to TO O O
follow VB O O
up RP O O
3 CD O O
The DT B-NP O
patient NN I-NP O
should MD O O
have VB O O
all DT O O
her PRP$ O O
blood NN B-NP O
cultures NNS I-NP O
followed VBD B-VP O
up RP O O
prior RB O O
to TO O O
her PRP$ O O
surgery NN B-NP O
If IN B-VP O
any DT O O
of IN B-VP O
her PRP$ O O
blood NN B-NP O
cultures VBZ O O
become VBN O O
positive JJ O O
in IN B-VP O
the DT O O
interim JJ O O
, , O O
we PRP O O
will MD O O
begin VB O O
a DT B-NP O
long JJ I-NP O
course NN I-NP O
of IN B-VP O
antibiotic JJ B-NP B-m
therapy NN I-NP O
and CC O O
delay NN B-NP O
surgery NN I-NP O
at IN B-VP O
the DT B-NP O
discussion NN I-NP O
of IN B-VP O
the DT B-NP O
Cardiovascular NNP I-NP O
Service NNP I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
eScription NN I-NP O
document: NN I-NP O
6-8225657 JJ B-NP O
IS NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
CURLESS NNP I-NP O
, , O O
OLIVER NNP B-NP O
Attending: NNP I-NP O
HERD NNP I-NP O
, , O O
ANDREAS NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
3110866 CD O O
D: NNP B-NP O
4/7/05 CD O O
T: NNP B-NP O
6/13/05 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#993109 VBZ O O
980908629 CD O O
RTH NNP B-NP O
25854739 CD O O
1468461 CD O O
4/7/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
atypical JJ B-NP O
chest NN I-NP O
pain NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
4/7/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
11/10/2005 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
WHITLACH NNP I-NP O
, , O O
REGINALD NNP B-NP O
273-89-77-3 JJ B-NP O
Ter NNP I-NP O
Highway NNP I-NP O
, , O O
Cra NNP B-NP O
Raldi NNP I-NP O
Kanenard NNP I-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
2/1/05 CD O O
AT NNP B-NP O
12:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
KAMANSKY NNP I-NP O
, , O O
HOUSTON NNP B-NP O
ASHLEY NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
DIAZEPAM NNP I-NP B-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QAM NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
March NNP I-NP O
LOPRESSOR NNP I-NP B-m
( ( O I-m
METOPROLOL NNP B-NP I-m
TARTRATE NNP I-NP I-m
) ) O I-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
March NNP I-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
PAXIL NNP I-NP B-m
( ( O I-m
PAROXETINE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ZOCOR NNP I-NP B-m
( ( O I-m
SIMVASTATIN NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
LISINOPRIL NNP B-NP B-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
2/1/05 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
LISINOPRIL NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
md NN I-NP O
aware JJ B-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QOD NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
RETURN NNP I-NP O
TO NNP I-NP O
WORK: NNP I-NP O
After IN B-VP O
Appt NNP B-NP O
with IN B-VP O
local JJ B-NP O
physician NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Shanberg NNP I-NP O
1-2 JJ B-NP O
weeks NNS I-NP O
, , O O
ALLERGY: NNP B-NP O
Codeine NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
chest JJS B-NP O
pain NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
atypical JJ B-NP O
chest NN I-NP O
pain NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
Htn NNP I-NP O
, , O O
hyperlipidemia NN B-NP O
, , O O
CAD NNP B-NP O
, , O O
anxiety NN B-NP O
disorder NN I-NP O
, , O O
obesity NN B-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
Cardiac NNP I-NP O
catheterization NN I-NP O
10/20 CD O O
40% CD O O
LAD NNP B-NP O
lesion NN I-NP O
, , O O
no DT B-NP O
intervention NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
None NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
46 CD O O
y/o NN B-NP O
f NN I-NP O
with IN B-VP O
h/o NN B-NP O
HTN NNP I-NP O
, , O O
high JJ B-NP O
lipids NNS I-NP O
with IN B-VP O
h/o NN B-NP O
abnormal JJ B-NP O
ETT NNP I-NP O
2/5 CD O O
by IN B-VP O
report NN B-NP O
who WP O O
p/w VBZ O O
several JJ B-NP O
months NNS I-NP O
of IN B-VP O
SSCP NNP B-NP O
, , O O
tightness NN B-NP O
Occas NNP I-NP O
SOB NNP I-NP O
Seen NNP I-NP O
by IN B-VP O
PCP NNP B-NP O
on IN B-VP O
DOA NNP B-NP O
and CC O O
sent VBD B-VP O
to TO O O
ED NNP B-NP O
4d CD O O
worsning VBG O O
sx NN B-NP O
Improved VBD B-VP O
pain NN B-NP B-r
with IN B-VP O
SL NNP B-NP B-mo
NTG NNP I-NP B-m
In IN B-VP O
ED NNP B-NP O
, , O O
afeb NN B-NP O
, , O O
168/74 CD O O
, , O O
HR NNP B-NP O
94 CD O O
, , O O
EKG NNP B-NP O
unchaged VBD B-VP O
, , O O
neg FW O O
first RB O O
set VBN O O
enzymes RB O O
Started VBN O O
on IN B-VP O
heparin NN B-NP B-m
=== NNP I-NP O
Exam: NNP I-NP O
98.0 CD O O
, , O O
58-60 JJ O O
, , O O
132/60 CD O O
, , O O
18 CD O O
, , O O
98% CD O O
2L CD O O
general: NN B-NP O
nad NN I-NP O
, , O O
euvolemic JJ O O
, , O O
clear JJ B-NP O
chest NN I-NP O
, , O O
rrr VBZ O O
no DT B-NP O
mgr NN I-NP O
, , O O
no DT B-NP O
edema NN I-NP O
=== VBZ O O
Labs: NNP B-NP O
TNI NNP I-NP O
neg VBD B-VP O
x $ O O
2 CD O O
=== NNP B-NP O
CATH NNP I-NP O
10/20 CD O O
40% CD O O
LAD NNP B-NP O
, , O O
no DT B-NP O
intervention NN I-NP O
=== VBZ O O
EKG: NNP B-NP O
Intial NNP I-NP O
ECG NNP I-NP O
unchanged JJ O O
from IN B-VP O
baseline NN B-NP O
with IN B-VP O
old JJ B-NP O
TWI NNP I-NP O
in IN B-VP O
v5-6 NN B-NP O
, , O O
1 CD O O
, , O O
avl RB O O
1/10/5 CD O O
am VBP O O
ECG: NNP B-NP O
TWI NNP I-NP O
in IN B-VP O
1 CD O O
, , O O
2 CD O O
, , O O
l NN B-NP O
, , O O
f NN B-NP O
, , O O
v4-v5 JJ B-NP O
=== NNP I-NP O
Assessment: NNP I-NP O
46 CD O O
y/o NN B-NP O
f NN I-NP O
with IN B-VP O
HTN NNP B-NP O
, , O O
high JJ B-NP O
lipds NN I-NP O
with IN B-VP O
chest NN B-NP O
pain NN I-NP O
, , O O
non-specific JJ B-NP O
TW NNP I-NP O
changes NNS I-NP O
and CC O O
negative JJ B-NP O
enzymes NNS I-NP O
x VBP O O
2 CD O O
=== JJ B-NP O
COURSE: NNP I-NP O
1 CD O O
Ischemia: NNP B-NP O
asa NN I-NP B-m
, , O O
statin RB O B-m
high JJ B-NP B-do
dose NN I-NP I-do
, , O O
BB NNP B-NP B-m
, , O O
ACE-I NNP B-NP B-m
On IN B-VP O
heparin NN B-NP B-m
until IN B-VP B-du
cathed VBN O O
on IN B-VP O
4/10 CD O O
-&gt; JJ O O
no DT B-NP O
significant JJ I-NP O
CAD NNP I-NP O
Discharged NNP I-NP O
on IN B-VP O
lisinopril NN B-NP B-m
and CC O O
lopressor NN B-NP B-m
, , O O
zocor NN B-NP B-m
, , O O
ASA; NNP B-NP B-m
d/c'd VBZ O O
HCTZ NNP B-NP B-m
for IN B-VP O
now RB O O
Chest NNP B-NP O
pain NN I-NP O
not RB O O
thought VBN O O
to TO O O
be VB O O
ischemic JJ O O
in IN B-VP O
origin JJ B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
1 CD O O
Liver NNP B-NP O
function NN I-NP O
tests NNS I-NP O
and CC O O
fasting VBG O O
lipid JJ B-NP O
profile NN I-NP O
pending VBG O O
at IN B-VP O
time NN B-NP O
of IN B-VP O
discharge NN B-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
PUERTAS NNP I-NP O
, , O O
CLEO NNP B-NP O
L NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
AS91 NNP B-NP O
) ) O O
2/1/05 CD O O
@ $ O O
11:41 CD O O
AM NNP B-NP O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#993550 VBZ O O
859846912 CD O O
SH NNP B-NP O
27937230 CD O O
8076199 CD O O
10/20/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
CHF NNP I-NP O
exacerbation NN I-NP O
, , O O
PNA NNP B-NP O
, , O O
viral JJ B-NP O
gastroenteritis NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
6/16/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
8/30/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
MICHALES NNP I-NP O
, , O O
DAREN NNP B-NP O
M NNP I-NP O
573-58-18-1 JJ B-NP O
Dego NNP I-NP O
Louisbi NNP I-NP O
Do NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
3/17/06 CD O O
AT NNP B-NP O
10:00 CD O O
AM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
2PM CD O O
K+ NNP B-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
JOELSON NNP I-NP O
, , O O
EFREN NNP B-NP O
M NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
No NNP I-NP O
CPR NNP I-NP O
/ VBZ O O
No DT B-NP O
defib NN I-NP O
/ VBZ O O
No DT B-NP O
intubation NN I-NP O
/ VBZ O O
DISPOSITION: NNP B-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/22/06 CD O O
by IN B-VP O
LINEA NNP B-NP O
, , O O
ALLEN NNP B-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
515597259 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
ALLOPURINOL NNP I-NP B-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/22/06 CD O O
by IN B-VP O
CORKRON NNP B-NP O
, , O O
FERDINAND NNP B-NP O
, , O O
M.D NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
ALLOPURINOL NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
TESSALON NNP I-NP B-m
PERLES NNP I-NP I-m
( ( O I-m
BENZONATATE NNP B-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
PRN NNP I-NP O
Other:Cough NNP I-NP B-r
COLACE NNP I-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
NEXIUM NNP I-NP B-m
( ( O I-m
ESOMEPRAZOLE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
FERROUS NNP I-NP B-m
SULFATE NNP I-NP I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
milk NN I-NP O
and CC O O
antacid JJ B-NP O
GLIPIZIDE NNP I-NP B-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
GUIATUSS NNP I-NP B-m
( ( O I-m
GUAIFENESIN NNP B-NP I-m
) ) O I-m
10 CD O B-do
MILLILITERS NNP B-NP I-do
PO NNP I-NP B-mo
Q4H NNP I-NP B-f
PRN NNP I-NP O
Other:Cough NNP I-NP B-r
KCL NNP I-NP B-m
SLOW NNP I-NP I-m
RELEASE NNP I-NP I-m
20 CD O B-do
MEQ NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
August NNP I-NP O
As IN B-VP O
per IN B-VP O
MH NNP B-NP O
Potassium NNP I-NP O
Chloride NNP I-NP O
Policy: NNP I-NP O
each DT O O
20 CD O O
mEq NNS B-NP O
dose VB O O
to TO O O
be VB O O
given VBN O O
with IN B-VP O
4 CD O O
oz NNS B-NP O
of IN B-VP O
fluid NN B-NP O
LEVOXYL NNP I-NP B-m
( ( O I-m
LEVOTHYROXINE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MCG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/22/06 CD O O
by IN B-VP O
PIZZULO NNP B-NP O
, , O O
CARLOS NNP B-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
515597259 CD O O
) ) O O
SERIOUS NNP B-NP O
INTERACTION: NNP I-NP O
LEVOTHYROXINE NNP I-NP B-m
SODIUM NNP I-NP I-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
LOPERAMIDE NNP I-NP B-m
HCL NNP I-NP I-m
2 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP I-f
Diarrhea NNP I-NP B-r
ATIVAN NNP I-NP B-m
( ( O I-m
LORAZEPAM NNP B-NP I-m
) ) O I-m
0.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
PRN NNP I-NP I-f
Anxiety NNP I-NP B-r
METOLAZONE NNP I-NP B-m
2.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP O
Starting VBG O O
Today NNP B-NP O
August NNP I-NP O
PRN NNP I-NP O
Other:Weight NNP I-NP B-r
gain NN I-NP I-r
TOPROL NNP I-NP B-m
XL NNP I-NP I-m
( ( O I-m
METOPROLOL NNP B-NP I-m
SUCCINATE NNP I-NP I-m
EXTENDED NNP I-NP I-m
RELEASE NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
PRAVACHOL NNP I-NP B-m
( ( O I-m
PRAVASTATIN NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BEDTIME NNP I-NP B-f
Instructions: NNP I-NP O
pt NN I-NP O
reports NNS I-NP O
problems NNS I-NP O
with IN B-VP O
simvastatin NN B-NP B-m
in IN B-VP O
the DT B-NP O
past JJ I-NP O
please NN I-NP O
do VB O O
not RB O O
substitute VB O O
thank NN B-NP O
you PRP O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
Alert NNP B-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
2/17/06 CD O O
by IN B-VP O
VOEDISCH NNP B-NP O
, , O O
MYLES NNP B-NP O
R NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
&amp; NNP I-NP O
PRAVASTATIN NNP I-NP B-m
SODIUM NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
MULTIVITAMIN NNP I-NP B-m
THERAPEUTIC NNP I-NP I-m
( ( O I-m
THERAPEUTIC NNP B-NP I-m
MULTIVI NNP I-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
2/17/06 CD O O
by IN B-VP O
BOYES NNP B-NP O
, , O O
GERARDO NNP B-NP O
R NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
PRAVACHOL NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
302238564 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
&amp; NNP I-NP O
PRAVASTATIN NNP I-NP B-m
SODIUM NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: RB O O
Previous NNP B-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/22/06 CD O O
by IN B-VP O
STEWART NNP B-NP O
, , O O
BRENDON NNP B-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
SIMVASTATIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
392909312 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
&amp; NNP I-NP O
SIMVASTATIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
TORSEMIDE NNP I-NP B-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
COUMADIN NNP I-NP B-m
( ( O I-m
WARFARIN NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
1 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QPM NNP I-NP B-f
Starting NNP I-NP O
ROUTINE NNP I-NP O
, , O O
20:00 CD O O
( ( O O
Standard NNP B-NP O
Admin NNP I-NP O
Time NNP I-NP O
) ) O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
No NNP I-NP O
high JJ B-NP O
Vitamin-K NNP I-NP O
containing VBG O O
foods NNS B-NP O
Alert NNP I-NP O
overridden: VBD B-VP O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
7/20/06 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ALLOPURINOL NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LEVOTHYROXINE NNP I-NP B-m
SODIUM NNP I-NP I-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
PRAVASTATIN NNP I-NP B-m
SODIUM NNP I-NP I-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LEVOFLOXACIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LEVOFLOXACIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
md NN I-NP O
aware JJ B-NP O
DIET: NNP I-NP O
Patient NNP I-NP O
should MD O O
measure VB O O
weight JJ B-NP O
daily JJ I-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
1800 CD O O
cals/dy NN B-NP O
DIET: NNP I-NP O
2 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Please NNP I-NP O
go VB O O
to TO O O
your PRP$ O O
scheduled VBN O O
appt NN B-NP O
with IN B-VP O
Dr NNP B-NP O
Loparo NNP I-NP O
5/13/06 CD O O
scheduled VBN O O
, , O O
Arrange NNP B-NP O
INR NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
on IN B-VP O
2/8/06 CD O O
with IN B-VP O
f/u JJ B-NP O
INR's NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
every DT O O
3 CD O O
days NNS B-NP O
INR's NNP I-NP O
will MD O O
be VB O O
followed VBN O O
by IN B-VP O
Jerald NNP B-NP O
Delguidice NNP I-NP O
via IN B-VP O
VNA NNP B-NP O
report NN I-NP O
to TO O O
Jordge NNP B-NP O
Tine NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
Medicine NNP I-NP O
ALLERGY: NNP I-NP O
NKA NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
CHF NNP I-NP O
exacerbation NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
CHF NNP B-NP O
exacerbation NN I-NP O
, , O O
PNA NNP B-NP O
, , O O
viral JJ B-NP O
gastroenteritis NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
CHF NNP I-NP O
( ( O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
) ) O O
cad NN B-NP O
( ( O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
) ) O O
htn NN B-NP O
( ( O O
hypertension NN B-NP O
) ) O O
dm NN B-NP O
( ( O O
diabetes VBZ O O
mellitus NN B-NP O
) ) O O
gerd NN B-NP O
( ( O O
gastroesophageal JJ B-NP O
reflux NN I-NP O
disease NN I-NP O
) ) O O
hypothyroidism NN B-NP O
( ( O O
hypothyroidism NN B-NP O
) ) O O
mitral JJ B-NP O
regurgitation NN I-NP O
( ( O O
2 CD O O
) ) O O
lung NN B-NP O
ca MD O O
s/p VB O O
lobectomy NN B-NP O
( ( O O
lung JJ B-NP O
cancer NN I-NP O
) ) O O
endometrial NN B-NP O
ca MD O O
s/p VB O O
TAH/BSO NNP B-NP O
( ( O O
endometrial JJ B-NP O
cancer NN I-NP O
) ) O O
basal NN B-NP O
cell NN I-NP O
ca MD O O
( ( O O
basal VB O O
cell NN B-NP O
carcinoma NN I-NP O
) ) O O
CRI NNP B-NP O
( ( O O
chronic JJ B-NP O
renal JJ I-NP O
dysfunction NN I-NP O
) ) O O
renal JJ B-NP O
artery NN I-NP O
stenosis NN I-NP O
s/p NN I-NP O
L NNP I-NP O
stent NN I-NP O
( ( O O
renal JJ B-NP O
artery NN I-NP O
stenosis NN I-NP O
) ) O O
recurrent NN B-NP O
flash NN I-NP O
pulm NN I-NP O
edema NN I-NP O
( ( O O
pulmonary JJ B-NP O
edema NN I-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
CXR NNP B-NP O
, , O O
diuresis NN B-NP O
with IN B-VP O
IV NNP B-NP B-mo
medications NNS I-NP B-m
, , O O
EKG NNP B-NP O
, , O O
R/O NNP B-NP O
MI NNP I-NP O
, , O O
Abdo NNP B-NP O
CT NNP I-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
Pt: NNP I-NP O
Ms NNP I-NP O
Watterson NNP I-NP O
, , O O
75M CD O O
**** NN B-NP O
CC: NNP I-NP O
increasing VBG O O
SOB NNP B-NP O
, , O O
weight VBD B-VP O
gain NN B-NP O
**** NN I-NP O
HPI: NNP I-NP O
Pt NNP I-NP O
is VBZ O O
a DT O O
75F JJ O O
with IN B-VP O
a DT B-NP O
h/o NN I-NP O
CHF/CAD NNP I-NP O
, , O O
A-fib NNP B-NP O
, , O O
lung NN B-NP O
CA NNP I-NP O
s/p NN I-NP O
R NNP I-NP O
wedge NN I-NP O
resection NN I-NP O
She PRP O O
has VBZ O O
been VBN O O
admitted VBN O O
5-6 JJ B-NP O
times NNS I-NP O
this DT B-NP O
year NN I-NP O
for IN B-VP O
CHF NNP B-NP O
exacerbation NN I-NP O
She PRP O O
was VBD B-VP O
in IN B-VP O
her PRP$ O O
USOH NN B-NP O
when WRB O O
over IN B-VP O
the DT O O
last JJ O O
6 CD O O
days NNS B-NP O
she PRP O O
has VBZ O O
noticed VBN O O
a DT O O
6lb CD O O
weight NN B-NP O
gain NN I-NP O
Additionally NNP I-NP O
, , O O
pt NN B-NP O
experienced VBD B-VP O
increasing VBG O O
SOB NNP B-NP O
, , O O
and CC O O
required VBD B-VP O
more JJR B-NP O
pillows NNS I-NP O
to TO O O
sleep VB O O
She PRP O O
uses VBZ O O
2 CD O O
pillows NNS B-NP O
at IN B-VP O
baseline NN B-NP O
Her NNP I-NP O
SOB/orthopnea NNP I-NP O
worsened VBD B-VP O
to TO O O
the DT B-NP O
point NN I-NP O
when WRB O O
on IN B-VP O
the DT B-NP O
night NN I-NP O
before IN B-VP O
admission NN B-NP O
, , O O
she PRP O O
was VBD B-VP O
unable JJ O O
to TO O O
fall VB O O
asleep RB O O
even RB O O
when WRB O O
almost RB O O
sitting VBG O O
up RP O O
Per NNP B-NP O
her PRP$ O O
PCP's NNP B-NP O
instructions NNS I-NP O
, , O O
pt NN B-NP O
took VBD B-VP O
Metolazone NNP B-NP B-m
2.5mg CD O B-do
and CC O O
Torsamide NNP B-NP B-m
40mg CD O B-do
x1 NNP B-NP B-f
which WDT O O
did VBD B-VP O
not RB O O
increase VB O O
her PRP$ O O
UOP NNP B-NP O
Pt NNP I-NP O
also RB O O
noticed VBD B-VP O
a DT B-NP O
fever NN I-NP O
to TO O O
101 CD O O
the DT B-NP O
night NN I-NP O
before IN B-VP O
admission NN B-NP O
**** NNP I-NP O
ROS: NNP I-NP O
+SOB NNP I-NP O
+PND NNP I-NP O
+orthopnea NNP I-NP O
+fever NNP I-NP O
+chills( NNP I-NP O
chronic NN I-NP O
) ) O O
+decreased VBD B-VP O
UOP NNP B-NP O
x NNP I-NP O
1-2 JJ B-NP O
days NNS I-NP O
+ VBP O O
L NNP B-NP O
leg NN I-NP O
swelling VBG O O
for IN B-VP O
weeks NNS B-NP O
, , O O
no DT B-NP O
CP NNP I-NP O
, , O O
no DT B-NP O
N/V/D NNP I-NP O
, , O O
no DT B-NP O
pyuria NN I-NP O
, , O O
no DT B-NP O
dizziness NN I-NP O
, , O O
no DT B-NP O
palpitations NNS I-NP O
Vitals NNS I-NP O
in IN B-VP O
ED: NNP B-NP O
T98.6 NNP I-NP O
P72 NNP I-NP O
BP121/65 NNP I-NP O
RR18 NNP I-NP O
SaO2 NNP I-NP O
on IN B-VP O
2L:98% CD O O
Pt NNP B-NP O
recieved VBD B-VP O
O2 NNP B-NP B-do
and CC O I-do
40 CD O I-do
Lasix NNP B-NP B-m
IV NNP I-NP B-mo
in IN B-VP O
the DT B-NP O
ED NNP I-NP O
**** NNP I-NP O
Rx NNP I-NP O
on IN B-VP O
admit: NN B-NP O
1 CD O O
ASA NNP B-NP B-m
( ( O I-m
Acetylsalicylic NNP B-NP I-m
Acid NNP I-NP I-m
) ) O I-m
PO NNP B-NP B-mo
QD NNP I-NP B-f
325MG CD O B-do
2 CD O O
Allopurinol NNP B-NP B-m
PO NNP I-NP B-mo
100 CD O B-do
MG NNP B-NP I-do
QD NNP I-NP B-f
3 CD O O
Docusate NNP B-NP B-m
Sodium NNP I-NP I-m
( ( O I-m
Colace NNP B-NP I-m
) ) O I-m
PO NNP B-NP B-mo
100 CD O B-do
MG NNP B-NP I-do
BID NNP I-NP B-f
4 CD O O
Esomeprazole NNP B-NP B-m
( ( O I-m
Nexium NNP B-NP I-m
) ) O I-m
PO NNP B-NP B-mo
20 CD O B-do
MG NNP B-NP I-do
QD NNP I-NP B-f
5 CD O O
Ferrous NNP B-NP B-m
Sulfate NNP I-NP I-m
PO NNP I-NP B-mo
325 CD O B-do
MG NNP B-NP I-do
TID NNP I-NP B-f
6 CD O O
Glipizide NNP B-NP B-m
PO NNP I-NP B-mo
5 CD O B-do
MG NNP B-NP I-do
BID NNP I-NP B-f
7 CD O O
Kcl NNP B-NP B-m
Slow NNP I-NP I-m
Release NNP I-NP I-m
( ( O I-m
Potassium NNP B-NP I-m
Chloride NNP I-NP I-m
Slow NNP I-NP I-m
Rel NNP I-NP I-m
) ) O I-m
20 CD O B-do
MEQ NNP B-NP I-do
QD NNP I-NP B-f
8 CD O O
Levoxyl NNP B-NP B-m
( ( O I-m
Levothyroxine NNP B-NP I-m
Sodium NNP I-NP I-m
) ) O I-m
PO NNP B-NP B-mo
100 CD O B-do
MCG NNP B-NP I-do
QD NNP I-NP B-f
9 CD O O
Lorazepam NNP B-NP B-m
Lorazepam NNP I-NP B-m
( ( O I-m
( ( O I-m
Ativan NNP B-NP I-m
Ativan NNP I-NP I-m
) ) O I-m
) ) O I-m
PO NNP B-NP B-mo
PO NNP I-NP B-mo
0.5 CD O B-do
0.5 CD O B-do
MG NNP B-NP I-do
MG NNP I-NP I-do
QD NNP I-NP B-f
QD NNP I-NP B-f
prn NN I-NP I-f
prn NN I-NP I-f
Insomnia NNP I-NP B-r
, , O O
Anxiety NNP B-NP B-r
10 CD O O
Metolazone NNP B-NP B-m
PO NNP I-NP B-mo
2.5 CD O B-do
MG NNP B-NP I-do
QAM NNP I-NP B-f
11 CD O O
Metoprolol NNP B-NP B-m
Succinate NNP I-NP I-m
Extended NNP I-NP I-m
Release NNP I-NP I-m
( ( O I-m
Toprol NNP B-NP I-m
Xl NNP I-NP I-m
) ) O I-m
PO NNP B-NP B-mo
100 CD O B-do
MG NNP B-NP I-do
QD NNP I-NP B-f
12 CD O O
Multivitamins NNP B-NP B-m
( ( O I-m
Ocuvite NNP B-NP I-m
) ) O I-m
PO NNP B-NP B-mo
1 CD O B-do
TAB NNP B-NP I-do
BID NNP I-NP B-f
13 CD O O
Pravastatin NNP B-NP B-m
PO NNP I-NP B-mo
40 CD O B-do
MG NNP B-NP I-do
QHS NNP I-NP B-f
14 CD O O
Torsemide NNP B-NP B-m
PO NNP I-NP B-mo
20 CD O B-do
MG NNP B-NP I-do
BID NNP I-NP B-f
15 CD O O
Warfarin NNP B-NP B-m
Sodium NNP I-NP I-m
( ( O I-m
Coumadin NNP B-NP I-m
) ) O I-m
PO NNP B-NP B-mo
2 CD O B-do
MG NNP B-NP I-do
QD NNP I-NP B-f
**** NNP I-NP O
Allergies: NNP I-NP O
NKDA NNP I-NP O
**** NNP I-NP O
PMH: NNP I-NP O
CRI NNP I-NP O
, , O O
hypothyroidism NN B-NP O
, , O O
paroxysmal JJ B-NP O
a-fib NN I-NP O
, , O O
DM NNP B-NP O
, , O O
CHF NNP B-NP O
, , O O
CAD NNP B-NP O
, , O O
lung NN B-NP O
CA NNP I-NP O
s/p NN I-NP O
R NNP I-NP O
wedge NN I-NP O
resection NN I-NP O
, , O O
basal NN B-NP O
cell NN I-NP O
CA NNP I-NP O
on IN B-VP O
lip NN B-NP O
s/p NN I-NP O
resection NN I-NP O
, , O O
uterine JJ B-NP O
CA NNP I-NP O
s/p NN I-NP O
TAH NNP I-NP O
**** NNP I-NP O
FHx: NNP I-NP O
non MD O O
contrib VB O O
**** NNP B-NP O
Social: NNP I-NP O
Lives VBZ O O
with IN B-VP O
husband NN B-NP O
across IN B-VP O
street NN B-NP O
from IN B-VP O
CCH NNP B-NP O
+tob NNP I-NP O
history NN I-NP O
, , O O
-EtOH NNP B-NP O
, , O O
-IVDU NNP B-NP O
**** NNP I-NP O
PE NNP I-NP O
on IN B-VP O
admit: NN B-NP O
VS:T: NNP I-NP O
97.6 CD O O
P77 NNP B-NP O
BP:NR NNP I-NP O
RR20 NNP I-NP O
SaO2100% NNP I-NP O
on IN B-VP O
2L CD O O
C/V NNP B-NP O
irreg NN I-NP O
irreg NN I-NP O
, , O O
no DT B-NP O
m/g/r NN I-NP O
Lungs VBZ O O
crackles NNS B-NP O
at IN B-VP O
L NNP B-NP O
base NN I-NP O
, , O O
faint NN B-NP O
crackles NNS I-NP O
at IN B-VP O
R NNP B-NP O
base NN I-NP O
Legs NNP I-NP O
trace NN I-NP O
edema NN I-NP O
but CC O O
equal JJ B-NP O
No NNP I-NP O
redness NN I-NP O
, , O O
+tenderness NN B-NP O
on IN B-VP O
L NNP B-NP O
shin JJ B-NP O
+faint NN I-NP O
ecchymosis NN I-NP O
CXR: NNP I-NP O
Small NNP I-NP O
L NNP I-NP O
effusion NN I-NP O
, , O O
+mild JJ B-NP O
pulm NN I-NP O
edema NN I-NP O
EKG: NNP I-NP O
A-fib NNP I-NP O
, , O O
unchanged JJ B-NP O
**** NNP I-NP O
A/P: NNP I-NP O
75F CD O O
with IN B-VP O
h/o NN B-NP O
CAD/CHF/lung NNP I-NP O
CA/Afib NNP I-NP O
with IN B-VP O
6 CD O O
days NNS B-NP O
of IN B-VP O
weight JJ B-NP O
gain NN I-NP O
, , O O
worsening VBG O O
SOB NNP B-NP O
and CC O O
PND NNP B-NP O
, , O O
with IN B-VP O
borderline NN B-NP O
elevated VBN O O
WBC NNP B-NP O
and CC O O
dysuria $ O O
1 CD O O
)C/V JJ B-NP O
+I- JJ I-NP O
Pt NNP I-NP O
was VBD B-VP O
R/OMI'ed VBN O O
with IN B-VP O
all DT O O
three CD O O
sets NNS B-NP O
negative JJ O O
for IN B-VP O
ischemia NN B-NP O
This DT O O
was VBD B-VP O
to TO O O
examine VB O O
for IN B-VP O
causes NNS B-NP O
of IN B-VP O
CHF NNP B-NP O
exacerbation NN I-NP O
Pt NNP I-NP O
was VBD B-VP O
continued VBN O O
on IN B-VP O
her PRP$ O O
home NN B-NP O
rx NN I-NP O
of IN B-VP O
betablocker NN B-NP B-m
, , O O
asa NN B-NP B-m
, , O O
statin JJ B-NP B-m
+P- JJ I-NP O
Pt NNP I-NP O
normotensive MD O O
Likely RB O O
fluid VB O O
overloaded VBD B-VP O
given VBN O O
CXR NNP B-NP O
, , O O
physical JJ B-NP O
exam NN I-NP O
, , O O
and CC O O
HPI NNP B-NP O
Pt NNP I-NP O
was VBD B-VP O
diuresed VBN O O
with IN B-VP O
IV NNP B-NP B-mo
Lasix NNP I-NP B-m
in IN B-VP O
the DT B-NP O
ED NNP I-NP O
On IN B-VP O
the DT B-NP O
floor NN I-NP O
she PRP O O
received VBD B-VP O
2.5mg CD O B-do
of IN B-VP O
Metolazone NN B-NP B-m
followed VBN O O
by IN B-VP O
60mg CD O B-do
of IN B-VP O
Torsemide NNP B-NP B-m
She PRP O O
was VBD B-VP O
then RB O O
diuresed VBN O O
with IN B-VP O
5mg CD O B-do
of IN B-VP O
Metolazone NN B-NP B-m
followed VBN O O
by IN B-VP O
120mg CD O B-do
of IN B-VP O
Torsemide NNP B-NP B-m
She PRP O O
was VBD B-VP O
roughly RB O O
negative JJ O O
1.3L CD O O
Pt NNP B-NP O
was VBD B-VP O
doing VBG O O
clinically RB O O
well RB O O
when WRB O O
on IN B-VP O
1/16 CD O O
pt's JJ B-NP O
Cr NNP I-NP O
increased VBD B-VP O
to TO O O
3.2 CD O O
from IN B-VP O
her PRP$ O O
baseline NN B-NP O
of IN B-VP O
about RB O O
2.5 CD O O
At IN B-VP O
that DT B-NP O
time NN I-NP O
Torsemide NNP I-NP B-m
and CC O O
Metolazone NNP B-NP B-m
were VBD B-VP O
held VBN O O
Pt's NNP B-NP O
daily JJ B-NP O
weights NNS I-NP O
continued VBD B-VP O
to TO O O
decrease VB O O
even RB O O
off IN B-VP O
of IN B-VP O
diuretics NNS B-NP B-m
On IN B-VP O
2/22 CD O O
, , O O
however RB O O
pt's JJ B-NP O
weight NN I-NP O
increased VBD B-VP O
to TO O O
72.9 CD O O
kg NNS B-NP O
from IN B-VP O
70.6kg CD O O
At IN B-VP O
this DT B-NP O
time NN I-NP O
pt NN I-NP O
was VBD B-VP O
restarted VBN O O
on IN B-VP O
her PRP$ O O
home NN B-NP O
rx NN I-NP O
of IN B-VP O
torsemide JJ O B-m
20mg CD O B-do
po NN B-NP B-mo
bid NN I-NP B-f
A NNP I-NP O
repeat NN I-NP O
weight NN I-NP O
was VBD B-VP O
checked VBN O O
in IN B-VP O
the DT B-NP O
pm NN I-NP O
returning VBG O O
as IN B-VP O
71.7kg CD O O
Pt NNP B-NP O
was VBD B-VP O
discharged VBN O O
on IN B-VP O
2/22 CD O O
at IN B-VP O
a DT B-NP O
weight NN I-NP O
of IN B-VP O
158 CD O O
lbs NN B-NP O
of IN B-VP O
discharge NN B-NP O
pt NN I-NP O
was VBD B-VP O
at IN B-VP O
or CC O O
better JJR O O
than IN B-VP O
her PRP$ O O
baseline JJ B-NP O
function NN I-NP O
in IN B-VP O
terms NNS B-NP O
of IN B-VP O
her PRP$ O O
orthopnea/SOB JJ O O
+R- JJ O O
During IN B-VP O
her PRP$ O O
stay NN B-NP O
the DT B-NP O
patient NN I-NP O
remained VBD B-VP O
in IN B-VP O
afib NN B-NP O
with IN B-VP O
good JJ B-NP O
rate NN I-NP B-r
control NN I-NP I-r
on IN B-VP O
her PRP$ O O
bblocker NN B-NP B-m
2 CD O O
) ) O O
Heme: NNP B-NP O
Pt NNP I-NP O
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
supertheraputic JJ O O
during IN B-VP O
her PRP$ O O
stay NN B-NP O
Her PRP$ O O
coumadin NN B-NP B-m
was VBD B-VP O
held VBN O O
throughout IN B-VP B-du
her PRP$ O I-du
admission NN B-NP I-du
as IN B-VP O
her PRP$ O O
INR NNP B-NP O
remained VBD B-VP O
3.9 CD O O
to TO O O
4.0 CD O O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
hemoptysis NN B-NP O
On IN B-VP O
discharge NN B-NP O
pt NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
1/2 CD O B-do
her PRP$ O O
home NN B-NP O
coumadin NN I-NP B-m
with IN B-VP O
VNA/PCP NNP B-NP O
f/u NN I-NP O
in IN B-VP O
2 CD O O
days NNS B-NP O
Pt NNP I-NP O
d/ced VBD B-VP O
on IN B-VP O
Coumadin NNP B-NP B-m
1mg CD O B-do
qpm RB O B-f
3 CD O O
) ) O O
ID- NNP B-NP O
Pt NNP I-NP O
had VBD B-VP O
a DT B-NP O
negative JJ I-NP O
UA NNP I-NP O
and CC O O
urine JJ B-NP O
CTX NNP I-NP O
However RB O O
during IN B-VP O
her PRP$ O O
admission NN B-NP O
pt NN I-NP O
developed VBD B-VP O
diarrhea NN B-NP O
Because IN B-VP O
of IN B-VP O
concern NN B-NP O
for IN B-VP O
c.diff NN B-NP O
colitis NN I-NP O
Pt NNP I-NP O
recieved VBD B-VP O
an DT B-NP O
abdominal JJ I-NP O
CT NNP I-NP O
CT NNP I-NP O
showed VBD B-VP O
no DT B-NP O
colitis NN I-NP O
but CC O O
did VBD B-VP O
show VB O O
a DT B-NP O
LLL NNP I-NP O
consolidation NN I-NP O
likely RB O O
PNA NNP B-NP B-r
Pt NNP I-NP O
was VBD B-VP O
initially RB O O
treated VBN O O
with IN B-VP O
azithromycin NN B-NP B-m
but CC O O
as IN B-VP O
her PRP$ O O
cough NN B-NP O
and CC O O
o2 JJ B-NP O
requirement NN I-NP O
did VBD B-VP O
not RB O O
improve VB O O
, , O O
as RB O O
well RB O O
as IN B-VP O
because IN B-VP O
pt NN B-NP O
began VBD B-VP O
to TO O O
spike VB O O
fevers NNS B-NP O
, , O O
pt NN B-NP O
was VBD B-VP O
begun VBN O O
on IN B-VP O
ceftaz NN B-NP B-m
and CC O O
levo NN B-NP B-m
for IN B-VP O
gram NN B-NP O
pos NN I-NP O
coverage NN I-NP O
( ( O O
levo NN B-NP B-m
) ) O O
double JJ B-NP O
gram NN I-NP O
neg NN I-NP O
coverage NN I-NP O
, , O O
and CC O O
atypical JJ B-NP O
coverage NN I-NP O
( ( O O
levo NN B-NP B-m
) ) O O
for IN B-VP O
presumed VBN O B-r
presumed JJ O B-r
presumed VBN O B-r
presumed JJ B-NP B-r
hospital NN I-NP O
aquired VBD B-VP O
PNA NNP B-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
pt's JJ B-NP O
multiple JJ I-NP O
hosp NN I-NP O
for IN B-VP O
CHF NNP B-NP O
exacerbation NN I-NP O
this DT B-NP O
year NN I-NP O
PT NNP I-NP O
improved VBD B-VP O
clinically RB O O
and CC O O
was VBD B-VP O
d/ced VBN O O
on IN B-VP O
levofloxacin NN B-NP B-m
500mg CD O B-do
q48h NN B-NP B-f
x VBD B-VP B-du
7 CD O I-du
days NNS B-NP I-du
and CC O O
ceftaz NNS B-NP B-m
changed VBD B-VP O
to TO O O
cefpodoxime VB O B-m
200mg CD O B-do
po NN B-NP B-mo
qd NN I-NP B-f
x $ O B-du
7 CD O I-du
days NNS B-NP I-du
Pt's NNP I-NP O
diarrhea NN I-NP O
was VBD B-VP O
concerning VBG O O
for IN B-VP O
c.diff NN B-NP O
given VBN O O
fever NN B-NP O
and CC O O
high JJ B-NP O
whitecount NN I-NP O
however RB O O
pt NN B-NP O
had VBD B-VP O
only RB O O
been VBN O O
on IN B-VP O
azithromycin JJ O B-m
x JJ O B-du
1 CD O I-du
day NN B-NP I-du
Cdiff NNP I-NP O
, , O O
fecal JJ B-NP O
leuks NN I-NP O
, , O O
and CC O O
all DT B-NP O
stool JJ I-NP O
studies NNS I-NP O
were VBD B-VP O
negative JJ O O
during IN B-VP O
admission NN B-NP O
Presumed NNP I-NP O
viral JJ B-NP O
gastroenteritis NN I-NP O
Pt NNP I-NP O
started VBD B-VP O
on IN B-VP O
loperamide NN B-NP B-m
before IN B-VP O
discharge NN B-NP O
to TO O O
be VB O O
continued VBN O O
prn JJ O B-f
diarrhea RB O B-r
4 CD O O
) ) O O
Endocrine NNP B-NP O
- : O O
Pt's NNP B-NP O
po NN I-NP B-mo
DM NNP I-NP B-m
rx NN I-NP I-m
were VBD B-VP O
held VBN O O
during IN B-VP O
her PRP$ O O
admission NN B-NP O
- : O O
she PRP O O
was VBD B-VP O
covered VBN O O
with IN B-VP O
Lantus NNP B-NP B-m
and CC O O
Insulin NNP B-NP B-m
Asp NNP I-NP I-m
SS NNP I-NP B-do
HgA1c NNP I-NP O
was VBD B-VP O
sent VBN O O
and CC O O
was VBD B-VP O
in IN B-VP O
nl JJ B-NP O
range NN I-NP O
Home NNP I-NP O
po NN I-NP B-mo
rx NN I-NP O
were VBD B-VP O
restarted VBN O O
on IN B-VP O
discharge NN B-NP O
Pt NNP I-NP O
was VBD B-VP O
kept VBN O O
on IN B-VP O
her PRP$ O O
home NN B-NP B-do
dose NN I-NP I-do
of IN B-VP O
levoxyl; JJ B-NP B-m
TSH NNP I-NP O
was VBD B-VP O
rechecked VBN O O
and CC O O
within IN B-VP O
nl JJ B-NP O
range NN I-NP O
Pt's NNP I-NP O
home NN I-NP O
rx NN I-NP O
Allopurinol NNP I-NP B-m
was VBD B-VP O
also RB O O
continued VBN O O
**** NNP B-NP O
PE NNP I-NP O
on IN B-VP O
D/C NNP B-NP O
C/V NNP I-NP O
irreg NN I-NP O
irreg NN I-NP O
no DT B-NP O
m/g/r NN I-NP O
Lungs VBZ O O
CTA NNP B-NP O
with IN B-VP O
faint NN B-NP O
bibasalar NN I-NP O
crackles NNS I-NP O
Trace NNP I-NP O
pedal VBP O O
edema NN B-NP O
**** NNP I-NP O
Code: NNP I-NP O
DNR/DNI NNP I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Please NNP I-NP O
resume VB O O
your PRP$ O O
normal JJ B-NP O
home NN I-NP O
medications NNS I-NP O
The DT B-NP O
following JJ I-NP O
antibiotics NNS I-NP B-m
were VBD B-VP O
added: JJ B-NP O
Levofloxacin NNP I-NP B-m
500mg CD O B-do
by IN B-VP B-mo
mouth NN B-NP I-mo
every DT O B-f
48 CD O I-f
hours NNS B-NP I-f
for IN B-VP B-du
7 CD O I-du
days NNS B-NP I-du
Cefpodoxime NNP I-NP B-m
200mg CD O B-do
by IN B-VP B-mo
moouth NN B-NP I-mo
once RB O B-f
daily JJ O I-f
for IN B-VP B-du
7 CD O I-du
days NNS B-NP I-du
** VBP O O
The DT B-NP O
following JJ I-NP O
medications NNS I-NP O
were VBD B-VP O
added: JJ B-NP O
Tessalon NNP I-NP B-m
Perels NNP I-NP I-m
100mg CD O B-do
by IN B-VP B-mo
mouth NN B-NP I-mo
three CD O B-f
times NNS B-NP I-f
daily RB O I-f
as IN B-VP I-f
needed VBN O I-f
for IN B-VP O
cough NN B-NP B-r
Guiatuss NNP I-NP B-m
10ml CD O B-do
by IN B-VP B-mo
mouth NN B-NP I-mo
every DT O B-f
4 CD O I-f
hours NNS B-NP I-f
as IN B-VP I-f
needed VBN O I-f
for IN B-VP O
cough JJ B-NP B-r
Loperamide NNP I-NP B-m
2mg CD O B-do
by IN B-VP B-mo
mouth NN B-NP I-mo
every DT O B-f
6 CD O I-f
hours NNS B-NP I-f
as IN B-VP I-f
needed VBN O I-f
for IN B-VP O
diarrhea NN B-NP B-r
** VBP O O
The DT B-NP O
following JJ I-NP O
medications NNS I-NP O
were VBD B-VP O
changed: JJ B-NP O
Coumadin: NNP I-NP B-m
Coumadin: NNP I-NP B-m
Were NNP I-NP O
taking VBG O O
2mg CD O B-do
by IN B-VP B-mo
by IN B-VP B-mo
mouth NN B-NP I-mo
mouth NN I-NP I-mo
in IN B-VP B-f
in IN B-VP B-f
the DT O I-f
the DT B-NP I-f
pm NN I-NP I-f
pm NN I-NP I-f
, , O O
now RB O O
take VBP O O
1mg CD O B-do
by IN B-VP O
mouth NN B-NP O
in IN B-VP O
the DT B-NP O
pm NN I-NP O
**** NNP I-NP O
Please NNP I-NP O
have VB O O
your PRP$ O O
VNA NNP B-NP O
draw VB O O
your PRP$ O O
INR NNP B-NP O
to TO O O
be VB O O
reported VBN O O
to TO O O
Antsaint NNP B-NP O
Hospital NNP I-NP O
Medicine NNP I-NP O
in IN B-VP O
2 CD O O
days NNS B-NP O
**** VBP O O
Call VB O O
your PRP$ O O
PCP/go NNP B-NP O
to TO O O
the DT B-NP O
ED NNP I-NP O
if IN B-VP O
you PRP O O
experience VBP O O
any DT O O
of IN B-VP O
the DT B-NP O
following: JJ I-NP O
increase NN I-NP O
in IN B-VP O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
chest NN B-NP O
pain NN I-NP O
, , O O
nausea NN B-NP O
, , O O
vomiting VBG O O
, , O O
decrease NN B-NP O
in IN B-VP O
urine JJ B-NP O
output NN I-NP O
, , O O
requiring VBG O O
more JJR O O
than IN B-VP O
2 CD O O
pillows NNS B-NP O
to TO O O
sleep VB O O
at IN B-VP O
night NN B-NP O
, , O O
any DT B-NP O
other JJ I-NP O
symptom NN I-NP O
that IN B-VP O
concerns NNS B-NP O
you PRP O O
DISCHARGE VBP O O
CONDITION: NNP B-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
To TO O O
PCP: NNP B-NP O
Pt NNP I-NP O
was VBD B-VP O
restarted VBN O O
on IN B-VP O
her PRP$ O O
home NN B-NP O
RX NNP I-NP O
Please NNP I-NP O
f/u NN I-NP O
with IN B-VP O
pt's JJ B-NP O
recurrent NN I-NP O
need NN I-NP O
for IN B-VP O
admission NN B-NP O
for IN B-VP O
CHF NNP B-NP O
exacerbation NN I-NP O
Pt NNP I-NP O
was VBD B-VP O
supertheraputic JJ O O
on IN B-VP O
her PRP$ O O
coumadin NN B-NP B-m
It PRP O O
was VBD B-VP O
held VBN O O
during IN B-VP O
this DT B-NP O
admission NN I-NP O
but CC O O
restarted VBN O O
on IN B-VP O
discharge NN B-NP O
Please NNP I-NP O
check VB O O
her PRP$ O O
coags JJ B-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
BARRIS NNP I-NP O
, , O O
WM NNP B-NP O
, , O O
M.D NNP B-NP O
( ( O O
DD31 NNP B-NP O
) ) O O
7/20/06 CD O O
@ $ O O
01:12 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#995723 VBZ O O
042186535 CD O O
SH NNP B-NP O
79373526 CD O O
115656 CD O O
1/23/2000 CD O O
12:00:00 CD O O
AM NNP B-NP O
ARRYTHMIA NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
2/25/2000 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
1/28/2000 CD O O
IDENTIFICATION: NNP B-NP O
Ms NNP I-NP O
Leezer NNP I-NP O
is VBZ O O
a DT O O
50 CD O O
year-old JJ B-NP O
woman NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
end NN B-NP O
stage NN I-NP O
renal JJ B-NP O
disease NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
renal JJ B-NP O
transplant NN I-NP O
and CC O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
grafting NN I-NP O
, , O O
now RB O O
with IN B-VP O
syncope NN B-NP O
and CC O O
palpitations NNS B-NP O
HISTORY NNP I-NP O
OF IN B-VP O
THE NNP B-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT O O
50 CD O O
year-old JJ B-NP O
woman NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
end NN B-NP O
stage NN I-NP O
renal JJ B-NP O
disease NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
transplant NN I-NP O
( ( O O
cadaveric JJ O O
) ) O O
in IN B-VP O
February NNP B-NP O
of IN B-VP O
1997 CD O O
, , O O
history NN B-NP O
of IN B-VP O
insulin NN B-NP O
dependent NN I-NP O
diabetes VBZ O O
mellitus RBS O O
, , O O
and CC O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
grafting NN I-NP O
in IN B-VP O
February NNP B-NP O
of IN B-VP O
1996 CD O O
, , O O
left VBD B-VP O
internal JJ B-NP O
mammary JJ I-NP O
artery NN I-NP O
to TO O O
the DT O O
left VBN O O
anterior JJ B-NP O
descending NN I-NP O
and CC O O
saphenous JJ B-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
obtuse VB O O
marginal JJ O O
, , O O
who WP O O
reports VBZ O O
having VBG O O
done VBN O O
fairly RB O O
well RB O O
until IN B-VP O
six CD O O
months NNS B-NP O
ago RB O O
when WRB O O
she PRP O O
had VBD B-VP O
an DT B-NP O
episode NN I-NP O
of IN B-VP O
chest NN B-NP B-r
pain NN I-NP I-r
which WDT O O
was VBD B-VP O
relieved VBN O O
by IN B-VP O
Nitroglycerin NNP B-NP B-m
Approximately RB O O
one CD O O
month NN B-NP O
ago RB O O
, , O O
she PRP O O
was VBD B-VP O
standing VBG O O
in IN B-VP O
her PRP$ O O
kitchen NN B-NP O
saying VBG O O
good-bye NN B-NP O
to TO O O
her PRP$ O O
husband NN B-NP O
at IN B-VP O
which WDT O O
point NN B-NP O
she PRP O O
passed VBD B-VP O
out RP O O
Her PRP$ O O
husband NN B-NP O
noted VBD B-VP O
her PRP$ O O
getting VBG O O
pale JJ O O
and CC O O
rolling VBG O O
her PRP$ O O
eyes NNS B-NP O
back RB O O
, , O O
states VBZ O O
that IN B-VP O
this DT O O
lasted VBD B-VP O
approximately RB O O
13 CD O O
seconds NNS B-NP O
She PRP O O
had VBD B-VP O
no DT B-NP O
symptoms NNS I-NP O
afterwards VBP O O
A DT B-NP O
few JJ I-NP O
months NNS I-NP O
prior RB O O
to TO O O
this DT O O
, , O O
the DT B-NP O
patient NN I-NP O
reports NNS I-NP O
having VBG O O
had VBD B-VP O
slurred VBN O O
speech NN B-NP O
for IN B-VP O
a DT B-NP O
few JJ I-NP O
minutes NNS I-NP O
More RBR O O
recently RB O O
, , O O
she PRP O O
has VBZ O O
had VBD B-VP O
several JJ B-NP O
episodes NNS I-NP O
of IN B-VP O
skipped JJ B-NP O
heart NN I-NP O
beats NNS I-NP O
during IN B-VP O
and CC O O
after IN B-VP O
which WDT O O
she PRP O O
feels VBZ O O
short JJ O O
of IN B-VP O
breath NN B-NP O
These DT B-NP O
episodes NNS I-NP O
last JJ O O
a DT B-NP O
few JJ I-NP O
minutes NNS I-NP O
and CC O O
are VBP O O
sometimes RB O O
relieved VBN O O
by IN B-VP O
sitting VBG O O
up RP O O
The DT O O
mostly RB O O
happen VBP O O
at IN B-VP O
night NN B-NP O
She PRP O O
had VBD B-VP O
one CD O O
episode NN B-NP O
of IN B-VP O
rapid JJ B-NP O
heart NN I-NP O
rate NN I-NP O
last JJ B-NP O
week NN I-NP O
which WDT O O
was VBD B-VP O
also RB O O
associated VBN O O
with IN B-VP O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
REVIEW NNP I-NP O
OF NNP I-NP O
SYSTEMS: NNP I-NP O
No NNP I-NP O
fevers NNS I-NP O
, , O O
no DT B-NP O
bowel NN I-NP O
changes NNS I-NP O
, , O O
no DT B-NP O
urinary JJ I-NP O
changes NNS I-NP O
, , O O
no DT B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
, , O O
no DT B-NP O
paroxysmal JJ I-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
, , O O
and CC O O
no DT B-NP O
orthopnea NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
End NNP B-NP O
stage NN I-NP O
renal JJ B-NP O
disease NN I-NP O
2 CD O O
Hypertension NNP B-NP O
3 CD O O
Status NNP B-NP O
post NN I-NP O
renal NN I-NP O
transplant NN I-NP O
4 CD O O
Insulin NNP B-NP O
dependent NN I-NP O
diabetes VBZ O O
mellitus $ O O
5 CD O O
Coronary NNP B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
grafting NN I-NP O
in IN B-VP O
1996 CD O O
6 CD O O
Hypertension NNP B-NP O
7 CD O O
Hypercholesterolemia NNP B-NP O
8 CD O O
Chronic NNP B-NP O
renal JJ B-NP O
insufficiency NN I-NP O
with IN B-VP O
a DT B-NP O
creatinine NN I-NP O
of IN B-VP O
1.7 CD O O
last JJ O O
in IN B-VP O
March NNP B-NP O
of IN B-VP O
1999 CD O O
9 CD O O
Cataracts NNPS B-NP O
ALLERGIES: NNP I-NP O
Erythromycin NNP I-NP O
, , O O
which WDT O O
causes VBZ O O
hives NNS B-NP O
, , O O
Benadryl NNP B-NP O
, , O O
which WDT O O
causes VBZ O O
hives NNS B-NP O
, , O O
Penicillin NNP B-NP O
, , O O
which WDT O O
causes VBZ O O
a DT B-NP O
rash NN I-NP O
, , O O
and CC O O
Dramamine NNP B-NP O
which WDT O O
causes VBZ O O
hives NNS B-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Aspirin NNP B-NP B-m
81 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
2 CD O O
Prilosec NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
3 CD O O
Simvastatin NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
4 CD O O
Cyclosporine NNP B-NP B-m
Cyclosporine NNP I-NP B-m
125 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
in IN B-VP B-f
the DT B-NP I-f
morning NN I-NP I-f
and CC O O
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
in IN B-VP B-f
the DT B-NP I-f
afternoon NN I-NP I-f
5 CD O O
Insulin NNP B-NP B-m
sliding VBG O B-do
scale JJ O I-do
6 CD O O
Lasix NNP B-NP B-m
60 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
7 CD O O
Atenolol NNP B-NP B-m
75 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
8 CD O O
Prednisone NNP B-NP B-m
Prednisone NNP I-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
p.o NN I-NP B-mo
on IN B-VP B-f
even JJ B-NP I-f
days NNS I-NP I-f
, , O O
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP O
on IN B-VP B-f
odd JJ B-NP I-f
days NNS I-NP I-f
9 CD O O
Cellcept NNP B-NP B-m
1 CD O B-do
, , O I-do
000 CD O I-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
10 CD O O
Prempro NNP B-NP B-m
0.625 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
Cigarettes NNP I-NP O
one-half JJ B-NP O
pack NN I-NP O
per IN B-VP O
day NN B-NP O
x31 CD O O
years NNS B-NP O
Alcohol NNP I-NP O
none NN I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
on IN B-VP O
disability NN B-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient's NN I-NP O
mother NN I-NP O
passed VBD B-VP O
away RB O O
with IN B-VP O
diabetes NNS B-NP O
mellitus VBP O O
PHYSICAL NNP B-NP O
EXAMINATION NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Temperature NNP I-NP O
98.8 CD O O
, , O O
pulse RB O O
96 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
120/70 CD O O
, , O O
and CC O O
respirations NNS B-NP O
18 CD O O
GENERAL: NNP B-NP O
In IN B-VP O
no DT B-NP O
apparent JJ I-NP O
distress NN I-NP O
HEENT: NNP I-NP O
Pupils NNP I-NP O
equal JJ O O
, , O O
round NN B-NP O
, , O O
and CC O O
reactive JJ O O
to TO O O
light JJ B-NP O
Extraocular JJ I-NP O
movements NNS I-NP O
were VBD B-VP O
intact JJ B-NP O
Cranial JJ I-NP O
nerves NNS I-NP O
II-XII NNP I-NP O
normal JJ O O
with IN B-VP O
bilateral JJ B-NP O
carotid NN I-NP O
bruits NNS I-NP O
, , O O
right RB O O
more JJR O O
than IN B-VP O
left VBD B-VP O
LUNGS: NNP B-NP O
Clear NNP I-NP O
to TO O O
auscultation VB O O
bilaterally RB O O
HEART: NNP B-NP O
Regular NNP I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
S1 NNP B-NP O
and CC O O
S2 NNP B-NP O
No NNP I-NP O
murmurs NN I-NP O
appreciated VBD B-VP O
ABDOMEN: NNP B-NP O
Soft NNP I-NP O
, , O O
non-tender NN B-NP O
, , O O
and CC O O
non-distended JJ B-NP O
Bowel NNP I-NP O
sounds VBZ O O
positive JJ B-NP O
EXTREMITIES: NNP I-NP O
Without NNP I-NP O
edema NN I-NP O
and CC O O
warm JJ B-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
sodium NN I-NP O
of IN B-VP O
137 CD O O
, , O O
potassium NN B-NP O
4.4 CD O O
, , O O
chloride RB O O
104 CD O O
, , O O
bicarbonate NN B-NP O
15 CD O O
, , O O
BUN NNP B-NP O
86 CD O O
, , O O
creatinine NN B-NP O
3.1 CD O O
Creatinine NNP B-NP O
on IN B-VP O
November NNP B-NP O
, , O O
1999 CD O O
was VBD B-VP O
2.7 CD O O
and CC O O
creatinine VB O O
on IN B-VP O
March NNP B-NP O
, , O O
1999 CD O O
was VBD B-VP O
3.0 CD O O
ALT NNP B-NP O
was VBD B-VP O
6 CD O O
, , O O
AST NNP B-NP O
11 CD O O
, , O O
alkaline JJ B-NP O
phosphatase NN I-NP O
44 CD O O
, , O O
bilirubin VBD B-VP O
total JJ O O
0.4 CD O O
, , O O
direct JJ B-NP O
bilirubin NN I-NP O
0.1 CD O O
, , O O
calcium NN B-NP O
9.5 CD O O
, , O O
cholesterol NN B-NP O
360 CD O O
, , O O
and CC O O
HDL NNP B-NP O
40 CD O O
White NNP B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
was VBD B-VP O
7.08 CD O O
, , O O
hematocrit NN B-NP O
25.9; CD O O
on IN B-VP O
November NNP B-NP O
, , O O
1999 CD O O
, , O O
the DT B-NP O
patient's NN I-NP O
hematocrit NN I-NP O
was VBD B-VP O
31.9 CD O O
, , O O
and CC O O
platelets NNS B-NP O
279 CD O O
Echocardiogram NNP B-NP O
from IN B-VP O
July NNP B-NP O
of IN B-VP O
1999 CD O O
had VBD B-VP O
moderate VBN O O
to TO O O
severe VB O O
left JJ B-NP O
ventricular JJ I-NP O
hypertrophy NN I-NP O
, , O O
ejection NN B-NP O
fraction NN I-NP O
of IN B-VP O
55% CD O O
, , O O
borderline NN B-NP O
hypokinetic JJ B-NP O
inferior NN I-NP O
left VBD B-VP O
ventricular JJ B-NP O
wall NN I-NP O
, , O O
mild JJ B-NP O
mitral JJ I-NP O
regurgitation NN I-NP O
, , O O
and CC O O
left VBD B-VP O
atrial JJ B-NP O
dilatation NN I-NP O
Carotid NNP I-NP O
noninvasives NNS I-NP O
from IN B-VP O
March NNP B-NP O
of IN B-VP O
1999 CD O O
showed VBD B-VP O
no DT B-NP O
significant JJ I-NP O
right NN I-NP O
or CC O O
left VBD B-VP O
internal JJ B-NP O
carotid NN I-NP O
stenosis NN I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
This DT O O
is VBZ O O
a DT O O
50 CD O O
year NN B-NP O
old JJ B-NP O
woman NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
end NN B-NP O
stage NN I-NP O
renal JJ B-NP O
disease NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
renal JJ B-NP O
transplant NN I-NP O
in IN B-VP O
February NNP B-NP O
of IN B-VP O
1997 CD O O
, , O O
history NN B-NP O
of IN B-VP O
insulin NN B-NP O
dependent NN I-NP O
diabetes VBZ O O
mellitus RBS O O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
grafting NN I-NP O
in IN B-VP O
1996 CD O O
( ( O O
left VBN O O
internal JJ B-NP O
mammary JJ I-NP O
artery NN I-NP O
to TO O O
left VB O O
anterior JJ B-NP O
descending NN I-NP O
and CC O O
saphenous JJ B-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
obtuse VB O O
marginal JJ O O
) ) O O
, , O O
now RB O O
with IN B-VP O
episodes NNS B-NP O
of IN B-VP O
rapid JJ B-NP O
heart NN I-NP O
rate NN I-NP O
and CC O O
episodes NNS B-NP O
of IN B-VP O
skipped JJ B-NP O
beats NNS I-NP O
in IN B-VP O
association NN B-NP O
without IN B-VP O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
Also RB O O
, , O O
the DT B-NP O
patient NN I-NP O
has VBZ O O
had VBN O O
a DT B-NP O
hematocrit JJ I-NP O
drop NN I-NP O
from IN B-VP O
31 CD O O
to TO O O
26 CD O O
on IN B-VP O
admission NN B-NP O
and CC O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
blood NN B-NP O
in IN B-VP O
stool NN B-NP O
over IN B-VP O
the DT B-NP O
last JJ I-NP O
month NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
guaiaced VBN O O
on IN B-VP O
admission NN B-NP O
and CC O O
during IN B-VP O
her PRP$ O O
stay NN B-NP O
and CC O O
remained VBD B-VP O
guaiac JJ O O
negative JJ O O
throughout IN B-VP O
the DT B-NP O
whole JJ I-NP O
time NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
placed VBN O O
on IN B-VP O
cardiac JJ B-NP O
monitoring NN I-NP O
and CC O O
had VBD B-VP O
no DT B-NP O
events NNS I-NP O
recorded VBN O O
on IN B-VP O
the DT B-NP O
monitor NN I-NP O
On IN B-VP O
July NNP B-NP O
, , O O
2000 CD O O
, , O O
the DT B-NP O
patient's NN I-NP O
hematocrit NN I-NP O
dropped VBD B-VP O
to TO O O
21 CD O O
She PRP O O
was VBD B-VP O
transfused VBN O O
two CD O B-do
units NNS B-NP I-do
of IN B-VP O
blood NN B-NP B-m
and CC O O
her PRP$ O O
hematocrit NN B-NP O
went VBD B-VP O
up RB O O
to TO O O
31 CD O O
An DT B-NP O
exercise NN I-NP O
tolerance NN I-NP O
test NN I-NP O
MIBI NNP I-NP O
was VBD B-VP O
performed VBN O O
which WDT O O
was VBD B-VP O
negative JJ O O
for IN B-VP O
ischemia NN B-NP O
The DT B-NP O
patient's NN I-NP O
ejection NN I-NP O
fraction NN I-NP O
from IN B-VP O
the DT B-NP O
MIBI NNP I-NP O
was VBD B-VP O
approximated VBN O O
to TO O O
be VB O O
69% CD O O
On IN B-VP O
November NNP B-NP O
, , O O
2000 CD O O
, , O O
carotid VBD B-VP O
non-invasives NNS B-NP O
were VBD B-VP O
repeated VBN O O
which WDT O O
revealed VBD B-VP O
moderate JJ B-NP O
internal JJ I-NP O
carotid NN I-NP O
plaque NN I-NP O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
Otherwise NNP I-NP O
, , O O
she PRP O O
had VBD B-VP O
mild JJ B-NP O
stenosis NN I-NP O
of IN B-VP O
the DT B-NP O
other JJ I-NP O
arteries NNS I-NP O
An DT B-NP O
echocardiogram NN I-NP O
was VBD B-VP O
also RB O O
performed VBN O O
which WDT O O
revealed VBD B-VP O
concentric NN B-NP O
left VBD B-VP O
ventricular JJ B-NP O
hypertrophy NN I-NP O
with IN B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
65% CD O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
taken VBN O O
to TO O O
Electrophysiology NNP B-NP O
Study NNP I-NP O
on IN B-VP O
March NNP B-NP O
, , O O
2000 CD O O
which WDT O O
revealed VBD B-VP O
nonsustained VBD B-VP O
ventricular JJ B-NP O
tachycardia NN I-NP O
with IN B-VP O
possible JJ B-NP O
right JJ I-NP O
ventricular NN I-NP O
outflow IN B-VP O
tract NN B-NP O
origin IN B-VP O
It PRP O O
was VBD B-VP O
hoped VBN O O
that IN B-VP O
she PRP O O
could MD O O
be VB O O
maintained VBN O O
on IN B-VP O
Lopressor NNP B-NP B-m
and CC O O
Verapamil NNP B-NP B-m
Due NNP I-NP O
to TO O O
the DT B-NP O
results NNS I-NP O
of IN B-VP O
this DT B-NP O
study NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
already RB O O
on IN B-VP O
Atenolol NNP B-NP B-m
for IN B-VP O
Beta NNP B-NP B-r
blockade NN I-NP I-r
and CC O O
Verapamil NNP B-NP B-m
was VBD B-VP O
tried VBN O O
However RB O O
, , O O
her PRP O O
blood NN B-NP O
pressure NN I-NP O
did VBD B-VP O
not RB O O
tolerate VB O O
this DT B-NP O
medication NN I-NP O
The DT B-NP O
day NN I-NP O
after IN B-VP O
the DT B-NP O
electrophysiology NN I-NP O
procedure NN I-NP O
on IN B-VP O
January NNP B-NP O
, , O O
2000 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
orthostatic JJ O O
She PRP O O
was VBD B-VP O
given VBN O O
a DT O O
250 CD O B-do
cc NN B-NP I-do
fluid NN I-NP B-m
bolus NN I-NP I-m
and CC O O
encouraged VBD B-VP O
to TO O O
drink VB O O
more JJR B-NP O
p.o JJ I-NP O
fluids NNS I-NP O
and CC O O
she PRP O O
was VBD B-VP O
discharged VBN O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
the DT B-NP O
next JJ I-NP O
day NN I-NP O
The DT B-NP O
patient NN I-NP O
remained VBD B-VP O
symptom JJ O O
free JJ O O
during IN B-VP O
the DT B-NP O
entire JJ I-NP O
hospital NN I-NP O
course NN I-NP O
The DT B-NP O
patient's NN I-NP O
triglycerides NNS I-NP O
were VBD B-VP O
checked VBN O O
during IN B-VP O
the DT B-NP O
hospitalization NN I-NP O
and CC O O
found VBD B-VP O
to TO O O
be VB O O
very RB O O
high JJ O O
in IN B-VP O
the DT O O
1 CD O O
, , O O
500 CD O O
range NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
therefore RB O O
taken VBN O O
off RP O O
Simvastatin NNP B-NP B-m
and CC O O
started VBD B-VP O
on IN B-VP O
Gemfibrozil NNP B-NP B-m
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Aspirin NNP B-NP B-m
81 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
2 CD O O
Vitamin NNP B-NP B-m
C NNP I-NP O
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
x14 NNP I-NP B-du
days NNS I-NP I-du
3 CD O O
Epogen NNP B-NP B-m
2 CD O B-do
, , O I-do
000 CD O I-do
subcu NN B-NP B-mo
q NN I-NP B-f
week NN I-NP I-f
4 CD O O
Lasix NNP B-NP B-m
60 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
5 CD O O
Gemfibrozil NNP B-NP B-m
300 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
6 CD O O
Lisinopril NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
7 CD O O
Prilosec NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
8 CD O O
Prednisone NNP B-NP B-m
Prednisone NNP I-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
on IN B-VP B-f
even JJ B-NP I-f
days NNS I-NP I-f
, , O O
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
on IN B-VP B-f
odd JJ B-NP I-f
days NNS I-NP I-f
9 CD O O
MVI NNP B-NP B-m
with IN B-VP I-m
minerals NNS B-NP I-m
one CD O B-do
tablet NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
10 CD O O
Thiamine NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
11 CD O O
Bicitra NNP B-NP B-m
15 CD O B-do
ml NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
12 CD O O
Cyclosporine NNP B-NP B-m
Cyclosporine NNP I-NP B-m
micromeral JJ O I-m
micromeral JJ O I-m
125 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q NN I-NP B-f
a.m NN I-NP I-f
and CC O O
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q NN I-NP B-f
p.m VBD B-VP O
13 CD O O
Cellcept NNP B-NP B-m
1 CD O B-do
, , O I-do
000 CD O I-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
14 CD O O
Prempro NNP B-NP B-m
0.625/0.25 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
15 CD O O
Nephrocaps NNP B-NP B-m
one CD O B-do
tablet NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
Dictated NNP I-NP O
By: NNP I-NP O
BRAIN NNP I-NP O
LINMAN NNP I-NP O
, , O O
M.D NNP B-NP O
JA25 NNP I-NP O
Attending: NNP I-NP O
SYDNEY NNP I-NP O
DUESTERHAUS NNP I-NP O
, , O O
M.D NNP B-NP O
MG85 NNP I-NP O
EQ681/3978 NNP I-NP O
Batch: NNP I-NP O
37609 CD O O
Index NNP B-NP O
No NNP I-NP O
FHOW8875S8 NNP I-NP O
D: NNP I-NP O
6/10 CD O O
T: NNP B-NP O
1/22 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NN I-NP O
